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Abstract of Thesis 
This thesis explores how medicine is practiced in a paediatric HIV clinic in outer London.  It 
draws on ethnographic research that took place in the clinic over the course of a year.  The 
significance of the topic is situated in the complexity of the issues presented clinically by 
children with HIV in London.  During practice recurrent associations of confidentiality, 
stigma, vulnerability, naivety and innocence emerges around the patient cohort that mainly 
comprises recent African migrants living their lives in complicated urban environments.  
These associations are contrasted by the uncompromising requirements of antiretroviral 
medicine which needs almost perfect dosing adherence in order to suppress the virus.  The 
incompatibilities between complex patient lives and medical requirements must be made 
compatible through clinical practice.  Therefore, the thesis emphasises the clinic as the key 
site where the ‘cultural’ issues presented by patients are consolidated with drug 
requirements to form a functional medicine.   
 
The argument is informed by discussions around Science and Technology Studies (STS), and 
the Sociology of Childhood (SoC).  These discussions highlight practice as ‘enacted’, where 
objects such as disease, the body or medicine are not ‘given’ but gain their shape through 
their recurrent enactions (Mol 2002, Mol and Law 2004).  I have used these discussions to 
argue that medicine and protocol do not pre-exist practice but must be enacted by 
practitioners and (child) patients in the clinic.  Clinical practice is shown in the thesis as 
consolidating protocol, drug requirements, patients, practitioners and representations of 
HIV in ongoing clinical enactions to make the antiretroviral medicine amongst the paediatric 
cohort operational.  To do this, the research focuses on a set of procedures enacted in the 
clinic: disclosure, adherence, HIV as chronic illness and transition.  These procedures inform 
practitioners on how to maintain care and make medical requirements explicit to child 
patients (and their parents), enforcing behaviour that accords with the goals of 
antiretroviral medicine.  In this way practice and protocol are negotiated and renegotiated 
to ensure their effectiveness between all of the associations involved in participating with 
the condition, paediatric HIV and the corresponding medicine. 
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Compared to existing STS on the subject of medicine and the clinic, paediatric HIV practice 
emphasises the clinic’s role to consolidate seemingly incompatible associations around 
patients such as stigma, vulnerability and innocence into medical requirements.  The result 
is that STS that advertently or inadvertently implies that medical practice is messy or 
disjointed are questioned in light of two important features of paediatric HIV.  Firstly, that 
practice must necessarily consolidate disparate patient lives into medical requirements if 
treatment is to be successful, and secondly, that practitioners must employ a logic to 
generate a coherent, well-organised clinical practice that is flexible and pliable to diverse 
eventualities.  The significance of this argument demonstrates the clinic’s importance in 
enacting interventions and attuning medicine, displacing a notion of protocol or guidelines 
as dictating practice without negotiation, or the belief that the ideal course of clinical 
practice is fully predefined in protocol.  Therefore, the implications of this research 
underline the clinic as a key site in rationalising how medicine is formulated and applied to 
patients. 
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1 Introduction 
This thesis discusses the relationship between clinical practice and Paediatric HIV.  It focuses 
on how diverse networks of social/scientific/medical/political entities are consolidated 
during clinical practice into care practices geared towards making viral suppression and the 
management of paediatric HIV possible.  It describes one clinic, but from this clinic’s practice 
the associations found have a broad scope, providing insights into the workings of a more 
general logic employed in clinical medicine.  It details the ethnographic observation of a 
clinic in a London hospital which will be referred to as University Outer Urban Hospital 
(UOUH).  The ethnographic data is used to illustrate the discrepancies between the 
paediatric patient as described in medical literature, guideline, policy and protocol and the 
child as presented in the clinic.  Amongst other conditions paediatric HIV is particularly 
interesting because of the complexity of patients’ lives and medical requirements that must 
be managed sensitively by the clinic.  This thesis addresses these issues by arguing that the 
clinic is not only a site where medicine is practiced, but is also central to the task of 
consolidating patient complexities with medical requirements and making medicine 
operational.  For paediatric HIV, psychosocial accounts are the most extensive and often 
cited explanations of ‘the social’ (Lewis et al., 1994; Melvin and Sherr, 1995; Battles and 
Wiener, 2002; Green and Smith, 2004; Naar-King et al., 2006; Steele, 2007; Santamaria et 
al., 2011).  However, these explanations often use predefined notions of what is social, what 
is medical and what is scientific.  In doing so, these accounts isolate phenomena to distinct 
spheres, ignoring the ways in which what is social or medical are enacted at the same time 
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in the clinic1.  Instead, the account presented here discusses how the clinical practice of 
paediatric HIV is enacted through the negotiations taking place in the clinic between 
patients and practitioners, medical science, protocol and their multiple material/semiotic 
associations (drawing heavily on medical practice as described by Mol, 2002 as will be 
discussed further).  In effect, the argument warrants a view of clinical practice as more 
nuanced where practitioners are not merely applying science to patients, but where 
scientific recommendations of dosage and treatment, the complex lifestyles and identities 
of patients, and interpretations of policy and protocol must be negotiated and enacted 
together through the same clinical processes.  The resulting practice that ensues in the clinic 
is therefore highly specialised and tailored through protocol whilst remaining flexible, 
dynamic and relevant to the negotiations that must take place between practitioners and 
diverse groups of child patients.  This project diverts an idea of protocol as pre-existing 
practice, offering instead a view of protocol as part of an emergent process.  Accordingly, 
protocol is framed as enacted, in negotiation, having a wider clinical context and as never 
fully completed in the documents presented.  Therefore, this piece of work will hopefully 
provide a resource to those who must imagine the administration of care regimes to 
children, i.e. practitioners, policy makers and sociologists alike.  In the clinical practice of 
paediatric HIV, antiretroviral requirements, protocol and patient knowledge/participation 
must be negotiated in order to make it possible for clinical interventions to make paediatric 
HIV medicine functional.        
 
The clinical practice of paediatric HIV offers a unique example for analysis because the 
condition has connotations not present in the adult HIV clinic or in the clinical practice of 
other conditions more generally.  A unique combination of associations around naivety, 
innocence, drug requirements, sex education, public health implications, immigration, and 
an urban context2, make paediatric HIV clinical practice a fine balance of sensitive issues 
(Brown et al., 2000).  For example, most UK patients are part of immigrant African 
communities, also HIV has wider stigmatising connotations around sex or drug abuse and in 
                                                        
1
 Armstrong (1987) offers a similar criticism of the psychosocial, arguing that the discipline puts social science 
in its place as “an emasculated, uncritical appendage of an invigorated biomedicine”. (p1217) 
2
 Melvin and Sherr (1995) and Hekster and Melvin (2006) specifically discuss issues affecting children with HIV 
in London. 
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addition paediatric HIV evokes wider issues around childhood, naivety, innocence and 
deservedness (Henderson, 2006; Fassin, 2008).  These considerations mean that the study 
of paediatric HIV clinical practice has a unique contribution to the Science Technology 
Studies (STS) and Sociology of Childhood (SoC) literature referenced in this thesis.  
Compared to other conditions, paediatric HIV demonstrates that clinical practice and 
protocol are not just performed in this context, but must be made possible through the 
adversity presented (or not presented) at the clinic.  Therefore, in comparison to questions 
of objectivity and standardisation in protocol and medicine, (such as is the focus of 
Cambrosio et al. 2009), this project diverts the question to assess the everyday challenge of 
maintaining practice alongside associations such as stigma, vulnerability and naivety that 
are contradictory to requirements and exceed the objectivity of protocol (also see Dodier, 
1998; Latimer et al., 2006; Timmermans and Buchbinder, 2010, 2012).  Practice must be 
made to consolidate disparate factors into one regime of care, and as alluded to, 
consolidation is achieved not through imposition but negotiation.  Therefore, rather than 
the clinic being hierarchically arranged under protocol, policy or laboratorial medicine (or 
‘biomedicine’), the clinic is a key site in the formalisation of the medical science and the 
condition.  Clinical practice must be accounted for when designing guidelines, protocol or 
policy.  Because of the high-profile cultural implications of paediatric HIV, such as stigma 
and vulnerability3 that must be made compatible with drug requirements through clinical 
interventions, this account offers a perspective that emphasises the clinic’s consolidating 
role more prominently than other conditions already dealt with in STS or SoC (such as 
atherosclerosis in Mol, 2002; or childhood asthma in Prout, 1996; or the general conditions 
of childhood illness described in Christensen, 1998).  As a result it makes a valuable 
contribution to the field by demonstrating the flexibility and cultural awareness required in 
the clinical management of paediatric HIV.  The remainder of the introduction will continue 
by presenting some of the context around paediatric HIV, the clinic and the research, before 
providing a chapter outline. 
                                                        
3 Authors such as Latimer et al. (2006) and Timmermans and Buchbinder (2010, 2012) have already used the 
process of genetic categorisation to describe the role of the clinic to formulate the medical science but I will 
use paediatric HIV to demonstrate that the clinic must also make compatible and formulate a broader range of 
medical tasks like for example the practicalities of protocol, policy and laboratorial medicine alongside the 
everyday lives of patients. 
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Setting the Scene 
UOUH is located in the outer zones of London.  The hospital primarily serves three London 
boroughs.  All patients of the clinic come from these three London boroughs, but formally 
the clinic has no clearly defined catchment area.  Alternatively, it was set up because of the 
large numbers of children with HIV in the local population around the hospital.  As a result, 
patients often have a choice of which London clinic they wish to attend.  Clinics that treat 
paediatric HIV are dotted around London but tend to be in the places where there are the 
highest numbers of patients nearby.  Together, the clinics form a network, one of ‘hubs and 
spokes’.  UOUH is not a large centre compared to other London services, being a ‘spoke’ 
directly linked to a central ‘hub’ hospital (which I will refer to from here on as CHH) and then 
to the wider network (CHIVA, 2012a; Judd et al., 2007).  The most readily observable 
manifestation of this coordination was that a consultant from the CHH would sit in on the 
clinic every month. 
 
 
1 A visualisation of the London-centred ‘hubs and spokes’ network from the CHIVA website 
 
Of the specific cohort of children and adolescents at UOUH at the time of research, there 
were 22 children enrolled at the clinic, almost all have both parents with ethnic connections 
to Sub-Saharan Africa.  The population of the area is transitory, and is made up of several 
multi-cultural communities and identities4.  Even though the area under research is 
                                                        
4
 Race and Ethnicity in the three boroughs according to the 2001 census have high proportions of ethnicity 
minorities, Those of non white British decent were recorded as being around 55% for the principal borough, 
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presented as anonymous, it is not easily placed under pseudonym as it has many unique 
attributes.  The borough which forms the largest part of UOUH’s catchment area has a bad 
reputation for street crime.  It was an area of unrest in the 2011 London riots where ensuing 
nights of unrest took place among the local communities there highlighting many 
unforeseen urban problems in the area (The Guardian Online, 2012).  The borough also has 
a predominant position amongst London boroughs in terms of children referred to social 
care services (Department for Education, 2011).  UOUH paediatric department sees it 
necessary to refer a very high number of cases to child protection (according to undisclosed 
clinical data).  At the time of research, the paediatric department was also dealing with 
some high profile cases that needed expert attention (Mason, 2005).  All of these factors are 
intended to enable the reader to gain a picture of a very specific urban landscape with 
multiple layers and dynamics. 
 
The first meeting held at UOUH regarding this project took place in the offices of the Old 
Nurse’s Home.  This block no longer exists.  Between this first meeting, gaining ethical 
approval and starting research, the paediatric department had been relocated into a new 
building as part of a 123 million pound investment project in the hospital (built on the tail 
end optimism of “the New NHS”, see SSFH, 2001).  What was once dispersed over a 
collection of dilapidated old buildings has been consolidated into a centralised hospital 
building, built to meet modern specifications.  Layered with a broader overlapping history 
and context, the site has served as a workhouse, then as a military hospital before gaining 
its current status in 1920.  The new building replacing the Old Nurse’s Home established in 
1910, was opened in June 2010.  The first days of research and contact with patients at the 
clinic coincided with the opening of the new hospital.  As I began attending the clinic I 
witnessed the dispersion of the old buildings, their cordoning off and their gradual 
demolition piece by piece.  By the last days of research a car park stood on the spot where 
the buildings used to be. 
 
                                                                                                                                                                            
40% the second and 30% for the most distant, this puts all of the boroughs over the average of England which 
is 13% and puts them alongside the London average which is 40% (UK Census data). 
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It is possible to see a lot of similarities and significances with this process of renovation and 
those processes involved with instigating clinical practice in paediatric HIV.  Within 
paediatric HIV, there are questions concerning a history and context of sex, morality and 
deservedness (or non-deservedness) that is not often openly spoken about (Henderson, 
2006; Fassin, 2008).  The gradual construction, demolition, transfer and consolidation co-
ordinated to raise as little public attention as possible, is evident in how medicine is 
practiced in the clinic, in the way patients choose to carry out their lives and the ways in 
which the two meet to manage the condition.  In outer London as elsewhere, HIV is 
referenced with discretion.  The practice of care set up for children with HIV does so in strict 
confidentiality and this discretion is deeply embedded in the medicine (U.K. Select 
Committee, 2011).  However, far from inactive, it is an area of medicine that is in constant 
flux and development.  The epidemic itself does not have a long history but its face and 
nature have changed rapidly (Goulder et al., 2001).  Perinatal infection of HIV (infection 
from mother to child) has its own rich sub-story in the HIV pandemic and is an area of 
medicine which poses its own questions of medical significance on HIV.  As far as the effects 
of antiretrovirals on body development are concerned, paediatric HIV is an under-
researched area (Doerholt and CHIPS, 2006), yet in a short span, it has become possible to 
prevent up to 97% of mothers passing HIV on to their children in the UK (Townsend et al., 
2009), and the population of those infected perinatally has begun to age with little 
precedence in clinical practice about how to proceed.  The latest models of life expectancy 
show that HIV treated with antiretroviral therapy results in a close to average life 
expectancy, commonly placed well into the 70s (May et al., 2011; Nakagawa et al., 2011).  
This is a significant development for children who have HIV.  Now that life expectancy has 
risen, it has become possible to anticipate that children with well maintained care will grow 
to an old age.  This projected future is contingent for every individual however, and not all 
children will have the same health prospects.   To ensure that the condition can be 
maintained as far into the future as possible, patients must follow antiretroviral drug 
regimes with as near 100% adherence as possible.  The virus must be monitored at regular 
intervals and antiretroviral treatments must be tailored to a patients’ personal profile.  
Implementing this regime to children as they grow has many challenges, most of which 
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requires a process of decision making that is contingent, time specific and context sensitive 
to each clinical encounter (see recommendations of Cunningham et al., 2006; Drotar, 2000).   
 
This thesis combines methodologies of Science and Technology Studies (STS), specifically 
Actor Network Theory (ANT)5, and the Sociology of Childhood (SoC) to focus on how clinical 
practice consolidates diverse child/adolescent patient lives with antiretroviral requirements 
and care regimes geared towards making HIV management possible. The consolidation of 
clinical practice runs from the inclusion of children into a compatible understanding of their 
HIV, to the task of maintaining adherence, conceptualising care, managing chronic illness 
over an entire lifespan and the eventual transition of patients into adult services.  In the 
process, patients tread the line between suppressing the virus and the dangers of the virus 
becoming resistant to treatment.  Therefore, the research is geared towards investigating 
the ways in which paediatric HIV is organised through clinical practice and made operational 
between groups of patients, practitioners, protocol and antiretroviral requirements with 
little room for failure (in this context, resistance or non-suppression).  This is confounded by 
the diversity presented by the patient cohort. 
 
Brock’s (2008) examination of Hari Kunzru’s novel Transmission offers an allegory of HIV as 
beyond the scope of one nation and prevention method, indistinguishable from its global 
context.  The allegory can be compared to the populations of migrants arriving in the UK 
who are infected with HIV.  Paediatric HIV is a transient condition beyond national 
boundaries and a simple infection route, meaning that populations are not uniform and 
have complex identities.  During the course of my PhD and especially in the early days 
before beginning fieldwork at UOUH when I was unfamiliar with the topic, I attended 
several charities.  Positive Parenting and Children (PPC) in South London where I attended 
the regular youth club organised for children affected by HIV, the Children with AIDS Charity 
(CWAC) to discuss the activities they take part in and also the Children’s HIV Association 
(CHIVA) where the project was discussed with key members of the organisation.    These 
                                                        
5
 Certain authors that will be discussed throughout the thesis could be described as using the methodology of 
‘after ANT’ such as Anne Marie Mol.  For simplicity I will stick to the term of ANT to describe the fields of ANT 
and after ANT, but discussion on the different implications of ANT and ‘after ANT’ can be found in the 
literature review and Methodology chapters.  
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charities affirm that there are many ways in which paediatric HIV is conceived or brings 
people to together6.  The actors that linked these organisations together were followed into 
the clinic.  Research stems from the conviction that no unified version of paediatric HIV 
exists which can encompass all of the situations and circumstances where paediatric HIV is 
referenced.  ANT emphasises that objects are formed through the enactment of networks of 
human and non-human actors, and do not have meaning beyond the networks that they are 
enacted within.  Therefore, objects do not have one version to be interpreted by a human 
agent, but many that depend upon the situation where the object is enacted (Law and Urry, 
2004).  From this perspective HIV is not one entity but many working over many networks of 
care and practice (in the sense of HIV as described in Rosengarten, 2009).   There seemed to 
be many relations between childhood and HIV that brought these groups together, charities 
would often switch focus between children with HIV to children affected by HIV.  PPC youth 
clubs would be organised with the aim of providing respite or reducing isolation and 
enriching children’s quality of life.  CWAC would educate school children about HIV and talk 
about stigma.  The clinic would take on many roles in the care of children into adulthood.  
All the while, the relationship between HIV and childhood would shift.  Ideas of stigma, 
deservedness, vulnerability, the route of infection or the relationship to HIV implies multiple 
avenues of potential analysis and the complexity of the condition.  Similarly, terminology 
could be used such as vertically transmitted, or perinatally infected, or paediatric HIV, or 
children with HIV, all of which have their own context.  Therefore, research is geared to be 
as receptive as possible to the definitions that the field itself would work with, and attempts 
to ensure that references to HIV in this thesis are context specific (this point will be 
discussed in relation to Latour, 2005 and methodology in chapter 3 on following actors).  
One such version of paediatric HIV in UK services comes from the Collaborative HIV 
Paediatric Study (CHIPS), which offers a collection of data on service provision given by all 
UK clinics caring for paediatric HIV.   
 
At its most broad, the number of paediatric HIV cases reported to CHIPS is 1699 (by March 
2011).  This comprises virtually all children who have received care from UK services (CHIPS, 
                                                        
6
 This way of looking at HIV can be linked to Bowker and Star’s (2000) description of the multiple faceted 
categorisations of tuberculosis, over many national contexts and histories. 
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2010).  The most common route of infection listed for this group is perinatally from mother 
to child, comprising 97% of those in the cohort7.  Of all the possibilities available for defining 
HIV, CHIPS is responsible for giving the numbers for the paediatric cohort.  When CHIPS is 
compared to the Survey of Prevalent HIV Infections Diagnosed (SOPHID) (which comprises 
CHIPS data alongside data from all UK HIV services) SOPHID doesn’t make the distinction 
between age and infection route in its public dissemination of data, preferring to detail the 
whole paediatric group by age.  In terms of defining HIV in light of ANT which describes 
objects as multiple, the thesis highlights the limitations of presenting this statistical 
reasoning as a definitive representation of all possible ways of representing paediatric HIV. 
The thesis attempts instead to argue how definitions of HIV must be negotiated.  However, 
it does acknowledge the important function SOPHID performs for services that follow these 
data sets and allocate resources accordingly.   
 
According to the 2011 Health Protection Agency report (which uses SOPHID and CHIPS data 
HPA, 2011), those under the age of 15 comprised only 1% of the overall HIV population 
receiving care in the UK in 2010.  These statistics render paediatric HIV as a small part of the 
UK’s total whilst requiring a specialised approach to care.  Moreover, when presented 
statistically, populations with HIV seem stable.  However, HIV is a global disease and the 
data reported in the UK does not reflect the movements of people and medicine received 
outside of the UK (Bancroft, 2001; Goulder et al., 2001).  79% of the cohort at UOUH are 
reported to be of Black African ethnicity.  The presentation of this epidemiological category 
of HIV in the UK is particularly marked by the demographics of immigration in and out of the 
UK.  It is beyond the scope of this thesis to elaborate on the complex reasons for the 
movement of individuals between national boundaries.  However I do want to acknowledge 
that there are multiple histories, cultures and ethnicities of those defined as ‘African’.  HIV 
                                                        
7 A different picture emerges when looking at the numbers given to the National Study of HIV in Pregnancy 
(NSHPC) between 1986 and 2011, which quotes 2384 cases of paediatric HIV infection.  1972 of these 
infections were reported to be from mother to child, 267 were blood factor treatment, 61 blood tissue 
transfers and 81 others were undetermined.  This reflects a very rapidly changing history (in terms of individual 
life) of HIV (NSHPC, 2011).  Knowledge of paediatric HIV and was of treating it have changed throughout its 
history.  CWAC’s inception was formed at time early on when the condition was still emerging.  However, the 
face of the disease has now altered again.  In many respects it also shows how differences can be made 
between reporting system.  Since 2000 the most influential data has been collected in CHIPS, which in many 
respects defines the area, and so we will uptake their definitions. 
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accompanies populations on these journeys, even if perinatal HIV is now defined as 
preventable, a unified treatment of these populations, medicines and histories beyond 
borders is not yet possible.  From the point of view of how representative, standardisable 
and generalisable these populations can be rendered, there are obvious implications upon 
what the condition is and how it is presented in UK statistics (U.K. Select Committee, 2011).  
For a condition that requires a near perfect level of adherence to ensure that viral 
suppression is achieved, the fact that members of the population often have a disparate 
medical history and cultural background poses problems for the standardised 
administration of care (Futterman et al., 2000).   
 
Each clinical negotiation regarding care has a high number of possible interpretations 
between patients and practitioners.  This thesis explores how clinical practice is central to 
the process of formulating an antiretroviral medicine that can suppress the HIV virus over 
the largest number of the cohort presented to the hospital.  Paediatric HIV requires a clinical 
approach so flexible that it is difficult to pre-empt definitively in guidelines the problems of 
uptake and development that children may present at the clinic.  This renders the clinic at 
the centre of processes that inform, define and deploy the resulting HIV medicine and 
paediatric condition.  The research chapters in this thesis offer insights into some of the 
clinic procedures in place to ensure, as much as possible, that medicine is unified, regimes 
are followed and what can be deemed as a normal life expectancy is made possible. 
 
Representations of paediatric HIV in popular culture offer a range of capricious peculiarities, 
so much so that I feel uncomfortable offering broad statements.  There is such a dispersal 
between representations that it is difficult to plot a course between stigmatised 
representations of HIV and ‘medical fact’ practiced in the clinic.  In the UK, families with HIV 
feel the need to live their lives so discretely that representations of children with HIV rarely 
reflect the nature of living with the disease and as a result can be factually very muted and 
homogeneous (Dorrell et al., 2008).  For example, when the stories of children with HIV are 
shown publicly they are nearly always left anonymous and when video is used the 
participants are blacked out (Body and Soul, 2011a, 2011b).  In contrast, it is possible to find 
examples in the United States of stories about children with HIV who are not blacked out 
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(Belluck, 2010a).  However, a general disparity can be seen between ‘victim’ children and 
more general HIV stigmatisation (Wilcox, 1996 is a prime example of a child with HIV being 
described as a 'victim').  Newspaper articles can also be found that seem to document the 
existence of an unwarranted, differentiated prejudice (Belluck, 2010b; Day, 2011).  What is 
not often factored in is that in families, HIV is not isolated just to children.  Parents who 
have acquired HIV through sexual transmission may feel responsible for transmission and 
this may contribute to the expression of the utmost discretion exercised by families and 
practitioners8.  These kinds of discussions and problems are present in the clinic through the 
awareness of practitioners when carrying out practice (Steele 2007; Lewis et al. 1994).  
Similarly, other cultural representations of HIV have an influence on clinical practice.  For 
example, care must be adapted around confidentiality.  When educating children about 
their condition and how to treat it, practitioners must consider stigmatised ideas of HIV and 
how to shield children away from them. 
 
As a result of the above considerations, paediatric HIV is a central ‘actor’ within the thesis.  
Compared to other terms, it is distinguished from cultural (and possibly stigmatising) 
references to HIV, or more general connotations of ‘children with HIV’.  Paediatric HIV is 
used in this thesis as the label that is presented and used by practitioners in literature, 
protocols and during practice as the formalised reference to the condition and 
corresponding medicine.  Therefore, in this introduction it is important to present paediatric 
HIV as it is established through practice.  Clinical practice must facilitate patient 
understandings of their condition and cultural representations, but also render them 
compatible with HIV care regimes.  Paediatric HIV has its own unique and immediate 
specificities: stigma, confidentiality, immigration, sex/innocence all work together in 
dynamic ways.  Children and adolescents have their own lives and networks to maintain, as 
do parents and families (Hekster and Melvin, 2006; Campbell et al., 2009 both offer 
examples of the 'social lives' of children with HIV).  By placing ourselves in the ‘shoes’ of 
others it is possible to think about how HIV has the potential to alter the lives of all 
                                                        
8 Fassin (2008) discusses the idea of deservedness in relation to childhood and HIV, arguing that children are 
seen as victims and undeserving in comparison to adults who are blamed and seen as culpable for their 
infection. 
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members of society, from young to old, individuals to families in many ways.  This thesis will 
ask readers to assess practice for the ways that it consolidates complex and ‘messy’ 
associations such as naivety, innocence, ethnicity, immigration, stigma, confidentiality and 
sex with drug requirements.  The central argument of the thesis is that these associations 
that are often difficult to place alongside the suppression requirements set for antiretroviral 
drugs must be negotiated in the clinic between patients and professionals and rendered 
compatible.  This process places the clinic not only as the site where complex requirements 
are organised, but means that clinical practice is centrally implicated in the generation of 
antiretroviral medicine.  Policy, protocol, guidelines and pill regimes must be adapted in 
clinical interventions to become functional and those designing policy must bear in mind 
how their policy will be practiced in the clinic. 
 
To demonstrate this argument, the practices of the UOUH clinical cohort have been selected 
and researched using arguments central to STS stressing the importance of following actors 
(Latour 2002). The specificities of UOUH’s patient cohort are considered in detail, but what 
will also become highly visible, yet difficult to separate and not possible to isolate, are 
places where confronting HIV means following interactions with larger networks of HIV, 
medicines, dispersed localities, protocols and routines.  I would like to invite a way of 
thinking about HIV medicine without scales, levels or hierarchies that become greater or 
more specific, but as a network that, when put into operation, references other networks 
(Latour, 2005).  Methodologically it has been deemed important to allow actors ‘infinite 
freedom and pliability’ to inform what is important in the field (Latour's 2002).  Scales or 
hierarchies around an object or entity do not exist in an already formed prior state, some 
form of agency must put them in motion and reference a change in scale.  In the space of 
the clinic, procedures such as disclosure, adherence and transition emerge, they are 
referenced and maintained in negotiations between patients and practitioners.  Alongside 
STS fits considerations of childhood taken from the Sociology of Childhood (SoC) and this 
literature has been used to ‘unpack’ childhood as a ‘charged’ object, especially in this 
context of sex, vulnerability and culpability (with the use of literature such as Kehily and 
Montgomery, 2008).  However, as in Oswell (2012), analysis has taken care to highlight the 
antagonisms but not to ‘police’ the inaccuracies in imaginations of childhood. 
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The Practice of the Clinic 
The clinic that takes place in UOUH is part of the standard paediatric ward, it was held 
regularly once a week, but also attends to other patients than children infected with HIV.  
The clinic also screens new-born babies to mothers with HIV, to ensure that HIV is tested for 
and prevented antenatally.  The clinic was also responsible for carrying out HIV tests on 
children or adolescents where HIV may be suspected for a certain reason such as a newly 
discovered HIV diagnosis in a family or dynamics around HIV and uncertainty caused by 
immigration.  The clinic was run by a paediatric consultant, whom I will call Dr Peters, who 
was responsible for managing the clinic and individual case records. However, roles were 
also shared and distributed between one Clinical Nurse Specialist (CNS) for the clinic. 
 
Children would usually come in once every three months.  Their first task was to go to the 
front desk and check in, then the CNS would usually greet them and take their urine if 
needed and ask the appropriate questions about themselves since their last appointment.  
She would then make sure the file was given to Dr Peters in the consultation room, the 
patient would then be ready to be seen by the Doctor.  If the patient was beginning 
adolescence, Dr Peters would see them in the consultation room on their own first to talk 
about their health and how they had been without their parents.  Then the parents would 
come in and discuss previous blood test results and plans of action.  The child/adolescent 
would then go for a new blood test with either Dr Peters or the CNS, before Dr Peters would 
fill in the pro forma and make some notes, the blood taken and urine would get a label and 
be sent off to the lab.  Between all these steps, there is and was a lot of room for variation.  
Some of these steps could often occur at different times, they could overlap, discussions 
could take place whilst another step is being carried out, e.g. with parents whilst children 
were having a blood test.  Nevertheless, this was the general structure that they aimed 
towards, as will be demonstrated later on.  The consultation is designed to be technology 
heavy, with obvious technologies like blood test results, antiretroviral medicine explications, 
as well as underpinning procedures like adherence, disclosure and transition (Blume, 1992).  
These technologies are made to function together in clinical procedure, like in the 
designated information given before and after disclosure to support adherence, or enable 
independence and to pave the way for transition.  Many tactics are employed and tested to 
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ensure effectiveness and re-negotiate care if needed (Dodier, 1998; White et al., 2012).  The 
clinics would be held every week on the same day in the morning from 9 am to 12 pm with a 
less regular evening clinic from 4 pm to 6 pm.  Over the year I attended the clinic, there was 
a general shift from most cases being seen in the morning clinic to the evening one.  As a 
result, the evening clinic went from being once a month to twice a month and most of the 
children/adolescents booked into evening slots, and my observations followed the patients. 
 
At less regular intervals, the clinic was coordinated in other ways.  There would be a staff 
meeting where all the CNSs, the Pharmacologist, T1 (adult services) consultant (who will be 
called Dr Chambers), the CHH consultant (Dr Phelps) and Dr Peters would go through each 
case at the hospital.  Dr Phelps would also sit in on clinics to regulate the service.  These 
regular meetings were an essential part of how the clinic was organised9.  Another essential 
practice, if more general, was the access given for SHO’s and trainees to attend the clinic.  
On many occasions, I would sit next to individuals attending the clinic for the purpose of 
training or gaining experience.  Those sitting in were from a variety of stages and 
professions within medicine, from medical students and trainee nurses, to SHO’s and visiting 
practitioners.  At a busy university hospital such as UOUH, education and training is never 
far from the practice of medicine (training even features highly in the classic clinical 
ethnographies of Becker, 1961; Atkinson, 1997).  One interesting visitor who will be 
encountered later in the text under the pseudonym Dr Wellington, was the former head of 
the clinic now based back in her native New Zealand.  She observed quite a few clinics 
towards the beginning of my fieldwork and took a lot of time to explain to me how 
paediatric HIV works (second only to Dr Peters’s countless and detailed explanations to my 
questions).  From all the professionals I observed at the clinic, I do not think that any of 
them ever stopped learning and developing in the field throughout their working lives (Peck, 
2000 describes the obligation on practitioners to continually develop).  This characteristic is 
complementary to the argument of the thesis that professional development is essential to 
making up a responsive and adaptable clinical practice.  It ensures that services remain 
                                                        
9 Davies (2003), Allen and Pilnick (2005) and Currie et al. (2012) argue that there is a lack of studies in 
organisational studies that discuss the importance of how the clinic is organised.  Clinical organisation is a 
consideration that is recurrent throughout this thesis. 
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relevant and informative to the patients they care for and that the clinic remains effective in 
reformulating medicine to the conditions presented in the consultation room. 
Layout of the Thesis 
The following chapters of this thesis seek to show some of the procedures that have been 
used to make paediatric HIV operational through clinical practice.  Contrary to the socio-
psychological research around paediatric HIV, this project is not geared to assess what does 
and does not ‘work’ in practice.  The question will not be framed in this way.  Rather, the 
aim is to show how medicine, the condition, routines of care and viral suppression are made 
possible through practices occurring in the clinic.  Therefore, instead of highlighting an 
isolated overview of cause in paediatric HIV, much of the research documented will be 
directed towards revealing how a range of effects and consequences are ordered into being 
and made operational (Latour, 2002).  Over the process of a year, the clinical logic guiding 
care that became prominent to me comprised: firstly disclosure which brings children into 
knowledge about their HIV (blood-tests, attending the clinic, taking antiretrovirals etc. 
Michaud et al., 2009); secondly, adherence which is the attempt to make sure children 
follow antiretroviral regimes as close to 100% as possible (Gibb et al., 2003); thirdly chronic 
illness which is used when planning care now and into the future (Bernard, 2008); and 
fourthly, transition which concerns the management of care between paediatric and adult 
services (Viner, 1999).  I assert that disclosure, adherence, chronic illness and transition are 
all used in the clinic as procedures designed to consolidate patient complexity with 
antiretroviral requirements and clinical regimes.  I have ordered these procedures into four 
empirical chapters, corresponding as much as possible to the ways that these procedures 
are presented and discussed in the clinic and corresponding protocol and literature. 
 
The four procedures are already four major areas of discussion in paediatric HIV and seen as 
responsible for the organisation of HIV care.  Disclosure, adherence and transition all have 
their own guidelines in CHIVA and each have extensive and specific literature reviews 
(CHIVA, 2011a).  As such they make their way in and out of clinical practice, they can be 
seen to be followed, ignored, or flagged up in order to make the medicine functional (White 
et al., 2012).  The exception is chronic illness, as compared to the other procedures, it is not 
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the subject of a specific clinical guideline.  However, practice and literature discussions are 
never far away from describing HIV as being managed as a chronic disease through the use 
of antiretrovirals, and as will be argued, usages of chronic illness are crucial to maintaining 
practice. 
 
In retrospect, the resulting chapter list could have been different.  Other foreseeable 
chapters could have been child protection, sexual health and public health.  Indeed, the list 
could go on as could the ways that other onlookers could have organised the same 
incidences observed differently.  However, it is hoped that those who are familiar with the 
condition or the medicine, as well as those new to this area, will be able to see some 
frequent and interesting themes develop from a reading of this thesis, as it demonstrates a 
clinical logic at work in the medicine that must necessarily be negotiated between both 
practitioners and patients. 
Chapter Outline 
1 Literature Review 
This chapter frames the project in three discussions found across the literature of STS and 
SoC.  The first is on the ‘turn to enaction’ within Actor Network Theory (ANT), which is 
concerned with how objects are constituted and altered over their different enactions.  This 
results in a position that questions the singularity of practice and clinical procedures in 
favour of viewing practice and procedures as multiple (Law, 2004a).  Clinical practice and 
suppression are subsequently framed as not only ‘enacted’ and ‘multiple’, but also as made 
possible through consolidating the multiplicities found in the clinic into the task of making 
patients adhere. The second discussion highlights the ways in which public and scientific 
knowledge are consolidated together through the procedures taking place in the clinic.  It 
argues that practice is necessarily negotiated between child patients, practitioners and 
protocol (Callon and Rabeharisoa, 2003; 2004).  I assert that it is a necessary task of the 
clinic to maintain the science behind viral suppression by facilitating the uptake of 
antiretroviral medicine in to the lives of patients (see Pontali, 2005 on facilitating 
adherence).  The third section discusses imaginations of childhood, naivety and agency in 
relation to clinical practice.  Discussions in SoC literature alternate between describing 
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children in clinical situations as naive, innocent and acted upon on the one hand, and on the 
other that children necessarily contribute/participate to clinical negotiations concerning 
them and cannot be reduced from the clinical situation.  Therefore, the section attempts to 
resolve some of these contradictions in order to consider how childhood, naivety and 
innocence are consolidated in clinical practice.  Compared to the general trend of literature 
on paediatric HIV that centres upon a psychosocial approach (e.g. Battles and Wiener, 2002; 
Naar-King et al., 2006), this thesis strays from this trend by concurring with alternative 
literature that diverts the search for psychosocial ‘causes’ and focuses instead upon the 
emergence of practice through enaction disbanding a hierarchical model of protocol 
dictating practice (Mol 2002).  Therefore, the chapter brings unique strands of theory and 
practice together to contribute to the STS and SoC discussions mentioned as well as more 
general literature around clinical practice and paediatric HIV. 
 
2 Methodology 
This chapter has been split into two main sections:  the first describes the methodological 
approach of the thesis, the second comprises a section of specific methods around how the 
research was carried out.  The first section on methodology builds up an approach to the 
study of paediatric HIV in regards to STS to discuss three principles relevant to this study.  
The principles discussed pertain to discussions of irreducibility, semiotics/materiality and 
the enaction of the social, before the section moves on to discuss how to follow actors 
through society, or in this case through the clinic (Latour, 2005).  This is important to enable 
research to identify the ways in which diverse patient lives are consolidated with medical 
requirement, and protocols are adapted flexibly in clinical negotiations.  The second section 
on research methods seeks to provide a guide to the practicalities of conducting research 
and ‘following actors‘ in the clinic and the main decisions made in the process of collecting 
data to its analysis and dissemination.   
 
3 Ethics 
After the methodology and before the empirical chapters lies a supplement on ethics.  It has 
been rendered as an intermediate chapter for two reasons:  firstly, the field of paediatric 
HIV is heavily charged or imbued with ideas of ethics, morals, innocence and deservedness.  
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Hence it seemed important to discuss how this project would consider these positions.  
Secondly, the formal ethical procedure for carrying out research in the NHS was so extensive 
that it also became relevant to the thesis of this project.  The ethics supplement considers 
the relationship between the formal ethics and the ethical stance of the research 
methodology to evaluate what is ethics and how to act ethically in this context. 
 
Empirical Chapters 
4 Disclosure 
The term ‘disclosure’ refers to a practice whereby child patients are given knowledge about 
their HIV.  It usually takes place when children are deemed ready to be informed about their 
HIV.  In the UK and consequently UOUH, the aim is to make children aware of their HIV 
diagnosis around the age of eleven or twelve (informed by policy of Committee on Pediatric 
AIDS, 1999a).  There is not one sole reason for this but many unique to paediatric HIV: one is 
that at this age they can understand.  Another is that at this age they can ask challenging 
questions that need well informed-answers.  Another is that at this age, it is less likely that 
the child will tell anyone else about their status.  A series of other issues can also be seen 
around the deliberation involved in when and why to tell children of their diagnosis as 
practitioners want children to understand the significance of the disease whilst protecting 
them from negative connotations around HIV (Mellins et al., 2002).  Leading up to the act of 
disclosing HIV to children, contradictions, inconsistencies, biases and over/under 
emphasises may all alter the dynamics influencing how practitioners will proceed with 
disclosure.  I argue that in the face the real danger posed through the mismanagement, 
disclosure is formalised as a procedure in the clinic in order to consolidate children into 
knowledge about HIV to patients and ensure that patients and practitioners have a shared 
knowledge about HIV.  According to this perspective disclosure is emphasised as not just 
one act or a series of acts but a long and complex process of educating, re-educating, 
discussing, asking questions and making explanations that can be compared to the STS 
notion of translation (Callon 1986; Akrich et al. 2006).  The patient, the family and the 
doctor all have their own role in this process of disclosing.  It also has important implications 
about how HIV is constituted and care initiated.  The analysis of this process found in UOUH 
and over higher scales of institutions and literature, focuses on these ways in which 
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disclosure is referenced and why it is used, providing an account of this very important step 
that attempts to incorporate children into medical reasoning.  
 
5 Adherence 
Adherence is a term that is used a lot in the clinic (see for example Gibb et al., 2003).  It has 
come to take on a meaning that indicates the regular uptake of medicine, but the chapter 
will ask the question if there is more at work than this.  Antiretrovirals need to be taken as 
close to 100% as possible to ensure that the virus is suppressed and that resistance to the 
medicine does not ensue.  The question of adherence is more immediate in paediatric HIV 
because of the broad range of issues patients present in the clinic combined with the 
absolute requirement for to take drugs as advised.  This means that it is crucial for 
practitioners to consider how to make patients adhere.  I argue that adherence must be 
achieved through uniting patients, professionals and biomedicine together under the 
common goal of viral suppression that allows each party to have a better understanding of 
what is required of them in order to achieve viral suppression.  It is important for patients 
because it involves ways in which they must moderate their behaviour in order to make it 
possible to take drugs regularly over long periods of time, it is important for biomedicine as 
it would not be possible to make the medicine functional without patients adhering to their 
medicine and it is useful to practitioners of HIV medicine as it allows them to make a link 
between antiretroviral medicine and their patients in order to deliver ‘good care’ (Mol, 
2008). This means that the procedure of adherence takes on a number of capacities.  It 
could be thought of as a form of surveillance, as a guide or as an enabling technology.  This 
chapter focuses on the places where adherence is presented and attempts to highlight some 
of the tasks and possibilities that adherence is used to appropriate.    
 
6 Paediatric HIV as chronic illness 
The development of a range of antiretroviral drugs has made it possible for users to 
suppress HIV for an undefined length of time into the future.  This means that in effect, HIV 
medicine must now plan to maintain HIV in a chronic state over a patients’ entire life-span.  
For children born with HIV, the implications of this are massive and require a sense of 
attentiveness in clinical management (Bernard, 2008).   Children must foreseeably live their 
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entire life-span according to the requirements of maintaining their HIV adequately.  Even 
though it may be useful for practitioners, there is no way to provide an exhaustive list as to 
how this can be dealt with, contained or managed as each situation has HIV bearing upon it 
in a unique way.  When abiding by chronic illness, patients and practitioners manage care 
with an eye on making sure it is possible to continue to suppress the virus into the future.  I 
argue that chronic illness is used in the same way as a procedure to unify medicine, clinical 
practice and extraneous patient factors together allowing practitioners and patients to 
achieve a consolidated view of the medicine as a whole.  Chronic illness allows patients to 
bear the everyday maintenance of their HIV and allow practitioners to imagine possible 
futures of the medicine and adapt reflexive policy (becoming an organising process of 
medicine White et al., 2012).  This chapter explores encounters from the clinic and parts of 
CHIVA and medical literature where chronic HIV is being discussed, or where a future of 
dealing with HIV is being imagined.  These incidences include thoughts of life with the 
disease, death, normal life and education on life with HIV and other general health 
conditions that blur the lines and at the same time become essential and unique aspects of 
managing HIV. 
 
7 Transition 
Transition in paediatric HIV occurs around the time when patients go from paediatric 
services to adult services.  This usually takes place between the ages of sixteen to eighteen.  
Rather than the act being contained in this hand-over period, it goes much further into the 
care that patients receive (Wiener, Battles, et al., 2007).  Paediatric HIV is particularly 
interesting because the clinic see it as imperative that patient complexities are tamed 
before patients are transitioned.  From an early age, children are educated into a specific 
knowledge of their HIV, then encouraged to become increasingly independent and 
responsible for their own health, leading up to transition.  Patients are then followed-up 
into adult services and eventually receive less and less attention from the paediatric 
department (Fair et al., 2011).  I argue that transition is used to coordinate paediatric 
medicine and more general adult services.  In doing so, it formally negates notions inherent 
to paediatric services of child vulnerability and lack of competence by asking patients to 
take on independence and responsibility for their own care.  There are a range of guidelines 
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and literature to support these processes, all pointing to a notion of transition that is highly 
functional and crucial in paediatric HIV care, yet also ephemeral and not so easy to define.  
This chapter looks at how transition takes place in the clinic and ways in which literature and 
procedure are put into practice and the issues that it causes. 
 
Conclusions  
The thesis concludes with a discussion of two themes that become increasingly evident 
through the course of my research.  Firstly, in the face of patient complexity, these 
procedures begin to converge together to form a clinical logic that is employed to serve the 
purpose of formulating, consolidating and perpetuating paediatric HIV medicine.  From this 
analysis of the very specific procedures found in the literature and clinic, none of them can 
be found to exist in isolation.  They are highly implicated: it is not possible (or doesn’t make 
sense) to engage with disclosure extensively as a precursory stage without adherence, 
considerations of chronic illness or the processes leading up to transition.  Rather than being 
linked in one distinct relation or even a range of relation, practices are related together over 
many dynamics to unify practice.  However, these links are not static.  They are multiple, 
dynamic and constantly linked and re-linked together in the practice of maintaining 
paediatric HIV.  Secondly, through the clinical attentiveness required in paediatric HIV care, 
the clinic can be seen as the site where patient complexities such as naivety, vulnerability 
and stigma are organised alongside medical requirements.  This is done through the 
employment of the clinical procedures identified.  However, the way in which they operate 
is to allow the practitioner to negotiate them flexibly with patients to ensure their 
effectiveness and their ability to remain applicable to the cohort.  Consequently, it is 
asserted that the clinic plays a key role in consolidating complexity and making antiretroviral 
medicine functional through negotiation, displacing the notion that protocol dictates 
practice.  
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2 Literature Review 
This chapter discusses Actor Network Theory as applied to Science and Technology Studies 
(STS), the Sociology of Childhood (SoC), Paediatric HIV and clinical practice.  The chapter 
aims to frame paediatric HIV amongst relevant discussions within the field of STS, and to 
render valuable insights from clinical practice and the condition of paediatric HIV to debates 
around STS.  Compared to existing studies of STS and SoC, paediatric HIV is particularly 
interesting because of the sensitivity required by the clinic to manage complex associations 
such as naivety, vulnerability and stigma into medical requirements.   STS has been adapted 
to demonstrate how practice/guidelines are negotiated between practitioners and patients 
in ongoing clinical enactions, displacing a model of practice that maintains that protocol 
dictates clinical practice hierarchically.  The resulting argument asserts that the clinic is a key 
site where patient complexity is consolidated with medical requirements.  This thesis argues 
that a clinical logic is employed when carrying out practice and maintaining protocol that 
aims to make medicine compatible with patients’ lives.  The emphasis on a ‘clinical logic’ 
ensures the need for STS and SoC as the topic is relevant to the status of medical science 
and childhood amongst wider social relations.  Therefore, the STS offered in this chapter 
discusses medicine, illness and clinical practice.  The first section discusses the ANT 
approaches of ‘ontology politics’ or ‘the turn to enaction’.  The approach is concerned with 
how objects are constituted and altered in the course of their different enactions.  The 
discussion of ‘ontology politics’ results in a position that questions how different versions of 
an object can be discussed and compared, and what it implies for practice.  Clinical practice, 
HIV medicine and virus suppression are subsequently framed not only as ‘enacted’ but also 
as ‘made possible’ through enactions taking place in the clinic.  This work is of major 
importance to the way in which paediatric HIV is approached in the research sections of this 
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thesis.  The ANT concepts of enaction and multiplicity put forward in Mol (2002) and Mol 
and Law (2004) provide a basis throughout the thesis for thinking about medicine, HIV and 
childhood as emerging from enactions taking place in clinical practice.  Therefore, they are 
outlined in detail in the first section of this litereature review.  The chapter then moves on 
to discuss STS in reference to the production of knowledge, patient participation in 
knowledge production and the concept of translation.  In particular, the collaborative 
articles of Callon and Rabeharisoa (2002; 2003; 2004) investigate the formation of patient 
identities and highlight the consolidation of patient outlooks and attitudes into medical 
reasoning.  Here Callon and Rabeharisoa’s work is used to consider how practice necessarily 
contains a translation between the medical science and the requests of the culturally 
diverse families that attend the clinic.  Subsequently, guidelines and protocol must be 
designed through clinical practice and re-appropriated within the clinic and so implicating 
the clinic as a key site in the formation of medical knowledge.  The second section on SoC 
emphasises how children’s agency can be discussed in relation to clinical practice.  On the 
one hand children can be perceived in the clinic as naive, innocent and lacking agency, but 
on the other children’s irreducible contribution to the negotiations in the clinic that they are 
a part of cannot be disregarded.  Therefore, this section attempts to resolve some of these 
contradictions from the SoC literature as well as demonstrate how childhood considerations 
are formulated into HIV medical doctrines through practice in the paediatric clinic.  This 
chapter will use debates in ANT around enaction, discussions of expert/lay knowledge, and 
debates in SoC around childhood agency to portray the clinic as a key site in consolidating 
and making functional disparate patient lives and antiretroviral medicine.  In contrast to the 
literature discussed, paediatric HIV emphasises the cultural awareness required in the clinic 
to ensure that medicine remains applicable to the issues faced by the patient cohort.  In so 
doing, the chapter also demonstrates how this project contributes to these wider fields of 
literature. 
 
Object Politics 
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A good example of ‘ontology politics’10 or the ‘turn to enaction’ can be seen through an 
article by Law (2004a) which reflects upon the development of STS and suggests three 
essential steps of the discipline.  Law’s first two steps are concepts that would now be 
considered conventional in STS.  First of all he puts forward that science and scientific 
knowledge is demystified into being viewed as cultural.  This means that science can be 
highlighted as culturally shaped rather than wholly objective.  Law (2004a) asserts that this 
may seem banal today but was revelatory in the 70s when such science studies as Kuhn’s 
(1970) Scientific Revolutions were being carried out.  The second step put forward in the 
article is the need to analyse science as a process.  According to this step, scientific 
knowledge is created and validated or superseded procedurally, which leads to speculation 
that the production of knowledge is contextual.  For the third turn, Law (2004b) exemplifies 
a more contemporary topic in STS, ‘the turn to enaction’ and subsequently ontology and 
objects.  This strand of STS argues that ontology and objects are enacted and re-enacted 
into being, replacing the notion that objects exist independently from our interactions with 
them, focusing instead on how objects are performed into being through one of many 
possible processes (Latour, 1987).  These processes do not create objects that are fully 
defined, instead an object must be re-enacted according to the context of each successive 
reference to the object, and each successive enactment of the object alters it from previous 
enactments according to the associations it is related to.  Therefore, according to Law 
(2004a), an individual object or ontology11 multiplies through these processes and each 
successive enaction brings new possibilities for objects to adapt to ongoing situations.  As a 
result, ontologies and objects are rendered multiple and not singular.  The ANT stance of 
multiplicity and enaction forms a major methodological consideration in the thesis.  The 
research chapters draw heavily upon literature, predominantly by Anne Marie Mol and John 
Law (around 1999 to 2004), detailing issues of multiplicity, enaction and health and so these 
                                                        
10 The term ‘object politics’ describes a particular ANT approach to objects that emphasises a view of objects, 
process and enactments multiple.  It is an adaptation of the term ontological politics by Mol (1999). The term 
retrospectively positions Mol and Law in the history of after-ANT as the ontology politics literature comes from 
what could be defined as a middling period in the contemporary state of STS, after the book ‘After ANT’ by 
Law, which attempted to argue that an epistemological break with earlier versions of ANT had occurred, and 
consequently promoted a turn to enactment, not just towards science and technology but towards other more 
mundane objects (Law 2004b, p.8). 
11 STS also has its own version of ontology that imagines that each specific set of associations formed around 
an object forms its own distinct ontology that is altered between its different enactions (Law, 2004a).  
Therefore different ontologies also become multiple and potentially contradictory. 
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discussion are presented in the first section of this literature review.  This section will 
evaluate the applicability of the ‘turn to enaction’ by relating some of the key studies of Mol 
and Law to a discussion of how medicine, guidelines and viral suppression must all be 
enacted in the paediatric HIV clinic.   
 
Following Foucault’s (2003) Birth of the Clinic which places the clinic as a key site for the 
production of medical knowledge, the ‘turn to enaction’ has significant implications for 
clinical practice and paediatric HIV (Latimer et al., 2006).  The principle that there is not one 
absolute version of paediatric HIV but many that each depend on the time and place where 
they are enacted, implies that the condition enacted in the consultation room and in 
guidelines is done so alongside a larger network of intervening objects.  For paediatric HIV 
this is significant because many objects have the potential to alter how the condition is 
viewed and, correspondingly, must be acted upon in the clinic.  For example child naivety, 
immigration and confidentiality all have implications about how the disease and treatment 
must be discussed and how drugs must be administered (Green and Smith, 2004; NAM, 
2010a).  For Law (2004b), it is through these enactions that objects and ontologies gain their 
shape whilst constantly being adapted to successive enactments. 
 
Through engaging in ‘object politics’, the study of clinical practice in paediatric HIV medicine 
becomes the task of tracing the enactments of objects or ontologies that occur in the clinic 
and enact the condition.  The view of objects as multiple and dependent upon enaction is 
drawn upon heavily throughout the research chapters of this thesis to describe paediatric 
HIV to emphasise the many complex mediating tasks that must be carried out in practice to 
ensure that antiretroviral therapy is successful.  This stance is in contrast to the discussion 
most often found in existing literature around paediatric HIV and clinical practice that 
delineates aspects of practice as de-contextualised from their enactment, documenting 
instead distinct spheres of knowledge and action such as the ‘social’, the ‘condition’, the 
‘science’ and the ‘medicine’ (Lewis et al., 1994; Melvin and Sherr, 1995; Battles and Wiener, 
2002; Gibb, 2003; e.g. Green and Smith, 2004; Steele, 2007; Mahajan et al., 2008).  Ontology 
politics implies that aspects of clinical practice such as HIV, medical science and social issues 
are necessarily enacted at the same time in the clinic and not isolatable from each other.  
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This point is also resonant compared to other predominant sociological positions of 
‘biomedical power’ applied to clinical practice.  It displaces the notion of power or 
biomedical power as unidirectional or singular, and exemplifies the work of Foucault as 
informing analysis (and ANT) of the clinic as a key site of knowledge production but 
modifying the relations implied around power/knowledge (see Foucault, 2003, 1988 for a 
notion of all pervasive clinical power; or Rose, 2006).  According to the ‘turn to enaction’ 
power is dispersed and enacted multiply and contradictorily over and between different 
enactions, and power can be enacted multi-directionally between patients and professionals 
(Munro, 2009).  This rejects a model of medicine as hierarchical where protocol dictates 
practice. 
 
A seminal study that uses the basis of the turn to enactment and ontology politics to analyse 
medical practice12 is Mol’s (2002) book The Body Multiple.  Mol’s study and its evocations of 
multiplicity and enaction in a clinical environment are crucial to the presentation of the 
clinic, childhood and HIV found in the research sections of the thesis.  Her work describes 
how arthrosclerosis is performed (or enacted) over different sites of one single hospital.  
Mol (2002) demonstrates that in different wings of the hospital, such as haematology and 
surgery, there are different ways of enacting the same object: for example the blood of the 
patient is enacted differently across different departments.  Haematology looks at the blood 
as a medical sample, using a microscope plate or a routine test.  In contrast, surgery sees 
blood is something that must be kept in the body and must continue to flow throughout an 
operation.  The ways in which the blood is enacted across these departments presents 
differences, yet the two sites are linked and combined into the larger term of 
atherosclerosis.  Mol (2002) gives an example of the enactment of blood and demonstrates 
how it is not the same over different sites of the hospital.  Each enaction of the object 
creates a difference, rendering the object multiple.  Over different sites and in different 
situations, objects that would appear to be the same, such as blood and atherosclerosis, in 
strict comparison actually contain differences.  Therefore, according to this line of reasoning 
each enaction of an object necessarily re-enacts parts of a previous enaction whilst aligning 
                                                        
12
 The focus of practice is different to the one referred to in this thesis as it offers a more general notion of 
‘medical practice’ rather than ‘clinical practice’.  This point is discussed further below. 
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the object with an alternative set of associations presented in ongoing encounters in the 
hospital. 
 
Mol’s (2002) focus on a general notion of ‘medical practice’ as opposed to ‘clinical practice’ 
as described, highlights that practices that take place across HIV medicine are never 
contained in the space of the clinic but are connected during each enactment to networks 
over different hospital departments.  For example, the blood of children is also something 
that during clinical practice is enacted over more than one hospital department.  Blood tests 
that take place in the clinic are sent away and tested in the laboratory and the results are 
enacted again to the parents and child.  This requires a complex chain of enactions which 
range from the clinic, to the laboratory and back to the clinic13.  The concept of enaction is 
crucial to the descriptions of paediatric HIV found in later research chapters.  However, this 
thesis adopts the concept of enactment in clinical practice more loosely than Mol (2002) to 
argue that protocol, guidelines (CHIVA, 2011a), policy such as hospital safeguards or child 
protection and the influences of other institutions such as CHIVA must all be enacted in the 
clinic (also see dynamics of protocol and decision making as described in Berg, 1997a, 
1997b; Timmermans and Berg, 1997, 2003).  This means that the medicine is reliant upon 
how it is practiced in clinic, warranting a description of clinical practice as specifically 
important to the formulation of the medicine above the generalised notion of medical 
practice found in Mol (2002).   
 
In comparison to the arthrosclerosis described in Mol (2002), paediatric HIV emphasises this 
point around the importance of clinical practice further.  For example, important 
associations of Paediatric HIV not present in arthrosclerosis are the vulnerability of children, 
ethnic diversity and the high public profile of HIV (Melvin and Sherr, 1995; Hekster and 
Melvin, 2006).  During the clinical practice of paediatric HIV these associations are present 
in the consultation room, which means that the practice of medicine must be highly 
contingent on them.  Policy and practice must ensure that the practice of HIV medicine does 
not have negative ramifications for patients.  For example if handled by the clinic in the 
                                                        
13
 The procedure for taking blood has its own set of guidelines see Nutbeam and Daniels (2010) demonstrating 
how different forms of childhood are also enacted between the clinic and the laboratory. 
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wrong way, if medicine is administered out of tune with patient lifestyles, if confidentiality is 
breached, or if the school asks questions about the child’s health (Maile, 2005; Melvin et al., 
2007; Cummings, 2008; Korbin and Zahorik, 1985).   
 
As a result, it becomes important to document paediatric HIV practice to account not only 
for recurring enactions over different sites of the hospital, but also the implications of a 
policy, practice and private life that have a highly complex and dynamic range of 
consequences which overlap to have profound implications for patients and professionals if 
enacted without sensitivity and caution (Misztal, 2011).   Paediatric HIV practice has to 
maintain a view of how patients will be able to minimise the effects of stigma as they 
develop and also much policy holds the clinic accountable for doing so (Munro, 2006; 
Beckett, 2007).  Together these aspects separate paediatric HIV from other diseases such as 
atherosclerosis and demonstrate how the paediatric HIV clinic must make sensitive, 
contextual discussions impossible to pre-empt in guidelines.  For example disclosure plans 
to bring patients into knowledge of their condition and how to care for it in a way that is 
compatible with their eventual transition out of paediatrics.  As an enactment this happens 
both momentarily in the clinic and also over 4 years of adolescent development.  In this 
time, guidelines must be interpreted repetitively whilst children and adolescents present 
many outside challenges to clinical practice (Atkins et al., 2010).  Guidelines in this instance 
must be made compatible in the face of diverse situations.  This is done through the 
maintenance of a constant dialogue between the clinic and the patient, and the clinic and 
the guideline, implicating the clinic as a key formulator of the procedures (such as 
disclosure, adherence and transition) that make their way into guidelines.  Guidelines must 
be designed with flexibility in order for them to be applicable to the clinic and if guidelines 
do not fit practice they must be changed.   
 
A related set of articles discuss how objects can be fluid and adapted to diverse settings.  
Law and Mol (2001) and correspondingly Law and Singleton (2005) have carried out further 
demonstrations of how objects are enacted and re-enacted in different locations that 
modify the types of conceptualisations found in Mol’s (2002) project.  An article by Law and 
Mol (2001) discusses developments of STS alongside Mol’s (de Laet and Mol, 2000) previous 
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work and classifies her approach in terms of exemplifying objects as ‘fluid’.  Describing 
objects as fluid allows analysis to conceptualise them as highly dynamic as they move over 
different sites and are re-enacted each time they move in order to become operational.  
Conceptualising objects as ‘fluid’ implies remnants of the object can be found over its 
different enactions.  Therefore, the concept of ‘fluid objects’ offers distinct possibilities for 
the analysis of certain aspects of the practice associated with paediatric HIV.  If procedures 
used in Paediatric HIV clinical practice such as disclosure, adherence and transition move as 
‘fluid objects’, the gap between the clinic and the behaviours and lifestyles of patients can 
be described as flowing amid individual patients and practitioners in the practice of the 
clinic (distinct from the psychosocial approaches detailed above).  This provides the 
advantage of incorporating aspects outside of the clinic into practice in the clinic over 
extended periods of time.  However, as will be seen in this chapter, it does not account for 
ways in which care may not translate itself outside of the clinic. 
 
In accordance with outside challenges to enactions in the clinic, Law and Mol (2001) add to 
the idea of fluid objects.  They argue that objects are not only defined by the entities that 
they are enacted with, but are also defined by what they are not, or what they must avoid 
happening.  These are referred to by Law and Mol (2001) as ‘fire objects’.  They give the 
example of Cold War jets which were designed to perform in the possibility of nuclear war 
and so could take off from short runways in the event of it being destroyed, as well as being 
able to go fast enough to avoid Soviet anti-aircraft missiles.  The example demonstrates how 
an object (the plane) moves through space and keeps its shape (i.e. not being destroyed) 
through a relation between presence and absence.  I.e. the concept that an object is 
designed not through what will be present in normal usage but the absent influences that 
form the potential for things to go wrong (i.e. against what could destroy the aircraft).  In 
relation to the practice of paediatric HIV it could be posed that adherence, transition and 
disclosure are objects designed by the clinic to remain active against the outside threats to 
the continued enaction of viral suppression brought into the clinic.  For example, with 
adherence, one of the fire aspects that could be highlighted are the concerns caused by the 
stigma of taking antiretrovirals in front of strangers, or the difficulty for the average child to 
swallow certain pills leading to the design of the drug to be easier for children to take and 
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adhere to (Haberer and Mellins, 2009; CHIVA, 2011b). It places the incentive on clinical 
practice to maintain a logic which ensures that children are willing to take the medicine and 
are recorded and encouraged to do so in the clinic.  However, this still brings in to question 
how the object of adherence travels outside of the clinic, or if children ever interpret their 
own behaviour in terms of adherence14. 
 
The conception of ‘fire’ objects is interesting to highlight because it demonstrates just how 
far this ‘object/ontological politics’ goes and further warrants the naming and delineating of 
‘object politics’ as a particular and historical part of ANT.  It illustrates that the logical 
conclusion to ‘object/ontology politics’ is irresolvable multiplicity.  This raises the concern 
that the further an object is analysed the more it will endlessly continue to reference other 
actors.  Irresolvable multiplicity is an interesting point to highlight here as it demonstrates a 
trope that the analysis contained in this project does not want to fall into.  For example, if 
the clinic is viewed in this way, it becomes swamped in an endlessly multiple web of 
associations.  Instead, I wish to argue that the clinic makes emergent regimes of care and 
versions of paediatric HIV that consolidate complexity and make HIV medicine and viral 
suppression possible amongst the patient cohort.  This emphasises the significance of the 
clinic in formulating medicine especially when considering how entangled HIV medicine is 
with wider ‘social’ issues (Melvin and Sherr, 1995; Hekster and Melvin, 2006).  More 
generally, in ANT the conceptualisation of ‘fire’ objects has not been taken forwards by Mol 
or Law.  Law (2004b) has discussed similar ideas by dropping the term of ‘fire objects’ in 
favour of a concept of absence and enactment that is less burdened with specific 
terminology.  Accordingly, further reference to these ideas in this chapter or the thesis will 
favour the conception of ‘absence’ in enactment.   
 
Mol and Law have used their focus on ontological politics more broadly to talk about health 
and illness. Two articles written and revised over the same time period (Law and Singleton, 
2003; Mol and Law, 2004) are committed to employing ways to explore the movement of 
                                                        
14
 Froerer (2011) discusses how childhood understandings of illness can alter between cultures.  Using 
ethnographic research from an Indian rural village, Froerer demonstrates ‘non-western’ childhoods often left 
obscured in childhood studies.  Considerations of non-western culture, illness and childhood are relevant to 
paediatric HIV, as the majority of patients are from Sub-Sahara Africa. 
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objects and the constitution of specific diseases (however, they do not specifically reference 
conceptions of fluids or fire, which suggests a lack of commitment to the conception of fluid 
and fire objects in favour of other descriptive methods to be discussed in more detail in the 
following section).  These articles offer further reflections on how to imagine the enaction of 
disease which is also drawn upon heavily in the description of paediatric HIV found in 
research chapters.  Mol and Law’s (2004) study on hypoglycaemia, is concerned with tracing 
how the condition is not constituted as a solid object within the body but how it is enacted 
through the places and situations where the body is performed.  They detail the ways in 
which the body not only carries the disease on the inside but also enacts it on the outside.  
Firstly, hypoglycaemia is enacted through a patent’s knowledge of it.  Secondly, bodies 
enact the disease through constantly counteracting the disease.  Thirdly, bodies are not in 
isolation: in everyday life the diseased body acts on, and is acted on by other objects.  What 
is inside the body becomes visible and active outside of the body in these processes.  
Fourthly, the body is never fully coherent with each of its enactments and must constantly 
re-enact itself through these different strands or it will perish (also see Prout, 1996; Prout et 
al., 1999 in relation to childhood asthma and ANT).  The study by Mol and Law (2004) 
explores hypoglycaemia through highlighting commonly overlooked processes around 
maintaining the disease to demonstrate how it is part of a complex dynamic beyond one 
simplified version of the disease.  
 
“Medicine should come to recognize that what it has to offer is not a knowledge 
of isolated bodies, but a range of diagnostic and therapeutic interventions into lived 
bodies, and thus into people’s daily lives. Even the pathological gaze is not merely a 
gaze, but involves manipulation. Medicine’s activities always concern both what is 
beneath and what is beyond the skin. But if all medical operations, even if they simply 
seem to address bodies, are interventions in lives, then they should be appreciated 
accordingly.” (Mol and Law, 2004, p58) 
 
These notions of disease as being beyond the skin hold a major implication for the 
description of paediatric HIV.  Paediatric HIV is a condition where the stigma and 
vulnerability felt by patients is beyond the clinic and must be dealt with in the space of the 
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clinic, and so this is a point that will be revisited throughout research chapters.  However, as 
with atherosclerosis demonstrated earlier, the concept of enaction occurring on the inside, 
outside and beyond the body has limited compatibility to paediatric HIV.  Rather it would be 
more accurate to imagine that enactions taking place both inside and outside of the clinic 
are designed to conceal the condition.   Issues of discretion make their way into the clinic 
and are clinically ordained, whilst pill taking procedures performed in the house of patients 
is done so in the utmost discretion (Campbell et al., 2009, 2010).  The contribution that 
paediatric HIV offers this literature over examples such as hypoglycaemia is that compared 
to these descriptions of illness that offers a serene ordering of objects and enactions, 
locating paediatric HIV, even when presented in clinical practices, is not as easy to define, 
classify and separate.  This means that the necessity for the clinic to formulate medicine 
around patients and interpret guidelines and drug requirements flexibly is a more obvious 
issue than in hypoglycaemia. 
 
This is also the case with another study by Law and Singleton (2003)15 which explores a 
different illness, alcoholic liver disease (ALD).  The article attempts to render the object ALD 
to analysis through following disease ‘trajectories’ through an out-patient clinic.  Law and 
Singleton (2003) describe how the process of making a map strips detail from the object 
that is being represented by attempting to render reality comprehensive and stable.  They 
go on to argue that it is impossible that an object can ever be understood as fully 
representative.  They also demonstrate the multitude of trajectories and differences of 
interpretation in each representation of an object and the inferences that can come to bear 
on an object.   In the last section of the article, Mol and Singleton (2003) argue how the site 
of the out-clinic is an allegory for alcoholic patients and the kinds of objects that move 
through there by analysing how the out-clinic creates trajectories and boundaries.  This 
relates to clinical practice.  In this instance the clinic is perceived as a place where 
trajectories of patients and medicine could be seen to move through practice.  This article 
emphasises how trajectories link to complexities.  The notion of complexity or multiplicity 
and the requirement for the clinic to create clear trajectories is an important basis for the 
description of paediatric HIV found in research chapters.  Objects such as childhood and HIV 
                                                        
15
 And to a lesser extent a relating supplementary study: (Law and Singleton, 2000). 
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are chaotic from the point of view of practitioners of health care services, and a major 
theme of the thesis is how these incompatibilities must be successfully ordered into 
practice.  The research chapters of this thesis attempt to describe how complexities around 
paediatric HIV are organised through the enaction of procedures such as disclosure, 
adherence and transition.  What becomes more pressing when analysing paediatric HIV 
however, is not the passing of objects through the clinic, but the cultural awareness 
required at the site of the clinic to consolidate patient complexities and requirements into a 
coherent, functional medical regime (see discussion of Gibb et al., 2003 in chapter 6).  It is a 
limitation not overlooked by the authors when demonstrating their notes: 
 
“[They are telling us that] our metaphor of mapping is too simple.  I feel we should 
have seen this.  We will need multiple maps, with multiple points of entry.  Then we 
will have the job of seeing how these multiple maps partially connect with one 
another.  Perhaps the metaphor of a map is a bad one?” 
(Law and Singleton, 2003 p236) 
 
Clinical objects such as adherence, disclosure and transition emerge from practice and are 
made necessary according to the negotiation between the issues that patients present to 
the clinic and drug requirements.  This has the potential to contradict the advice of HIV care 
regimes, which means that patient movements are not linear but contingent.  Good 
examples of this are the role of disclosure in the face of child naivety to identify cultural 
representations of HIV as unhelpful to care, or transition planning to anticipate the allure of 
sexuality and peer pressure before patients are handed over to adult services.  All of these 
aspects must be negotiated and made compatible during clinic practice in order for it to 
succeed. 
 
Where the study on hypoglycaemia (Mol and Law, 2004) adds complexity to the condition, 
the other study on ALD seeks to trace linear trajectories through the complexities of the 
out-clinic (Law and Singleton, 2003).  Both approaches highlight different aspects of the 
interpretation of analysing heterogeneous objects and the conceptualisation of illness.  The 
considerations of disease being inside and outside of the body and the idea of patient 
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trajectories running through the clinic form the basis of several lines of enquiry found 
throughout the dissemination of research in this thesis.   For example they are used to 
imagine HIV stigma, childhood vulnerability, its existence beyond the clinic and how 
complexities can be followed through clinical practice.  However, by focussing so heavily on 
objects and ontologies the negotiation that takes place making these ontologies and objects 
possible is often overlooked.  These articles have their roots in debates around disease and 
its relation to the body rather than practice (good accounts of the relation between the 
body and illness can be found in Turner, 1992; Lupton, 2003).  Therefore, what is offered in 
this account in relation to these studies is a more acute focus on the role of the clinic to 
consolidate complexity and medical requirement rather than following associations through 
their multiple enactions beyond the clinic.   
 
In contrast to the psycho-social study of paediatric HIV (Battles and Wiener, 2002; Gibb et 
al., 2003 Green and Smith, 2004), Mol and Law (2004), Law and Singleton (2003) offer a 
mode of analysis that goes beyond a ‘matter of fact’ view of the body containing the virus or 
clinical intervention being either psychological, sociology, clinical or scientific.  These STS 
authors provide an analysis that describes the child, the condition, and interventions as 
simultaneously enacted together, which has greatly contributed to the approach to 
paediatric HIV in this thesis.  However, while Mol, Law and Singleton emphasise complexity 
and contradictions between categories, their own accounts are contrarily precise, ordered 
and lacking in patient/practitioner/protocol negotiation when compared to the complexity 
generated in accounts of paediatric HIV.  Spheres of knowledge, practice, lifestyle, ethnicity, 
representation and stigma within paediatric HIV are often not possible to differentiate in 
practice.  What is emphasised in this thesis is the clinic’s key role to consolidate patient 
complexity and drug requirements into functional medicine.  In paediatric HIV cases, the 
operation of clinical practice relies precisely on the fact that medical requirements are made 
flexible enough to span and make compatible many spheres of knowledge, practice, 
lifestyle, representations, stigma etc. 
 
As stated before, the focus of this thesis is on the role of clinical practice in the formulation 
of HIV medicine and treatment.  The work of Mol and Law plus others who identify with ANT 
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is important for demonstrating how objects are presented and practiced in the clinic over 
many enactions of HIV, childhood, blood tests and antiretroviral medicines.  By discussing 
‘the turn to enaction’, a number of advances in epistemology become apparent.  For 
example that practice must constantly re-enact aspects of care and the condition that occur 
repetitively.  For example different versions of childhood, or clinical and laboratorial 
medicine and drug recommendations must all be re-enacted.  Each aspect of clinical 
practice does not occur prior to the situation that it is enacted within, and therefore must 
be re-enacted each time it is used (White et al., 2012).  As noted above, this has many 
implications for practice and power over explanations of the ‘social’ in clinical practice 
found in literature such as the psychosocial (Battles and Wiener, 2002; Green and Smith, 
2004; Steele, 2007), or sociological literature tracing biomedical power (Rose, 2006; 
Foucault, 2010).  Therefore, as argued, a model of care as hierarchical where protocol 
dictates practice becomes untenable as protocol must be constantly enacted, and adapted, 
in the clinic.  These articles are referenced heavily in the research chapters as they open up 
lines of enquiry around the condition that highlights paediatric HIV practice as an endeavour 
to organise the multiplicity presented during recurrent clinical enactions.  However, many 
questions and considerations still remain around the ways in which this literature can be 
applied to paediatric HIV and clinical practice.  Compared to the discussion of practice and 
disease offered by the texts discussed above, paediatric HIV requires a clinical practice that 
requires sensitivity and flexibility in order to span the divides presented by patients and 
medical requirements.  Therefore, beyond the endless multiplicity generated through 
engaging in ‘object/ontology politics’ the thesis wishes to assert how the clinic must be 
arranged to consolidate medical requirements with complex patient dispositions.  It follows 
that the discussion of the empirical chapters on disclosure, transition and adherence will 
contribute to this literature by offering a discussion of how enactions taking place in the 
clinic that consolidate disparate situations into a coherent medicine and make suppression 
possible. 
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Patient Negotiations 
The next section turns to scientific knowledge, patient participation and the discussion of 
three articles by Callon and Rabeharisoa (2002; 2003, 2004) that were written around the 
same time as the articles in the previous section16.  The main articles chosen for this section 
have direct relevance to clinical practice as they demonstrate how care is administered in 
protocol and practice through the negotiations that take place between patients and 
practitioners in the clinic.  The study will examine clinical practice as a series of processes 
engaged in enacting and re-enacting, but also as processes of translation where patients as 
well as practitioners negotiate care.  These negotiations decide what is relevant in the 
medicine and how to apply protocol, guidelines, treatments and resources.  Whereas in the 
articles by Mol and Law (e.g. Mol, 2002; Mol and Law, 2004) the discussion led to focusing 
on the enactment of specific objects and ontologies in clinical practice, Callon and 
Rabeharisoa on the other hand can be used to trace how clinical practice and the medicine 
that is practiced is participatory between patients and practitioners and wider networks of 
policy, protocol and patient cultures.  The focus of Callon and Rabeharisoa is diverted from 
enactment of distinct ontologies towards emphasising negotiation and translation between 
actors. 
 
Within STS the relation between scientific knowledge and public participation forms a 
central debate of the discipline.  I will briefly contextualise these debates before moving 
onto the work of Callon and co-authors.  One important preoccupation is that a 
misconception prevails between the practice of science and the general public.  Firstly, that 
there exists two distinct spheres between medical knowledge and patient/ lay knowledge; 
and secondly that it is possible to separate objects and tasks definitively between the two 
spheres (Williams and Popay, 1994;  Alderson and Montgomery, 1996)17.  The stance of ANT 
would contrast against this style of reasoning by emphasising that the position of 
participants in scientific knowledge is dependent upon the assemblage of actors enacted 
                                                        
16 Michael Callon is a cofounder of ANT, but I argue that there are large differences between the type of ANT 
that he advocates and the one that can be found in the work already presented in this chapter, these 
differences have implications for how clinical practice can be conceptualised as enacted and by whom.   
17 Williams and Popay (1994) offer a prime example of reasoning from the position of using differing spheres to 
account for public and scientific knowledge.  This could be confused further by considering a sphere separately 
for the knowledge of childhood as suggested in Alderson and Montgomery (1996). 
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around a scientific debate.  This means that ANT abandons the centrality of the scientific 
sphere in favour of a more contextualised notion of scientific knowledge as individual 
assemblages (Latour, 1987).  This is significant for clinical practice as the debate informs 
how child patients and practitioners negotiate the necessary scientific knowledge required 
for suppression of HIV with antiretroviral medicine.  A large amount of literature already 
exists on this subject which will only be briefly discussed here.  This discussion includes how 
scientific knowledge is entangled within many other forms of knowledge, and how 
knowledge that is generated outside of scientific method becomes included within scientific 
enquiries (Irwin and Wynne, 1996).     
 
Wynne’s (1996) study of risk and the environment is one notable study that developed the 
argument for an understanding of scientific knowledge as having a cultural/hermeneutic 
character.  The study examines the way in which discourses concerning the environment 
and the risks associated with it almost exclusively verify each claim through linking it to 
something seemingly scientific or the opinion of an ‘expert’ (see also Wynne, 1988; Irwin 
and Wynne, 1996).  Like other projects written during or before this period, Wynne wanted 
to alter the ways in which science is used and conceptualised in order to emphasise its 
construction through cultural processes (see Law, 2004a).  Later literature extends this 
cultural consideration towards a model of knowledge that emphasises the procedural 
aspect of the generation of scientific knowledge, rather than there being a pre-existing 
category of scientific knowledge.  Irwin and Michael (2003) produce a model of scientific 
knowledge that conceptualises scientific issues as ‘ethno-epistemic assemblages’.  Their 
model sees the social world as made up of artefacts that move freely across different 
spectrums of knowledge, from public knowledge to scientific and medical knowledge.  
Rather than any one form of knowledge sending out intermediaries to take over another 
form of knowledge, they have boundary areas that allow artefacts to be exchanged 
between the two without any loss of identity.  Irwin and Michael (2003) look at places 
where the boundaries between public knowledge and science overlap.  They emphasise that 
pure scientific knowledge is impossible to achieve because it must always be in reference to 
something else, and so advocate tracing how knowledge must be presented as a ‘scientific’ 
issue rather than searching for places where public knowledge and science meet.   
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Although the main focus of the studies discussed above is scientific knowledge, it has large 
implications for clinical practice.  Aside from patient groups, the model of Irwin and Michael 
(2003) would imply that when patients are in clinical consultations, they are engaging with a 
form of medical scientific knowledge and that the treatment of HIV is made possible 
through a patients’ engagement in the medical knowledge ordained by practitioners.  
Rather than clinical practice imposing protocol or biomedical knowledge upon patients (as 
set in motion by Canguilhem, 1991 and; Foucault, 2010), patients engage in boundary areas 
and have the potential to participate in the enaction of medical knowledge and the 
application of protocol (also see Dodier, 1998; Latimer et al., 2006; Timmermans S and 
Buchbinder M, 2010, 2012).  This has a double implication when considering child patients 
because there exists an additional debate around their capability to make clinical decisions, 
or their naivety when talking about death or sex (Bluebond-Langner and Nordquest 
Schwallie, 2008; Kehily and Montgomery, 2008; Bluebond-Langner et al., 2010).  However, 
by applying the same logic it is asserted that children and adolescents presented at the clinic 
must also be negotiated when engaging in clinical practice (Christensen, 2004; and Prout, 
2005).   
 
This thesis will not present power in the same way as discussed in studies such as Foucault 
(2010) or Canguilhem (1991).  The thesis does not describe the interactions going on in the 
clinic between child patients and practitioners principally as an issue of power.  Descriptions 
of power as central to clinical relations are circumvented in this thesis and power is 
alternately framed as being multiple and diffused contradictorily through-out the clinic.  
Agency is recognised as being able to be mutually exerted in both directions from 
practitioners to child patients and from child patients to practitioners.  Therefore, the 
notion of power is avoided in favour of a conceptualisation of clinical relations as enacted 
through the continuous negotiation of agency rather than a one-directional imposition of 
power.  The focus on enaction also avoids a conception of power as existent beyond the 
specific enactions taking place in the clinic, in each successive enaction patients and 
practitioners must renegotiate how medicine will be practiced.  In research chapters, 
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references to power are minimised due to the commitment of conceptualising practice as 
enacted.  
 
Callon’s own contribution to debates around the distribution of scientific authority could be 
linked to the concept of translation (Callon, 1986).  In its original presentation, when applied 
to the example of the Fishermen of St Brieuc Bay, Callon poses that each time scientific 
knowledge is practiced it is not simply applied but must be translated between relevant 
actors, simply put, that knowledge must be rendered comprehendible and compatible over 
the groups of actors that will use the knowledge.  According to Callon, translation develops 
through four stages:  problematisation, where a problem is identified and made distinct, 
interessement, the process of interest and accepting of the problem between actors, 
enrolment, where the group delegates roles, and the mobilization of allies, the process of 
mass adoption or rejection.  The power of the concept of translation is that knowledge is 
highly contingent upon the negotiation of actors present in the translation.  The adaptability 
of the concept of translation means that it can be used to describe public participation with 
science as well as the wider transfer of public knowledge.  Indeed in French academia the 
term ‘sociology of translation’ is more commonly used than ANT (Akrich et al., 2006).  
Therefore, using the concept of translation could describe clinical procedures such as 
adherence or transition as translations of protocol between patients and practitioners 
required by the scientific knowledge of antiretroviral medicine to ensure the ongoing 
possibility of viral suppression.  However, this is not to say that the application of the 
concept of translation will always be so clearly formulated with one particular mode of 
employment.  Protocols of adherence, disclosure and transition would not simply be 
translating medical knowledge but also contain a much more complicated dispersion of 
connotations about ethnicity, childhood, secrecy and stigma (Futterman et al.,2000). 
 
Callon and Rabeharisoa (2003; 2004; 2002) demonstrate a more subtle use of the concept of 
translation to argue that patient groups18 form a platform where patients can exert pressure 
                                                        
18
 In the original articles by Callon and Rabeharisoa (2002, 2003, 2004) they use the term ‘patient associations’, 
this term has been substituted here to ‘patient groups’.  This is to avoid confusion as throughout the thesis I 
refer to the term ‘association’ mainly inspired by its defined in STS analysis such as Latour (2005).  The term 
‘association’ is used in STS to describe the relationship between actors.    
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onto medical knowledge.  They argue that clinical practice must refer to the considerations 
of patient groups when being ‘translated’, and that the agendas of patient groups have a 
direct influence upon scientific agendas and the clinical practice of medicine.  For HIV, many 
patient groups exist with varying functions and levels of influence, like for example UKCAB, 
iBase, Microbicides Working Group, Terrence Higgins Trust or AIDSMAP19.  A smaller 
amount exists solely for children, a few London-based examples are Body and Soul, Positive 
Parenting and Children (PPC)20 and CHIVA, whilst some larger HIV organisations are also 
involved with issues around children and families like NAM.  The group that will be taken 
forward as an example for the remainder of this section is CHIVA.  As a group, CHIVA is not 
strictly a patient group but started out as a professional group designed to set policy and 
practice guidelines and protocol.  However, the role of the organisation has broadened to 
include contributions from a young person’s advisory board and make recommendations to 
families and children (CHIVA, 2012b).  Therefore, CHIVA operates over many levels of public 
and scientific channels.  I have chosen to focus upon its functioning in this section and the 
ensuing thesis because it also plays an indistinguishable role in laying down clinical 
guidelines for practice. 
 
Rabeharisoa and Callon (2002) support the idea that patient groups have a participatory 
relationship in the scientific knowledge of their condition.  Their article (2002) draws on 
research conducted on French patients’ organisations and suggests that patient groups 
make up major contributions to the study of medical science.  The article highlights that 
patient groups in France provided substantial funds to the research of many conditions such 
as Creutzfeldt-Jakob disease, ataxia, haemochromatosis, Alzheimer’s, cystic fibrosis, 
lysosomal disease, cancer, autism and AIDS.  Rabeharisoa and Callon (2002) argue that 
through paying for research, patient groups shape the medical science around the disease 
by setting the research agenda and paying for the research they want to be done and which 
they surmise is worthwhile.  These arguments highlight that patient groups are responsible 
for informing the research agenda and what is known in medical science on a particular 
disease (Epstein, 1998).  This corresponds to the role that CHIVA and other patient groups 
                                                        
19
 UK based charities that offer support to those infected with HIV/AIDS. 
20
 Body and Soul and PPC are London based charities that are organised around children with HIV.  
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have in shaping paediatric HIV.  However, the process that CHIVA plays in informing medical 
science is embroiled in the way that the condition is encountered in the clinic.  For example, 
in the face of high levels of African immigration, HIV being a high-profile issue and heavily 
stigmatised, one implication is that clinical practice and corresponding CHIVA policy tends to 
focus heavily on the issues of confidentiality and the privacy of families rather than 
arguments common in other groups around visibility and engagement (Boulton, 
forthcoming; Parker and Aggleton, 2003).  Within CHIVA, guidelines are negotiated in 
practice to ensure that children are protected from the negative stigma of HIV.  For 
example, CHIVA guidelines on disclosure are geared towards educating children on HIV, the 
inaccuracies common in the public sphere and the importance that they should not tell 
anyone else about their HIV (Committee on Pediatric AIDS, 1999b; Wiener, Mellins, et al., 
2007; CHIVA, 2011c).  The effect of patient/practitioner negotiations has made its way into 
the guidelines and the administration of care through the concern of patients and their 
families in the clinic, forcing practitioners to engage in the task of repetitively scrutinising 
the relationship between patients, protocol and their practice in order to facilitate patients.  
Practice must be aware of the issues presented and demanded from patients, and this is 
reflected in the CHIVA guidelines that emphasises an approach (or to relate the point to 
Raebaharisoa and Callon 2002 a type of scientific knowledge and public engagement) that is 
discreet, educative and flexible to clinical encounters where confidentiality, stigma and 
ethnicity may have multiple implications. 
 
The emphasis on flexibility in guidelines for clinical practice can be compared to how patient 
groups influence the local deployment of medicine according to Callon and Rabeharisoa 
(2003), who focus specifically on the Association Française contre les Myopathies (AFM).  
Their argument emphasises how the group works to facilitate cooperation between patients 
and professionals.  Callon and Rabeharrisoa (2003) conclude by arguing that the emphasis 
on communication stressed by the AFM results in the standardisation of the medicine 
through the group collating many patients’ voices and accounts into one resource.  This 
enables the group to make comparisons on the deployment of the medicine over the entire 
country with an eye on improving care, resulting in the creation of a set of standards 
patients can expect from the medicine (Timmermans and Berg, 2003).  CHIVA guidelines 
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also have the role of consolidating patient and practitioner consultations into standardised 
procedure (CHIVA, 2011d).  Although strictly speaking these guidelines are not organised 
and exercised by patients (as guidelines are written by practitioners), this process of 
informing and re-informing practicing must be reflected in the assembly of guidelines.  
According to Latimer et al (2006) medical guidelines, more generally, are designed to be 
flexible to patients’ situations and are revised on a regular basis to insure that they are still 
relevant to their local deployment.  In HIV medicine, as I will show, clinical encounters, 
protocol and clinical practice is further standardised and shaped through 
patient/practitioner interactions (Inversely, the patient group also places expectations on 
patients around how to understand and engage with the medicine – more on this 
consideration later).  Callon and Rabeharisoa (2003) put forward that a major error in the 
analysis of these contributions from patient organisations would be to assume that they are 
contrary to science or, the inverse, to claim the superiority of lay knowledge due to 
increased realism.  In their words: 
 
“On the one hand, it is claimed that objective and universal scientific knowledge is 
necessarily produced in laboratories within the community of specialists; on the other, 
it is asserted that truth and effectiveness are local and contextual.” (Callon and 
Rabeharisoa, 2003).  
 
Callon and Rabeharisoa (2003) argue that the types of knowledge applied by these groups 
mutually constitute each other.  This implies that in order to deploy medical science in an 
area, local knowledge and local groups must be taken into account.  Correspondingly the 
organisation of local groups must take into account established scientific view points (see 
also Landsman, 2006).  This can be interpreted in relation to CHIVA clinical guidelines that 
aim to be flexible towards the personal circumstances of patients.  The contrast between 
what is scientific and what is cultural is emphasised when considering the practice of 
paediatric HIV.  The biomedically defined requirement for suppression, although 
conceptualised as absolute, is rendered redundant if it is not interpreted by patients and 
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adhered to by them21.  For this reason, rather than protocol dictating what practitioners 
must make patients do, protocol must instead detail to practitioners how to look for 
contingency in application, negotiation, persuasiveness and flexibility in interpretation of 
requirements whilst prioritising the overall task of adherence (Drotar, 2000).  Therefore, 
when guidelines are followed in the clinic, Callon and Rabeharisoa (2003) would describe 
this process as one of local deployment.  The process whereby the guidelines/protocols are 
locally deployed further constitutes the formation of the medicine as it establishes what 
standards it will adhere to, and what components are essential parts of the medicine and its 
identity.  For paediatric HIV, the deployment of local services has a further innate 
implication because in the UK the condition is not evenly distributed geographically.  The 
majority of families with HIV are clustered around urban centres and the vast majority 
around London (CHIPS, 2010).  Therefore, the deployment of services between these 
locations and other areas of the UK must also reflect this in guidelines.   
 
This raises a subsequent consideration around how patients’ identities are also being 
constituted through interactions with patient groups and the application of protocol.  
Clinical practice has an influence upon how patients’ identities are formed (also see 
narrative analysis as applied to chronic illness Williams, 1984; Sontag 1988; Bury, 2001; 
Frank, 2010).  Patient associations are formed to give patients an opening for 
communicating with practitioners.  The group also organises patients into acceptable ways 
of interacting with the requirements of, in this case, antiretroviral medicine.  It verses 
patients collectively on how to interact with the medical requirements and through exerting 
its aims, gives patients an idea on what they should be expecting from adhering to the 
medicine.  For Paediatric HIV, CHIVA has interpreted this as giving children and families the 
opportunity to follow developments in the medicine.  For example they provide sections on 
the website designed to inform about care and common issues, and allow children to 
address the collective of practitioners through a formalised child advisory board (CHIVA, 
                                                        
21 This is complimented by Stengers (2003) who argues that because the scientific object of medical science is 
the human body which has the possibility to give an unreliable testimony, there will always be a central 
question in medical science about the possibility of the practitioner becoming a charlatan.  Also linking to a 
range of discussions in the sociology of health and illness around the limits of creating an evidence based 
practice through protocol and practice see Berg (1997b); Mykhalovskiy and Weir (2004); Harrison and 
Checkland (2009); Broom et al. (2009)  
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2012c).  Consequently, in order to be effective, patients who use or participate in the 
resource must take on the outlook and concerns of the group.  However, the ways that 
patients live with the condition may not always be as simple as patients taking on board the 
outlook of the patient group.  As already stated, for children with HIV, the difficult 
associations between patients and practice including childhood, ethnicity and inner-urban 
cultures, often render patients’ attitudes incompatible with CHIVA recommendations of 
practice22.  When brought together, the practice of medicine (or adherence to antiretroviral 
medicine) and the lifestyles of sufferers form a complex set of considerations, and it may be 
the case that child patients do not act in ways compatible with the standpoint a certain 
patients’ association wishes to project, (Gosling et al., 2004; Hekster and Melvin, 2006; 
Dorrell et al., 2008; Campbell et al., 2010).   
 
Callon and Rabeharisoa (2004) conducted a case study of a patient whose outlook was 
contrary to that of the Reunion Isles Muscular Dystrophy Association (ARM).  The article 
describes an interview with Gino the brother of the vice chairman of ARM.  In the interview 
Gino only contributed to three dialogues.  In these dialogues, Gino seems to refuse the ARM 
and its view of medicine.  In the first dialogue he details that he has not searched out a 
specialist doctor because he knew from other members of the family what he has and that it 
is non-curable.  In the second dialogue he states that he does not participate in ARM 
meetings.  In the third dialogue he says that he has not tested the children for the condition 
and would rather not know whether the children have it or not.  In the first instance, Gino’s 
refusals could be taken as being reckless and amoral.  They argue that medical, as well as 
the social sciences construct public arenas that propagate certain morals and the 
acceptability of such values.  These morals seek to define what is proper and what is human.  
The authors assert that by Gino remaining silent and refusing to answer some questions 
fully, it is not a demonstration of Gino’s amorality but instead the enactment of different 
forms of humanity. For Callon and Rabeharisoa (2004) this is a rally for a type of sociology 
which is reflexive enough to gain symmetrical views of the social world, but can also be 
                                                        
22 This could be considered in relation to the “child voice” as described in Komulainen, (2007); Lewis, (2010) 
where gaining opinions from children is deemed as important, but children may not have formulated an 
opinion compatible for research, or in this case practice. 
Literature Review 
 
52 
 
taken as a commentary between a public arena, the ARM, and the implications, variances 
and reactions that this assemblage creates towards members and associates. 
 
Within paediatric HIV, a patients’ integration into CHIVA, Body and Soul, PPC, clinical 
practice or any other organisation is therefore subjected to the personal circumstances and 
disposition of the individual (Persson and Newman, 2006).  Within the empirical chapters of 
this thesis many examples of staunch participant opinions are seemingly contrasted against 
the requirements of antiretroviral medicine.  However, it is in this process where 
negotiation in clinical practice and the adoption of protocol and drug requirements as 
flexible become paramount (Persson et al., 2003).  Over time, a patients’ requirements 
change, children get older and develop, the issues they face and convictions they hold also 
change and must be facilitated into the practice of the clinic and administration of the 
medicine (Fielden et al., 2006; Bernard, 2008).  What can be highlighted from this approach 
of focusing on negotiation is the process where patients inform and are informed by 
practice in the clinic which is an essential part of achieving adherence (Casta eda, 2002 talks 
about this process in relation to the reverberations of imaginations of childhood).  Thus, 
rather than scientific knowledge being something separate to these clinical negotiations 
with children, negotiations inform how the medicine will be interpreted, understood, 
valued, researched and subsequently practiced (see Rosengarten, 2009 for discussion of 
complex interplays between biological materials and knowledges around HIV). 
 
Overall, the discussion of patient groups being involved in the medical science and 
mediating patient interactions with medicine highlights some interesting nuances in the 
relationship between scientific and public knowledge.  There is not just one way to relate to 
the medicine but many, and there are also many ways in which the condition and notions of 
humanity exist (Lee and Brown, 1994).  The key implication (and therefore contribution to 
the literature detailed in this section) for this thesis is that it is in the clinic where disparate 
patient complexities, humanities, medical requirements and protocol are negotiated.  The 
cohort of children at UOUH live in an urban environment and have diverse backgrounds.  
The potentiality for difference amongst this group is large, thus it requires flexible and 
thorough clinical practice (Conway, 2006; Foster et al., 2007).  Scientific discourse, clinical 
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practice and the professional organisation (CHIVA) have linked sets of codes, guidelines and 
protocol.  These guidelines seek to order the complexity of paediatric HIV and render it 
treatable.  However, the ways in which guidelines must necessarily be interpreted and 
practiced in the clinic allow for a large amount of dynamism, overlap and contradiction.  
Stengers (2003) further highlights this antagonism and argues that the figure of the 
charlatan is inherent to the medicine and that ‘scientific’ medicine strives to distance itself 
away from it but at the same time cannot eradicate it as the object under research, the 
‘suffering body’, is not capable of giving a ‘reliable’ testimony of facts.  Consequently, in this 
project the aim is not to emphasise these antagonisms or highlight ‘unscientific’ aspects of 
paediatric HIV medicine, but to demonstrate ways in which the practice works in spite of 
them and is made coherent in accordance to them (also see discussions on evidence based 
medicine Harrison and Checkland, 2009).   
 
This section is not exhaustive in defining what constitutes patient/practitioner negotiations 
and medical science, just one particular branch of it.  Building on the previous section, this 
section has focused upon processes of negotiation between patients, practitioners and 
protocol necessarily central to practice in order to make viral suppression possible.  Through 
the process of ongoing facilitation of the outside concerns of patients into adherence 
guidelines in the clinic, the consolidation of disparate patient dispositions into knowledge of 
the virus and responsibility for maintaining it is made possible (Pontali, 2005).  The 
differences between this version of ANT and the one found in the first section can be seen 
to have alternative implications for how to approach Paediatric HIV. Unlike the discussed 
Law and Mol (Law, 2004a) articles on ‘object politics’, Callon and Rebharissoa (2003) 
advocate a more keen focus on negotiation between patients, families, medicine, 
practitioners, protocol and patient groups etc., rather than tracing a minute view of specific 
objects.  This offers more freedom and avoids being overly caught up in considerations of 
the differences between objects.  Through focussing on CHIVA and other organisations and 
the way they inform/are informed by practice, analysis is provided with a resource that 
holds many important considerations around the mediation between the practice of 
medical science in paediatric HIV and the assemblages of the patients as children who are 
naive, ethnically diverse or culturally different.  Within the condition of paediatric HIV, a 
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wide array of medical/professional and patient groups play a part in the translation of the 
condition into practice, informing versions of the medicine and informing the identities of 
patients, resulting in a mutually negotiated definition of paediatric HIV and antiretroviral 
treatment (Preda, 2005; Fassin, 2008).  Through viewing organisations such as CHIVA and 
the specific clinic, the study of the clinical practice of paediatric HIV is made even more 
versatile and dynamic as it offers an insight into the ways the application of knowledge and 
patient/practitioner concern is performed/made possible in accordance to protocol.  What 
is asserted in contrast to a hierarchical model of medicine that dictates practice follows 
protocol is that the clinic is a key site in the formulation and consolidation of the medicine. 
The Sociology of Childhood 
This section is concerned with two issues about childhood: firstly how childhood can be 
imagined in the clinical practice of paediatric HIV and secondly, the extent to which clinical 
needs to alter practice according to child naivety, innocence and vulnerability.  These are 
important concerns as they question how clinical practice is made possible around 
childhood innocence and also how this innocence can be viewed in relation to the clinic and 
the task of viral suppression.  The section will frame the Sociology of Childhood (SoC) in 
relation to clinical practice through a discussion on social constructionism and ANT23.  I will 
use the literature to argue that clinical enactions in paediatric HIV must negotiate issues of 
childhood when administering medicine.  The literature will also be used to highlight 
processes in the clinic where medicine is operationalised along with ideas of childhood 
through the application of guidelines to child patients during practice.  In the paediatric 
clinic, what SoC would term ‘the imagination of childhood’ has many implications for 
practice.  It defines the boundaries between paediatrics and general services (Armstrong, 
1979), the role of children in decision making and participation (Alderson and Montgomery, 
1996; Bluebond-Langner et al., 2010) as well as the administration of medicines and 
procedures (Christensen, 1998; Cohen et al., 1999).   The key debates to be discussed 
                                                        
23 A wider array of studies also exist under the name of childhood studies, which broadly follows the new 
sociology of childhood shown here but also has developed theory aside from SoC.  One particular approach we 
could assess as to whether it can be used to explore HIV comes from Corsaro (2003, 2005), who has forwarded 
his own approach to the sociology of childhood.  This work runs parallel to the social constructionist accounts 
detailed above but does not take on the same approach to viewing childhood, following the work of Pierre 
Bourdieu instead of STS. 
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around SoC are in relation to childhood power, imaginations of childhood (e.g. as vulnerable 
or naive) and viral suppression being made possible by facilitating children into clinical 
practice and guidelines.  
 
James and Prout (1997) credit the new sociology of childhood24 as emerging from a general 
paradigm based on a range of problems identified with common held views of childhood, 
and the study of childhood within the social sciences.  They see this as the point in which 
the study of childhood became of interest more broadly in the social sciences and 
distinguished itself away from developmental psychology, which up until then was the only 
discipline interested in childhood issues of this type25.  The new paradigm expressed a 
number of core concerns for the study of childhood.  Specifically, it placed emphasis on 
childhood being socially constructed; stopped idyllic ideas of childhood that obscure other 
social variants such as class and race; put forward childhood as an object for study in its own 
right; and stressed the idea that children are active participants in their social landscapes 
and not just passive subjects (James and Prout 1997).  The purpose of this paradigm was to 
establish new and more satisfactory ways of viewing childhood.  Since then, the study of 
childhood across the social sciences has grown and now contains a diverse array of studies 
(see Moran-Ellis, 2010 for a historical overview of the discipline).   Applying SoC to paediatric 
clinical practice offers insights that highlight some underlying assumptions about childhood, 
especially around vulnerability, naivety, innocence or incompetence etc.  These assumptions 
often result in diminishing the agency of children in clinical participations and decision 
making (Mason, 2005).  The aim of this section will be to review some of these approaches 
to the study of childhood and ‘imaginations’ of childhood.  When highlighting these 
considerations on childhood the emphasis is not ‘to police the line of difference’ (in line with 
the general approach of Oswell, 2012), but to trace how practice is made possible in 
accordance to them, ensuring that this thesis has a reflexive deliberation on common held 
conceptions of childhood. 
                                                        
24 When James and Prout’s (1997) first edition was published in 1992, they used the term ‘new sociology of 
childhood’ to distinguish it from work that had previously been carried out.  For use here the sociology of 
childhood will not be referred to as new other than to reflect upon the period when the social constructionism 
was used to study childhood.  Other than as use for distinguishing subsequent studies should always be new. 
25
 Also see: http://www.brunel.ac.uk/research/profiles/sssl/jenks 
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The early literature of SoC, developed in the UK during the 90’s and predominately used 
social constructionism to approach issues of childhood (Moran-Ellis, 2010)26.  This approach 
sees childhood as an entity that is constructed wholly through social interactions (Burr, 
2003).  It detaches childhood from the view that it is a stage of mental, intellectual or bodily 
development from childhood into adulthood, but instead that childhood is a process 
constructed by society and projected onto children, separate from the biological process of 
the growth of the body.  In this view, childhood becomes a construct wholly created through 
social and cultural processes that informs the nature of childhood and how children should 
be interacted with, independently from the ‘actual’ biological immaturity of the individual.  
This culture/nature discrepancy leads to an idea of childhood as culturally constructed 
irrespective of the biological ‘actuality’ of the child.  This highlights commonly-held cultural 
ideas of childhood as being based on falsehoods and idealisms, like the idea of child naivety 
or childhood being free of worries and cares, or of the child as pure innocence.  The 
approach argues that these views of childhood result in conceptions of childhood as 
stripped of any agency, seen as abstracted and incapable of being part of the social worlds 
that surround them (James et al., 1998; Matthews, 2007; Jenks, 2008).  In relation to social 
constructionism, clinical practice would be considered a key site where childhood is socially 
construed as naive resulting in practitioners stripping child patients of their agency.   
According to this model, clinical practice culturally constructs the child patient as naive 
towards regimes of care and treatments they will follow, excluding them from participation 
in the clinic and the decision making process according to the justification that children 
cannot capably rationalise their complex health needs in the long-term before they are an 
adult ( Christensen, 1998; or Mason, 2005). 
 
In the book Constructing Childhood, James and James (2004), put forwards ways in which 
child healthcare is socially constructed.  The book uses policy in the form of Acts of 
                                                        
26 Authors such as James, Prout and Jenks (see James et al., 1998 for a collaborative example) worked 
collaboratively to explore childhood with social constuctionism.  In more recent literature, Prout has moved 
away from social constructionism (as in James and Prout, 1997) towards ANT, Deleuze and STS (Prout, 1996, 
2005; Prout et al., 1999) whilst James (2004) has continued to champion it, providing a variety of approaches  
in SoC as a discipline.   
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Parliament and institutional health policies to exemplify ‘social practices’ where childhood is 
seen as a time of naivety and diminished rationality.  They go on to argue that these policies 
hold ideas of childhood that are misconceived and result in policy makers seeing children as 
a ‘becoming’ and not an ‘actuality’ which leads to bad health policy and practice.  
Subsequently, James and James argue that health policy makers see children as a 
potentiality (this can also be linked to an idea of ‘becoming’27) and not an entity able to 
reason in the present.  This means that through policy and in the clinic, children are viewed 
from their potential as healthy adults rather than being dealt with as an ‘actuality’ of the 
present.  James and James (2004) use the example of obese children and argue that policy is 
formed not around the child, but around preventing adult obesity and seeing childhood as 
the place to tackle adult obesity.  One of the strengths of social constructionism is that it can 
be used to challenge many commonsensical ideas of childhood found in clinical practice or 
protocol that are based on false or exaggerated conceptualisations that would not normally 
be contested.  For example, the idea that through naivety, children are not able to take on 
the decisions for themselves that will later decide what kind of life they will lead (also see 
Woodhead, 1999).  Applying this type of social constructionism to paediatric HIV can explain 
the political nature of some accounts of HIV and children, especially in media reports of 
children (e.g. media report of Day, 2011) that denote them as being innocent victims caught 
up in a disease ill-matched with childhood (Meintjes and Giese, 2006; Fassin, 2008).   The 
sensationalised public account of children with HIV as 'innocent victims’ is often present in 
the reasoning of clinical practice and protocol.  For example this can be seen when looking 
at the procedure of disclosure.  Policy and practice argue that disclosing HIV to a child 
should take place at around the age of 11 or 12 when they are able to keep a secret, but 
before they have taken on public stigma of the disease (Committee on Pediatric AIDS, 
1999b; CHIVA, 2011c). Disclosure effectively educates children about a clinical and ‘un-
stigmatised’ version of HIV at the earliest opportunity, which demonstrates how politically 
aware of childhood innocence those who administer care and policy must be.  Variations of 
the social construction of childhood innocence and sexuality have been used to discuss 
                                                        
27 The idea of a child as becoming is theme that can be seen in much literature of the sociology of childhood, 
but the idea of becoming is different over these accounts. The idea of becoming is one that has differences in 
meaning over the different stances In SoC (see Prout, 2005). 
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childhood, HIV and sexuality.  These debates argue that the sexual rights of children should 
be considered not from the perspective of children being protected from outside sexual 
influences but rather as the owners of their own sexuality and capable of making decisions 
regarding their own sexuality (Mitchell and Smith, 2001; Mitchell et al., 2004; Bhana, 2007; 
Kehily and Montgomery, 2008).   
 
However, the approach of this thesis seeks to highlight how antagonisms in clinical practice 
are made compatible and, therefore, naivety and diminished agency are not described as 
being ‘policed’ but highlighted as ‘facilitated’ in the clinic and protocol.  Imagining childhood 
as a ‘potentiality’ implies a power structures that is uni-directionally applied by adults on to 
children which negates all the other possible ways childhood interacts in a given situation, 
and the wider networks of associations (such as stigma or confidentiality) that are active in 
clinical practice28.  The focus on potentialities ignores many other complex impetuses to 
make clinical interventions (Gallagher, 2008).  One counter example that can be sited here is 
the fact that the antiretroviral medicine that must be taken to allow children to grow into 
adults will adversely affect their health in the long term (Nachman and Pediatric AIDS 
Clinical Trials Group 377 Study Team, 2005; Kim, 2010).  Consequently, these ideas of 
enforcement through potentiality and childhood becoming are incompatible to the central 
argument of this thesis that guidelines are mutual negotiated between patients and 
practitioners, and that children do exert an influence in the formulation of paediatric HIV 
medicine.  Even in the example given in the previous paragraph on disclosure, a line of 
power is not so easy to draw when taking into account the wider context that practice 
operates within (there are serious ethical implications at stake beyond what is “social 
constructed” for both the family and the clinic if there is a breach in confidentiality, see 
Santamaria et al., 2011; and Koenig et al., 2011). 
 
The question of power in the sociology of childhood has been discussed at length in terms of 
‘child voice’.  For example, in reaction to childhood studies that have expressed a need to 
focus specifically on the ‘suppressed’ child voice in research (Alderson 1996; A. James and 
Prout 1997), Komulainen (2007) has argued that the focus on ‘voice’ is misguided and 
                                                        
28
 Qvortrup (1994) offers a defence and complexification of power dynamics in SoC and social constructionism. 
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invites researchers to search for issues that may not be present.  Komulainen, as well as 
others in the field have subsequently argued for research to focus on dialogue actually 
expressed rather than to search for a ‘child voice’ in order to provide a sounder basis for 
representing the expressed agency of childhood in areas such as clinical practice (Graham 
and Fitzgerald, 2010; see Lewis, 2010).  This question around the ‘child voice’ can also be 
interpreted as a more general question of how power is enacted in relation to childhood.  
Here, power is expressed in the style of the social construction of childhood and emphasises 
a view of power that is uni-directional, from practitioner to child patient, thus obscuring the 
ways in which power can be viewed in practice as going from child patient to practitioner ( 
Christensen 2004).  For example, it does not account for the complex arrangements of 
power found in antiretroviral administration around measurements of body size, 
antiretroviral dosage, confidentiality, public health, community/ethnicity and the 
attitudes/commitments of child patients and their families.  This complex interplay between 
medical literature, guidelines and negotiations in the clinic does not fit well with notions of 
practice as enforced through a child’s potential to ‘become an adult’.  A general problem 
identified by other authors is that ‘the social construction of childhood’ resorts to 
reductionism as it relies on a separation between biological and cultural ideas of the child.  
In effect it ignores the ways in which the biological is present in cultural ideas of childhood 
and vice versa (also see Hacking, 1999 for a general criticism; Prout, 2005; Lee and Motzkau, 
2011). 
 
Other debates exist within the Sociology of Childhood that are distinguished from social 
constructionism.  For example, debates around childhood, ANT and STS are more 
compatible with ideas of clinical practice that place childhood alongside other aspects found 
in the clinic.  One such study focusing on the imaginations of childhood in areas such as 
practice is Castaneda’s (2002) book ‘Figurations’29.  The perspective of this study aligns SoC 
approaches more generally to feminist theory that seeks to highlight inequalities in the 
representation of gender, science and technology (Haraway, 1991 offers a parallel 
                                                        
29 Although the degree to what kind of STS it constitutes is open to discussion as its influence could be seen as 
most heavily informed by the work of Donna Haraway.  Haraway (1991) offers an introduction on feminism, 
science and technology. 
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discussion of feminist theory, science and technology).  Castenada’s (2002) work shares 
similar aims to James and James (2004), as it is concerned with the ideas and conceptions of 
childhood in both health policy and practice.  However, by adopting STS, Castenada 
develops a distinct approach away from a view of practice as deploying a version of 
childhood as culturally constructed around child patients.  Castaneda (2002) agues towards 
an idea of childhood that avoids emphasising a rift between how childhood is socially 
constructed and independent from its material reality by tracing how childhood is 
embodied, and its imaginative appeal across diverse scientific settings such as nineteenth-
century science, cognitive neuroscience, international adoption and accounts of child organ 
stealing.  Through these studies she asserts that the study of associations should not make a 
differentiation between material and semiotic processes.  Figurations therefore rejects a 
disjointed view of childhood as between culturally constructed elements on the one hand 
and the biological, ‘natural’ state of the child on the other. 
 
One key relevance of Castaneda’s study is the demonstration of the ways in which 
‘figurations’ of childhood are pervaded through the formulation of guidelines, policy and 
practice and how ideas of what childhood is are also made up through these processes.  Her 
study conceptualises these representations of the child through the concept of ‘figurations’, 
or more specifically, as each representation of a certain type of childhood as being a ‘figure’.  
She puts forward that a figure of childhood is simultaneously made through semiotic and 
material practices and implicated over multiple locals and situations.  Castenada argues that 
childhood is not socially constructed and detached from the biological immaturity of the 
child, but instead is assembled through material practices such as the body of the child 
interacting with semiotic practices of designating and defining aspects of childhood.  The 
discussion operates from the idea that semiotic and material practices are embroiled 
together in the enaction of childhood, each interacting with the other.  The child figure 
alters and changes over the settings it appears within, in turn altering and changing the 
places and situations where it appears, whilst always being corresponded back to a material 
child body.  Over the historical and geographical presentation of the child, a powerful figure 
of the idea of childhood can be traced between diverse locations and histories.  Castaneda 
(2002) uses the examples of nineteenth-century science, transnational adoptees and child-
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organ theft, but to this list the example of clinical practice and paediatric HIV could also 
pose an interesting comparison, especially where patients come from across international 
borders and often depart back over them (Goulder et al., 2001; see concerns of CHIPS, 
2011).  Figurations concludes that the figure of childhood is constantly enacted over the 
places studied as a potentiality (which can be linked to the idea of becoming) and not a 
being or actuality.  This is certainly similar to the ways presented in the social constructionist 
approach.  The key difference however, is that the idea of becoming is specific to the 
moment and context where it is found and is malleable back to the material child itself.   
 
The usefulness of this approach for children with HIV lies in the fact that it brings to light the 
many situations where the child figure is posed between policy, protocol, procedure and 
clinical practice.  The advantage of taking on an approach that is inclusive of both 
materialities and the semiotics of childhood is that it does not force analysis to isolate the 
requirements of physical child body from the child in the clinic as presented or imagined 
with HIV.  This is especially advantageous when considering something like the 
consequences of clinical decision making, which is relevant when considering that HIV is a 
high profile disease, and that the child cohort is distributed over various ages and stages of 
development (Bogart et al., 2000; Alderson, 2007a; and Bluebond-Langner et al., 2010).  The 
decisions made in the clinic have serious implications if practiced incorrectly.  For example, 
if the doctor discloses to a child too soon, he risks a breach in confidentially.  If an 
adolescent with HIV is unaware of the implications of their HIV and become sexually active 
they risk a violation of public health (Christianson et al., 2008).  Therefore, it is important to 
recognise conceptualisations of childhood that recognise the material aspects of the 
condition.  In paediatric HIV clinical practice it is a defining factor that practitioners are 
faced with difficult decisions in the clinic between cultural aspects of HIV and childhood and 
a child’s present material health needs. 
 
Questions can be posed around how materialities of childhood, imaginations of childhood 
and childhood naivety are adopted in the dynamics of clinical practice when shaping 
protocol (and consequently being shaped by protocol).  Imaginations of childhood pervade 
the protocol and guidelines provided by CHIVA (CHIVA, 2011d).  If imagined as a figuration, 
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childhood can be depicted as being affirmed by the dynamic between practice and protocol 
where protocol must be adapted to clinical settings to insure its relevance and taken up by 
child patients (Callon, 1986).  This is important for practice which must regularly deal with 
associations of HIV, childhood, immigration, the child body and antiretroviral medicines that 
must be rendered ‘compatible’ in order to achieve viral suppression with antiretroviral 
therapy.  This adds to the question of how policy and practices are consolidated around 
child patients. 
 
However, if the idea of child agency as ‘becoming’ or  the ‘potentiality’ of being an adult is 
again challenged, some reservations still exist when applied to paediatric clinical practice.  
Even though figurations deals with childhood in a looser, less absolute way than that 
expressed in the literature on social constructionism, the description of childhood as a 
‘potentiality’ rather than existing in the present is still difficult to apply to HIV practice.  This 
is because, as already mentioned, the problem remains unresolved that the implied 
underlying power dynamics are contradictory to observed clinical practice.  For example, 
children with HIV generally need medicine to become adult and this medicine can be 
detrimental to their health.  Moreover, the paediatric HIV clinic is also responsible for the 
very pressing concern of the sexual health of their patients and the public health of the 
community (see the epidemiological concerns of Wilson et al., 2010 and Campsmith et al., 
2009).  Many policy articles written by practitioners must foreground the idea of childhood 
imagined as in ‘becoming’ to deal with the immediate issues (such as sex and 
confidentiality) presented in the clinic (Vigano et al., 2004; Watson and Counts, 2004; 
Nachman and Pediatric AIDS Clinical Trials Group 377 Study Team, 2005; Kim, 2010).    
 
Caution needs to be raised towards the idea of power implied in child figurations.  Although 
it is presented as more dispersed between different geographical and historical contexts, it 
is unclear who is re-imagining the figure of a child and for what reason.  If the child is being 
constantly re-enacted as naive and as a potentiality, it implies that there is a constant 
enaction of power being cast towards children over these contexts.  It would be poignant to 
question in relation to the figures of child naivety that are being re-imagined if there is also 
a corresponding enaction of power.  In the analysis of clinical practice provided in this thesis 
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I would not like to suggest that there is no enaction of practitioner power or reverberation 
of child naivety.  However, I would like to emphasise the ways in which child patients are 
also necessarily in negotiation with practitioners in clinical practice.  In this context, power 
can be described as more dispersed and contradictory (as discussed in the section above, 
Patient Negotiations).  In clinical practice child patients exert power on to practitioners 
through negotiations at the clinic (Christensen, 2004).  This is made even more important as 
the patient cohort have a diverse range of cultural differences, like ethnic origin (as stated 
all patients in UOUH were of African origin), viral load, school, financial problems or 
circumstance, all these factors and many more have a bearing on the identity of the patient 
and how clinical practice will take place (Green and Smith, 2004; Dorrell et al., 2008).  In 
effect the discussion reverts back to the question of power and oppression (Christensen, 
2004; Komulainen, 2007; Graham and Fitzgerald, 2010; see Lewis, 2010). The focus on the 
figure of the child linked through constant suppression by naivety, obscures other 
contextual interactions between child patients and practitioners.  Figurations aims to 
explore the idea of how childhood permeates through different areas of society and 
knowledge.  As a result it inhibits the other associations that also inhabit the same spaces as 
these child figures, for example the ways childhood, stigma or ethnicity influence practice.  
Therefore, the application of child figures in relation to HIV is partial to issues surrounding 
the portrayal of practice in paediatric HIV.  The caution identified towards the idea of 
becoming and the representations of power in studies of childhood will be important as the 
thesis moves on to explore more literature. 
 
Moving more specifically on to link ANT with studies of childhood and its application to 
clinical practice, Alan Prout (1999; 2005) is an author who has championed methodologies 
developed in STS (as well as ANT see Prout, 1996) in the sociology of childhood.   Over 
recent years, possibly through Prout’s influence, debates in the sociology of childhood have 
taken on an approach that increasingly develops STS and reacts against the social 
constructionist view of childhood (also see Lee, 2001).  One of Prout’s more recent 
theoretical studies has been the Future of Childhood where he argues towards a 
reassessment of the New Sociology of Childhood.  One basis for this reassessment is upon 
the theory of hybridisation as applied to childhood and how these hybridisations create new 
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objects and new possibilities (can be linked to a reading of Deleuze, 1998).  For example, 
through the intervention of the clinic, childhood could be imagined as hybridised between 
the child, HIV and antiretrovirals to create a new object combining the three.  Prout (2005) 
asserts that a child should not be seen as something that is in the process of achieving 
completeness or social and biological completeness, but instead that it is something that is 
never complete and always being hybridised through social and biological processes (see 
Latour, 1993; also see the description of the body in Prout, 2000). According to Prout 
(2005), childhood is dynamic and contains no essential entities, as it is constantly enacted 
with wider associations.  Prout’s (1996, 2000, 2005) studies in ANT/STS urge the reader to 
view childhood not as something that is independent from the places where it is performed, 
but something that is always reliant on the other factors that are involved in the situations 
that use imaginations of childhood.  The versions of childhood that can be found in 
situations analysed in this way are non-reducible from the other associations that they are 
also enacted alongside (see irreductions Latour, 1988).  Relating STS ideas of childhood back 
to clinical practice highlights the ways in which procedures taking place in the clinic such as 
disclosure, adherence, chronic illness or transition do not simply act upon child patients, but 
consolidate childhood between policy, procedure and practice alongside regimes of practice 
and healthcare with wider societal/political/biological processes such as stigma, identity and 
ethnicity.  Childhood is not isolated from these practices but formed together with them, 
and in turn alters the way these practices are performed (Ryan, 2011).  This implies that 
practice must be negotiated with the child cohort to ensure that antiretroviral requirements 
are made compatible alongside the many child specific associations of patients such as 
vulnerability, and innocence. 
 
This approach to childhood further alters the social constructionist view of childhood 
already given and its implication for clinical practice.  The challenge is framed by Prout 
(2005) by a call to reject a view of childhood as separated between mutually exclusive  
dualisms between nature and cultural, or being and becoming (stemming from Latour, 
1993; also see Lee and Motzkau, 2011 for a discussion on dualisms and childhood).  The 
argument demonstrates how childhood is not entirely reducible to either material or 
semiotic, cultural or biological, being or becoming representations.  Rather, representations 
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of childhood are never fully finished versions of either side of the dualism and constantly 
hybridised between the two. This approach has the advantage of modifying the discussion 
of becoming and potentiality away from connotations of child agency (or voice) as 
suppressed in the present over their potential as adults.  It remodels child agency and 
imaginations of childhood as particular versions of childhood with their own specific 
context.  The approach does not reject notions of childhood as being naive, innocent, 
vulnerable or incompetent, but rather modifies each enaction as having its own particular 
context, and multi-faceted network.  The acknowledgement of childhood as contextual 
allows the analysis of clinical practice to more accurately assess how childhood is being 
accommodated and made possible around child patients.  The presentation of children and 
adolescents in the clinic offered here is heavily burdened with contradictory 
recommendations for the treatment of patients in practice.  The involvement of many 
conflicting cultural and societal aspects such as immigration, stigma and community makes 
the idea that agency is simply deferred into the future problematic. Therefore, the relation 
of power and enaction of knowledge in consultations between patients and practitioners is 
better represented as multidirectional, which is more freely accommodated in STS versions 
of SoC (Prout 2005; or Lee, 2008).  Associations of naivety and innocence are found within 
paediatric HIV practice, procedure and guidelines and influence the way that the clinic 
approaches the child and care is administered.  Through the use of STS these 
representations do not have one version, but many, and can be found to be enacted 
contradictorily with many facets of power being implied in one enaction.  This way of 
approaching childhood allows the influence of child actors to emerge from the research 
data rather than being imposed upon it according to a pre-requisite adult-child power 
structure.  Therefore, what is emphasised in research is the role of the clinic to consolidate 
and make compatible associations of childhood with medical requirements. 
 
The way that SoC is perceived in relation to this project is not an attempt to render the 
authentic childhood within paediatric HIV or ‘police’ the line between the agency and 
imagination of childhood in paediatric HIV practice.  Rather it is an attempt to render 
analysis aware of divisions and describe why the clinic deems it valuable to uphold observed 
notions of childhood, or in the case of practice how it is organised in spite of medical 
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adversity and contradictions to make suppression possible.  This is in line with the approach 
of Oswell (2012) in his discussion of child agency.  Oswell (2012) meticulously develops an 
account of child agency as presented over many contexts and histories of health and 
medicine relating to childhood.  The aim is not to pass ‘moral judgement’ but rather 
‘sociological reflection’, which according to the analysis is framed by contrasting accounts, 
and posing questions around child agency.  The analysis of childhood in the clinic 
documented in this thesis was conceived under this pretence.  When considering 
retrospectively the encounters observed at the clinic, it is impossible not to appreciate the 
impetus, implication and urgency of decision making that is carried out in the clinic in 
regards to considerations around childhood.  The implications of growing up adhering to 
antiretrovirals, and sexual health pre-requisites, or the interruption of child protection 
services when care is deemed as inadequate (Mason, 2005; Guldberg, 2009), mean that 
childhood cannot be viewed by practitioners or policy makers as neutral (Lee, 1999).  
Paediatric HIV is highly ethical due to the interlaced connotations of childhood, HIV and 
immigration.  One of the key considerations for clinical practice is how to treat a condition 
and child patient with such complex requirements.  Therefore, the following empirical 
accounts of childhood, clinical agency and ‘imaginations’ of childhood highlight how clinical 
care accommodates and is made compatible with complex associations of childhood (such 
as vulnerability or naivety) and HIV, which as a result, constitutes the contribution of this 
thesis to SoC. 
 
This section has looked at child agency and imagination of childhood in the new sociology of 
childhood and its relation to clinical practice.  In relation to paediatric HIV, it has evaluated 
the insights gained from the social constructionist approach to childhood, and explored the 
contribution of ANT/STS to SoC, through approaches such as the idea of figurations by 
Castenada (2002) and ideas of hybridity and childhood from Prout (2005).  Some major 
themes have emerged such as ideas around children seen through their potential of 
becoming an adult, an idea that is demonstrated in this chapter as containing inadvertent 
power structures, and a discussion of agency and imaginations of childhood as dispersed 
over material and semiotic interrelations.   Considerations around how childhood is 
represented have a resonance for this thesis.  In the negotiation of protocol and practice 
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formulated in the clinic, considerations and ‘imaginations’ of childhood must be included.  It 
follows that there is a mutual negotiation between guidelines and the child patients 
practiced upon.  This means that child patients are highly implicated in the process of 
consolidating requirements into a coherent medicine that successfully suppresses HIV over 
the paediatric cohort.  The principal distinction maintained in this section has focused upon 
the enaction of clinical power to child patients.  In the study of practice and protocol that 
follows, the notion of ‘power’ is seen as dispersed over a broad array of actors, and capable 
of being enacted in many compliant or contradictory ways in the clinic and the negotiation 
of guidelines.  Therefore any notion of childhood, innocence and naivety, or enforcement of 
clinical recommendations will be analysed not as dictated on to child patients but as under 
negotiation in the clinic. 
Conclusion 
This chapter has asserted several perspectives between STS and SoC.  The aim has been to 
frame the discussion of clinical practice and paediatric HIV which will be found in this thesis.  
Compared to other chronic conditions discussed in STS and SoC, paediatric HIV presents an 
exceptional amount of complexity to the clinic.  All three sections have assessed how 
objects, associations and knowledges are negotiated in the clinic in complex enactions and 
translations of care.  The chapter has focused upon how paediatric HIV practice is not only 
defined through these processes, but how practice is mobilised in order to consolidate 
medicine with children and adolescents to make antiretroviral requirements compatible 
with complex patient associations, such as stigma, vulnerability and naivety.  This locates 
the clinic as a key site in the formulation of medicine over a model of medicine that dictates 
that practice follows protocol.  The discussions offered have focused upon the ‘turn to 
enaction’ in ANT, the collation of patient, practitioner and scientific knowledge and the 
imagination of childhood in clinical practice.  These debates assert that practice is enacted 
and re-enacted in the clinic according to the associations present, that patients exert 
pressure and can formulate medical science through practice, and that child patients are 
highly implicated in the consolidation and formulation of HIV medicine.  In the process, 
notions of power are displaced that do not account for enactions of power and hierarchy 
that are complexified, contingent and often contradictory.  Overall, the preoccupation has 
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been to conceptualise how incompatible, contradictory associations emerge in enactions of 
protocol and health care at the clinic, and how these seemingly incompatible associations of 
e.g. childhood, immigration, stigma, guidelines, protocol and medical requirement are under 
negotiation together at the clinic and made compatible under the same common goal of 
suppression.  Consequently, all clinical associations from the formal (e.g. protocol, policy, 
guidelines) to the impromptu (patient concerns, attitudes, aspirations) have been framed as 
in negotiation during practice.  The chapter has also framed the contribution of this thesis to 
the discussed literature by demonstrating that the specificities of paediatric HIV highlight 
the clinic as a key site of organising a multiple and incompatible range of associations into a 
coherent medicine.  The range of incompatible associations around HIV and the absolute 
requirements of antiretroviral medicine make paediatric HIV and the necessity for clinical 
flexibility a distinctive topic when applied to STS, ANT and SoC. The next chapter on 
methodology will develop some of the key methodological principles of researching practice 
as ‘enacted’, whilst concentrating more readily on how to apply these concerns to 
researching paediatric HIV and the clinic at UOUH. 
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3 Methodology 
In this chapter I discuss the methodological approach employed to study paediatric HIV and 
more specifically the clinic at UOUH.  The chapter will detail the methodological implications 
of disregarding the search for pre-existing hierarchies of practice in favour of focusing upon 
how medicine, guidelines and the condition are emergent through practice in the clinic.  
STS/ANT has been employed as a central tenet of the methodology in an attempt to answer 
the question of how actors can be followed through negotiations of clinical practice and 
protocol, through complex patient associations, such as stigma, vulnerability and naivety to 
be consolidated into functional HIV medicine.  ‘Following actors’ is made especially relevant 
through the consolidation of seemingly incompatible, politically and culturally ‘charged’ 
entities such as childhood, innocence, stigma, HIV, ethnicity, and the requirements of HIV 
medicine.  Designing and conducting research has been as much an exercise in conceiving 
methods as it has been in making possible the study of a highly contingent and controversial 
condition30.  Added to this are the managements of time and practicalities found in every 
piece of research.  STS/ANT has assisted primarily as a method to follow what may seem like 
contradictory actors through the clinic into a coherent account. 
 
The chapter has been split into two sections between methodology and methods.  The first 
is a description of the methodology considered in this project, and introduces us to three 
relevant principles of ANT methodology – irreducibility, the focus on semiotics and 
materiality and the ‘enaction of the social’ – and how they will be applied.  The focus will 
                                                        
30 Gad and Brun-Jensen (2010) go as far as putting forwards that ANT is neither a theory or a methodology, 
stating that notions such as “postplural attitude” or “nonhumanist disposition” (Gad and Bruun Jensen, 2010) 
as being more useful. 
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predominately refer back to the question of how to follow actors through clinical practice in 
the face of complexity and multiple enactions.  The second section on research methods 
comprises a documentation of how the research was carried out.  The section seeks to 
provide a guide to the practicalities of conducting research in the paediatric HIV clinic and 
the main decisions made in the process of collecting data. 
What is ANT (and after)? 
According to Latour (1988), a principal factor in the development of thought that led to ANT 
is that no entity is reducible to any other.  In wider process philosophy this has been 
referred to as the principle of irreducibility31.  It implies that no entities should be isolated in 
a description of the social world at the expense of reducing or dismissing another (see 
Whitehead, 1979; Stengers, 1997; Deleuze and Guattari, 2004).  One prime example of the 
use of this principle can be interpreted as the intention to eliminate dualisms from 
sociological thought.  Dualisms can be described as the reduction of complex issues to 
simple binarys such as between nature and culture (or biology and culture as in Prout 2005).  
Dualisms are challenged by ANT as they ignore the many other possible ways in which the 
same issues and questions can be posed (Latour, 1993).  In reference to the clinic this means 
that practice should not be viewed as divided between biological/cultural aspects e.g. the 
disease and its effect on the body on one hand and the formulation/consolidation of 
guidelines on the other.  Similarly children should not be seen as between nature/culture, 
e.g. between the natural state of innocence and development, and the cultural 
interventions of adulthood (Prout, 2005; Oswell, 2012).   Instead it is through practice that 
these assemblages of childhood, HIV, medicine etc. emerge within the clinic and should be 
analysed as such32.    
 
                                                        
31 The predominant method of analysis used before ANT to approach cultural aspects of science was social 
constructionism.  Before ‘Irreductions’, Latour (Latour and Woolgar, 1979) was using a form of 
constructionism, but ANT soon developed big differences, its own terminology and a unique methodological 
stance. 
32 Latour credits thought on the irreducibility of objects as giving rise to the methodology (Latour, 1988).  In a 
personal Communication to Graham Harman Latour writes ‘Any argument about my “philosophy” has to start 
with Irreductions, which is a totally orphan book.’ (Harman, 2009)  Although it would be contradictory to state 
that ANT has one source rather than a process encompassing many sources, and different versions of the early 
origins.  Consequently, right from its inception, an ambiguity exists and as a result, whatever the origins are, 
they are looser than being able to be defined within one version of early thoughts. 
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In relation to existing studies of clinical practice and paediatric HIV, the principle of 
irreducibility immediately brings the proposed research into conflict when compared with 
the predominant description of ‘the social’ in relation to the topic.  A substantial body of 
literature on practice already exists in the form of psychosocial studies of paediatric HIV 
(Lewis et al., 1994; Melvin and Sherr, 1995; Battles and Wiener, 2002; Gibb, 2003; see Green 
and Smith, 2004; Steele, 2007; Mahajan et al., 2008).  What is significant about these 
studies from the perspective of Irreductions is that they work from a model of medicine that 
dictates that practice follows protocol.  These studies are tasked with suggesting ways to 
improve the efficiency of the medicine by making ‘overlooked’, ‘psychosocial issues’ 
accountable in guidelines (Green and Smith, 2004).  As a result the psycho-social reduces 
the phenomena it describes into, on the one hand the medical intervention and on the 
other the ‘social’ aspect of patients that ‘disrupt’ the administration of the medicine.  This 
emphasis constitutes a breach to the principle of irreducibility as it prompts the reduction of 
clinical encounters between conceptualisations of clinical regimes, psychosocial issues and 
the ‘ulterior’, ‘social’ world of patients.  In effect the psychosocial approach is unmindful of 
the ways in which so defined ‘psychosocial issues’ and clinical regimes (e.g. protocol, 
guidelines and practice) are emergent and intertwined through the same processes taking 
place in the clinic.  Therefore, a basis for this project is to treat the incidences under 
research and guidelines as contextualised and emergent through the negotiations observed 
at the clinic and avoid taking reductions or dualisms as explanations.  This has implications 
for research from data collection to analysis.  Accordingly, if related to ethnography, it 
implies that the collection of data is altered from long-standing ethnographic traditions that 
focus predominantly on behaviours and interactions.  Rapidly, all clinical objects, processes, 
procedures, practices, protocols, policies, and influences introduced by child patients and 
their families become relevant, and the ways that they can be put together becomes 
multiple33.  These issues have been referred to in other terms as the problem of complexity, 
multiplicity or ‘messiness’ (Urry, 2005; Law, 2007).  The solution posed by Law (2004b) and 
                                                        
33 also complexified by literature on the ‘child voice’ and its pertained agency (Alderson and Montgomery, 
1996; Komulainen, 2007; Lewis, 2010), such as how intently we should listen to the ‘voice’ of child research 
participants. 
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Latour (2005), as will be discussed in more detail below, lies in the way that actors are 
conceptualised and followed. 
 
A second relevant principle of ANT’s methodological focus is upon process: for ANT, 
ontology is achieved through human and non-human actors emerging from material and 
semiotic processes.  Ontology is not simply a question of human agency but rather made up 
of interactions between the agency of human and non-human actants into a network.  As a 
result, ANT makes a concerted effort to accommodate explorations of materiality into 
sociological enquiry, and can uphold the assertion that no lines of enquiry are reducible to 
another (Latour 1996).  ANT rejects the idea of a break between the human/culture and 
nature which maintains that there is a distinction between how reality and the ‘natural’ 
world are conceptualised.  Latour argues that methodologically, ANT practice can be linked 
to the insights gained from the turn to semiotics, most commonly defined in post-
structuralism of the 60s and 70s, in the way that it shares:  
 
“a semiotic definition of entity building [...] [This approach maintains] that actors 
are not conceived as fixed entities but as flows, as circulating objects, undergoing 
trials, and their stability, continuity [...] has to be obtained by other actions and other 
trials” (Latour 1996, p.275).   
 
The crucial difference of ANT however, is the introduction of a method distinguished from 
post-stucturalism that reconsolidates semiotics with materiality.  As Latour explains: 
 
“a method to describe the deployment of associations like semiotics is a method 
to describe the generative path of any narration.  It does not say anything about the 
shape of entities and actions, but only what the recording device should be that would 
allow entities to be described in all their details.  A[N]T places the burden of theory on 
the recording not on the specific shape that is recorded. When it says that actors may 
be human or unhuman, that they are infinitely pliable, heterogeneous, that they are 
free associationists, know no differences of scale, that there is no inertia, no order, 
that they build their own temporality, this does not qualify any real observed actor, 
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but is the necessary condition for the observation and the recording of actors to be 
possible.  Instead of constantly predicting how an actor should behave, and which 
association are allowed a priori, A[N]T makes no assumption at all, and in order to 
remain uncommitted needs to set its instrument by insisting on infinite pliability and 
absolute freedom.” (Latour 1996, p.376) 
 
Therefore, the quote suggests that the starting point of research on paediatric HIV should 
not be an issue defined ‘a priori’.  Instead, the research should hold back judgement in the 
field about how actors are related.  For example, when researching the ‘voice’ of the child 
(Komulainen, 2007) ANT would not begin by looking for places where it could be 
demonstrated, but rather focus on the ‘free’ (emphasis of Latour 1996) recording and 
collection of data and how (or if) the voice of the child emerges from the data collected 
(revising accounts such as Alderson, 1996).  Similarly, definitions of medicine should not rely 
upon conceptualisations of power and its result in practice.  For example, that practitioners 
decree what is practice or what is pathological and normal34.  ANT suggests that the 
research of practice must follow the voice of each actor as presented, the child patient and 
practitioner involved as well as the specific material interventions involved in the encounter.  
The problem of messiness and complexity therefore, is approached through the method of 
allowing actors freedom and flexibility when recording practice.    Consequently, the 
researcher should avoid prioritising points of reference around the condition, such as that of 
childhood, or HIV, immigration, or medicine, or science, protocol, representation, or politics 
etc, instead what becomes important is the way that practices will be recorded in the clinic.  
The interactions taking place at the clinic will inform how a representation of paediatric 
practice emerges, and is accompanied by a stance that allows actors ‘infinite pliability and 
absolute freedom’ to demonstrate how they emerge and what influence they have (Latour, 
1996, p376).  This modifies much ethnographic or qualitative social scientific methodology.  
The focus is still linked to the ‘behaviours, languages, definitions and attitudes’ of those 
                                                        
34 ANTs conceptualisation of power marks the departure point with the semiotics of Canguilhem, 1991; and 
Foucault, 2010.  Both authors have a conception of medical power that is imposes what is ‘normal’ or 
‘pathological’ onto patients. 
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studied as in other forms of ethnography (see Denzin 1988, p.7), but ANT’s emphasis is upon 
following actors and the emergence of associations and materialities. 
 
As a result, ANT method gives up the search for psychosocial causes as is more usual within 
social studies of paediatric HIV and evident in works such as Mellins, (2004) when looking at 
adherence; or Santamaria et al., (2011) with disclosure, and instead looks for the circulation 
of effects (Munro, 2009).  Therefore, this thesis on clinical practice looks for effects.  When 
focussing on parent, patient and practitioner interactions it attempts to detail how clinical 
practice is made possible through the consolidation of medical and cultural associations, 
such as stigma, vulnerability, naivety and drug requirements into practice and procedure.  It 
does not form an explanation of how clinical practices cause problems for the daily lives or 
cultures of children with HIV or vice versa, instead the emphasis is upon how entities are 
presented in the clinic, the emergent assemblages of the clinic and their interrelated effects.  
In the case of paediatric HIV this may prove to be difficult to justify as those committed to 
the psychosocial approach may cite the heightened significance of the disease and its 
treatment and what the consequences of the mismanagement of practice mean for both 
patients and practitioners35.  In this context, it is questionable if abstract and ‘a priori’ 
definitions of the outcomes of clinical practice are avoidable.  This thesis does not wish to 
refute these claims, and acknowledges the necessity and application of logics such as these 
to guide and recommend practice, but wishes to differentiate what is deemed as ‘social’ in 
this clinical context (Hacking, 1992).   
 
The third relevant ANT principle to be discussed in this chapter is that this account is not 
designed to supersede other accounts but recognises that it is one version among many.  
This principle can be interpreted contradictorily as advantageous in disbanding notions of 
privilege and bias from our account or as antagonistic over the role of analysis.  The primary 
antagonism stems from the fact that the name and operation of the theory are at odds with 
the main thrust of the approach.   As ANT has evolved, it has become more and more aware 
of itself becoming like a school of thought or discipline (see essays collected in Law, 1999).  
This highlights an incompatibility within ANT, because ANT emphasises the procedural and 
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 Treichler, 1999 argues that HIV has a heightened rhetoric in comparison to other diseases. 
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multiple nature of ontology as enacted in specific locations and therefore ANT theorists 
reject the idea that ANT can make universal metaphysical claims.  Rather than being a 
generalisable theory of ontology, ANT itself must be enacted in specific locations and vary 
between its enactions (i.e. the social itself must be ‘enacted’ Law 2003).  Throughout the 
development of ANT, authors have necessarily distanced themselves from a formalised set 
of metaphysics, preferring to emphasise the range of non-exclusive stances it is possible to 
pose towards a given problem (Law, 1999).  However, it seems that in recent years the 
pressure to offer an unequivocal metaphysics (and therefore a resulting singular 
methodology) has become more pressing36.  Much contention exists about what its role, or 
place is.  ANT carries a distrust of grand theories with it.  Modern ANT does not want to 
consider itself as constant and universal like scientific method.  The creation of a model of 
social scientific rationale that supersedes knowledge outside of its scope is exactly what 
protagonists of ANT would like to efface (Stengers, 2000 see “superscience”).   
 
The antagonism highlighted has an impact upon how researcher accounts must position 
themselves amongst other research methodologies.  Therefore, the account will be cautious 
about disregarding other explanations of paediatric HIV, as it is important to maintain a 
stance that acknowledges the necessity and importance of all encountered methods (see for 
example Bogart et al., 2000 on factors influencing the administration of antiretrovirals).  
Consequently, methodologically, analysis is presented with a problem and a solution, the 
account that will be made around HIV will not attempt to displace or negate other accounts 
and their uses.  Any disseminated piece of research on clinical practice, is limited in its 
scope.  There are possibilities of referencing the networks of HIV at work, but not to 
definitively set them out once and for all.  It should be accepted as being a prerequisite of 
the research process, rather than a flaw in the research (as is made clear in the small 
methods section of Mol, 2008).  Perhaps the ANT principle of plurality can even be 
interpreted as being a strength because it offers the possibility of allowing research to 
acknowledge the utility of what could otherwise be deemed as contradictory 
                                                        
36 For example Latour is pressed on the question of metaphysics in a recording made of a discussion at LSE: 
http://www.lse.ac.uk/collections/informationSystems/newsAndEvents/2008events/HarmanLatour.htm 
[accessed 14 May 2012 16:28:27] 
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methodologically.  It accommodates the requirement of the psychosocial search for causes, 
and also means that childhood can be allowed to emerge as innocent or naive and 
evaluated in the context that deems it necessary, rather than searching for a constructed 
imposition of naivety onto children (more on this point in the childhood section below).  It 
does not necessarily mean that research is futile, lacking validity or inaccurate, the research 
will add to the richness of the social world and offer new perspectives, and possibilities 
entrenched in the accounts of actors themselves.  This is an important point when 
considering ANT as a perspective that emphasises new and convincing paradigms beyond 
those already conceived in the psychosocial approach.   
 
Therefore, the methodology of this thesis aims to facilitate a multi-directional model of 
power, participation, negotiation, protocol, the induction of knowledge, childhood ethical 
prerequisites and the consolidation of practice/participation with antiretroviral goals into 
the research account using the three principles of ANT/STS discussed above.  These 
principles will be adapted to address how incompatible associations of paediatric HIV such 
as stigma and naivety are consolidated in the clinic into a coherent medicine, and how the 
clinic becomes a key site of formulating complexity into functional medicine (as presented in 
the previous chapter). 
Latour vs. Law: following the actor / enacting worlds 
Now that these three methodological principles of irreducibility, the dual emergence of 
materiality and semiotics and the enaction of the social have been introduced, it is possible 
to turn to the question of how to follow actors?  Two of the most extensive methodological 
literatures on using ANT in social research are Bruno Latour's Reassembling the Social and 
John Law's After Method.  This section aims to clarify on how to follow actors through their 
associations and how the research methods are not only descriptive but productive of the 
realities they describe.  In accordance to the context of the clinic, the consideration of how 
to follow such charged and contingent entities as childhood, HIV and immigration as they 
are presented and adapted to clinical settings is of foremost importance.  Therefore, it is 
prudent to consider the extent to which theory can be applied to following associations such 
as these that are necessarily left ambiguous in contrast to biomedical research, and consider 
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what account is being produced when describing these associations and practices using ANT 
or STS.  Methodologically, Latour (2005) and Law (2003) build upon the three principles 
detailed in the previous section whilst highlighting antagonisms arising from applying them 
in the field. 
Bruno Latour, Reassembling the Social 
In Latour’s Reassembling the social, two relevant arguments are, firstly, caution should be 
shown when using the term the 'social' and secondly, that the ‘controversies’ presented by 
participants should be more closely followed than those inclined by the predispositions of 
the researcher.  The first argument asserts that common concepts of the social give the 
impression of an entity, ‘the social’ that exists beyond any one individual and beyond any 
one situation, it has become an entity unto itself that is impossible to situate 
(Latour, 2005 p159-164).  The book argues that society is the product of ongoing 
assemblages between human and non-human actors, and as such any description of an 
assemblage can be made up of many intermediary entities unable to be distinguished as 
solely political, cultural, scientific or social.  Therefore, when using the word ‘social’, Latour 
asserts that it needs to be conceptualised not as a domain in and of itself but as a 
description of assemblages that references many others.  For example, in clinical practice a 
trope often used in the literature is that clinical practice must be contrasted against the 
‘social’ issues that children bring into the clinic that must be resolved or negated (especially 
how Gibb et al., 2003 uses the word “social” when discussing adherence, see chapter 6).  
The use of the word ‘social’ to refer to an ulterior domain obscures how other actions taking 
place within the clinic could also be described as social, and aspects of the lives of patients 
outside of the clinic could also be seen as clinical rather than purely social. 
 
The second argument is that social research should concentrate less on its own theoretical 
presumptions or overarching ideas of society, and instead allow itself to be prompted by the 
‘ontological weight’ of participants’ accounts and the associations they describe.  Social 
researchers must not sort participants into their own preconceptions, or dismiss, or 
undermine participant viewpoints.  The researcher should allow the participants to inform 
what associations are existent and the value and structure of the social worlds they are 
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involved within (Latour, 2005 p165-172).  He goes further to suggest that researchers should 
avoid going out a priori to define a social issue and instead feed off controversies as much as 
possible (Latour, 2005).  This theoretical turn that emphasises following the participant, 
brings ANT and STS in to a cursory alignment with ethnomethodology.  The key principle of 
ethnomethodology emphasises the pursuit of the perspectives of researched individuals 
above that of theory or the researcher.  According to ethnomethodology, researchers are 
advised not to be guided by theory but instead to let theory come from “within [the] actual 
settings as an ongoing accomplishment of those settings” (Garfinkel, 1984 p8).  The benefits 
of adopting ethnomethodology are already well stated as blurring the line of micro/macro 
sociology and the individual and society.  This link with ethnomethodolgy is little stated or 
discussed in ANT methodology, however in two footnotes in a similar essay to Reassembling 
the Social on the conceptualisation of the ‘social’, Latour (2002) compares his approach to 
that of ethnomethodology.  Latour (2002) acknowledges the similarity, stating that 
ethnomethodologists have daringly attempted to follow actors with no predefined structure 
in a similar manner to ANT.  However, Latour also distinguishes that against its best efforts, 
ethnomethodology is constantly brought back to the ‘micro’ order of society.  Latour’s 
(2002, 2005) version of ANT is one that can conceptualise associations between actors not 
as degrees that get bigger or smaller, or micro to macro dimensions that fit into one another 
like Russian dolls.  Instead, Latour imagines following accounts as ‘flattened out’.  This 
means that when following the accounts of actors referring to structures or scales, 
researchers should treat each ‘speech act’ as equal, never reconfiguring a structure but 
tracing the emergence of associations between entities. 
 
On the basis of the above discussion, following paediatric HIV is not an exercise in 
configuring the structure of clinical practice.  An attempt to describe social worlds must 
avoid recreating the social structures of the HIV clinic, with layers leading from practitioners 
to child patients.  The example of ‘child rights’ evokes the notion of a hierarchical structure 
to paediatric HIV.  Analysis of this structure could go from the clinic to the hospital, to the 
paediatric HIV hospital network of ‘hub and spokes’, to the CHIVA network of professions 
and then government policy and international organisations such as the UN (e.g. the “rights 
of the child” found in UN. Commission on Human Rights, 1999) ad infinitum (see Alderson, 
Methodology 
 
79 
 
2002).  Or similarly protocol could stem from the WHO (WHO Technical Consultation, 2011) 
down through CHIVA guidelines and into the clinic.  However, this overlooks the mutual 
constitution of these categories and the clinical negotiation taking place in their 
administration.  Imposing structures such as these obscures the many possibilities made 
available to actors when negotiating these entities and the many more intermediaries found 
between each entity.   This point will be poignant in research chapters as analysis relies 
upon highlighting clinical observations along with the guidelines of CHIVA, and many other 
protocols such as the American Pediatric Association (APA) and the results of drug trials.  
These different organisations could be seen as dominating or being dictated by clinical 
practice and I would not like to suggest that both processes are not occurring.  However 
their interrelations with practice is multiple and contradictory and necessarily in negotiation 
with patients.  The usages of guidelines, policies and scientific requirements have many 
capacities for practice, according to their emergence during each clinical encounter.  
Therefore, during clinical encounters which document is active is not so clear cut to isolate.  
Consequently, it is worth qualifying that when conducting the analysis of observations and 
the textual analysis of protocol, I attempted to follow actor’s references that corresponded 
with protocol, made protocol relevant and so introduced aspects of protocol as an actor. 
 
The next text on ANT methodology, Law’s ‘After Method’, will be used to compare and 
contrast Latour’s reflection on following the ‘social’. 
John Law, After Method  
John Law’s After Method also discusses ANT methodology, but the recommendations that 
he reaches about following actors are not fully harmonious with Latour (2005).   One of the 
main aims of Law’s book is to explore how social methods itself is a particular assemblage.  
Building upon the idea that research methodologies have more than one possible version 
that can claim validity, Law puts forwards that method is not only a set of procedures for 
reporting on a given reality, instead arguing that research methods go onto produce distinct 
realities (Law, 2004b).  This means that data collection is embroiled in the enactions of 
participants, and research results can contribute to the further enactions of the participants 
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(also see Law and Urry, 2004).  Law (2004a) suggests that the act of creating an argument or 
account around a topic, gains its voice through necessarily silencing something else.  
 
“Not everything can be known: it depends on what is not there. The argument is 
against what these philosophers call a ‘metaphysics of presence’: the idea that 
everything could be brought together and created or joined or known in a single 
location.  What is being made present always depends on what is also being made 
absent.” (Law, 2004a, p83)  
 
In the context of paediatric HIV some implications become clear and must be considered 
carefully, depending upon whom the account is read by (assuming that the account is read 
at all).  Some immediate questions come to mind:  Children and HIV is stigmatised and 
played out in confidentiality, therefore, how will our account modify the representation of 
the disease?  E.g. is it possible that the public consciousness of HIV positive adolescents 
could be antagonised if adolescents are represented as refusing to take their medicine and 
posing a sexual public health risk to their community (Hekster and Melvin, 2006)?  
Moreover, if the agency of childhood is highlighted as having a productive role in clinical 
practice, can this adversely affect the imagination of innocence and naivety that may make 
possible other regimes of care (Cohen et al., 1999)? Also, in each consideration what am I 
making absent? The social construction of childhood? The psychosocial search for causes?  
Considerations such as these seem to imply that following the associations provided by 
actors should never be done naively.  Firstly research should acknowledge the use and utility 
of other contradictory accounts, ensuring that it doesn’t obscure the validity of other 
research, and secondly the researcher still needs to be acutely aware of the implications and 
applications of their planned research37, as is the case here.  This poses a modification to 
Latour (2005) and suggests that a balance is needed between the absolute freedom given to 
actors and the hindsight required by the researcher when putting accounts together. 
 
                                                        
37 A similar consideration well formulated in research could be discussed in terms of research ethics, especially 
relevant to research with children (Alderson, 2007b).   However, the sense as presented in Law (2004a) is not 
limited to ethics but broader implications in networks of representation, politics, culture etc 
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Both Latour’s (2005) and Law’s (2004) books talks of methodology in relation to ANT, and 
they are both written around the same time in the vein of ‘after ANT’ (see Law, 1999).  
However, there are some sticking points between the underlining principles of each book.  
The position this project develops on how to conduct research and the validly of the 
resulting research will vary depending upon which methodology is taken up.  Two 
considerations come to mind, one of the ability of the participants to define their own 
worlds and the other of the extent that ANT can allow the researcher to imagine how 
planned research enacts versions of the social worlds it describes (this can be related to the 
discussion of an earlier antagonism between Latour, 2004a; and Law and Urry, 2004; by 
Fraser, 2006).  If the study were to subscribe to Law’s (2004a) considerations on the impact 
of its own methodology, it would consequently put in jeopardy the possibility of 
concentrating on the self definition of participants as the question becomes who do we 
follow and for what reason?  Latour (2005) advocates a more intent focus upon the 
participant’s ‘absolute freedom and pliability’ to guide research, rather than focusing on the 
social world the methodology is creating.  Therefore, according to Latour (2005), it 
constitutes an endangerment of allowing participants to define the clinic and how they 
make it operational.  On the other hand, Law’s (2004) perspective suggests that the 
representation of the clinic must be made to fit into a thesis argument and must ensure that 
the research will have a positive impact.  The methodological stance of this research does 
not attempt to resolve this antagonism in position.   
 
Consequently, both texts have extensive implications for the description of clinical practice, 
Latour’s approach attempts to ensure that clinical actors reference the ways the clinic 
consolidates care, whilst Law emphasises the need to ensure that the research deliberates 
over providing a coherent argument and positive contribution.  Therefore, the method 
employed must offer a balance between the freedom given to clinical agents to self-define 
the dynamics of practice and the researcher’s reflexivity on the effect of describing research 
findings in wider public arenas (which limits the extent that actor’s can self-define). 
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Childhood Naivety  
One unavoidable preconception of paediatric HIV is that patients are seen in practice and 
research as naive, innocent and vulnerable (Allen and Marshall, 2008).  Therefore, childhood 
and HIV in this context is not so straight forward to follow in the clinic or protocol and 
requires a methodological deliberation (beyond the balance proposed in the last section) as 
to how naivety and innocence should be approached in research.  Without disregarding the 
description of following actors outlined above, the project’s methodological approach to 
childhood will coincide with allowing the emergence of childhood as it is presented through 
the ‘recording device’ in the clinic, whilst still maintaining some ethical reservations around 
researching childhood and HIV (Latour, 1996).  Childhood naivety and innocence forms one 
of the most extensive predispositions in the literature of SoC, including studies conducted 
around medicine38.  For this project and paediatric HIV in particular, naivety and innocence 
have an extra significance because HIV has numerous cultural associations that are 
incompatible with childhood, such as sex and drug abuse, and subsequently brings about 
discourses of innocence and deservedness (Fassin, 2008).  For example, when contrasting a 
child cohort whose HIV infection is perinatal against a wider public representation of the 
HIV disease as most commonly sexually transmitted, connotations of childhood innocence 
become significant (Henderson, 2006).   As stated, connotations of deservedness, 
victimisation and orphanhood form impetuses for specific charity action to be taken and 
public interest into how the problems associated with this population are met (Boulton, 
forthcoming).  In studies of HIV and childhood, innocence and naivety feature heavily in the 
descriptions of all aspects of the disease from representation and education to prevention 
and treatment (Mitchell and Smith, 2001; Mitchell C. and Smith A., 2003; Mitchell et al., 
2004; Bhana, 2007; Bhana and Epstein, 2007).  Therefore, this focus on innocence and 
consequent vulnerability is something already affecting our imagination of the condition 
before researching or reading accounts of HIV, or following actors.  Innocence and 
vulnerability have a heavy bearing on researching clinical practice and the analysis of data. 
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 Dixon-Woods et al (2005), Davis et al (2008), Christensen (1998, 2000) and Cohen et al (1999) offer useful 
examples of children being seen as innocent or incompetent in illness or disability. 
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Accordingly, discussions in SoC have charted the resulting relationship dynamics as they are 
presented in the clinic. Christensen states: 
 
“In everyday child illness, interactions at home and school between children and 
adults draw on the traditional hierarchies and values of biomedicine in various ways: 
Parents and teachers are delegated responsibility, competence and intervention rights 
“rational” methods are employed in preference to children’s subjective experiences; 
children’s ability in giving and receiving affection is both valued as part of the 
reciprocity of human relationships but remains subordinate to other competencies; 
and children’s actual contribution to practical care is rendered invisible to adults.” 
(Christensen, 1998) 
 
Examples from the clinic are times when the doctor negates a child by talking to the 
parents, or when parents control the administration of medicine to their child (Clark, 2003).  
Christensen (1998), along with SoC more generally, argues that commonly held perspectives 
in medicine and policy rarely see the child as participating in the ‘doctor’s’ clinic or in the 
administration of taking medicine.  However, a contrasting literature also exists that argues 
against imagining ‘child actors’ as repressed, as it possesses a danger for researchers to 
misconstrue the extent of domination or the existence of dissent when out in the field 
(Robinson and Delahooke, 2001; Komulainen, 2007).  Successive accounts within SoC have 
demonstrated the ways in which power between children and adults is not limited to one 
direction, i.e. from practitioner to patient, and have instead chosen to emphasise the many 
influences that children can pose in childhood assemblages, both complimentary or 
contradictory to the practice of medicine, confusing the question of how to follow child 
actors (Christensen, 2004). 
 
The idea of power as enacted in one direction from practitioners to patients negates the 
many other ways in which patients could be seen to influence the interactions that take 
place in the clinic.  For example, ANT could be employed to assert that in the clinical 
relationship between the practitioner and child, the dynamics of how the child, mother and 
doctor are brought into being and enforced is also an irreducible aspect of the condition.  As 
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such it is not possible to reduce a child’s agency from the clinical encounter, and therefore 
has no unspoken hidden agency ignored by ‘adult’ practitioners and parents (Prout, 2005; 
Lee, 2008).  From this point of view the questions around dominance, competence and 
responsibility become doubly serrated and would suggest that the most important 
methodological procedure for the research will be an awareness and attentiveness of all the 
possible positions of research participants.  However, the question of innocence and naivety 
remains.  As already stated in the many assemblages demonstrated in the clinic around HIV 
and childhood, innocence still figures highly.  According to the practice of following 
participants detailed throughout this chapter, allowing actors the freedom to demonstrate 
the emergence of innocence and naivety will offer a good guide on how to proceed.  One 
issue that keeps coming up in research chapters however, is that with an object such as 
children with HIV, there always seems to be a ‘residue’ of innocence, naivety or ethics 
alluded to outside of any assemblage (or beyond the clinic) that is impossible to follow.  It is 
not possible to fully follow all of the guises of this innocence, as it contains associations such 
as sex and stigma open to becoming sensationalised that have the potential to alter the 
interpretation of our recording device, the acute focus on clinical consolidation and the 
dissemination of any research findings, reverting us back to the discussion of Law (2004a).  
This confuses the recommendation of method, but has been highlighted here as it forms an 
important key unresolved reservation of the thesis in reference to ANT.  It raises the 
question of whether it is correct to ‘flatten out’ and follow charged associations of 
childhood in the way Latour (2005, 2002) recommends in relation more generally to other 
objects?  Consequently, considerations of childhood innocence will be followed up in the 
next chapter on ethics. 
Implications for the Study 
The main point of departure for the first part of this chapter has been to consider how 
associations of ethnic diversity, urbanity, childhood, HIV and medicine can be followed from 
its ‘emergence’ through successive processes of formation and reformation in clinical 
practice.  The discussion on methodology in this chapter leaves the recommendations on 
how to proceed far from clear-cut and makes the term ANT ambiguous and cautions 
researchers towards fully subscribing to it.  Tracing the main discussions gives insights on 
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the principles of irreductions, semiotic and material processes and the assimilation of 
broader research accounts into our own account.  Accordingly, in the context of paediatric 
HIV, following the actor through the clinic allowing them pliability has been interpreted as 
being best served by conducting ethnographic observations at the clinic, whilst following 
actors over the corresponding protocol referenced in the clinic.  My participant observations 
have been designed to allow the role of practitioners, patients, childhood and protocol to 
emerge from practice in the research setting.  My disposition when following actors has 
emphasised allowing actors’ own references to other sources to define what is relevant39.  
This doesn’t mean the attempt to gain a natural or pure form of the interactions taking 
place, as discussed, childhood vulnerability contradicts such a stance.  Ultimately, the 
methodological stance of this thesis is that this account is also responsible for enacting the 
social worlds it describes and consequently a balance had to be struck between following 
actors with ‘infinite freedom’ and upholding the concerns of vulnerability in the conduct and 
dissemination of research (Law 2004a).  Therefore, following actors in the context of the 
clinic has been designed to maintain an intent and continuous art of listening, prompting 
and probing of actors to uncover what is making them act and how they are being 
consolidated into practice.  Research has attempted to follow the actors that accord with 
the formulation of medical doctrine and render viral suppression compatible with patient 
dispositions. 
Research Methods 
For the remainder of the chapter I will explore how the considerations above translated into 
specific research decisions employed in the clinic and during analysis.  The research site for 
this project was a small clinic for children with HIV at University Outer Urban Hospital 
(UOUH).  Research began at UOUH with a loosely formed methodology borrowed from STS 
with the aim of applying it to children with HIV.  Throughout fieldwork, the research 
conducted was also aware of the large body of traditional ethnomethodological pieces of 
fieldwork and drew inspiration from them, but infused them with STS and SoC, to focus on 
the processes that obtain reality rather than the centrality of subjects (I have in mind here 
“naturalistic interactionist” classics such as Goffman’s Asylums, 1991; Atkinson’s Clinical 
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 Much as that of ethnomethodology but with the emphasis on following both material and semiotic actors 
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Experience, 1997, and Becker’s, Outsiders, 1997)40.  Therefore, I sought to be immersed in 
the clinic to uncover the materialities and associations emerging around HIV41, and modify 
the traditional ethnographic focus of behaviours, languages, definitions and attitudes of 
those studied (Denzin, 1988), towards the development of a stance that followed the 
objects, agency and potential associations present as informed by STS and ANT (Latour 
2005).  The following discussion will proceed by describing the field as it presented itself and 
the objects under study, before moving on to discuss how research was conducted in the 
clinic, finishing by detailing how the data was analysed and disseminated. 
 
UOUH is a medium sized London hospital located between the boundaries of zone 3-4, 
affiliated to a University.  I would go there on the train once a week and attend the HIV 
clinic held in the paediatric ward.  Most weeks there was a clinic at 900 to 1200hrs, but 
twice every month there was also a second session in the afternoon from 1600 till 1800hrs.  
During the days when there was a second clinic I would attend both, leave at 1200 and 
come back at 1600.  Research was conducted at the clinic for just over a year from August 
2010 to October 2011, in which time I saw almost every consultation that took place with 
children who had HIV. 
 
In comparison to other London clinics, the clinic at UOUH is relatively low scale with 
approximately only twenty children with HIV registered.  This number however, is difficult to 
give definitively, the number of patients I saw during research was twenty two.  But during 
this time, some patients registered were in the process of transferring to adult services 
which occurs around 16.  One patient was not attending regularly for her own reasons, and 
others would drift in and out of the service due to immigration or moving between areas.  
There was a core of patients that had seen Dr Peters from a very young age right through to 
transition, but the population of the clinic on the whole was aging.  Three new patients 
enrolled during research. One, Rob, coming from Zimbabwe, one new diagnosis (not 
                                                        
40
 I would not describe this account as a naturalist interactionist account, but I do not wish to ignore the 
wealth and tradition of relevant sociological work that has taken place engaging with the same problematic. 
41
 My emphasis here to use the concept of emergence often used in STS as it focuses on process and not 
necessarily that of Denzin 1998, see section above on Reassembling the Social. 
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included in research) and one transfer Erica from Manchester.  These were the first new 
cases at the clinic in 2 years and the first paediatric diagnosis at the hospital. 
 
The clinic was run by one Paediatric Consultant, Dr Peters with the help of a specialist nurse 
who will be called “the CNS”.  I was lucky enough to forge a good working relationship with 
Dr Peters who supported my study and helped me to organise research in the clinic.  He 
came to fulfil the role of the gatekeeper, according to classical ethnography, defined as 
taking on the job of granting access to the researcher, introducing the researcher to the 
field and having a personal stake in the research (Whyte, 1988).  With great patience, Dr 
Peters instructed me through the formal NHS ethics approval, guided me through the 
workings of the clinic and HIV medicine and would answer my questions, and discuss 
relevant issues in extensive detail.  However, from the initial meeting with Dr Peters, he had 
made it clear that he would help me to understand the medicine, but he could not advise on 
sociology, so was leaving that part up to me to apply once I had become more familiar with 
the clinic. 
 
In the usual clinic, I was sat down against the wall facing the doctor’s desk often alongside 
other observing professionals who were training or affiliated to other departments.  The 
patient chairs were closest to the door and the clinic was arranged for patients to feel 
comfortable, and feel that they can come and go from the consultation room freely.  All 
patients came into the clinic with their guardians, most were the child’s parents but in 
Bianca’s case she was living with her aunty as her mother had died and the father 
whereabouts were unknown. 
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2 A diagram of the layout of the consultation room, giving the reader an idea of movements in the clinic (not to scale). 
 
Most patients at the clinic came from Sub-Saharan Africa.  The exceptions being Abbey, 
whose mother was from Zambia and father was White-British, and Celina whose father was 
Afro-Caribbean.  A selection of the stated countries of origin for the population studied 
were Ghana (with the majority), Zimbabwe, Congo, Ethiopia and Angola.  All the children 
could speak English, most of the parents could also communicate in English.  However, there 
were three parents that had difficulty in English and on one occasion a translator was called 
in.  Some adolescents had to explain words to their parents on occasion, especially the 
mothers of Tabitha and Virgil (who are all discussed further in the empirical chapters).  The 
majority of the population that the research investigated was children who had had HIV 
perinatally transmitted to them (Foster et al., 2009).  Most cases were traced back to 
transmission from mother to baby, but the team were uncertain in some cases, like Erica’s, 
who was diagnosed at the hospital aged 15, so research settled upon the looser terms of, 
paediatric HIV for denoting the medicine practiced on individuals under the age of sixteen42, 
children with HIV to refer more generally to populations of adolescents and perinatally 
acquired HIV to describe the infection route.     
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 This consideration leads to questions of assessing the differences in defining the condition between other 
possible ways of transmitting whilst young, what is the significance between alternate transmissions? 
Principally through sexual abuse, as this was suspected in Erica’s case, and how care and medicine must adapt 
differently to this situation (e.g. adolescent testing Emmanuel and Martinez, 2011; Mullins et al., 2012). 
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Therefore, led by the STS methodology described above one of the early delineations was 
identifying which actors to follow in the consultation room.  The terms of ‘perinatally 
transmitted’, ‘children with HIV’ or even ‘paediatric HIV’ that were originally used to set up 
and conceptualise the project instituted a broad scope during the first days of fieldwork.  
Children were followed through the state of the HIV infection; between different clinics; 
over different communities and over different individuals43.  In practice, this meant 
investigating the interactions of children with HIV and medical staff, but also tracing the 
coalescence of medical protocols with the lives of children/adolescents, the role of the 
doctor who must administer care and channels of medicine, as well as tracing other 
associations referred to in the clinic.  The encounters that were deemed as principally 
important were situations where the concerns of patients and medical practitioners 
intersected.  Through this process of allowing participants to inform research, the 
procedures of disclosure, adherence, chronic illness and transition, became prominent.  All 
of these procedures figure heavily in both discussions at the clinic and in the literature and 
made themselves prominent in paediatric HIV health care and were also followed in 
research. 
 
Before starting research I had to gain ethical approval from an NHS ethics board, through 
the Integrated Research Application System (IRAS).  This process took me six months in 
total.  During this time I wrote an initial formal ethics application, and had it reviewed in 
front of a board of around seven people, the first application was rejected with 
recommendations about how to amend it in order for it to be ethical.  After I had made the 
amendments and attended a second review meeting, it was approved.  The process made 
me think extensively about my research and its ethical stance and is dealt with in more 
detail in the following chapter on ethics.  One of the main outcomes of the meetings was 
the problem of informed consent.  Initially I had made one information sheet for all 
participants, but the board wanted me to focus more specifically on gaining informed 
consent with individual sheets for children and adults in a different and more accessible 
English.  When in the clinic, on my first meeting with parents and children, Dr Peters would 
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 Research methods of children and medical settings forms its own field of study (Woodhead, 1999; Alderson, 
2001, 2002, 2007b). 
Methodology 
 
90 
 
give patients and their parents an information sheet and consent form and inform them 
about the study.  This was done in the consultation room, as it would have caused 
confidentiality problems if done in the waiting room.  Dr Peters then gave participants the 
option of asking me to leave the room.  Overall, the parents and patients of the clinic’s 
cohort were keen to allow me to observe, often parents would comment when I gave 
details of my study that they thought it was a good thing to generate more information 
about the condition.  The most major concern for all parents was that their personal 
information remained confidential, which I informed them that I would stringently do by 
anonymising them in anything that was written including notes.  Another concern was 
observing patients that had not been disclosed to.  For these children, Dr Peters would ask 
parents for their consent on behalf of the child when children were in another room from 
their parents getting a blood test. In these cases I didn’t approach children personally or 
observe practices such as disclosure sessions outside of the consultation room in case my 
intervention would lead to an unwarranted disclosure.   
 
The first point of data collection for the project was observing consultations.  Observations 
were undertaken as the primary stage of field work to fit the pre-requisite of maintaining an 
insight on the ‘associations emerging’ at the clinic whilst applying as little of my own 
preconceptions as possible in accordance with the work of Latour (2005) outlined above.  
Rather than turning up for every clinic (the clinic also saw cases of prenatal HIV prevention 
and the HIV testing of ‘at risk’ children), I only attended clinics that had children with HIV 
booked.  During these clinics, I would sit in the consultation room for the duration of the 
session (in the style of the advice given in Hammersley and Atkinson, 1983).   
 
I often felt like I occupied a strange place in the clinic compared to other professionals and I 
would sometimes be mistaken for a junior doctor (SHO).  To patients in consultations Dr 
Peters would announce me as a sociologist, inform them that I was conducting research and 
ask if it was ok for me to sit in.  Even after the initial consent form had been given to 
patients, Dr Peter’s would still announce me at each consultation and it would often seem 
like patients would forget who I was and my purpose.  From a patients’ viewpoint, my 
observations seemed to make me indiscriminate from the other regular visitors who would 
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be sitting in on the clinic and would also have to be announced.  Patients at the clinic were 
used to being observed.  Even though I did the utmost to inform participants of my research 
intentions, the space of the clinic is a place where patients take for granted the fidelity of 
practitioners.  I took on board the trust of patients and responsibility of access to 
consultations to make my presence as unobtrusive as possible and use the data collected in 
a responsible and useful way.  Most practitioners would also get on as if I was not there, or 
at least I could not detect a difference.  Perhaps there were incidences where I would make 
someone uncomfortable or modify the behaviour of professionals attempting to be seen in 
a positive light, but as there is no way to confirm this, I sought to document as best I could 
the context of each clinical encounter.  I questioned my role as observer in relation to 
classical ethnographic texts44, like for example Junker’s (2004) the Field Work Situation, 
which provides a matrix between observational styles.  On one side, he places observational 
roles pertaining to heavy involvement with groups under research, citing two roles: 
‘participant as observer’ and ‘complete participant’, and on the other side roles of 
comparative detachment to the research site: ‘observer as participant’ and ‘complete 
observer’.  Amongst these roles, I’m not sure which role I attained, at different times in the 
clinic I would switch from being detached to attached, all the while questioning which actors 
I was following and the ‘social’ that I was responsible for enacting (Law and Urry, 2004; 
Latour, 2005).  I would often talk to practitioners and patients.  However, I rarely intervened 
during consultations and so I did manage to have some detachment from participants. 
 
When the doctor began his consultation with the patient or family, I would take notes in a 
spiral bound A5 jotter.  As most consultations contained complex discussions of medicines 
and regimes, I would often fall behind, and had to develop a shorthand in order to keep up.  
Faced with the classical dilemma, of what is it important to document , Lofland et al. (2004) 
pose a list of things to look out for: acts, activities, meanings, participation, relationships 
and settings45 .  However, due to STS methodologies already predisposing the relationship 
                                                        
44 Also following on from accounts such as Corsaro (2003), I came to question separately the capacity with 
which I could observe the children under study. Especially the nature of the adult/child relationship that was 
present between those being observed and me. 
45
 The question of what to put into a research account and how to take field notes is beautifully rendered in 
Taussig (2011), when reflecting upon drawing he has made in his fieldwork notebooks. 
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the researcher must have towards objects and networks, these categories were not 
approached as already defined, needing instead to emerge from the data.  Each one is 
achieved with the participation of all actors found at the research setting.   Instead, I tried to 
allow participants to define units of analysis by following what they chose to emphasise and 
how they would put them together.  This may have resulted in some entities becoming 
more prominent and others hidden, like associations of childhood46.  I deemed it necessary 
however, to investigate what participant emphasised, and why these associations are taken 
up.  In effect engaging with questions of what makes the medicine functional (as well as 
grounding how I choose to conduct research whilst still adhering to Latour’s 2005 
conception of Sociology). 
 
Before beginning research at the clinic I had toyed with the idea of tape recording 
consultations (even putting this forwards to the ethics committee), but after discussing it 
with the HIV reading group of other PhD student based around Goldsmiths I decided to take 
notes instead.  In retrospect, I still welcome this omission as what would have been gained 
in precision, would have been lost through the awkwardness of the device being present.  
Taking recordings of consultations would have also provoked a series of ethical dilemmas as 
in most cases parents are concerned about the disclosure of their HIV and the recorder 
would have had big implications as to how consultations were conducted (Lee, 2004; Back, 
2010).  Taking notes allowed me to fit in more as an 'insider' of the clinic for both patients 
and doctor alike, my presence was more negotiable.  In effect however, the examples that 
have been detailed in this project are approximations based on the notes taken in clinic and 
my memory when I came to write my notes up.  Reminiscent of some of the central themes 
of the essays found in Clifford (1992) who notes: 
 
                                                        
46 I was acutely aware of discussions that exist in the Sociology of Childhood around the voice of the child and 
how to think about documenting it in the account.  As it would alter the way that notes are taken in relation to 
things that children do not say.  In the end I decided that this would constitute an over emphasis on the child, 
and so I have tried to keep the documentation of children’s actions relative to those of adults (James et al., 
1998; Komulainen, 2007).  
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“Ethnographic writing is allegorical at the level both of its content (what it says 
about cultures and their histories) and of its form (what is implied by its mode of 
textualization).” (Clifford, 1992, p98) 
 
On most occasions during the consultation I didn't say anything other than smile and say 
hello, but there were situations where I was included in incidences that would unfold in the 
clinic, like when a parent misplaced their bag, the doctor would lose his pen, or parents 
would lead a discussion about sociology.  Over time, parents and children got used to seeing 
me in the clinic and so I began talking to many of them on the occasions when the doctor 
would have to leave the room or when the doctor and child would go for blood tests.  As 
stated, my role as observer therefore, changed in relation to what was taking place in the 
clinic.  On the occasions where my note taking was deemed inappropriate or against the 
wishes of the parents, Dr Peters would usher me out of the room.  This happened on three 
occasions, twice when he wished to have a private conversation in the process of disclosure, 
where the child was shy to talk in front of more than one person and once when discussing 
a personal grievance between a parent and the hospital. 
 
Between these consultations, Dr Peters would often inform me and other professionals 
present about some of the case histories.  This was a major point of functioning for the 
clinic, he would discuss narratives and developments with the CNS, with Dr Phelps from CHH 
who would come in once a month to advice and to coordinate, with Dr Chambers from the 
adult ward T1, with the pharmacologist and at once a month meetings for all members of 
staff at the ward.  These types of narratives were for a myriad of different reasons but 
became a great source of data for the project.  In time, once I became more familiar with 
the cohort of patients I also became part of some of these stories and narratives (White, 
2002).  I wrote notes during these moments or just after them, if I was required to verify the 
story.  Stories, narratives and discussions relevant to care or the running of the clinic also 
proved challenging for note keeping for additional reasons as statements useful to the 
research would often start and stop very quickly and come out of nowhere (see Atkinson, 
1995 on “medical talk”).  As time went on and I understood more about the functioning of 
the clinic, tracing these discussions and passages became easier. 
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As part of the ethnographic approach of the research, during my time at the clinic I had 
many direct dialogues with professional participants.  These took the form of ethnographic 
style interviews (i.e. asking impromptu questions, or formulating questions and discussion 
points between days attending to bring up at opportune moments) with parents and 
professionals to more formal recorded interviews with adolescents (Spradley, 1979 defines 
the ethnographic interview style).  To organise interviews with adolescents, initially Dr 
Peters assessed which patients were suitable for me to interview and those that were not.  
This was dependent upon how much the child understood about their HIV, or the family 
situation.  After I had sat in on at least two consultations with participants Dr Peters asked if 
the child would also be willing to take part in an interview47.    
 
Not all of the children who were observed in consultations were eligible to be interviewed.  
Children who were unsure or getting used to their diagnosis were not included.  The clinic 
puts many resources towards disclosing HIV in a way that will introduce children to the 
diseases and its implications in a gradual and gentle manner.  It was deemed that any 
questions that I would have asked children at this stage or even the act of conducting an 
interview itself would be damaging to this process.  There were also some children that 
were not asked because Dr Peters deemed that it was not suitable for them to be involved 
in interviews, for example for families who had a lot to deal with already like transition, busy 
schedules or who had other appointments to attend to (see Bluebond-Langner, 2005 on 
children’s participation being dependant on contextual clinical factors). In traditional 
naturalism, this would have obvious implications for ideas of representation, but it is a 
consideration that had to come second to the possibility of causing harm or distress to 
participants (e.g. Hammersley and Atkinson, 1983; Denzin, 1988, 2003).  All is not lost 
however, according to the principal of STS that stipulates participants should define relative 
size and scale, the selection of ‘who it is acceptable to interview’ can be seen as a finding in 
itself of the process of a number of medical procedures that ensures good practice (like 
disclosure to be discussed later).  In total, I conducted six interviews with adolescents from 
                                                        
47
 Research involving children must satisfy specific ethical prerequisites in order to get ethical approval, see 
collection of Greene and Hogan (2005) and proceeding chapter on ethics. 
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the ages of 12-16, these were done in a spare consultation room after the patient had 
completed their appointment and were recorded onto a dictaphone.  I have been hesitant 
to place a lot of prominence on these interviews in the analysis, but they have been 
important in offering a different perspective on occurrences at the clinic and procedures 
such as adherence and disclosure. 
 
Research had to fit around the busy activities of the clinic and of the ward in general.  Any 
observations, conversations or interviews that were carried out had to fit in around the 
schedule of the clinic, consultations and blood tests.  Other constraints on schedule came 
from the parents or children who had to go back to school, or had places to be, or did not 
want to spend their time to talk to me for whatever reason.  It is important to consider how 
these constraints of representation, the trust of the doctor, the confidence of parents and 
adolescents shaped the research.  Before consenting their children to the study, most 
parents were worried about confidentiality and it became important to go through the 
information sheet and fully explain to participants the processes in place to ensure 
confidentiality (Alderson, 2002).  Adolescents in the clinic had the chance to refuse to take 
part but most were keen to answer my questions.  A further problem in gaining consent was 
caused by the fact that the information sheets said HIV on them.  Parents and adolescents 
did not want to take away anything that said HIV on it in fear that somebody may find it.  
These factors may seem trivial, but they do have a bearing upon how the field presents 
itself. 
 
I was fortunate enough to form a positive relationship with all the staff and am especially 
grateful to Dr Peters who acted as my ‘gatekeeper’ giving me access to the clinic and being 
patient enough to answer my questions and introduce me to much of the medicine.  
Therefore, the analysis and dissemination that follows research is not a task in criticism or to 
highlight the failings of the medicine and has been written to avoid these connotations, 
instead it attempts to describe the specific occurrences that took place in the clinic, what 
constitutes the medicine, the condition, and how these entities relate in the treatment of 
Paediatric HIV.  
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Research chapters are set out to retain the associations present as accurately as possible.  
And analysis runs directly from incidences at the hospital.  Data that is used as an example 
attempts to retain what was actually said and who said it.  However, as note taking or the 
process of adapting a situation to text can never claim to capture an unaltered piece of 
reality, there will be discrepancies between the 'reality', that is written and the ways in 
which readers will interpret the text.  For example, even the difference between child 
agency and attributing ‘weight’ to the research accounts of children can never be neutral.  
Whether trying to over/under compensate for the ‘voice’ of the child, it will always be 
altered through the readers stance towards childhood (a debate running from Alderson, 
1996; to Komulainen, 2007; and Lewis, 2010).   Therefore, it is more realistic to say that the 
analysis of the data collected has taken place over stages, where data has been ordered and 
made relevant in order to make a final research chapter and then a doctoral thesis.  Notes 
and interview recordings that were taken at the clinic were entered into a word processor, 
attempting as much as possible to transcribe notes whilst the incidences were still fresh in 
memory.  These documents were then analysed using Nvivo. When actors reference 
structures beyond the clinic, such as policy and protocol the reference was followed through 
these documents into a textual analysis (Fairclough, 2003).  The references between 
practice and protocol are not often explicit and so require a certain amount of abstraction 
to ascertain which jurisdiction actions occurring at the clinic were under.  For example, 
when an entity like disclosure or adherence is referred to, there is often no specific 
reference to the guidelines such as those found on CHIVA.org.uk, but there is nevertheless a 
correlation between the two and the impetus for clinical actions can be followed into the 
protocol.  Therefore, the relevant documents pertaining to procedure were analysed 
alongside the data placed in Nvivo from the clinic, where the focus was on following the 
impetus for ‘actors to act’ (see Mützel, 2009 for corresponding discussion of ANT).  In Nvivo, 
case notes were viewed alongside each other with the policy and guideline documentation 
pertained to in clinic, allowing relevant sections to be 'coded' together (borrowed from the 
grounded theory approach with reservations Glaser and Strauss 1999, STS emphasises that 
the associations that are followed are the ones provided by participants, the creation of 
codes therefore was as much as possible factors that participants would provide 
themselves). The use of Nvivo to render data collected in the clinic forms a particular 
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adaptation of what could be construed as ‘research data’ and allows certain versions of 
‘sociological conceptualisations’ to come into being (Law 2004a).  For this reason, I deemed 
it important once the data was coded to go back over the coding and consider its context 
carefully.  In relation to these considerations Latour (2005) advocates using three 
notebooks, one as a log, the second to record data and the third to write in as research is 
going along.  Although this research did not formally adopt three notebooks, I have noted 
and endorsed the task of distinguishing between processes of producing data which are not 
so easily defined and placed between one part of the research and another.  This suggestion 
helps to ensure that data is reflective and relevant to the process that made the researcher 
document it in the first place, beyond that of grounded theory. 
 
As a result, although abandoning the idea that my analysis could create a wholly 
accountable and verifiable version of events, the resulting thesis contains a salient analysis 
of the relationships that occur in clinical practice and the logic employed to organise the 
context of paediatric HIV to regimes of care.  As a result the ensuing thesis offers many 
accounts of contingent negotiations between child patients, families, professionals and 
protocol. 
Summary 
The discussions that have been presented in this chapter serve to provide an insight into the 
logic used in setting up the research.  The first section of the chapter discussed the 
methodological stance with which I have approached the subject under study.  It considers 
how to make it possible to follow actors that are seemingly chaotic, through the 
consolidation of childhood, HIV and antiretroviral requirements in clinical practice, and the 
limits of rendering this complexity into one coherent account.  The second section on 
research methods charts the process of how data was collected in the clinic to encompass 
the existing dynamics between patients, practitioners, protocol, procedure and practice.  
Overall, this chapter provides a discussion of how actors have been followed through 
paediatric clinical practice as ‘emergent’ in order to observe how practice consolidates 
patients’ attitudes, dispositions and associations such as naivety, vulnerability and 
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innocence into care requirements.  This is built upon in the next chapter through a challenge 
to the ethical position adopted whilst carrying out this thesis.     
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4 Ethics and Paediatric HIV Practice 
This chapter has been placed between the methodology and the empirical chapters because 
at each stage of this project, from compiling literature, to research in the clinic and 
dissemination of research findings, the ethical deliberations of HIV and childhood have 
emerged in ever more challenging guises. This section is not wholly methodological or 
empirical but fits between the two.  
 
The chapter examines the ethical issues resulting from this thesis and its relation to the 
clinical procedure of paediatric HIV.  As the process of gaining ethics was relatively 
extensive, I decided to produce an extended ethical supplement for the project.  What 
follows is a discussion of the formal ethical procedures applied for, alongside other ethical 
deliberations encountered during the project.  In particular one incident is discussed where 
the ethical principle of informed consent turned into an unethical scenario that risked a 
breach to confidentiality in the process of giving an information sheet to an adolescent 
patient.  Rather than approaching ethics as a simple code that can be applied to any 
situation, or an absolute set of principles that governs the acceptability of research, the 
project sees ethics as a complex process that emerges from within the networks where it is 
applied and implicated.  The value of an ethical consideration, good or bad comes from all 
the entities involved in the emergence of a specific enaction.  The argument here will link to 
ideas already developed from STS that place the clinic as a key site in the consolidation of 
guidelines and medical requirements with associations, such as stigma and naivety, patients 
present during practice.  Amongst these processes of consolidation I would like to introduce 
ethics as a deliberation that must be negotiated in each clinical encounter, and 
subsequently in each decision made during research.   Fraser (2006) argues that many see 
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STS, and in particular work by Latour, as lacking a sustained ethical approach.  I will discuss 
this claim using Latour’s Politics of Nature in reference to Fraser (2006), and to this account I 
would like to offer a second dimension from Latour (1992) around the ethical design of 
objects and other ethical themes arising from STS more generally.  The application of STS to 
ethics is made particularly significant in this thesis because of the complexity of ethics in 
relation to paediatric HIV.  In this chapter, the discussion of these texts will be related to 
what this style of ethics means for the project.  The discussion is split into three main 
sections, the first one examines the formal ethical approval that the project had to gain, and 
through using STS, what sort of ethics these procedures generated.  The second challenges 
the concept of what ethics meant in the ‘field’ by offering an example where formal ethics 
was difficult to adhere to in the clinic.  The third brings the discussion together with 
considerations of childhood and the problems that it causes for an STS version of ethics.  
The discussion does not aim to draw a clear conclusion about ethics, rather it considers the 
problem of ethics for the specific situation of researching paediatric clinical practice in HIV 
and highlights the problems found in relation to using STS and SoC literature. 
Informal Versus Formal Ethics 
Before fieldwork could begin in the clinic, the formal ethical procedure of the NHS dictated 
that the research had to gain approval through IRAS48 from a Research Ethics Committee 
(REC), and R&D at UOUH.  For this process, applicants fill out a lengthy online questionnaire 
about their research and research design alongside a set of predefined issues.  The 
completed form is then logged, sent off within four days, and an appointment to have the 
form evaluated in front of a committee is booked.  This procedure is designed to make 
researchers reflect on what could potentially be ethical issues in their planned research.  It 
could be argued that the completed form creates a comprehensive set of principles for the 
research to follow (Parker et al., 2005; Taylor HA, 2007; Jong et al., 2012).  For illustrative 
purposes, below are a few details about the REC form followed by how the project fulfilled 
REC requirements to gain formal ethics approval.   
 
                                                        
48
 Integrated Research  Application System (IRAS) https://www.myresearchproject.org.uk/ 
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Among the first questions on the form are a series of tick boxes to be filled in if research will 
enrol one of the identified vulnerable groups i.e. children, those unable to communicate, 
those with a criminal record.  The form then goes on to ask applicants to make an 
assessment between on one side, whether their research is worthwhile and of scientific 
merit and on the other, the amount of risk or burden it would place upon participants.  
Once this criterion is met, the rationale of the remaining sections of the form is to provide 
the committee with enough information to judge whether specific aspects of the design are 
ethical.  For this purpose, the form goes on to ask for a summary of the main points of the 
project and its scientific rationale.  The rest of the form is split into sub-headings that 
require a research specific response to predefined ethical issues of medical research.  In 
order these sections are: Research participants including the inclusion/exclusion criteria, 
research procedures, length of study, extent of intervention, risk to participant and myself 
partaking in research, recruitment and informed consent, confidentiality, incentives and 
payments, notification of other professionals and publications and dissemination.  The final 
sections ask the researcher to detail again the scientific review undertaken and 
management of research.  Before beginning research in the clinic I made two applications 
through IRAS, reviewed over two separate meeting by the same board.  The whole process 
took me around six months.        
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3 a scan of the completed IRAS form submitted for this project 
 
Armstrong (2006) traces the development of conceptualisations of ethics in British 
medicine, such as those contained in IRAS.  He argues that the roots of medical ethics do not 
arise through considerations of patient well being, but through branches of professional 
conduct and later public health.  He puts forward that early ethical doctrines were mainly 
concerned with professional etiquette, and the description of the duty of the physician to 
their patients was brief.  Armstrong states that one of the main aims of ethics was to 
protect the discipline from unqualified practitioners while promoting the interests of 
medicine generally.  In the 20th century, ideas of how health was caused by external factors 
infiltrating the internal body shifted ethics to questions of maintaining the integrity of a 
respective body.  Later in the 20th century, ethics developed into seeing professional or 
social aspects as being potential sources of threat to a patients’ health.   Bioethics emerged 
as a compliment to the medicine.  The history of ethics is therefore not continuous but 
engaged in the development of medicine, ideas of public health and within the 
understanding of the causes of health problems: 
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“This idea of continuity pervades the history of ethics but, [...] within the last two 
centuries alone, medical ethics has shown remarkable shifts in focus and it requires a 
major effort to link each of the recent strands – from questions of appropriate 
etiquette to protecting the patient from the doctor – with a long distant past.” 
(Armstrong, 2006, p878) 
 
Ethics goes from being something not associated with the body, to relating to internal 
pathologies and the transmission of dirt and pollution to internal parts of the body, to 
considerations of how the processes of treating the body can be potentially harmful.   
 
Rather than taking Armstrong’s condensed history as a complete representation of ethical 
developments, it is more useful to consider how Armstrong has contrasted historical 
perspectives of ethics.  From these perspectives, the model of ethics that is used to review 
the IRAS form is decentred49.  Aspects of the ethical code can be seen as altering according 
to their context rather than their intrinsic values (also see O’Reilly et al., 2008).  One intrinsic 
logic to REC procedure is that it makes researchers speculate as to the potential harm or 
discomfort that research could cause to participants or themselves (Department of Health, 
2005, 2001).  That is to say, it asks researchers to make a context specific evaluation of their 
research.  Therefore, as with any other project, my application included a number of 
measures that the research sought to incorporate in order to meet with REC policy. 
 
One of the most significant considerations (as it will be visited later on) was that parents and 
children would be given information sheets at least 24 hours before they gave informed 
consent.  To meet this requirement, I verified that information sheets would be given to 
participants when they attended the clinic and consent would be taken at their next 
consultation around 3 months later.  Formal ethics under this notion has the role of being a 
                                                        
49
 The Department of Health (2005) poses an example of a medical ethical model that implies ethics as 
continuous  
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safeguard against un-sound research50,51.  Discussions such as these have a wider bioethical 
context and have a hotly debated politics and constitution (Widdows, 2007; Ashcroft, 2010; 
Petersen, 2010)( also see Armstrong 2006). 
 
I would like to foreground these discussions, and approach the debate by asking if the 
completed ethical application is all there is to acting ethically?  Does the formal REC code 
offer a sufficient basis from which all subsequent actions taken during research can refer 
back to?  Just how broad can the scope of formal ethics considered to be?  And how does it 
relate more generally to the ethics emerging from clinical practice?   
 
To begin to engage with some of these questions, I would like to use Latour’s Politics of 
Nature.  According to Fraser (2006), the Politics of Nature can be interpreted as offering an 
approach to ethics that does not engage with a fact and value approach, recommending 
instead a situation based evaluation of the quality of the specific process involved in making 
something ethical.  As Latour himself states: 
 
“Behind the false distinction between facts and values were hidden an essential 
question about the quality of the procedure to be followed and the outline of its 
trajectory, a question now liberated from the confused quarrel that (political) 
epistemology sustained with ethics.”  (Latour, 2004b)   
 
Moreover, in the Politics of Nature, Latour argues that his version of STS (applied to 
environmental politics) involving specific material and semiotic networks cannot exclude but 
is rather nourished by moral preoccupations.  Latour (2004) would see each moment where 
ethics is denoted as being a unique ethical assemblage.  Acting ethically under this notion 
                                                        
50 A further set of policies that I incorporated were to only interview children who had sufficient knowledge of 
their HIV to ensure that I would not disclose anything that they didn't already know about HIV was: to detail 
that the storage of any data that could identify participants would only be stored on secure university drives, 
to confirm that Dr Peters would identify potential participants independently, and more generally, to make 
sure that I recognised the sensitive nature of qualitative medical research in consultations and interviews and 
confirm that if the research would cause discomfort or was unwarranted at any time I would leave the 
consultation room or cease the interview and withdraw them from the study. 
51 Also see ESRC Research Framework 2010 
http://www.esrcsocietytoday.ac.uk/ESRCInfoCentre/Images/Framework%20for%20Research%20Ethics%2020
10_tcm6-35811.pdf [Accessed 17 May 2010] 
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therefore, is a process where objects are temporarily aligned or misaligned to render 
actions ethically acceptable or unacceptable. 
 
According to this principle, every project evaluation that is undertaken by the REC must 
involve an independent set of context specific relationships between the form, the research 
team, the committee and extraneous entities.  Therefore, what is deemed as ethical during 
these evaluations is not exactly the same between different projects, different members, 
and different RECs over the passing of time.  Furthermore, this highlights the ways that the 
REC must preside over the ethics of a project from an abstracted position in the interests of 
a certain form of science, and can never permanently declare that a project is ethical or un-
ethical.  Instead, it judges over the conduct implied in the research plan at a distance, to 
assess if it is ethical towards participants, and if the project has a scientific rationale which 
makes it worthwhile (Fitzgerald et al., 2006).  The ethics themselves are not contained in the 
final report of the judgement of the REC.  What will become of the ethics will also depend 
upon what happens in the many instances when the research is being carried out.  The 
research plan discussed between the researcher and the REC becomes a set of rules agreed 
upon and constantly re-applied to the research of clinical practice thereafter. 
 
NHS type ethical frameworks are implicated at many levels and the reasons why it is 
important to adhere to them forms a wider argument around facts, values and morality (STS 
seems to imply). However, making this project ethical is a larger task, the ethical 
considerations that will shape fieldwork will be more complex, broader in scope and implied 
at all stages of the research.  Adhering to an ethical code will be a task that will mediate 
between every subject under research from inception to clinical practice to dissemination 
(Dixon-Woods and Angell, 2009).  Rather than creating a line between what would 
traditionally be seen as formal ethics and informal ethics, each ethical consideration can be 
seen as being part of a larger process of enactments that gives ethical systems their value.  
Therefore, the ethical considerations of this project must negotiate many diverse stances of 
what is ethically right or wrong, not one single ethically right or wrong social world or 
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clinical consultation.52  (As can be seen through Gino’s alternative adoption of ethics found 
in Callon and Rabeharisoa, 2004 discussed in chapter 2). 
 
Complex Ethics 
This pulls into question the concept of creating a predefined ethical code before research 
begins.  Many of the ethical decisions that are made whilst carrying out research would not 
specifically make it on to an REC form about ethics.  In addition, what is deemed as ethical 
can be different between the process of applying for formal ethics and what occurs at the 
research sites. 
 
I will use the example here of a discrepancy that opened up in the field concerning the 
information sheets (IS) for the project.  To recap, it was required for my submission to the 
REC that the application included a pre-made IS, to be evaluated and approved before being 
used.  For this purpose, I designed an information sheet that attempted firstly, to contain 
easy to follow digestible information that was as comprehensive as possible, and secondly, 
to act as a resource that participants could take away, reference, and question me about. In 
my first application to the REC, an integrated information sheet was presented and 
reviewed in front of the committee.  The application was rejected as amongst other 
reasons, the IS was deemed not to be comprehensive enough for each particular group 
taking part.  The board suggested that I created separate sheets, one for adults and another 
for children in a more basic language53.  Following revaluation, these information sheets 
were then approved with minor errors to correct.  The task of applying for ethical approval 
is an extensive one and if an application fails, a researcher must wait at least a month 
before the committee can reconvene and re-review the application (Department of Health, 
2001). One of the criteria that the committee judge an information sheet from is how well 
participants will be able to understand why they are being asked to take part in the 
research.  This was interpreted as a task that must reference HIV in order to explain to 
                                                        
52 This is not to suggest that ethics are valueless, instead their values are contained in the networks they are 
embroiled within, and have a value amongst the actors and objects they are enacted alongside.(Williams-Jones 
and Graham, 2003) 
53
 Faden et al., (1986) have charted the history of informed consent and document much of the legal, moral 
and philosophical framework of the concept. 
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participants why I am researching HIV and childhood.  In the moments when research was 
being formulated, complying with this task seemed wholly ethical (Examples of the 
information sheets and consent forms can be found in the appendix 1.1 -1.4). 
 
I was aware of how stigmatising HIV was relative to other illnesses (I had spent some time at 
a charity before researching in the clinic who informed me of the difficulty of organising 
events, or raising awareness as parents and children would be wary to pick up a leaflet with 
HIV written on it.)  At the clinic however, good services rely on giving patients precise and 
well thought out information.  Supplying articles that have HIV written on them, such as 
antiretrovirals and pamphlets are essential to providing HIV healthcare.  Many groups like 
charities, the clinic and drug companies do attempt to give out paraphernalia with HIV 
written on them, so it did not constitute an ethical breach per se, and when completing my 
IRAS application I did not see any reason to change the IS54. 
 
In the clinic I gave out information sheets with the Consultant present, he would usually 
introduce the study and then I would explain it, and give participants an information sheet, 
asking them to take it away, read it and think about taking part.  The last thing that I would 
explain is that the sheet had the word HIV on it and participants should be aware of where 
they put it.  For me it was a simple matter of them looking after the sheet, but for a few 
participants the issue became more serious.  One distinct example was a patient I will refer 
to as Jemima, who chose to let the specialist nurse hold on to the sheet because she had 
sports straight after the consultation and was afraid that somebody might look into her bag 
as she was changing.  In this situation, a formal ethical requirement came into conflict with 
the situation at hand in the clinic and switched to become unethical55. The fact that the 
document was potentially risking a breach in confidentially of the child’s status arose from 
the method employed by me to create a document that sought to provide the maximum 
amount of transparency to participants.  Although participants must take and sometimes 
                                                        
54 Savage (2000) provides a discussion from a practitioners view-point of identifying issues when conducting 
ethnography in the clinic, emphasising the need for contingency.  
55 Possible ways that I could have resolved it during planning were to not use the word HIV and instead 'your 
condition' but this would then allay even more ethical considerations of the possible interrogation if found and 
participants may not be clear as to why they are taking part. 
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hide boxes of antiretrovirals from undisclosed family members at home, it was 
unreasonable in this situation to ask them to conceal yet more incriminating artefacts.  The 
decision to let participants read the sheet in the clinic was not the ideal formal ethical 
situation imagined before research.  One of the functions of the sheet was to be a reference 
at home for participants to refer to.  However, in this situation it became more ethical to let 
the participant read the sheet in the clinic, and inform them to contact the clinic with any 
questions, who would then be able to give out my contact details.  This demonstrates how 
ethics worked in practice (see Gallagher, 2009 for other case studies involving childhood). 
 
Following the discussion of Latour earlier, positions the ethical considerations amongst all of 
the objects and actors found at the scene.  In this instance with Jemima, an ethical paradigm 
was set up between me, the Consultant, the information sheet, her bag, her classmates, her 
parents, the school, the clinic etc.  It could be asserted that ideally, all potential ethical 
issues should be identified and planned-out before research begins.  However, the 
specificity of the ethical set up found in this situation is too complex to pre-empt on an 
ethics form, and even if it could be pre-empted, it would be a lengthy and unpractical task 
to detail it all in one form. 
 
This leads to an idea of ethics as something that must be re-formulated and applied at each 
successive moment in the research.  Every event of the research must be judged as to 
whether it is acceptable or causes harm to participants or the researcher, it is not the simple 
application of a code but something emergent alongside all other entities in a specific 
situation (Latour 2004).  In accordance to this view, it could be suggested that ethics is 
irreducibly bound with the situation that it is enacted within, and is altered between the 
different places where it is enacted (see Irreductions in Latour, 1988).  Moreover, rather 
than ethics being a singular entity, there can be discrepancies between ethical 
considerations that overlap or contradict each other depending upon the context in which 
they are applied.  There is more than one ethical consideration at play during these 
encounters at the clinic.  One is the desire to provide participants with a resource that 
explains the purpose and procedure of the research and gives them details of who to 
contact if they have any problems or questions.  Another is the fact that it is the 
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researcher’s responsibility to maintain or avoid situations where there is a risk to breach 
confidentiality (Benjamin and Sohnen-Moe, 2004).  For these situations, the pursuit of the 
ethical action emerged from the interaction itself and involved the application of 
considerations developed outside of IRAS.  According to Latour’s (2004b) version of ANT, 
ethics would not be something that humans send out in their interpretations of the natural 
world (as in the Copernican revolution stance).  Ethics are not a set of considerations that 
are wholly deployed by a human actor when navigating the outside world.  Instead, ethics 
are created through the interaction between human and non human-actors together 
(Shaviro, 2009).  Objects such as an Information Sheet and a gym bag are able to cast ethical 
agency with humans.  The IS is designed to act as an intermediary that attempts to pre-empt 
the main concerns of participants and as a resource they can refer back to.  Therefore, it 
contained information about why I wanted them to participate, how the data will be 
handled, the safe guards in place that will ensure that no harm will come to participants 
from taking part, the measures taken to ensure anonymity and the assurance that 
participation was voluntary.  The IS was designed to be read by children and adolescents 
and was written in a clear and accessible English, and therefore its use by someone other 
than the child was not foreseen, or part of the IS’s planning. 
 
An older text by Latour (1992) can be used to demonstrate other ways to examine ethics as 
formulated through the process of enacting objects.  Along with objects such as seatbelts 
and sleeping policemen, Latour (1992) uses the example of a doorstop of La Halle aux Cuirs 
at La Villette in Paris to illustrate how people can act at a distance through objects.  In order 
to keep the heat in the conference hall, the door must be kept closed.  The door to La Halle 
aux Cuirs is not only designed to be a barrier to keep the heat in the building, it is also 
designed to let people move easily in and out of the museum.  However, if the people who 
use the door leave it open, it causes the problem of letting the cold air in again, and so an 
extra device, a groom, is designed to make sure that the door closes itself when people 
forget to close it.  The groom then, is designed to perform and re-perform a process 
between human and non-human actors, it is making sure that those who have opened the 
door close it again for the wellbeing of those who will continue to use the building and the 
heating bill of a publicly funded building, maintained for public use.  Performing these 
Ethics 
 
110 
 
actions ensures that the groom acts in accordance to a set of morals each time it is left 
open, in this case the morals of public money and public space.  It is a demonstration that 
ethics is a complex interplay between human and nonhuman objects.  In the same way, this 
could be applied to the information sheet that was used in the clinic as it had the ability to 
act unethically if handed out at the wrong time.  The IS can be seen to perform a process at 
a distance to inform participants about the research and answer questions that may arise.  
However, this becomes exposed when the IS was taken out of its intended clinical context.  
The interplay between the sheet, the bag and the movement of Jemima after the clinical 
appointment – what I’ve referred to above as an ethical assemblage – was something that 
had to be disciplined into acting ethically.  In this instance by explaining that the IS needs to 
be kept secret and preferably not giving the sheet to Jemima to take away.  Instead she 
might have been advised to contact the clinic with any questions56. 
 
The negotiation of ethics can be seen as becoming an assemblage of allies, keeping human 
and non-human entities as acting compatibly with the research aims to keep the research 
ethically sound.  A criticism made towards this kind of STS argues that it takes on a ‘winner-
loser’ terminology.  Radder (1992) finds a problem with the way Latour (1992) uses ideas 
such as allies and opponents, strategic negotiations, and technical manoeuvres to explain 
how scientific ideas and ethical norms are maintained.   He argues that these types of 
militaristic ideas do not favour analysis of the ‘loser’, scientific dissent or the things science 
tries to suppress.  Analysis usually results in a normative stance of science, which creates a 
tension as the STS of Latour is apprehensive about normativity (also see Keulartz et al., 
2004).  Fraser (2006) also launches a similar criticism in reference to Latour (2004), 
commenting that Latour’s analysis of the actual relations at work around a specific ethic 
takes attention away from other possible versions of ethics.  As has been demonstrated in 
the methodology chapter, Latour advocates research methods that allow actors to emerge 
and inform what to follow when conducting research (Latour 2005).  This complicates our 
ethical stance as following through actors and giving them free reign will mean that the 
                                                        
56
 Michael (2004) also offers a similar demonstration of human and non-human actors acting contradictorily in 
the incident of the ‘disastrous interview episode’.  Where the intervention of a dog sitting on the legs of the 
researcher, a cat pulling away the tape recorder and unwilling participant make it impossible to conduct a 
recorded interview. 
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researcher will pay the most attention to what is made prominent to the research at the 
expense of less distinct connotations.  For example, by following through the ethics 
contained on the IS, is a versions of ethics being foreshadowed that may have not been 
formalised into the IS (Law 2004)?  Using a Latourian style of STS in ethics, means that ethics 
must be seen as an association that when enacted, suppresses many aspects deemed as 
unethical.   The functionality of STS relies upon the importance of not being able to reduce 
entities from the networks that have created them, and focus on identifying, without 
researcher-bias, the relations that are at work in and around each enaction.  So, although it 
is opposed to going off and following the suppressed strands and their possibilities, a sound 
account should still attempt to identify what is suppressed in a version of ethics or science 
and the relations it shares.  The question is whether it is a more useful approach to trace 
ethical relations of a certain network, or to trace all possible ethical considerations 
neglected or otherwise.  A Latourian style of STS would see the search for the possibilities as 
allowing a purposeful inventiveness of the researcher that would lead to an inaccurate 
account (see discussion of Latour, 2005 in chapter 3). 
 
Ethical Assemblages of Innocence 
A further ethical dimension opens up for the project when considering associations of 
childhood innocence, as doing research with children brings its own set of ethical 
considerations (Alderson and Morrow, 2011).  This is further complicated in the context of 
illness and HIV.  The idea that ethics is formed in complex patterns of ordering and 
disordering between human and non-human agents is incompatible with certain notions of 
childhood, that views childhood agency as always in the process of ‘becoming’ (Casta eda, 
2002)57.  This means that children are seen as objects that are not finished, or are seen from 
their potential of becoming adults.  From the point of view of an ethics that is formed in a 
complex process around the interaction of objects, much policy renders them as not being 
                                                        
57  The concept of becoming has a subtle range of meanings in Social theory.  A broad distinction of becoming 
can be made on the one side between the philosophy of Deleuze, who had an idea of becoming as a flow that 
never crystallises into specific entities.  And on the other, Latour’s modern alteration of the Deleuzian concept 
that concentrates upon the specific moment where entities become so specific that each further evocation of 
that object renders it as different, (see Harman, 2009 p6, p30). 
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capable of engaging with ethics (Alderson, 2007b).  Adults must make interventions on their 
behalf to make them adhere to ethics.   
 
This confuses the idea of an ethical enaction, or a process that makes research ethical, 
creating a view of children as being ulterior to ethical actions.  It renders them to the 
contradictory status of an object with diminished agency.  STS discourse focuses on how the 
interaction between objects makes them part of assemblages that are ethical or non-ethical, 
whereas common-held views of childhood as unfinished, depict children as apart from 
ethical assemblages.  A child instead becomes something that is acted upon ethically by an 
adult.  This is not to say that children should necessarily share blame if involved in an ethical 
issue, but rather that the enaction of ethics and the ethical consideration would be reliant 
upon the presence of the child.  Going back to the example of the clinic, if I did give an 
information sheet to a child and they take it without complaint, the point is not that I would 
not be to blame, the point is that in this instance the child is ethically charged58, and the 
process that would subsequently hold me to blame would be a complex assemblage 
drawing on the ethics around the child and processes occurring in the clinic.  Therefore, to 
state that ethical responsibility is only in the jurisdiction of the adult practitioner or 
researcher is a simplification of the process of being ethical and disregards the many ways 
child patients can pose ethical interventions.  
 
A stance taken from the sociology of childhood develops the idea that childhood and 
adulthood are mutually constituted objects, and that this is hidden in many everyday scenes 
of childhood illness.  Christensen (1998) points to ways in which children’s incompetence is 
constituted in illness.  One such example given is in the design of medicine bottles.  Many 
                                                        
58 It is questionable if it is possible to describe something as ethically charged or ever be able to pose an STS 
style account and avoid being essentialist about what an ethical charge would constitute.  A conflict arises 
between the ideas of childhood that formal research ethics work from, an STS point of view that stresses 
finding the value of objects from tracing the actual relations between objects, and a child-centred deliberation 
that seems to lie unreachably entangled in the formal ethics.  One aspect left unclear is what constitutes these 
supplementary ideas of ethical caution that have gravitated around childhood.  The argument put forwards 
that ethics is a process found in the relation between objects at a given moment, does not begin to explain 
why ethical considerations are more charged around objects like children, or the difference between ethically 
charged groups like between childhood and disability.  The origin of each ethical dilemma, childhood or 
disability, come from different objects and set of relations, yet formal ethics can bring the two together 
seamlessly as requiring the same type of ethical deliberation (Miller, 2003). 
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bottles of medicine including those designed for children have a top that is designed to be 
pushed down as it is screwed off making it very difficult for young children to open.   
Although Christensen does not specifically talk about ethics, the example of the bottle can 
be seen to have an ethical consideration built into it (similar to the groom).  The design 
renders the child as part of an ethical consideration that they are unable to engage in on 
their own, they must be supervised or monitored.  Since the writing of Christensen’s article 
it has become necessary to distinguish between the considerations of social 
constructionism59 that this supplement does not wish to suggest.  To modify the argument 
for use here, it must be distinguished that the competency of children who are ill cannot be 
constructed outside of ethical considerations, this would be impossible.  In each enaction, 
the competency of the child is an irreducible part, and however the child’s body is viewed, it 
still has a direct impact within the situation.  The medicine bottle may seem like it has 
rendered the child incompetent and not a part of the process of opening the bottle, but in 
fact the specific incompetency of the child must still be enacted with a child failing to take 
off the top of the bottle, or with an adult taking the top off of a medicine bottle to give 
some medicine to the child.  In each situation the child has not been reduced from the 
process of opening the bottle, an idea of childhood dexterity is at work each time the bottle 
is opened due to its design.  This can also be seen alongside the discussion of action at a 
distance, detailed above.  The medicine bottle becomes a non-human actor which acts 
according to the potential for children to be unaware of the dangers posed by taking the 
medicine and to cause harm to themselves.  In situations where a child is trying to open or 
tampers with the bottle unsupervised, the bottle fails to open and so becomes part of an 
ethical process to restrict access to the medicine where it could cause harm (Christensen, 
1998, p196-198).  
 
                                                        
59 Ian Hacking (1999) highlights the internal irrationality of Social Constructionism, in his book ‘The Social 
Construction of What’.  He points out the difference made by Social Constructionists between local claims and 
general ones.  For example, for Hacking when the Social Construction of Child Abuse makes the claim that it is 
socially constructed, the argument remains oblivious to the constructions of grownups who were abused but 
were not aware of it until a later construction of child abuse, leaving questions as to what is constructed 
(chapter 5, p125-163).  It also causes a friction between the locally constructed entity and idea of it being apart 
from a general nature or reality of things.  This makes it unclear as to what is constructed in each instance the 
concept is used for analysis.  Hacking concludes that the most useful task of a social constructionist account is 
as a device to raise a reader’s consciousness. 
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Relating this back to formal ethics procedures, both the research ethics for Goldsmiths and 
the IRAS application for the NHS have questions relating to children.  In this way, the project 
must be designed with a certain idea of childhood in mind.  The research has to 
demonstrate how vulnerable groups such as children will not be taken advantage of during 
the research or subjected to something that they would not want to do if they ‘understood 
the situation better’.  The formal ethics procedures want to insure that children understand 
as much as possible about the research, have the opportunity to say no, and make sure that 
they are not subjected to any harm during the research process (Alderson, 2001, 2002).  
Thus, the methodology and research methods are imbued with a reductionist idea of the 
child and child vulnerability.  Once out in the field, the formal ethical approval intends on 
research having an idea of the vulnerable, non-understanding child in mind when interacting 
with them.  A similarity arises between the way the child is represented in formal ethical 
approval and the ways in which research will engage with notions of how the child should 
be interacted with.  To relate the two examples of formal ethics and the IS given to Jemima 
at the clinic, a similar idea of the child is evoked over the two places.  The formal ethics 
application asks specific questions that conjure up a naive and incompetent version of the 
child, and at the clinic, the relation between the doctor, the IS and the gym bag was also 
working under a version of the vulnerability of the child.  The idea of the child in each 
instance is different but it is also possible to compare the two.   Certain ethical 
considerations can be seen to permeate through the whole project in similar ways, yet also 
rely upon the relations and set up of specific moments in the research.  Even though STS can 
be seen through this argument as pioneering a way in which ethics can be explored as 
emergent, the extent to which it can be applied to children with vulnerable or incompetent 
agency that seem to exude the situation in unknown ways is uncertain.  More generally, the 
task at hand for formal ethics is to consistently project a version of research, the tools used 
for research and the objects under research that is accepted by each group involved.   
Whether reductionist or not, research must seek to be compatible with the concerns of 
formal ethics and carry out the committee’s wishes in the field, whilst working within the 
bounds of what is acceptable to everyone encountered in the research (Mannion, 2007). 
However, what is acceptable in a given context is not something straightforward or stable, 
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as relationships are subject to constant re-negotiation and each consideration must also be 
compatible with the wider scientific rationale of the research. 
 
Conclusion 
This chapter has focused on the deliberation of ethics carried out in the course of this 
project.  In relation to the thesis argument that places the clinic as a key location where 
medical doctrine is consolidated with patient complexity, this chapter has demonstrated 
how ethics must be maintained and interpreted in each clinical encounter and the effect 
this has on research.  Paediatric HIV in particular evokes a complex array of ethics.   This 
implies that clinical deliberations around ethics must be constantly interpreted in practice 
and protocol, and are highly implicated in the process of formulating of what is acceptable 
in HIV treatment.  This project has had to adapt to these ethical ‘assemblages’ and 
successively ensure that the execution of research is acceptable alongside them. 
 
The ethical components that this project has deliberated over have been: that childhood 
HIV is a heterogeneous assemblage; that a child’s agency in ethical considerations is a 
complex process that defines their competency and potential for the future; and that the 
task of being ethical is a complex navigation of gaining ethical approval from formal 
committees, to each person I encounter in research and each object that is used in research 
along the way.  This section has discussed many of the objects that are embroiled with 
insuring this project acts ethically, from formal ethics such as the REC and CRB check, which 
made me pledge and consider how I would act ethically at each opportunity, to other 
objects of the research.  For example, the IS in my hand extended towards Jemima, the 
poster on the wall of the clinic, the highly charged body of the child.  Each entity that was 
present in the phenomenon is irreducibly part of the resulting ethical consideration.  The 
encounters detailed in this chapter are largely simplified from the much larger network of 
assembled objects that move through the clinic, but still demonstrates how many human 
and non-human objects are involved in the process of rendering a dilemma ethical or 
unethical, and more widely, how ethics is a complex and dynamic process that must be 
continually navigated, rather than a fixed set of rules to be applied.    In this chapter I have 
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been apprehensive about the extent that it can absolutely define a set of ethics, instead 
trying to illustrate the many levels of ethical considerations that must be used to make a 
project ethically sound.  Rather than just following a list of artificial scenarios or 
predetermined codes, the task of rendering this project ethical will instead be down to a 
complex set of processes and considerations that must be evaluated at every stage to deem 
whether they are ethical or not, from research design to writing the research up.  This 
emphasises the argument of the whole thesis by demonstrating the ethical complexity 
presented in the clinic by the patient cohort.  This chapter has discussed how ethics has 
been navigated in research, but the same ethical complexities must also be negotiated in 
the course of clinical practice.  One unresolved problem in the chapter has been that by 
using the STS of Latour, there remains a level of doubt as to the suppression of less 
dominant ethical possibilities and to the limits of using STS over vulnerable groups such as 
children, health and illness and the problematic ways that child agency is thought of and 
enacted (also see Misztal, 2011). 
 
Combined with the methodology section, this chapter has attempted to provide evidence of 
how a reflexive and thoughtful approach to the ethics of paediatric HIV research and 
practice has been attempted in this project.  The limitations raised in relation to ethics and 
its applicability are placed highly on the research agenda.  This chapter has been designed to 
highlight the deliberations made towards ethics, and the ethical approach of the thesis 
before introducing research.  The proceeding chapter and the remaining chapters of this 
thesis will present research data collected from clinical observations and will focus on 
empirical research findings. 
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5 Disclosure 
The purpose of this chapter and the research chapters that follow, is to trace a medical 
procedure already well defined in paediatric HIV and the clinic.  The chapters in this 
research section will follow the procedures of disclosure, adherence, chronic illness and 
transition.  They will explore how these medical procedures are enacted through the 
negotiation between patients and practitioners.  It is argued that these procedures are used 
to coordinate patients and practitioners to make compatible complex patient associations, 
such as stigma, vulnerability and naivety with antiretroviral requirements and instruct each 
group on how they should conduct themselves in accordance with the medicine.  Rather 
than arguing that there is a hierarchical structure ordaining that protocol dictates these 
procedures and practice in the clinic, the research of this project emphasises how these 
procedures must be negotiated in the clinic each time they are enacted.  Therefore, the 
clinic is emphasised as a key site in the formalisation and consolidation of HIV medicine.  
This chapter will look at disclosure and investigate the ways in which the procedure acts to 
bring patients into knowledge of paediatric HIV medicine and as a result make care regimes 
that rely on patient responsibility possible.  Disclosure is a good place to start these research 
chapters as one of the primary formal tasks of the paediatric HIV clinic is to provide patients 
with knowledge of their HIV.   
 
Individuals perinatally infected with HIV experience a period as they are growing up where 
they are surrounded by, and therefore necessarily informed about HIV.  The stigma that 
surrounds the condition often excludes what can and cannot be said to a young child in the 
context of assumed child naivety (Letteney and LaPorte, 2004; Ostrom et al., 2006). In this 
respect, HIV differentiates itself from other chronic conditions and has big implications upon 
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how HIV must be disclosed to infected children.  The fact that children are coming from a 
position of not knowing to knowing evokes questions around what extent the news will be 
distressing for children and when to tell them.  A patients’ consciousness of their HIV status 
can have a large impact on a patients’ self-projected life course.  Disclosure is one set of 
formalised guidelines and protocols that practitioners will refer to when addressing how to 
orchestrate in the clinic a child coming into knowledge of their HIV, and is deemed as an 
important step toward creating a knowledgeable and responsible patient (Santamaria et al., 
2011).  Consequently, disclosure not only prioritises, but makes possible a medicine 
foundered upon consent and mutual understanding, asking patients to uptake medical 
knowledge of HIV and act responsibly.  Therefore, I will assert that when practiced in the 
clinic, disclosure consolidates a disparate range of medicines, technologies, practices, 
professions, childhoods and patient attitudes together.  The formalisation of disclosure 
guidelines are designed to show practitioners how to systematically inform patients on what 
is deemed as important for them to know about the medicine and HIV.  Accordingly, 
patients are asked to take on that knowledge of the virus in the way it is presented to them 
and internalise it into their conduct outside of the clinic (CHIVA, 2011c).   However, rather 
than overemphasising one group over the exclusion of the other, it is argued that all 
relevant groups of child patients and professionals are organised into the medicine and have 
a role to play to ensure the medicine’s effectiveness and the suppression of the virus.  HIV 
imposes its own specificities onto the medicine.  The fact that patients may be taking 
antiretroviral drugs for something they may otherwise see as invisible, or the fact that 
stigma installs fear in staff at the clinic to ensure that children do not become informed in 
an ‘unwarranted disclosure’, or the fact that families and the consultant must be confident 
that the child is capable of keeping their HIV a secret means that disclosure for paediatric 
HIV must be highly developed and meticulous in the way it is conceived, carried out, 
explained and re-explained to children (Gosling et al., 2004).  Disclosure is not fully 
contained in the written guidelines, instead it must be negotiated at each clinical encounter 
between patients, parents and professionals in accordance with drug requirements and 
protocol.  
  
Disclosure 
 
119 
 
Using concepts developed in STS, that of translation, encation and multiplicity, I argue that 
disclosure is used to coordinate care regimes between the attitudes and behaviours of 
children and the aims and tasks decreed by medical science and practice.  My aim is to 
frame disclosure as taking place between negotiations of parents and professionals where 
each party mutually influences the other.  Accordingly, disclosure can be seen as a 
technique that brings together patients and professionals through the creation of common 
conceptualisations practiced in the clinic that make it possible for professionals to relate 
medicine to children and for children to understand and start to question the significance of 
the medicine.  This draws upon the discussion in chapter 2 around lay/expert knowledge 
Callon (1986; 2004).  The exercising of disclosure in practice locates the clinic as a key site in 
the consolidation and formulation of medicine as coherent and functional.  Even though it 
could be stated that the formalisation of the procedure of disclosure into a guideline or 
protocol is done exclusively between practitioners and then imposed onto children, this 
process of the formalisation of disclosure is not isolated from practices in the clinic or the 
interactions that have been used to identify certain clinical factors as problematic.  
Therefore, what is irreducible from the formalisation and practice of disclosure in the clinic 
is a mutual negotiation of medicines and wider societal factors that result in a shared 
knowledge of HIV being built between child patients and practitioners (see Berg, 1997b; 
Timmermans and Berg, 1997, 2003).  This means that analysis must take into account 
outlying connotations such as childhood naivety, incompetence and HIV stigma 
(Christensen, 1998; Cohen et al., 1999; Atkins et al., 2010).  Whereas much STS, for example 
the object politics in literature review of Mol (2002), or Mol and Law (2004) would point to 
the endless complexity and diffusion of these entities across their different enactions, in the 
face of the incompatibility of associations around paediatric HIV such as stigma, 
vulnerability and naivety with medical requirement, the discussion of this chapter and thesis 
places the paediatric HIV clinic as a key location where complex patient associations and 
drug requirements must be consolidated if HIV medicine is be to made functional and 
successfully suppresses the virus. 
 
The discussion below centres on how disclosure is used in the clinic to consolidate child 
patients into knowledge, through techniques that adapt and readapt to situations with 
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children to build up a common knowledge of HIV and how to deal with the condition that 
will form the beginning of a knowledge base designed to develop throughout a patients’ life. 
 
Formulations of disclosure 
Enactions of disclosure have a range of subtle differences that inform and guide practices in 
the clinic.  The CHIVA model of disclosure (CHIVA, 2011a) is the model that practitioners in 
the UK (including UOUH) subscribe to when beginning disclosure.  The CHIVA model echoes 
the stance put forward in a policy statement made by the American Academy of Pediatrics 
(AAP)(Committee on Pediatric AIDS, 1999a) which recommends that it is ethically right for 
children to be given their diagnosis, even though each case is acknowledged as particular.  
Internationally, this is the most influential policy around disclosure of HIV to children, and is 
far reaching across many national services, although interpretations of how to proceed 
according to the policy aren’t necessarily the same. (Wiener, Mellins, et al., 2007). 
 
The interpretation made by the CHIVA model of disclosure advices practitioners that:  
 
“Children and young people should have ongoing explanations about their health 
condition appropriate to their age and level of understanding. This knowledge should 
be built upon in stages over time.”  And that “The majority of children should have had 
an open discussion about having HIV by the time of transfer to secondary school. 
Exceptions should be documented, along with the plan for ongoing appropriate 
interventions to advance the child’s knowledge” (CHIVA, 2011c). 
 
Although this is in line with the AAP statement that advocates an individualistic approach 
and stresses the requirement to disclose, it more specifically details recommendations of 
‘building up’ knowledge of HIV and details an ideal age limit where the AAP does not. 
 
Therefore, networks of medicine from large institutions to individual practitioners use 
disclosure as a terminology that refers to a process that is not a single incident of telling 
children they have HIV.  As is regularly advised to parents, disclosure is not a onetime 
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ordeal, but something that is ongoing as a child grows up (NAM 2010a).  Moreover, 
according to the CHIVA model and observed in the clinic, disclosure is a process of gradual 
education for children about how a virus works and is transmitted, the immune system and 
medicine. Although this may seem straightforward, some of the complexities of 
implementing disclosure as a procedure in the clinic will be explored further in this chapter.   
 
If disclosure is analysed as a clinical technique (alongside the other chapter headings of 
Adherence and Transition), one key question is how it makes certain ways of treating HIV 
possible.  This invites us to view the larger role of disclosure in the ordering of children and 
parents into compatible interactions with broader tasks of the medicine and the treatment 
of HIV.  I argue that disclosure is used in the clinic to ensure the effectiveness of drugs, 
define the boundaries of medicine and enable HIV treatments regimes that rely upon 
patients understanding and taking responsibility for their condition.  Therefore, disclosure 
works to coordinate medicine between the naivety/competency of child patients and the 
prevailing medical knowledge of HIV treatment.  In these processes of coordination codes of 
ethics and sanctions for procedures are implicated over many levels locally, nationally and 
internationally (Committee on Pediatric AIDS, 1999a).  The recommendations of the CHIVA 
model make their way into the clinical practice in dynamic ways (CHIVA recognise this 
themselves in their advice to parents, but made clear the unacceptability of not telling a 
child over 12 see CHIVA, 2011a; NAM, 2010a).  As practitioners including Dr Peters are only 
too aware, each case has its own particularities that confound interpretations of the ethical 
code and methods to disclose accordingly (Foster et al., 2007, 2009).  On the one hand, 
disclosure can be seen as a procedure formalised to consolidate a shared knowledge of HIV 
between patients and practitioners.  However, on the other hand, a highly subjective 
question lies behind the reasons as to why it is necessary to disclose to children.  The 
process of disclosing evokes more than questions about the necessity to include children in 
knowledge of HIV to make individuals responsible with a stake in their care (as in the 
Disclosure Processes Model see Chaudoir et al., 2011).  The fact that children are coming 
from a position of not knowing to knowing evokes questions around what extent the news 
will be distressing for children and when to tell them.  Ideas of vulnerability are inseparable 
from the act of disclosing to children, which is related more generally with associations 
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around illness and childhood (Bluebond-Langner and Nordquest Schwallie, 2008).  In 
accordance to the already difficult task of conveying the bad news of HIV infection to the 
patient, doing so with child patients activates an intervening charged association of child 
vulnerability making the procedure more uncertain.  These questions of conveying 
knowledge of HIV according to a child’s disposition must be coordinated in the clinic.  The 
task forms part of a logic that seeks to make children compatible with medical 
requirements.  The question will become more acute when discussing how children are 
deemed ready to be disclosed to. 
 
A Time to Begin Disclosure 
At UOUH the formal process of disclosure begins in sessions between the children and the 
clinical nurse specialist (CNS).   In the majority of cases the decision of when to start is made 
in a negotiation between case history, the desire of the parents, Dr Peters’ judgement and 
the recommendations of protocol to approach the subject before children are 12 years old.  
When disclosure is deemed appropriate, children have a session booked to see the CNS 
where she uses a set of slides to begin to approach the subject of HIV.  The process takes 
place between the clinic and at patients’ homes, using slides and a laptop. 
 
 
4 A slide taken from the disclosure presentation depicting a T cell fighting infection 
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5 A slide used to describe white blood cells 
 
When I asked the CNS how she discloses to patients she responded:  
 
“The first one [presentation] I use is about blood, the second one is on a virus and how it 
works, and we just go through like that.  First session I’ll talk about one then we’ll go over it 
in another session and then go over it again”  
After looking at the slides I asked “it doesn’t say HIV on these slides, how long do you go 
through like that without using the word HIV?” 
“We do about six sessions like that building up the knowledge of how it works and then 
after about six sessions I’ll introduce that they have a virus, then I’ll ask the parents how 
they want to proceed, some of them want us to tell them, others want us all to be together, 
some will want to tell them themselves.”60 
 
The slides that the CNS uses seek to define aspects of the immune system without 
mentioning the word HIV.  The logic behind this method is that children will be introduced 
slowly to relevant knowledge about the biological consequences of having HIV before being 
told that they have the disease in a pre-emptive attempt to circumnavigate negative stigma, 
as will be demonstrated later.  Within these considerations lies a connotation of distress, 
child vulnerability and the potential misconception of HIV that seems inherent to paediatric 
                                                        
60 Taken from informal interview with the CNS, Nov 2010 
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HIV61.  After these sessions take place Dr Peters can begin to talk in consultations openly 
about HIV.  Children then become part of discussions about blood test results and drug 
regimes that would previously have only been relayed to their parents.  Therefore, getting 
to this stage is important to allow children to get used to actively participating in the 
ongoing medicine concerned with their treatment and understand how to avoid public 
health risks and further transmission (Campbell et al., 2009). 
   
These procedures of disclosure consolidate and inform patients upon what the clinic expects 
them to know and allows practitioners to discuss care regimes (making it possible to achieve 
tasks like “facilitating adherence” Pontali, 2005).  This demonstrates that the logic of 
disclosure seeks to equip the child with a common biomedical knowledge of what is HIV, 
what it does, how it works, how it is transmitted and what are the consequences.  
Therefore, the default position of those who treat children is that they are naive and do not 
understand the implications of HIV, the medicine used to treat it and the ensuing potential 
threats to public health, and so formalised disclosure methods are employed to introduce to 
children why they must visit the clinic and the significance of confidentiality (see discussion 
of education, innocence and children’s sexual rights in Mitchell et al., 2004; Bhana, 2007).   
 
To aid the disclosure model, support is sought from the psychiatry team at the ward and 
practitioners refer children when they identify distress (Santamaria et al., 2011; Mellins et 
al., 2002).  For the clinic it becomes important to consider how individuals will react to the 
procedure of disclosure, and when it is the best time to begin.  As each of the issues 
discussed has the potential to interact differently in each case, the age range and stages of 
disclosure vary.  The CHIVA recommendation is intentionally wide, with the recommended 
age below 1262. At UOUH the age between cases for beginning disclosure work ranged 
broadly from broaching the topic at 8 or 9 years old to reaching the deadline of 12 years of 
age.  During the first ‘warm-up’ stage the word HIV is absent from the discussion until the 
                                                        
61 Melvin, (1999; 1995) is written by a psychiatrist in the UK in particular discusses the importance of gradual 
steps of disclosure although an international discrepancy exists as can be seen across the articles reviewed in; 
Wiener, Mellins, et al., (2007) 
62 Cases of children over 12 years not knowing their status are common.  At the clinic two new cases, Rob and 
Erica, were enrolled at the clinic respectively at the age of 12 and 15 not knowing their diagnosis.  The plan by 
health professionals in the clinic was to disclose as soon as possible. 
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team are sure that the child can keep a secret.  Factors which prompted warm-up disclosure 
sessions were often on the types of questions children were asking at home such as why 
they were taking medicine and why they had to come to the clinic.  Another contributing 
factor in a few cases, (such as Harry, Celina or Bianca63) was that they had family members 
who had died from HIV, in these cases the potential for asking questions was even more 
feared by staff.  In several cases, for example like Harry’s mother, parents may wish to tell 
their children on their own without the team.  The job of Dr Peters then becomes one of 
putting pressure on the mother to disclose, but he is limited in the ways he can deal with 
the situation. 
 
In each case therefore, a number of individual factors are evaluated alongside the CHIVA 
model recommendations, and disclosure becomes a negotiation.  This negotiation promotes 
the general benefits of including patients in knowledge of their care, and the construction a 
shared knowledge of HIV and how to treat it.  However, other questions can also be seen to 
become embedded in these decisions like that of vulnerability or cultural difference, and the 
threshold to distress.  Disclosure in this case is not the straightforward inclusion of patients 
into knowledge, but the navigation of medical knowledge and child standpoints to arrive at 
a mediated, age appropriate, ethically acceptable knowledge of HIV64.  In this context, the 
critical question for the clinical logic becomes when is the right time to start to talk about 
HIV? 
 
The reasons for starting disclosure in the cases I observed in the clinic were case specific.  
For example, warm-up disclosure sessions began at the age of eight for Celina, firstly 
because her father was willing, secondly the nature of the questions she was asking (see 
Blade incident detailed later), thirdly the fact that her mother had died from the disease and 
fourthly her bad behaviour reported from school made Dr Peters deem it necessary to 
begin.  Similarly, with Bianca who was nine, the team began disclosure when the school 
                                                        
63 Three cases existed where a parent had died from AIDS:  Harry was living alone with his mother after his 
father had died, Bianca was living with her aunty as her mother had died and the father’s whereabouts were 
unknown and Celina lived with her father after the death of her mother.  All of these parent deaths had taken 
place when the child was young and the children had limited reminiscence of the parent. 
64
 This point is relevant to discussion of ‘age appropriate development’ in Kelle (2001; 2010); and ’what 
children know about their disease' in Bluebond-Langner et al. (1990; 1991) 
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reported her mood as ‘angry’ and her auntie was struggling to understand the cause.  It led 
the team to speculate as to the reasons for the anger.  She knew that her mother had died 
but not the reason for her death.  This coupled with the fact that she must take 
antiretrovirals and visit the clinic prompted Dr Peters to send her for sessions with the CNS 
and the ward psychiatrist.   Another nine year old, Pierce was also advocated to start early 
due to his perceived intelligence, the questions he was beginning to ask and his wit in 
consultation.  Dr Peters proposed to the mother to begin disclosing over the next year.  His 
mother agreed he that was ready to start immediately.  Both the mother and the doctor 
remarked that he is a ‘bright kid’, and expressing the desire to start early to pre-empt 
awkward questions. 
 
As is recommended in the NAM booklet (NAM, 2010a) and accounted for in most leading 
literature (see for example Battles and Wiener 2002), the process of informing children 
about HIV should not be considered as a singular event but something that may take time 
and discussion between children, parents and professionals to come out.  Informing patients 
about HIV is a process, a process that will improve medicine by allowing individuals to 
develop a rapport around talking about their condition openly with professionals.  As with 
other model patients of chronic conditions, children will be responsible for building upon 
this knowledge over the rest of their lives to best understand how to manage their 
condition.  The involvement of children makes the question of disclosure essentially 
different to the way that disclosure is presented to adults.  For example, there are questions 
of vulnerability and distress that are more easily overruled when disclosing to adults, and 
also HIV has an added specificity that it has a negative stigma that, on the one hand, 
practitioners must avoid and on the other must educate on in a manner that 
circumnavigates negative connotations (see Cummings, 2008 on managing stigma in an 
Indiana public school).  This demonstrates that disclosure in this context is specific and 
requires a highly flexible set of procedures if it is to fulfil its task of building a shared 
knowledge whilst accounting for this unquantifiable vulnerability.  As will be discussed, in 
contrast to STS accounts of the clinic detailing the proliferation of complexity through 
enaction, such as Mol (2002); Mol and Law (2004), paediatric HIV exemplifies the 
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importance of how procedures of disclosure must be enacted cautiously, but meticulously in 
the clinic to consolidate the complexities presented by patients into functional medicine. 
 
Participation, Adherence, and Impartation of Knowledge 
The process of disclosure is designed to emphasise the gradual inclusion of diagnosed 
children into the knowledge of current understandings of HIV, its treatment and how it is 
transmitted.  It is assumed prior to beginning disclosure that children need to be taught the 
conceptualisations necessary to have an appropriate comprehension of HIV and what that 
implies.  Consequently, children are educated on what HIV is, what is a virus, how the 
immune system works, different types of cells, the medicine and how they all work 
together.  However, in the early stages of disclosure work, which can last from 8 to 12 years 
of age, the word HIV and descriptions of the disease are absent from the discourse.  This 
results in an interplay between the CSN and the Consultant, where each one seeks to build a 
neutral knowledge base before being ready to impart what is deemed as a neutral 
understanding of HIV to be developed as the child grows older65.  
 
This neutral impartation of knowledge can be seen as emergent in a negotiation between Dr 
Peters and twelve year old Abbey when in the process of being disclosed to.  Her mother 
and father brought her in for a consultation after the CNS had given Abbey some sessions on 
disclosure. 
 
Dr Peters: “I know that [CNS] came to see you, what did she talk about?  
Abbey: “She talked about blood cells”  
Dr Peters: “Did she tell you about red and white blood cells”  
Abbey: “Forgotten”  
Dr Peters: “The white ones are important they fight infection... [The CNS] will see you again 
in the next few weeks to go through a few more things...  We looked at your blood cells and 
                                                        
65
 Walkerdine (2009, 1993) challenges the way in which the practice of developmental psychology 
universalises concepts such as masculinity and is Euro-centric.  Similarly then I would like to raise a caveat as to 
how ‘neutrally’ conceptualisations of HIV can be taught to children, even though the neutral impartation of 
knowledge remains a key aspiration for professionals. 
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that was good 420.  We want that number to be high, and we will continue with things the 
way they are as long as it stays like that.”   
 
Abbey was not yet taking antiretrovirals but had apparently been asking difficult questions 
throughout the whole process.  There was the fear that she was receiving a stigmatised 
message about HIV from school.  As Abbey left the consultation room to get a blood test 
done with the CNS, without Abbey in the room, her mother began to question Dr Peters.  
 
Mother: “Sometimes she asks me why she comes here and what it’s for, and why she has to 
have blood tests.  And we have to tell her that she comes here so that we can watch over 
her.  Then she comes home from school sometimes and she said she learnt this about HIV 
and that.”   
 
Disclosure work had already begun with Abbey but she was still asking some questions 
about the nature of the condition.  Dr Peters needed to make a clinical judgement as to how 
Abbey conceptualised HIV.  There are things that he wished to discuss with her and things 
he wished her to understand.  In this incident alone he attempted to go through a blood test 
with Abbey.  The team were seeking to build conceptualisations with Abbey of what blood 
cells do and how the immune system fights infection.  Dr Peters hadn't used the word HIV 
yet, but was preparing ways to impart the knowledge.  The extract demonstrates that the 
clinic is attempting to consolidate Abbey into understandings of HIV compatible with the 
goal of virus suppression.  During this slow introduction to HIV, Abbey must conceptualise 
her CD4 count as a number that equates to her health, the logic is she will want a stake in 
keeping the CD4 number high and approach her HIV in this tact of keeping numbers high 
and managing medicines.   
 
The culmination of Abbey’s disclosure sessions came when she contracted an unknown virus 
and was hospitalised for a few days.  The virus was interpreted as being symptomatic of the 
HIV becoming more active in Abbey’s body.  At Abbey’s next consultation after 
hospitalisation, it was decided to put her on to antiretrovirals and to tell her that she has 
HIV during the proceeding consultation.   Whilst Abbey was getting a blood test in another 
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room, Dr Peters informed the parents that they will start Abbey on antiretrovirals.  In 
consultation with the parents Dr Peters recommended that Abbey is told her diagnosis 
immediately before going on to ask how they wanted to do it.  It was decided that the CNS 
will tell Abbey with her parents and Dr Peters present.  Once Abbey had finished they went 
into a separate room and disclosed her virus to her.  The element that gave disclosure 
immediacy was the fact that Abbey would have to start treatment.  It was important that Dr 
Peters can talk openly to Abbey about HIV before administering medicine and making her 
take tablets.  The decision to disclose must be balanced between the necessity to disclosure 
as early as possible and competence of the child to bear the news and keep it a secret 
(Alderson, 2007a).  Therefore, disclosure is never fully defined in this situation but can be 
seen as emergent depending upon the negotiations prevalent in the clinic. 
   
The logic at work guiding disclosure aims to facilitate a common knowledge of HIV asks 
children to participate much more heavily in the medicine of which they are centrally 
implicated.  This logic demands that good HIV medicine follows from a well maintained 
patient consciousness of HIV (Fassin, 2008).  Children are being asked to take on 
conceptions of HIV and given the room to develop a further knowledge over time and come 
back and question the doctor about it.  From this point of view, patient knowledge has been 
seen as important to aid adherence, facilitate a child’s adjustment, decrease the prevalence 
of ‘risky’ behaviours (i.e. public health Campbell et al., 2009) and promote patient consent 
and  good ethics66. 
 
Therefore, the negotiation that can be found in the literature is no longer whether 
disclosure should take place for children with HIV but how it should be done and the best 
time to do it.  Disclosure can be seen to be designed to be conscientious of the ethical and 
competence ramifications associated with HIV, but also as a triumphant consolidator of 
patients and professionals together into a common knowledge of HIV.  This balance is 
                                                        
66 Alderson (2007a; 2006) details the tricky relation between competence and consent, these implications are 
also prevalent in literature on disclosure. Wiener, Mellins, et al.  (2007) have made a literature review of HIV 
disclosure to children where consent and adherence are highlighted as a recurrent issue. 
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necessary as a counter for the absolute confidentiality required around a patients’ HIV 
status. 
 
Confidentiality – a unique problem that affects what is possible 
Unlike other chronic illnesses affecting childhood which must also disclose in terms of 
educating how the body and their disease works (e.g. see Levi et al., 2012), paediatric HIV is 
distinctive because of the utmost importance placed upon insuring that children will not tell 
anyone else once they are given their diagnosis (Dorrell et al., 2008).  One of the principal 
concerns of parents when educating children about HIV is the fear of a breach in 
confidentiality.  This demonstrates the awareness adopted in clinical to attune practice 
according to the possibility of a breach in confidentiality.  As argued in chapters 2 and 10, 
this sensitivity makes paediatric HIV distinct in comparison to STS models of clinical enaction 
found in Mol (2002), Mol and Law (2004).  Paradoxically, it is the case that practitioners 
want to talk about HIV in a neutral way from as young age as possible but must be sure that 
the child can act responsibly with the information before being told.  Dr Peters made it 
explicit to me on several occasions in quiet moments at the clinic that, in his opinion, the 
biggest issue of proceeding with disclosure is that the “parents are worried about the child 
telling someone”67. 
 
For example, going back to Abbey, before disclosure work began her mother was concerned 
of a potential breach in confidentiality.  Dr Peters explained this situation to me in the clinic. 
 
Dr Peters: "[Abbey is a] twelve year old girl who doesn't know her diagnosis which is not 
great.  Mum was doing an experiment with her and she was going to tell her a secret and if 
she can keep it, then we can start to tell her status.  It’s always the professionals who cock 
up in my experience.  I don't know of any child who has told.  It’s the big scare with the 
parents, it’s usually the big issue that the child will tell someone.  When I was a boy it was 
                                                        
67
 This is not an isolated view, Waugh's (2003) study in South London also implied that word getting out was 
the biggest barrier to disclosure. 
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the thing in the playground you would call someone a spastic.  Now it’s that you say they 
have AIDS" 
 
In this respect, HIV differentiates itself from other chronic conditions, and has a big impact 
upon how it must be disclosed to children.  The negative connotations around HIV are at 
odds with treatment (see Cunningham et al., 2006 on adherence).  In all cases observed, a 
highly sensitive assemblage formulated around the fear that the child may be unaware of 
how sensitive knowledge about their status can be, the potential situations where the child 
could make an unwarranted disclosure and the implications this could have for the lives of 
families in their communities. 
 
The immediacy of confidentiality in the consultation room was salient in the case of Gregory 
who was 13 years old at the time of research.  His family had immigrated to the UK from 
Ghana when Gregory was young.  The news that Gregory had HIV was a shock to the family 
who were uncertain of the infection’s origin.  At the end of Gregory’s consultation, 
Gregory's father explained to us in detail some of the problems associated with making a 
HIV status public. 
 
Father: "The reason I say is because, if he goes there [Body and Soul] and he makes some 
friends and he gets some numbers and they start saying where they got the disease from... 
[Starts to look at me I assume it is because he had just been given an IS] I haven't got it, my 
wife, I have been with her for a long time she has got it.  I have another girl and she hasn't 
got it.  No one in the family has got it. He will start to ask questions where did he get it?  
Sometimes I sit and think about these things.  Sometimes I cry... I cry.  Especially after I come 
here.  If people know, they will not want to drink anything, not want to eat anything, they 
will not want to come to my house.  We are Africans and we do not have sympathy for these 
things.  I wonder what people will think." 
 
As well as demonstrating the considerations of confidentiality the passage also introduces 
complexities around ethnicity. The sense of community expressed here around the 
difference between African and European sensibilities towards HIV is not something 
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explicitly part of the protocol making process or the expansion of a child’s knowledge base.  
However, it translates and must be consolidated into clinic practice in other ways.  The 
differences that can be seen in the sensitivity when disclosing HIV to children compared to 
other diseases is one of them, another can be seen in public health measures that seek to 
elucidate the HIV status of members of the patient cohorts family and community.  Dr 
Peters explained to me:  
 
"It's important to go through to see if any of the family has HIV, because if individuals don't 
say they have the virus it causes problems." 
 
Treatments of many other chronic conditions take it as their aim to increase patient 
knowledge and so improve the general medicine (for example the collection of essays in 
Budd and Sharma, 1994).  However, with these considerations, the aim to educate children 
with HIV on their condition can be seen to have stigma issues interacting with it.  Here, it is 
in the concern of a breach of confidentiality, propounded mostly by the parents.  In other 
conditions such as asthma, diabetes, sickle-cell anaemia or cancer there are no such parties 
advocating blanket confidentiality of an individual having the condition (Dyson et al., 2010).  
 
Within these examples exists the stigma associated with HIV.  Being stigmatised by HIV is 
the reason many families fear a breach in confidentiality (Mahajan et al., 2008).  I would like 
to suggest that the CHIVA model of paediatric HIV disclosure is associated with stigma 
through the mutual negotiation between clinical practice and guidelines.  Stigma affects the 
way that HIV is disclosed.  As discussed, the parents seek to make sure that knowledge will 
remain confidential and demand the clinic to act accordingly (Alonzo and Reynolds, 1995).  
This activates concerns of children being subjected to stigma.  Therefore, the CHIVA model 
must accommodate the dangers of ostracisation of immigrant communities, whilst giving 
children a non-stigmatising view of HIV (U.K. Select Committee, 2011).  The way that it is 
recommended that HIV is taught and talked about in the clinic is to emphasise that HIV is a 
disease like any other in an attempt to actively minimise stigma.  The following case of 
Celina demonstrates how a negative connotation of HIV emerges from a clinical negotiation 
and is minimised by the staff. 
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Celina’s mother died when she was very young, and so she was living with her father who 
wasn’t infected with HIV.  Celina was born in the UK and had been attending the clinic since 
a young age.  During an afternoon clinic, 7 year old Celina attends with her father. The staff 
in the consultation room comprised Dr Wellington, a visiting consultant who used to be 
head of the clinic and Dr Peters.  Celina‘s mother died from AIDs several years ago and so 
she lives alone with her father who takes care of her.  During the appointment Celina had to 
leave the main consultation room to have a blood test.  Dr Peters took her into the other 
room where the CNS did the blood test, leaving myself, Dr Wellington and Celina’s Father in 
the room. As Dr Peters is out of the room Dr Wellington started to talk to the father.  
 
Dr Wellington: “How is she at home?”  
Father: “She can be a handful sometimes, she keeps me on my toes”  
Dr Peters came back in the room as Celina is being tested.  He sat back down at the desk and 
turned to the father.  
Dr Peters: “Have you tried to tell Celina about her status?”   
Father: “Yes I have started to explain small things to her, I tell her that her mummy and 
sister had weak blood and that she has the same thing.”   
Dr Peters: “She’s getting wiser”  
Father: “Yeah she asks lots of questions”  
Dr Peters: “What kinds of questions do you try and answer then?”  
Father:  “For example I was watching Blade and she came and sat on my knee, I made sure 
that I cover her eyes when there are scary parts.  I say to her that Blade has bad blood and 
that her sister and mother had bad blood and that she has the same thing, then she asks me 
‘is your blood strong’, and I say yes and she says ‘you’ll look after me then’”.  
Dr Peters: “We usually start to tell them when there about 11 or 12 for two reasons, because 
they can start to understand it and they won’t tell others.”  
Dr Wellington interrupted: “The trouble with using Blade is that you can’t be sure as to how 
she’s going to understand it.  She could start to think that she’s like a vampire and she could 
think that there’s something wrong, like that she’s the same as a vampire.”  
Dr Peters: “Would you like [the CNS] to start talking to her about HIV  
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Father: “Yes that would be a good idea”  
 
Then Dr Peters changed the subject to talk about the future of her treatment. After the 
blood test Celina and her father left the clinic and Dr Peters came back into the consultation 
room and started to write up notes on the appointment.  As he started to write, Dr 
Wellington to spoke to him: “I thought I had to speak up when he was talking about Blade, it 
seems to me that the vampires in that film are depicted as evil.  Even though, Blade himself 
is a good character who fights off the disease and is not turned evil because he gets it from 
his mother” 
Dr Peters: “I’m not sure that I know enough about it”  
Dr Wellington then turns to me: “Have you seen it?”  
Me: “Yes, the vampires get scary faces when they drink blood.”  
Dr Wellington: “Yes there are all sorts of negative things, she might start to relate to the 
vampires and it has all sorts of negative stigma”  
Dr Peters: “Yes sure.” 
 
In this passage a negative connotation of HIV was presented in the clinic, and through 
negotiation with the parent, an alternate ‘acceptable’ version of HIV emerges and is relayed 
to the father.  It demonstrates the key role the clinic plays to adapt medical regimes to 
patient dispositions. 
 
A few weeks later whilst Celina was doing a blood test, I asked the father some questions:  
Me: "What does she know about her... HIV? [Father says her situation at the same time].  
Father: Well not much she might ask me some things but I find it hard to answer.  She 
sometimes asks me why she has to take medicine and I say that it’s because of her blood and 
she says ‘don’t I have enough blood already?’  That’s why we need help from the 
professionals.  The closest we came was when we were watching the film Blade, you know 
that film Blade? [I nod], we were watching it together and she asked me the question, blades 
mummy had something wrong and gave it to blade, but he’s a good one and the others are 
bad ones, am I like blade?  And I say you’re not a vampire like blade, but you do have a virus, 
like your mother. That’s why we need a bit of help from the professionals who will be able to  
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do it better.  I don’t want her to go along and then suddenly find out...  She reads the 
newspaper, I don’t want her to find out from somewhere else and then for it to become like 
a blow to her”. 
Me: “She’s very intelligent.”   
Father: “Yes she is, she tests me some times, I think she got [her intelligence] from her mum 
who used to be supervisor in Waitrose, you have to be intelligent to do that, she got that 
from her mother, from me she got the rebellious side, she tests me sometimes, which she got 
from me.  [After a Pause] But life is beautiful, I’m glad to be alive, I just want her to have a 
nice life and then I can rest my eyes, I want her to have a chance, the best chance".68   
 
The consensus reached by the staff and father was to minimise the possibility of Celina 
stigmatising herself by educating her about the virus whilst avoiding negative connotations 
of HIV.  This again demonstrates the awareness required in the clinic to limit the many 
possible interpretations of HIV to versions of HIV that are compatible with ongoing care and 
a patients’ ‘quality of life’.  This is in contrast to an STS notion of clinical practice that 
generates further complexity as in Mol (2002), here complexity interpretations of HIV are 
being consolidated into functional practice.  
 
Four weeks later in a morning clinic in the same room during a quiet period an SHO asked Dr 
Peters a question about the difficulty of disclosing a HIV status to young children.  He 
replied:   
 
“Yes there are difficulties we generally try to tell them when they ’re 10-11.  There was a dad 
a few weeks ago I think you were here weren't you [referring to me]?  When the dad spoke 
about that vampire thing... Blade, when he started talking about bad blood”  
 
Me: “Weak blood”  
Dr Peters: “Yes weak blood, we want to avoid that.”   
 
                                                        
68
 Informal interview with Celina’s father Oct 2010. 
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Through this model a contradiction in clinical practice also emerges.  One cause of action 
sees the risk of stigma as too great to let anyone other than the clinical team become aware 
of the child’s HIV, but another seeks to reassure children that HIV is not the condition they 
may hear about from the ‘outside’ world (Sankar and Luborsky, 2003).  Confusingly, from 
whatever the CHIVA model shares with other chronic illness models of disclosure, it is 
unable to offer the recommendation that the answer to disclosure without any stigma lies in 
educating those around the child about the disease, for example at school.  In contrast to 
HIV in other international contexts such as those described in Maile (2005) and Cummings 
(2008) clinical staff in the UK strictly discourage disclosure to the school or anyone else 
outside of direct family and HIV professionals.  Instead, staff at the clinic must concede that 
any breach of confidentiality could have disastrous consequences, and so educate the child 
that HIV is not negative on the one hand, and on the other tell them to keep it a secret.  
From this angle, disclosure also has public health implications as practitioners want to 
ensure that ‘naive’ children will become knowledgeable and responsible before becoming 
sexually active to avoid inadvertently transmitting HIV.  It is difficult to present this factor in 
a way that does not make adolescents imagine a negative self image of themselves when 
socialising or meeting prospective partners (Michaud et al., 2009).  However, this message 
must also be conveyed to children, and it is imperative that it is done in a way that 
circumnavigates negative stereotypes.  Therefore, the clinic facilitates a dynamic in each 
clinical encounter that evaluates whether the entities presented are acceptable or non-
acceptable to the task of maintaining confidentiality.  This ensures that it remains possible 
for patients to be able to continue to take tablets uninterrupted. 
 
For example, in an incident during a staff meeting the clinical team discuss Harry.  Harry’s 
mother had held off giving him his diagnosis but had told him that his father had died of 
HIV, prompting the pharmacologist to question whether this will make Harry associate HIV 
with death. 
 
The potential distress involved in disclosure is not merely confined to the stigmatising effect 
of HIV.  Practitioners recognise that a patients’ consciousness of their HIV status can have a 
large impact on their psyche and self-projected life course (Bradford, 2002; Santamaria et 
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al., 2011).  During this period the team seek to protect children from misinformation about 
HIV.  The clinic is in a race to educate children before they gain unwanted knowledge.  Some 
issues identified are that HIV could be connected with mortality, stigmatisation and their 
contagiousness.  During disclosure from the age of about 8 to 12, children are closely 
monitored by the clinic and any problems are referred to the ward psychiatrist.  Two cases 
that were seen as symptomatic for displaying mental health illnesses were Celina and 
Bianca.  Celina was showing her genitals to boys at school, and Bianca's behaviour was 
interpreted by her school as being ‘very angry’.  The use of the psychiatrist is intended to 
help children come to terms with the condition and ease any anguish HIV may cause.  As a 
supplement to the model of disclosure, psychiatry is the mode of choice to resolve these 
wider issues of distress such as anxiety and depression caused around the time of disclosure 
(according to both AAP and CHIVA guidelines).  The use of the psychiatrist is further 
complimentary to the process of creating a shared knowledge base of HIV and promotes 
ways of thinking and dealing with confidentiality and stigma that are compatible to medical 
models of adherence (Steele, 2007).  The examples demonstrate that complex connotations 
of HIV that maybe taken up by children must be negated through clinical practice as a 
matter of priority. 
 
Dangerous Disclosure? 
Compared to existing STS approaches to illness such as Mol and Law (2004) and the turn to 
enaction, paediatric HIV holds a real sense of harm that can be caused through the 
inadvertent impartation of patients’ HIV status, that highlights the necessity of systematic 
policy when introducing children into knowledge of their HIV treatment.  The example of 
paediatric HIV demonstrates how charged the objects of childhood and HIV are, and the 
importance of clinic as a key site in the consolidation of complexity into a functional 
medicine.  In the management of complexity, the communication of any medical knowledge 
to children must be screened to ensure that it won’t be taken and used in a detrimental way 
at a later date. 
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While research was being conducted, Rob had recently come over from Zimbabwe.  He was 
living alone with his mother who was also infected with HIV, whilst the father was assumed 
to still be in Zimbabwe.  Any clinical negotiation with Rob was further complexified by the 
fact that he was also infected with hepatitis B69.  At the time of research he was twelve 
years old, a bit older than the clinic would normally like to begin disclosure, triggering a 
scramble to disclose to him effectively. Rob attended the clinic a few times to have some 
sessions on disclosure.  The CNS had attempted to explain what HIV and hepatitis B are, how 
they work and to disclose to him that he had both viruses. 
 
Before Rob's appointment, Dr Peters explained to us that Rob didn't know his diagnosis, so 
it was the first time that they could talk openly about his HIV.  Towards the beginning of a 
consultation, Dr Peters began to question Rob about disclosure sessions: “Did the CNS come 
to your house to talk to you about your diagnosis?”   
Rob: “No... But my mum told me.” 
Dr Peters: “Was it a shock? “ 
Rob: “No I knew that I had something.”  
Dr Peters: “Do you know was it is?”  
Rob: “...No”  
Dr Peters: “What did she say”  
Rob: “That it’s important to take my medication everyday to stop me from getting sick.”   
Dr Peters: “Did she say what it was called?”  
Mother: “[nudges him] When we came to see... [the CNS]”  
Rob: “She said not to talk to people.”   
Dr Peters: “Are you sure you can't remember what it’s called?”   
Rob: “No”  
Dr Peters: “What you have is HIV.  It’s a disease that attacks the immune system that you 
contracted when you were very young.  We were worried about you telling anyone as we 
don't want people to be mean to you.  [Goes onto talk about his test results.]” 
                                                        
69 The populations of African immigrants in the UK that have a high prevalence of HIV are also linked to high 
levels of hepatitis B.  At the clinic every child is tested for hepatitis B and treated if necessary alongside HIV, 
see Futterman et al., (2000) 
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Later in the consultation Dr Peters goes on to talk about Rob's regime with his mother:  So 
you're [referring to Rob] on 3 tablets a day.  Because he's got hep b we...  
Rob: “What?”   
Dr Peters: “Do you know you have hep B?”  
Rob:  “No”  
Dr Peters: “Didn't [the CNS] go through it when...”  
Rob: “No [pause]”  
Dr Peters: “I’m sorry then that's the worst way to find out.  Hepatitis B is an infection that 
attacks the liver, and sometimes people who are infected with HIV are also infected with hep 
B.”  
Rob: “40,000 people die of Hep C a year, I read it in a book.”  
Dr Peters: “You don't have Hep C, the infection goes up to about E, some are caused by blood 
to blood contact others through things like uncooked meat.  You have hep B which is not as 
bad and we can treat it at the same time as HIV.  I'm really sorry to tell you like that, it's the 
worst way to find out, but at least now you know.” 
 
After the appointment when the CNS comes in,  
Dr Peters: “He couldn't remember the name HIV”  
CNS: “Ah bless” 
Dr Peters: “And he didn't know about his hep B.”  
CNS: “We talked about it”  
Dr Peters: “I’m sure, I’m sure.  He probably blanked it.”   
Although Rob’s shock here was about hepatitis B, this is due to the complex nature of 
having to disclose HIV at the same time as hepatitis B, and the enactment of the procedure 
displays the link between the severity of being diagnosed and mortality. 
 
From this example what is evident is a rushed, and thus altered version of the attempt to 
disclose to Rob using a neutral standardised knowledge of HIV, negating stigma and 
misinformation.  However, the focus on the process of HIV disclosure is at the expense of 
taking away emphasis from hepatitis B.  What is at stake in terms of disclosure’s impact on 
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Rob is revealed through his reaction to finding out he has hepatitis B.   In this case the 
recommendations put forward by CHIVA begin to define what is not warranted during 
disclosure, in this case non-understanding, stigma and distress.  Underneath the treatment 
of paediatric HIV there are deep malignancies that must be allayed systematically.  
However, the full extent of how HIV will impact upon a patients’ life is rarely clear, and so 
the approach to disclosure must be purposefully skilful at pre-empting potential problems.  
Disclosure is not a simple enaction or translation of knowledge but is a complex 
engagement of associations and management of incompatibilities around HIV and a child’s 
community.  Decisions must be made in the clinic that plan how patients will manage their 
treatment alongside their everyday lives/school lives ensuring that confidentiality will be 
maintained in every situation.  However, in contrast to the generation of endless multiplicity 
in medicine described in STS studies such as Mol (2002) and Mol and Law (2004) the 
complexities highlighted by disclosure must be addressed immediately in clinical practice.  
An aspect that is unclear is the extent to which disclosure is responsible for posing ethical 
issues between different cases that are not necessarily the pressing ethical concerns for 
patients.  For example, child vulnerability is felt acutely by medical staff, but what is 
uncertain is how patients will interpret vulnerability.  Different individuals will have different 
thresholds of distress (see Henderson, 2006 around South African orphan’s perception of 
vulnerability).  
 
A Caveat Apart: Age and Applicability of Disclosure 
After a consultation with 12 year old Gregory I posed a question to Dr Peters about if he has 
any difficulty to explain HIV in a way that a child can understand?  He responded to me:  
 
“Yes, that’s one of the challenges of paediatrics, to explain in ways that both mum and child 
can understand.  He’s only known his diagnosis for 6 months.  The real challenge is to explain 
in ways that the parent understands and not to reveal things to the child.”  
 
This statement brings up a recurrent question about age and competence, and how to 
address children and parents differently often whilst in the same room.  
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As discussed earlier, the purpose of disclosure is referenced in CHIVA and consequently by 
Dr Peters as being useful in promoting adherence and making patients able to maintain their 
HIV in a chronic state.  It is a fundamental notion in protocol that children gradually gain the 
knowledge of their diagnosis before puberty.  However, it is worth considering further the 
internal negotiation around vulnerability and competence that goes on when making 
decisions about disclosure (Christensen, 1998; Cohen et al., 1999; Alderson et al., 2006).   
 
In cases of paediatric HIV, when the patient diagnosed is older than 12 years, disclosure is 
undertaken immediately.  In a similar case to Rob, Erica had recently come from the Congo.  
She was 15 years old when she was admitted to UOUH with an AIDS defining illness and 
diagnosed as HIV positive70.  Once diagnosed, Dr Peters decided to tell her immediately that 
she had HIV.  The case became more akin (although important differences remained) to how 
disclosure would be approached in an adult case.  The issues considered did not centre upon 
whether she was ready or able to conceptualise HIV and the importance of keeping it 
confidential, as would be the case in paediatrics.  The only issue that was deemed distressful 
was finding out her HIV positive status, which is not isolated to, but is antagonised by the 
fact that the case is in paediatrics (Armstrong, 1979).  From Dr Peters’s perspective he 
wanted to tell her immediately in order to start treatment as soon as possible. 
 
This can be branded as an extreme case of disclosure compared to the CHIVA model, what 
this example highlights is the contingent nature of disclosure and the idea of vulnerability 
and competence applied to younger age groups.  Although the clinic works from a protocol, 
many factors need to be decided upon independently in each case.  Even though the age of 
12 is a recommended target and a slow procedure of education is detailed for use in the 
clinic, the way these ideas must be applied and the objects that further make the model 
applicable to individual cases are ongoing and progressive.  The dangers are also detailed by 
what the medical model wants to avoid, mostly around misunderstanding.  If the age is 
adjusted then the model must be altered.  However far a case may differ from the model, 
                                                        
70
 The differentiation between HIV and AIDS is that a case is defined as developing into AIDS when the immune 
system has deteriorated to the extent that opportunistic infections are no longer suppressed. 
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the necessity for disclosure doesn't cease to be any less relevant.  Treatment, 
empowerment, minimisation of distress/QoL, consent are still sought under the term 
disclosure (Mellins et al., 2002).  However, what is different in Erica’s case is the association 
disclosure has with age and development, as the child in question is in fact adolescent, the 
connotations of vulnerability and competence are blurred between childhood and 
adulthood and so disclosure can take place immediately.  In this context of a more 
immediate notion of disclosure, the technique at work becomes less prolonged and 
extensive.  The difference in clinical approach contrasts the measures employed to manage 
complexity in younger patients.  Disclosure is still used to consolidate adolescents into 
medicine and render them responsible, but it is not the extensive process of building up a 
carefully managed initial knowledge base around HIV as it is with younger children. 
 
Conclusion 
The way disclosure has been followed through this chapter has been informed by STS (see 
chapter 3 on following actors) and demonstrates that disclosure is enacted within the clinic 
to bring patients into medical knowledge and create a shared understanding of HIV between 
patient and practitioner that informs care, standardises practice and can be built upon 
throughout a patients’ lifetime.  The different cases detailed in this chapter highlight 
disclosure designed to consolidate patient complexity into compatible understanding of HIV 
and HIV medicine.  In this chapter (along with the others that will follow) I have 
demonstrated the places in the clinic where procedures of disclosure are applied.  
Disclosure has been referenced alongside discussions taking place in professional bodies 
responsible for setting policy, protocol and guidelines.  Hopefully this has demonstrated the 
different forums in which disclosure is referred to.  Inspired by ‘object politics’, it can be 
postulated that protocol and guidelines are enacted and interpreted recurrently in the 
space of the clinic during the task of disclosure.  It is the negotiation in the clinic between 
the practitioner and the patient that implies the ways that these relations are at work and 
how the medicine is to be relayed, practiced and responded to.  Therefore, protocol is under 
negotiation whilst remaining an impetus for action in the clinic (Berg, 1997b).  However, 
beyond ‘object politics’, the enaction of disclosure guidelines as described in this chapter 
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must also perform the task of consolidating patient complexity into medical knowledges of 
HIV.  Accordingly, the clinic is a key site in the formulation and application of disclosure.  
 
Consequently, disclosure is not uniform, in each case where disclosure is implied there are 
associations that are unique.  Disclosure in paediatric HIV has more than one version when 
taken as a whole or even when applied to individual cases (Mol, 2002).  Factors of stigma, 
confidentiality, the importance of avoiding resistance, public health considerations and age 
all interact with differing outcomes and consequences.  All of these factors manifest 
differently across the clinic and highlight the attentiveness required in practice to address 
them.  What has come into question throughout the chapter are the implications generated 
from adopting a systematic approach to disclosing HIV to children who are receiving 
treatment (Timmermans and Berg, 2003), and the antagonism between vulnerability and 
competence in relation to disclosure.  In this light, disclosure is responsible for bringing 
children into medicine by making them aware of their HIV.  In contrast to the other STS 
accounts of clinical enaction discused in chaper two, that demonstrate practice as 
generating multiplicity over multiple sites, such as Mol, (2002), or Law and Singleton (2003), 
disclosure emphasises the importance of ordering complexity in the clinic in the act of 
imparting knowledge to children.  Disclosure contributes to the reciprocation between the 
medicine and the lives of children with HIV, and makes sure a certain mode of defining and 
treating HIV become and remain possible.    The procedure attempts to ensure that patients 
possess the knowledge necessary to understand the importance of drug regimes, aiming to 
maintain that the condition can remain chronic for the largest number of cases (as is the 
logic of Lepping, 2007).  Therefore, disclosure is a facilitator for the long-term maintenance 
of HIV.  It acts as a go-between that will address complexity through making sure that 
patients reason with their HIV in the ways presented resolutely to them by practitioners. 
 
When the impact of medicine is taken as a whole, it is difficult to assess the full extent that 
disclosure has upon the operation of the clinic.  It can certainly be traced across a broad 
range of the activities that take place there.  It can be seen in incidences of children asking 
certain questions, to Dr Peters being freer to discuss regimes with the child present in the 
consultation room.  Consequently, disclosure becomes necessary to protect ‘vulnerable’ and 
Disclosure 
 
144 
 
‘naive’ children from knowledge of their HIV in an attempt to minimise the risk of distress 
and a breach in confidentiality (Kelle, 2001).  However, the implications as to how these 
processes of disclosing permeate much further into treatment are also salient.  The extent 
of how disclosure will impact upon a child’s development, adjustment and future attitudes 
towards HIV medicine can be questioned71. 
 
The connotations of vulnerability and competence that are to be found formalised in the 
guidelines to individuals below the age of 12 can also be questioned.  When discussing 
disclosure in the light of STS descriptions of clinical enactions it is these factors that are 
difficult to place.  On the one hand it could be argued that childhood is multiple in protocol 
and practice and that ideas of vulnerability and competence are constantly re-enacted 
between the clinic and presenting children.  However, this seems to leave us with some 
loose ends, knowledge of HIV and childhood here seems to have some serious and very 
dangerous implications.  The fact that parents and practitioners need to be extremely 
worried about what a child may disclose to others, or the very real harm that could be done 
to children if the version of HIV presented to them is not well screened seems to imply some 
ulterior connotations to concepts such as multiplicity, transition and irreducibility.  When 
the objects of childhood and HIV are presented in this way the complexity and contradiction 
generated are seemingly overwhelming.  Compared with STS accounts discussed in the 
literature review that make the elucidation of this complexity as their goal, such as Mol 
(2002), Law and Singleton (2003) and Law and Mol (2004), this chapter has shown how 
complexity must be ordered and made compatible as a matter of immediacy in the clinic 
through the negotiation of disclosure between patients and professionals. 
 
The concluding argument of the chapter is that the formalised introduction of children, into 
specific knowledge around HIV is part of a larger clinical logic that reasons to make large-
scale paediatric HIV suppression possible, as will be elaborated through-out the proceeding 
chapters.  Even though the extent of disclosure’s impact may be difficult to quantify 
definitively, it can be asserted that from this angle, when put into process, disclosure 
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 Articles such as Steele et al (2007) highlight this issue as having important implications for the administration 
of treatment. 
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becomes a unifier of clinical practice whilst remaining dynamic and never fully defined (Mol, 
2002).  The processes demonstrated document the attempts by the clinical team to bring 
patients into knowledge through a negotiation between the practitioner, the medicine, 
issues of community and ethnicity, cultural representations of HIV and broader issues 
around the lives of children coming into adolescence.  Through this negotiation, disclosure 
and its formalisation in practice and negotiation in the clinic can be seen as a concerted 
attempt to unify and make compatible disparate associations of childhood and HIV to the 
clinical treatment of HIV. 
 
The next chapter will be about adherence where I will continue to follow techniques 
designed to bring patients into knowledge, consolidate practice between patients and 
professionals, standardise care and make the suppression of HIV with antiretroviral 
medicine possible.  Subsequently, the idea that clinical procedures are unified through 
formalised procedure will be employed in all of the following research chapters of 
adherence, chronic illness and transition. 
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6 Adherence 
The previous chapter introduced us to the formalised procedure of disclosure which was 
shown to determine how children are included into knowledge of HIV.  Building upon these 
findings, this chapter will explore how the procedure of adherence can be described as a 
technique that encourages patients to conform to antiretroviral regimes.   
 
To those infected with HIV, antiretroviral medicine provides the promise of being able to 
suppress their virus unforeseeably, for an extended time period into the future.  For 
children who acquired HIV at birth before the advent of antiretroviral medicine, the outlook 
was that they would face an AIDS defining illness and mortality before adulthood.  With the 
advancement of antiretroviral therapy it has become possible to interrupt the progression 
of HIV and increase the life course of an infected individual (Sharland et al., 2002; Foster and 
Lyall, 2005).  The advancement carries a limitation however.  If anti-retroviral drugs are not 
taken at strict regular intervals and doses, patients risk viral suppression failing and 
becoming resistant to that drug and all antiretroviral drugs in that category72.  Therefore, in 
this context the issue of adherence to antiretroviral treatment has become salient (Chesney 
et al., 2000; Marhefka, 2004).  
 
As with other chapters, adherence is seen as a procedure that consolidates the medicine, 
the patient and the practitioner through clinical practice and protocol to make viral 
suppression possible over the largest number of the patient cohort.  As will be discussed 
                                                        
72 Antiretrovirals are categorised into groups according to which phase of the retrovirus life-cycle that the drug 
inhibits.  There are several categories, the most common used examples in the clinic are Protease inhibitors 
and Nucleoside reverse transcriptase inhibitors (WHO, 2011). 
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however, with adherence there is a fundamental difference.  All of the other procedures 
that are described: disclosure to transition have emphasised their flexibility and adaptability 
in approaching child patients.  Adherence does not.  If suppression is to be achieved, the 
regime must be followed exactly as given, the processes of disclosure and transition can 
afford to be flexible to ensure that maintenance of paediatric HIV is possible, negotiation 
around adherence is limited.  Any deviation jeopardises the possibility of viral suppression.  
Therefore, practitioners must persuade patients to follow adherence guidelines exactly ( 
McCoy, 2009).  In any negotiations around the uptake of medicine, the factor of adhering 
must be portrayed as absolute, as once breached, the negotiation no longer becomes 
around how to adopt medicine but between resistance and salvation, life and death.  The 
implications this has on practice distinguishes paediatric HIV amongst other accounts of STS  
as it stresses the absolute requisite that practice successfully translates to children the need 
to stick 100% to their antiretroviral drug regime.  For example, the arthrosclerosis and STS 
described in Mol (2002) lacks the immediate clinical requirement for practice to coordinate 
medical requirements with complex patient lifestyles and everyday actions.  The promise 
given to HIV patients that they can manage their illness seamlessly into their daily lives over 
their lifetime is contingent upon patients following drug regimes (Pontali, 2005). 
 
In relation to STS, adherence can be seen as an imperative enaction or translation that often 
offers patients an unsettling choice (Rosengarten, 2004; Persson and Newman, 2006).  
Adherence is formalised through a protocol to facilitate a negotiation that aligns drug taking 
into individual lives, and demonstrates to patients what is required in order to suppress the 
virus.  For patients it offers a regime to follow everyday that promises suppression (Gibb, 
2003).  It is in this process (as with the previous chapter) that adherence consolidates 
affected populations, practitioners and medicine together.  Aside from the concept of 
adherence between practitioner and patient however, there is also a translation taking 
place between the medical science and clinical care (this antagonism is applicable to all 
chapters but it is in adherence it becomes particularly obvious).  The medical science behind 
antiretroviral therapy has a clear requirement in order to produce itself effectively, i.e. that 
patients take their medicine when required (Mol, 2002).  The problem for the medical 
science comes when considering how to reproduce suppression alongside patients who can 
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cause many unforeseen and unaccounted problems outside of the optimum conditions.  It is 
the job of clinical medicine therefore to make patients reliable, organise the application of 
the science and make suppression possible.  In this context, I will consider the ways in which 
adherence emerges in the clinical negotiation and re-negotiations of drug requirements 
between children and practitioners over a child’s growth into the consequent ‘responsible’ 
adult HIV patient. 
 
In relation to childhood, HIV and antiretrovirals, 'adherence' takes on a particular set of 
contextual meanings and responsibilities.  This chapter discusses how, as well as being 
descriptive of an act, adherence also refers to a set of techniques and tools developed to 
ensure drug regimes are monitored and followed effectively.  However, rather than 
asserting that adherence is a task laid out and defined by medical science, the aim here is to 
assess ways in which adherence is a negotiation between drug development, protocol, 
practitioners and patients through the clinic (Lutfey, 2005).  Considerations of adherence 
are integral to paediatric HIV medicine. Organisations of professionals such as the Paediatric 
European Network for Treatment of AIDS (PENTA) and CHIVA regularly discuss how to make 
children adhere to antiretroviral medicine.  The presentation of adherence in CHIVA and 
PENTA relative to the field will be our starting point, before going on to discuss the common 
ground needed between patents’ and professionals to make regimes work, and finally the 
concept of good care that is used to curb scientific priorities and unify the desires of 
patients with the scientific discussions of professionals. 
 
CHIVA Adherence Guidelines 
On the website for the 'Children's HIV Association' (CHIVA) under the heading Guidelines: 
Adherence (CHIVA, 2011d) there is a selection of resources i.e. protocols and guidelines 
designed for use in the UK across health services dealing with paediatric HIV.  Amongst this 
section there are four documents on adherence.  Two are for practitioners, titled Protocol to 
Enhance Adherence and Pill Swallowing Techniques (CHIVA, 2011e), one is for parents or 
carers called Taking medication: a fact sheet for parents and carers (CHIVA, 2011f) and one 
factsheet has been made for children, You and your medicine: A factsheet for young people 
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(CHIVA, 2011g).  The protocol (CHIVA, 2011b), made for practitioners attempts to offer a set 
of key points.  When followed, the protocol ensures that practitioners will think through the 
potential barriers to adherence in individual cases and how demanding the regimes will be 
for individuals.  It asks practitioners to think of how they can potentially give adherence 
support to patients, such as pill swallowing techniques, pill boxes or the arrangement of 
follow ups and the timings of appointments when starting and maintaining a pill regime.  
When starting a regime the protocol advices that a series of consultations be booked, the 
first one assesses what time to start, then an appointment is booked within two weeks of 
starting the treatment, followed up by the CNS on the telephone.  After four weeks patients 
are supposed to attend another appointment to assess how the treatment is going and then 
appointments go back to the regular once every 3 month consultation.  The perceived aim 
of these documents details the measures practitioners can employ to ‘enhance adherence’ 
and gives advice to children on how to maintain an easy routine of medicine taking. 
 
The documents set out what is expected of practitioners and children and introduces a 
standard to follow.  Dr Peters is well integrated in the HIV network.  He uses CHIVA 
guidelines, has contributed to certain documents and regularly advises some of the SHOs to 
look at them.  Consequently, this version of adherence is something that figures highly and 
is discussed frequently as part of his role of paediatric HIV management.  However, from the 
outset these guidelines of adherence can be seen as particular and applied to a specific 
problem73.  Therefore, it will be useful to consider how the problem of adherence is 
specifically conceptualised and interpreted in clinical practice in relation to the wider field 
found in journal literature and professional organisations?  
 
The definition of adherence that is fed down to the clinic is perhaps ambiguous.  In relation 
to children with HIV, Simoli et al (2007) posses the definition:  
 
                                                        
73 For example it could be considered how blood tests and other necessities of the medicine are also under the 
gambit of adherence, or how specific it is about children going away taking their antiretrovirals rather than the 
idea they must adhere with all branches of the medicine.  These lines of questioning could be followed, but 
they threaten to become confusing and ambiguous. The question of how it is constituted in the clinic assumes 
more clarity whilst engaging with the particular notion of adherence to pill regimes. 
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“the extent to which a patients’ behaviour coincides with medical advice mutually 
negotiated between the health professional and the patient, is a universal challenge 
with all illnesses and in all age groups.” (p e1372) 
   
This would suggest that there exists a well developed notion of adherence in medical 
terminology to denote patient behaviour.  However, this chapter would like to elaborate on 
this definition by firstly suggesting, inspired by Mol 2002, that there are multiple versions of 
adherence at work in paediatric HIV that are highly attuned not only to the condition of 
children with HIV but also to each individual case.  And secondly that adherence is 
indistinguishable from the negotiation itself between practitioners and patients that aims to 
make interventions work, and circumnavigate personal patient barriers, behaviours and 
attitudes that are incompatible with adherence.  (Cunningham et al., 2006; Naar-King et al., 
2006). 
 
There are further versions of adherence as presented in journal literature designed for 
practitioners (additional to the adherence documents on CHIVA), that seek to identify 
behaviours and factors that could indicate the likelihood of non-adherence.  Commonly 
stated reasons for non-adherence amongst this literature were: knowledge of HIV status, 
depression and anxiety, medicine side-effects, medicine size or taste, care giver status or 
relationship, confidentiality, regimen characteristics formulation or changing regime (Simoni 
et al., 2007; Steele and Grauer, 2003; Haberer and Mellins, 2009).  These authors are tasked 
with rendering the disparate actions and behaviours of their patients into a series of 
recommendations compatible for use in medical science to improve its effectiveness.  It is 
not possible to state definitively, or to account for every patient action in relation to 
adherence, but these assessments are necessarily positioned in order to make a procedure 
such as adherence and therefore the suppression of HIV on a large scale possible.  Also the 
discussion of 'enacting the social' in chapter 3 brings into question what ideas of care and 
sociality are enacted, (Law and Urry, 2004).  In contrast to the ways that STS, such as Mol 
(2002), or Mol and Law (2004) describes multiplicity as unfettered in medical practice, 
paediatric HIV adherence purveys the cultural awareness required in the clinic to negotiate 
patients’ dispositions in accordance to adherence requirements.  It is the role of 
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practitioners in the clinic to consolidate and apply these discussions of adherence and make 
them compatible in a clinical setting.   
 
In order to make antiretroviral medicine functional, the role of those who administer the 
medicine in this negotiation, identify and predict incompatible personal barriers, behaviours 
and attitudes with adherence.  Amongst some articles, the way that this is problematised is 
to suggest that medicine must make itself responsible for making the wider ‘social’74 aspects 
compatible with the medical laboratory and drug trial recommendations.  
 
“Conclusion. Good adherence with taking prescribed medication was associated with 
virologic response. Social factors were important in explaining nonadherence.” (Gibb et 
al., 2003) 
 
In attempting to instigate this process, actions in the clinic ask for children and parents to 
participate with larger scales of ordering into medicine, asking children to work towards and 
take responsibility for viral suppression (see for example McCoy, 2009 and the patient work 
that goes on to adhere). In effect to embrace antiretroviral adherence alongside their own 
everyday culture. 
 
Adherence can be conceptualised here as a procedure that is made to work over different 
forums, from literature discussions and protocol, to individual cases, to larger groups of 
patients.  It translates individual behaviours to make them applicable over larger collective 
groups of patients (Callon, 1986).  Individuals are involved in shaping this process but also 
perceive the routine of taking the medicine differently. 
 
Rather than describing adherence as simply behavioural, I will argue that adherence 
pertains to the negotiation of clinical encounters into predictable patterns that inform 
guidelines, protocol and the situations that are presented in the clinic.  The starting point is 
to consider how clinical interventions involve a specific negotiation of what adherence is 
                                                        
74
 I have highlighted the word social here, as I think that this way of presenting a problem as social is overly 
simplistic and reductive to the incidences and relationships going on in each circumstance (Latour, 2005). 
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and what it will be taken to mean by both patients and practitioners in order to make 
antiretroviral medicine functional. 
 
Over a few months in the clinic, a case where adherence was negotiated unfolded, arising 
from a consultation where the adolescent was informed that they would have to 
recommence antiretroviral therapy.  Jemima was born in the UK to African parents.  She had 
been attending the clinic for virtually her entire life.  At the time of research Jemima was 16 
years old, she had been off of antiretroviral medicine for five years.  But after her last blood 
test, her CD4 count was found to be lower than 100, the recommended level to flag her up 
as being at risk, and so the team decided it was time to restart her on anti-retroviral 
therapy.  A week previously at the monthly staff meeting, the team of nurses came together 
with Dr Peters, Dr Phelps from CHH, Dr Chambres from T1 and the pharmacologist to discuss 
Jemima’s case.  Using her record they devised a regimen based upon her resistance profile.  
Although there was some uncertainty, they agreed to put her on a regime that contained 
some of the drugs that she was previously taking at 11 to prolong their usefulness.  
Jemima’s appointment was brought forwards from her usual date due in 3 months to the 
clinic taking place in the next week.  Consequently, during a morning clinic, Jemima and her 
mother came into the consultation room.  In attendance at the clinic were myself, the CNS 
and Dr Peters.  For about 20 minutes Dr Peters explained to Jemima the need for her to go 
back on anti-retrovirals and detailed the regime, possible side effects and the importance of 
taking it regularly when Jemima interrupted him: ‘I just want to get my prescription and go, 
how much longer is this going to take?’ [pause]  
Dr Peters: ‘Why?’  
Jemima: ‘I need to go to school’ [pause] 
Dr Peters: ‘Do you discuss your HIV much with your mum?’  
Jemima: ‘When we leave here it’s like it doesn't exist, we never talk about it.’  
Dr Peters: ‘Do you think much about your HIV?’  
Jemima: ‘No, the only time I think about it is when I come here’  
Dr Peters: ‘Will taking your meds remind you of your HIV?’  
Jemima: ‘Yep’  
Dr Peters: ‘And if they weren't there how would it be?’  
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Jemima: ‘Pretty normal’  
Dr Peters: ‘would you like to see the counsellor?’  
Jemima: ‘Nope’  
Dr Peters: ‘Sometimes it helps to get things out in the open’  
Jemima: ‘Yeah but they won't be able to change anything, it is the way it is.’  
Dr Peters: ‘It can be quite helpful to talk about these things, you think about it and tell me 
next time.’ 
After the clinic Dr Peters came back into the room.  The CNS is out of the room doing a 
blood test, he closes the door and says to me:  
‘There isn't a much clearer way of putting it, she was very articulate in saying why she 
doesn't want to take her medicine; because it reminds her of HIV.’ 
 
 
This passage demonstrates the attentiveness a practitioner must uphold to fit guidelines to 
adolescent attitudes in the clinic.  Dr Peters was quick to locate Jemima's attitude in relation 
to adherence and identified it as a common response.  Before Dr Peters begins to discuss 
with Jemima the need to take treatment again, he is well versed on how to portray 
acceptable ways to pursue adherence when starting a new treatment, and interprets the 
situation in relation to his knowledge of protocol.  The clinical intervention is crucial in 
processes of adapting protocol to patients’ lives.  One question that arises is how adherence 
problems are discussed abstractly between wider networks of professionals, identified in 
the clinic and policy is translated for use?  The differing interest in adherence between 
CHIVA, Dr Peters and the specific patient (and parents) in consultation, points to a 
negotiation between what is recommended and the case at hand.  Dr Peters sees it as his 
role to manage between the requirements of anti-retroviral medicine and what he sees as 
an attitude contrary to treatment. 
 
A few weeks later Dr Peters highlighted to me that he was familiar with Jemima’s attitude 
by saying that problems usually start when children get to about 14 or 15.  He used the 
example of Nadine who he had a very good relationship with up until she was 14 years old, 
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but then apparently (as Nadine did not attend a clinic during the year I did research), started 
to have problems with her mother and her sister and then with the clinic75.  
 
In seeming quick to place Jemima in the incident, a process can be seen to take place where 
the clinical encounter in the consultation with Jemima is simplified in order to organise it 
into the context of an overall case alongside a set of adherence issues.  Her case can then be 
collated alongside other cases (White, 2002; Atkinson, 1995).  Another place where this can 
be highlighted is during a staff consultation meeting where Jemima's case came up again 
alongside Nadine’s.  Dr Peters was talking to two other consultants [Dr Chambers and Dr 
Phelps] about what to do with Nadine, an adolescent who had been referred to social 
services. Dr Peters:  
  
“She’s [Nadine] a girl 16 going on 25, she has her life and she doesn't want HIV to be a part 
of it.  [Refers to me] was here last time when Jemima was in and she said quite clearly that 
every time she’s in here and takes the medicine it reminds her of her HIV.”   
 
Procedures such as adherence influence how Jemima's case is discussed and considered at 
the clinic.  The way her attitude is understood also influences the kind of attention she 
receives.  Immediately, Jemima is understood as lacking in competence and in need of 
sensitive management76. 
 
At the most basic level, ready evidence for this comes from how Dr Peters immediately 
interprets Jemima’s stance as a potential barrier to treatment and makes it a priority to 
address, monitor and alleviate these perceived issues. The stance that is taken here flags up 
an adherence issue and relates it both to Jemima and Nadine.  Before the confirmation is 
received about whether Jemima will take the medicine, the potential problem and dangers 
                                                        
75 A BBC Radio 4 programme, Inside the Ethics Committee, contains a similar practitioner deliberation where 
practitioners discuss the ethics and decisions made towards an adolescent with HIV who refused to take their 
medicine and eventual died from AIDS.  The practitioners involved in the programme lamented over the lack of 
institutional control they had to force the adolescent to adhere but conclude that adherence based on 
coercive practices is counter-productive (see BBC, 2010). 
76
 See Miller and Drotar, (2007) for an example of the type of criteria used in clinical reasoning to evaluate 
competence or Christensen, (1998) for SoC critique. 
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have been calculated and the team are made aware and are ready for any slip ups (as 
already discussed, papers such as Gibbs et al 2003 would call this the social element).  
Therefore, in contrast to the proliferation of multiplicity generated at the clinic described in 
Mol (2002) and Mol and Law (2004) the pre-emption of possible adherence issues here 
shows an attempt to tame complexity before it arises.  At the point that this discussion took 
place, Dr Peters had not had any further contact with Jemima since the dialogue described 
in the previous paragraph. 
 
In the event, Dr Peters was proven to be hasty as in the weeks and months to follow Jemima 
attended the clinic regularly and adhered to her medication  even though after a few weeks 
she was found to be resistant to one of the drugs and so had to come back the clinic 
intensively to arrange an effective regime.  For Jemima, blood tests became more and more 
difficult, at one point in frustration Dr Peters says to the CNS: 'she has no veins that girl'.  
 
Within this employed CHIVA logic, there is an uneasy balance between what is required and 
the anticipated ways that patients may respond to treatment.  Cases are monitored in terms 
of adherence and potential threats to good adherence.  Therefore, the clinic is a place 
where case specific issues are assimilated with the recommendations of anti-retroviral 
medicine in an ongoing negotiation. This negotiation develops the idea that adolescents 
may lack the competence to adhere and must be imparted with the skills to adhere (see 
Anderson et al., 2000).   With this ongoing concern for adherence, the amount to which this 
negotiation affects the management and what is pushed forwards to children about HIV is 
significant.  The actions that are carried out under the guise of adherence are inherent to 
the management of the clinic.   From a sociological perspective (as well as STS) it is useful to 
trace the ways that adherence is used as a technique and question what is under 
negotiation? For what reasons? What this negotiation makes visible?  What is made 
possible? And what is assumed (e.g. vulnerability and incompetence)?  In order to decipher 
other important nuances of how adherence functions, attention should be given to other 
parties responsible for organising data about drug trials. 
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PENTA Guidelines for the use of Antiretroviral Therapy 
In addition to the guidelines of CHIVA, another body, the Paediatric European Network for 
the Treatment of AIDS (PENTA) uses a version of adherence to build up policy on the 
paediatric administration of anti-retroviral drugs.  However, a necessary discrepancy is 
opened up between the version of adherence described in CHIVA and observed at the clinic 
and the one used to communicate between affiliates of PENTA.  PENTA is made up of many 
members who are also implicated in CHIVA and London based departments, Dr Peters and 
UOUH are also integrated in this network.  The self-professed role of the organisation is 
different to CHIVA who aim to be a first point of call for UK professionals.  PENTA is a 
collaboration between European paediatric HIV centres and mostly carries out large scale 
antiretroviral trials.  The centre piece of PENTA's campaign and subsequent website is an 
attempt to provide a definitive guideline on paediatric treatment entitled: 'The 2009 PENTA 
Guidelines for the use of antiretroviral therapy in paediatric HIV infection' (Welch and PENTA 
Steering Committee, 2009).  This offers a set of stripped down recommendations for those 
responsible for the administration of antiretrovirals.  Primarily, it details how to make the 
decision of when to start treatment, what drugs to start with and recommendations on 
resistance testing and drug monitoring.  The idea of adherence within these 
recommendations does not entertain an idea of adherence as judged by 'social' factors 
(referencing the usage of Gibbs 2003 again) such as in the previous example of CHIVA 
guidelines.  Although it does offer some recommendations useful in cases of bad resistance, 
the guidelines rely upon adherence being as close to 100% as possible, and so non-
negotiable. 
 
Even though this underlines the discourse involved with Jemima in the clinic, the way the 
subject of adhering to antiretrovirals was approached during the consultation was different.  
Even if Jemima did everything that was required of her by the medicine, the idea of 
adherence was approached with an alternative tact.  The notion of adherence that Dr Peters 
was negotiating towards was not only the task of giving tablets and advice on when to take 
medicine in order to suppress the virus, but also the factors that are likely to come in the 
way of this, how to fit the regular taking of drugs into children’s and parent’s lives, and the 
importance for adherence’s sake to organise follow-ups.  It is the clinic’s role to insure that 
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the body of the patient is compatible with the version of viral suppression developed in 
medical science77 and applied to the protocol.  Between the stripped down 
recommendations of groups such as PENTA and the actual implementation of drugs over 
prolonged periods, the clinic must deal with a broader range of personal issues and 
complexities that affect the implementations of administering antiretrovirals to children and 
adolescents (Dorrell et al., 2008).  
 
To do this, in each situation where Dr Peters must start or alter a course of anti-retrovirals 
he must use a broader gambit of tools to ensure adherence is as compatible as possible to 
the way adherence is presented in PENTA guidelines. 
 
Compared to other accounts of STS that emphasise different versions of disease over 
different sites of medicine, such as Mol (2002) and Mol and Law (2004), the focus of this 
chapter is not the proliferation of adherence, but the cultural awareness employed in 
practice to make medical requirements compatible with patient dispositions.  This is not to 
suggest a deficit in the different branches and organisations of the medicine, but to 
highlight the utility of adherence in clinical practice to coordinate different notions of 
adherence in the overall task of viral suppression.  There are obvious differences between 
the way that drug data relying on adherence is collated into documents that can be used as 
a recommendation in the mass suppression of paediatric HIV, and over each circumstance in 
the clinic where adherence is implied.  Therefore, in order for the guidelines to be relevant 
there is a negotiation that takes place in the clinic between these recommendations, the 
clinical advice on pill regimens and the act of ingesting a pill at home.  A certain amount of 
                                                        
77
  Stengers’ (2003) concept of medical science argues that unlike other branches of science, medicine cannot 
escape the fact that the object of its practice is always going to be the suffering body and as a witness to 
objective proof it offers a poor testimony.  By this she means that in the process of evaluating good medicine 
from bad medicine, the agency of the patient cannot be cut out of the equation.  Unlike the natural sciences 
that can claim objective facts from the objects they study, medicine must also rely upon the testimony of the 
suffering patient to say if they are healed or not.  In her essay she puts forwards that this is why the figure of 
the charlatan is never far away from those that practice medicine.  Much as it would like to eliminate the 
human subject from medical procedure it is impossible, as the human subject is always going to define the 
questions that are demanded of medicine, as medicine is always going to endeavour to seek a cure.  Although 
this argument becomes unclear when compared to branches of medicine such as preventative medicine that 
do not deal with the body itself.  Perhaps medical branches such as preventative medicine are also 
symptomatic of the need for medicine to organise broader ‘social’ aspects that the natural sciences do not 
have to engage with. 
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unavoidable ineloquence in this negotiation on the part of medicine is that in effect some 
enactions of adherence ask children to face up to their illness, their mortality or to 
stigmatise themselves (which can be found in discussions around paediatric HIV and 
depression see Scharko, 2006). 
 
One striking example Dr Peters informed me of was about Gregory's case before he was 
diagnosed with HIV.  When presented at UOUH, Gregory was critically ill and was 
immediately put onto life support, his condition was found to be due to an opportunistic 
infection resulting from AIDS.  His parents were told of his diagnosis and advised that the 
hospital would like to start antiretroviral therapy immediately.  Initially the parents refused 
to consent to treatment because they would not accept the hospital’s diagnosis of AIDS.  A 
child protection case was filed against them and it was not until the day before they were 
summoned to court under child protection policy that they agreed to the treatment 
(Beckett, 2007).  For Gregory’s parents, HIV is implicit of a deeper ignominy and so to grant 
Gregory antiretrovirals was to admit that he had the virus78. 
 
In other asymptomatic paediatric HIV cases, the team fear that for children, taking the 
medicine assumes visibility and is also an admission of illness and HIV. For Jemima, as she 
stated, the disease is not visible without visiting the clinic or taking antiretrovirals.  The 
worry for the clinic is that the tasks undertaken in the interest of adherence become the 
most noticeable time when children will think through the consequences of 
immunodeficiency, and the need to suppress a virus79. 
 
Inevitably then, the clinic must negate the equation children may have that taking the 
medicine and talking about it in the clinic makes  HIV, stigma and their own mortality visible.  
Separately to Luke, Marty and Serge I posed the question: do you talk about HIV at home?   
Each one responded that they do not talk about it at home and they only talk about it in the 
                                                        
78Accounts more extensively focused on the role of patients in making children with HIV adhere to 
antiretroviral medicine are also present in the literature (see Reddington et al., 2000; Wrubel, 2005) 
79
Persson (2005) argues that when HIV is made visible through lypodystrophy it generates a large cultural 
anxiety.  Creating associations from stigma, differentiation, and discrimination to affinity, empathy, and desire.  
In the circumstance of negative connotations it is logical that those infected would like to keep their HIV 
invisible. 
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clinic80.  It is impossible to explain something like the danger of drug resistance to children 
without conjuring up at some point the consequences and inevitability of what resistance 
will mean (Silverman, 2000).  Dr Peters reasons that in negotiating medicine for HIV, these 
patients should consider that the medicine will keep the virus repressed and hence invisible, 
which is an acceptable reasoning for adherence.  However, the reasoning necessarily 
involves setting itself against a notion of the consequences of the HIV virus.  It becomes the 
job of those involved in caring for children that they take on board compatible and non 
threatening concepts of HIV, antiretroviral medicine, normality, invisibility, and the 
consequences of immuno-compromisation (Wrubel et al., 2011).  As seen in reference to 
Jemima, the doctor must make sure that she doesn’t reason that the virus is invisible and so 
not take the medicine, and instead reason that the virus is invisible and it will be the job of 
the medicine to keep it invisible, and that she should trust the doctor’s analysis of blood 
tests and recommended pill regimes. 
 
It is worth noting here that this relationship between antiretroviral medicine and child 
patients necessarily involves a clinical assumption of what children’s priorities and concerns 
when dealing with HIV treatment are, and the necessity to maintain the patient practitioner 
relationship as paternalistic (Baines, 2008).  If adherence is to be made compatible between 
the children taking antiretrovirals in the clinic and the discussions that go on in PENTA, there 
must be a common ground tread in the clinic.  The clinic must find ways of stressing the 
importance of adherence to children from when they are young and unknowledgeable (or 
put another way, naive and lacking competence), to the point where it is deemed that they 
are ‘responsible’ adults (Fair et al., 2011).  This is a unique factor in paediatric HIV 
adherence and one that is addressed in clinical medicine and CHIVA between the discourses 
that take place for children and parents and discussions about dosing going on in PENTA.  
The clinical awareness implied is little discussed in STS descriptions of clinical enactions and 
offers a contrast to accounts of atherosclerosis or hypoglycaemia discussed in chapter 2, 
‘object politics’ by Mol (2002) or Mol and Law (2004).  Adherence is tasked with 
                                                        
80 Taken from interviews with Luke, Marty and Serge between May and July 2011. 
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communicating between all groups and aligning them towards the same goal of viral 
suppression. 
 
Common Ground 
However, even if PENTA and CHIVA play a role in educating children about the dangers of 
non-adherence, the medicine (or tellingly the meds as they are referred to in the clinic) 
must also be personalised and internalised by children as they take them.  It perhaps makes 
more sense if antiretrovirals are conceptualised as not entirely created and given meaning 
in medical science and imposed upon children (as in the Gibbs’ 2003 article only for the 
wider culture that children introduce to jeopardise it), but instead that the antiretrovirals 
only become functional when negotiated successfully by the child into their wider cultural 
networks (Prout, 1996; Scheldeman, 2010).  For example, during several consultations 
children and adolescents spoke about tablets in terms of shapes, sizes and colours, when 
discussing pill regimes.  Routinely in consultations Dr Peters would talk about antiretrovirals 
with patients, informing them about their regimes, what they were designed for and what 
they were doing, answering if they were working and any questions that may arise.  In the 
clinic when discussing with Luke (aged 16) the roles of the individual tablets he was taking, 
Luke asked 'colours please' when Dr Peters would refer to a particular antiretroviral.  
Similarly during a consultation with Dorothy (aged 16), she became mixed up with her pill 
regime when asked by Dr Peters to confirm what antiretrovirals she had received from the 
pharmacy, she explained what she was taking in terms of size81.  This indicates that children 
have their own approach to medicine and adherence, and that they organise the medicines 
into ways compatible for them to remember and adhere to successfully.  This could also 
imply that children’s understanding of antiretroviral medicine such as these, are interpreted 
by practitioners as lacking in competence or displaying naivety82.  However, In contrast to 
notions of incompetence as constructed in SoC such as Christensen (1998), the process 
                                                        
81 Katko et al (2001) suggest that there is a correlation between non adherence and caregivers not being able 
to identify pill regimes.  However I would argue that there are more complex levels of understanding and 
internalizing knowledge about antiretrovirals than the approach presented in this article. 
82
 The discussion here draws on classic studies of children’s understanding of their medicine by Perrin and 
Gerrity, (1981); Korbin and Zahorik, (1985); Bluebond-Langner et al., (1990) 
Adherence 
 
161 
 
crating naivety documented here is a process made visible between the complexities 
presented at the clinic and the attempt of practice to make patients adhere.   
 
The perceived child’s interpretation can be seen to make its way into the medicine in certain 
ways, observed evidence points to places where Dr Peters must navigate discrepancies 
between what he interprets as the common attitudes of children and adolescents and the 
specifications of drug requirements.  In this context, the clinic is highly geared, pedagogically 
towards alleviating any potential problems.  For this reason, a folder with an A4 sized sheet 
that has all of the antiretrovirals attached to it, is regularly used in clinic, I observed the 
sheet being used to explain new drug regimes to children and to settle disputes between 
children and the doctor about which antiretrovirals they were taking.  This sheet has the 
potential to be used in many other circumstances and is an example of the clinic facilitating 
or finding common ground between a medical knowledge of the tablets and a child’s 
interpretation (Alderson et al., 2006). 
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6 The NAM drug chart widely available to patients, shares an informative logic with the sheet used in the clinic, but 
doesn't give as much of an illustration of size as the actual pills used in clinic 
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Another example of finding common ground is the effort put into insuring children take 
their medicine as quickly as possible to minimise the bad taste, and make children more 
likely to adhere (also considered in CHIVA, 2011e guidelines). 
 
In a clinic with Francine (aged 14) Dr Peters asked her how quickly she takes her medicine 
and if she is still having problems swallowing it like she did when she was younger?  She 
responded that she is now much quicker, her mother then added that she uses a piece of 
apple to take away the taste.  Dr Peters then shared that he knows how bad they can taste 
and he says that he went on a course where he had to taste them, consequently he advised 
Francine to swallow them as quickly as possible (asking these questions about pill taking is 
not a unique incidence see CHIVA factsheets). 
 
This extract can also be read as an attempt to facilitate the concerns of children into 
regimes that aim to maximise adherence.  Along with a specific section for practitioners on 
the CHIVA website to advice on pill swallowing techniques, Dr Peters administers advice to 
children in an individual negotiation to each patient (Garvie et al., 2007; Diamond and 
Lavallee, 2010; CHIVA, 2011e).  And so in each negotiation the advice is honed in (here on a 
child insufficiency, that of diminished swallowing capability) and made to fit alongside the 
input and considerations of the child and their parent.  The logic that is employed is one 
which therefore brings together and manages ideas and requirements of adherence into 
individual cases, and in so doing, seeks ways to make them compatible, creating a unique 
and effective mode of adherence to each individual patient.   This point can be seen as 
internal to adherence.  Adherence operates as a compelling force that can be applicable 
over the full cohort of relevant patients and professionals and unites these groups together 
under the common aim of suppressing the virus and avoiding resistance.  
 
Good Care 
Therefore, when identifying what adherence makes visible, what is not suggested is that 
adherence is an imposition of medical power upon child patients but rather is an ongoing 
negotiation between drug requirements and the issues encountered with the uptake of 
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medicine for children.  In the process of administering antiretrovirals at the clinic, each case 
is evaluated individually between the drug requirements, ways to make children comply and 
ways to enact medicine moralistically, this process is encompassed in concepts such as good 
care and alters what it means to adhere. I will appropriate Mol (2008) here when she argues 
that  
 
“good care grows from the collaborative and continuing attempts to attune knowledge 
and technologies to diseased bodies and complex lives.” (back cover) 
 
For Jemima, Dr Peters translates good care as the opposite of laying down a regime that 
must be arbitrarily followed regardlessly.  He takes care to fully explain the implications of 
the medicine to her, and in the process is attentive to reasons why she would not want to 
take it and gives flex where he can.  In Jemima’s consultation mentioned above where 
treatment was started, Dr Peter’s negotiates with Jemima her pill burden and the start date 
of her regime to ensure continuity and gain trust, proposing that she starts on the Monday 
instead of Friday so she can go out with her friends without having to worry.  In the clinic 
there is nonetheless an uneasy tension between the imagined desires of Jemima and the 
absolute necessity of the regime. 
 
In the week before the consultation at the staff meeting.  Dr Phelps a consultant from CHH 
asked: 'Will she take the tablets?’  
Dr Peters: 'I think she will, [the CNS] is going to sit on her.’  
CNS: ‘Yeah I will.’ 
Dr Peters: ‘That will be 8 pills a day she'll balk at that'  (The discussion was in relation to the 
possibility of putting her on a new regime, which they toyed with before deciding to 
prescribe her old regime with less of a pill burden.)  
 
In incidences such as this, the process of administering drugs is considered individually for 
the ways it can fit into what is known about the patients’ disposition and life. 
 
Adherence 
 
165 
 
Not only does this display a more abstracted version of adherence than that which the 
CHIVA or PENTA guidelines work from, but it also highlights the engagement of several 
different versions of adherence.  One (I will call) as a laboratorial requirement of taking the 
drug 100% on time, and another as a set of considerations to make children as compliant as 
possible, motivated to take their medicine, there also exists a possible third that 
encompasses choice and a notion of what is morally right in a specific case i.e. for the good 
of the patient.  Overall these enactions of adherence can combine and are translated and 
used strategically in dynamic ways over departments and organisations to attempt to 
achieve a comprehensive understanding of the mechanisms of the drugs and to maximise 
their effectiveness (see discussion of the charlatan in Stengers, 2003). 
 
To this, observed examples can be included of pill regimes being altered in individual cases 
to insure the multi-faceted (laboratorial, compliance, moralistic) requirements of 
adherence.  For example, Pierce (aged 8) was changed over to a regime of Combivir with a 
smaller pill burden on the demand of his mother as the old regime was deemed to have too 
many requirements.  In Pierce’s case, the laboratorial requirements of viral suppression was 
moulded around the wishes of the parent who must organise the treatment in everyday life.  
Dr Peters told me after the consultation that Combivir was not ideal for Pierce as it was 
usually administered as an adult regime, as the dose is too high.  Therefore, what can be 
seen by prescribing Combivir to Pierce is the clinical work taking place to facilitate an 
ongoing, multilayered negotiation in the clinic around the appropriate action to take to 
ensure adherence (Sharland et al. 2000 provides details on paediatric specific regimes).  This 
process of attuning antiretroviral regimes demonstrates the flexibility adopted at the clinic 
to facilitate complex patient dispositions to medical requirements. 
 
In a similar case that demonstrates multiplicity, Rob aged 12, was reluctantly taken off of 
Atazanavir as it was making him jaundice and his eyes visibly yellow.  Rob came to the UK 
from Zimbabwe and was referred to the clinic during the year research was conducted.  A 
GP that saw Rob when arriving in the UK made the wrong decision to stop treatment, and so 
during his first appointments the team were worried about resistance.  After consulting Dr 
Phelps at CHH and the pharmacologist, it was decided that he should be put on a regime 
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that included Atazanavir.  After 3 months on the treatment Rob reported in the next 
consultation that the regime was causing his eyes to go yellow and that he was being bullied 
at school because of it.  Dr Peters identified that it was the Atazanavir causing it (NAM, 
2011) and the regime was changed to another protease inhibitor, Darunavir, to ensure for 
one reason, that Rob was happy to continue to take the medicine.  Again, after the 
consultation Dr Peters shared his reluctance with me to change him over as the Atazanavir 
was proving effective, but in the end it came down to a quality of life issue and so was 
accepted that the regime should be changed (Welch and PENTA Steering Committee, 2009 
offer guidelines on inconvenience of changing regimes).  In comparison to other STS 
accounts of multiplicity, such as that of Mol (2002) and Mol and Law (2004) that highlight 
multiplicity in practice, paediatric HIV demonstrates the importance for practice to manage 
patient complexity flexibly into drug requirements.  Whereas Mol (2002) points to the 
generative process of objects becoming multiple, the account given here focuses on how 
multiplicity becomes ordered into a necessary clinical process.  The antiretroviral drugs of 
Atazanavir, Darunavir etc, their positive effects on the body, their many unwanted effects, 
the desire of the child and the bullying taking place in the school playground point to an 
idea of multiplicity that must be managed into the task of viral suppression.  This emphasis 
on the consolidation of complexity is especially pressing when applying enactment to the 
study of paediatric HIV.      
 
The role of the team at UOUH is not only to manage these disparate branches of CHIVA, 
PENTA and patient wishes, but also to seek ways in which to make contradictions in 
adherence compatible.  One way this is done, as has been demonstrated, is to suggest 
alternative regimes.  However, this negotiation goes much further into ways to monitor, 
identify and ensure adherence. 
 
One of the most conspicuous ways this negotiation of contradictions becomes visible is from 
looking at some of the technologies proposed for use in the clinic with the idea of aiding 
children to adhere (Blume, 1992).  At the half way point of fieldwork, Dr Peters became 
aware of the PointCare NOW machine, which if purchased for the clinic would be able to 
give CD4 results during a child’s appointment.  Dr Peters recognised the application of the 
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machine for improving adherence as it would make it possible for him to check if patients 
are being truthful in consultation about taking their anti-retrovirals.  If patients were to say 
that they were following their treatment and the machine would suggest an irregularity in 
the CD4 measurement, Dr Peters would be able to confront them and attempt to resolve 
any issues or push the importance of taking them reliably. 
 
7 A picture of the PointCare Now machine taken from www.pointcare.net 
 
Kirk, 15, was in the consultation room on his own without his mother, Dr Peters routinely 
has preliminary consultations with children without their parents, before calling them in 
later, (this is to make sure that children can talk about things they may not be comfortable 
talking about with their parents present).  Dr Peters asked if Kirk had missed any doses in 
the past month.  Kirk responded tentatively looking at the floor and said that he missed one 
dose.  After the meeting Dr Peters turned to me and said that if he had a machine on his 
desk he could tell in cases like Kirk’s if he was lying and that he would be able to tell for 
himself how many doses he had missed and then stop issues before they became larger 
problems.  The incompatibility displayed here is balanced between good care on the one 
hand and requirement on the other, and highlights that the notion of good care is itself 
reliant upon the testimony of the patient being reliable (combining Mol, 2008; with 
Stengers, 2003).  
 
These incidences show the logic that Dr Peters employs to straighten out contradictions in 
negotiations of adherence.  This is based upon the attempt to achieve the ideal state of 
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objectified, reliable medical science and antiretroviral medicine through clinical 
intervention.  The logic employed by Dr Peters wishes to take exact measurements at exact 
timings and to make visible the times when the medicine is not followed so that it can 
investigate and hope to quantify and resolve some of the reasons why a child may not want 
to take their medicine.  What it also shows is a logic that could potentially standardise, to 
some degree, all consultations to insure that children cannot lie about taking their medicine.  
It shows a desire to circumnavigate ‘the social’ (as identified in the literature earlier see 
Gibbs et al. 2003), a desire (going back to Stengers 2003) to make bodies give a reliable 
testimony.  Although no such circumnavigation is ever possible, the agency of the patient 
can never be reduced from a doctor/patient clinical enaction.  In contrast to the description 
of medical power as uni-directional such as in Foucault (2010), even if Dr Peters had the 
machine, he would still have to enact and negotiate the patients’ blood into the machine 
and interpret the results from the machine back to the patient as adherence 
recommendations.  The incident implies that the clinic is a key place where complexity is 
consolidated and that a logic ensues in the clinic which seeks to negotiate complexity 
between patient and practitioner.  This passage uses the concept of enaction and mutual 
constitution taken from the description of atherosclerosis or hypoglycaemia described in 
Mol (2002) and Mol and Law (2004) in the literature review.  In contrast to these studies 
however, this extract again emphasises the attentiveness required in Paediatric HIV practice 
to manage complexity in the clinic (see ‘object politics’ in literature review).   Ultimately 
however, literature on the management of drug requirements and patient uptake lays down 
an enaction of adherence as something that must be constantly improved rather than 
something that is maintained or adapted and essentially different over the different places 
it is enacted (as can be seen from literature that aims to identify all possible reasons for non 
adherence, Steele and Grauer, 2003; Haberer and Mellins, 2009; see especially Simoni et al., 
2007).  
 
Therefore, even though it can be asserted that all of the actors discussed throughout this 
chapter are eventually united in the goal of suppressing the virus, the associations 
maintained by individuals, the means individuals wish to employ to suppress the virus and 
the ends that individuals warrant all contain important differences between different 
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groups of patients, practitioners and professionals.  In the clinic, incompatibilities between 
usages of adherence are encountered and negotiated to ensure positive results.  During 
these practices the priorities of medical science are balanced by the notion of ‘good care’.  
‘Good care’ ensures that the outcome for parents is not wholly decided by the application of 
scientific method but requires an assessment of what will ultimately be beneficial to each 
individual patient.  The role of ‘good care’ is used to unify enactions of adherence in the 
clinic, between patients and the discussions of PENTA.  Therefore, ‘good care’ in this context 
places a responsibility on the medical science to maintain a sound rationale for action in 
each individual situation and makes patients responsible for acting morally in their own 
interests, inviting them to reflect on what they want from care83.  As can be seen in the 
example of both Jemima and the circumnavigation of responsibility from the Pointcarenow 
machine (Mol, 2008). 
 
Conclusion 
This chapter has highlighted a mutual negotiation that takes place in the clinic, one between 
the recommendations of antiretroviral medicine, the clinic and the child at home who must 
take the medicine.  Adherence in the context of STS becomes a translation between the 
medical model of viral suppression and the lives of children and parents that must take the 
pills regularly.  Adherence requires doctors to understand common reasons for patient non-
adherence, organise cases together to identify common themes, and act authoritatively and 
patriarchally towards children to make judgments in their best interests (Alderson, 2008).  
Adherence asks children and parents to take on board the importance of taking medicine at 
regular intervals and act accordingly in ways compatible to meet requirements.  To those 
collating drug trials, adherence must be quantified as a constant variable which has its own 
implications on the medicine.  Adherence works towards unifying groups of practitioners, 
patients and biochemists (and CHIVA and PENTA).   Adherence has specific meanings and 
purposes in each of these different contexts and groups.  From trials, to guidelines, to 
                                                        
83 I am not suggesting here that the desires of children will necessarily result in a direct alteration to the 
medical science, but rather suggesting that a nuanced dialogue takes place between the way children present 
their opinions to carers and the way care will consequently be tailored and adjusted accordingly.  
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practice, to the home there exist scales of adherence that all actors imply (Mol, 2002; 
Latour, 2005).  However, there is a central allure to adherence that encourages each group 
to unify their efforts and standpoints to achieve the task of viral suppression.  It is at this 
point where adherence can be questioned as to what it is and what purpose it ultimately 
serves.  Adherence can be described in a variety of different ways, for example adherence 
could be described as a technology that is applied to patients and professionals, or the 
employment of a method.  Evoking Foucault (2010), adherence could be described as a form 
of surveillance used to modify the behaviour of individuals according to knowledge/power 
structures.  It is more persuasive however, to consider the ways in which adherence is 
employed in negotiation according to the context presented in the clinic.  To emphasise any 
of these roles of adherence over another would obscure the main strength of adherence: its 
flexibility.  The concept of surveillance assumes that power structures act in one direction 
and for one purpose, whereas the strength of adherence lies in its continued applicability 
between each relevant party.  Patients can be seen to take up the logic of adherence and 
actively shape how adherence is constituted.  For example, Jemima’s refusal discussed 
earlier can be read as Jemima placing her will onto adherence and consequently altering the 
way adherence must be conceived and applied.  If adherence is to be imagined as a method, 
a technique or even a form of surveillance, the contingent nature of adherence must be 
stressed, it is neither exclusively applied, employed or enforced, but is a combination of 
situation-specific dynamics which have been designed to be applicable (but non-breakable) 
in the most contingent way possible that will still result in viral suppression.  It is this clinical 
immediacy to consolidate complexity ‘at all costs’ that sets paediatric aside from other 
clinical studies of STS such as those in chapter 3 on object politics.  For example, in 
comparison to the idea of allegory found in Law and Singleton (2003) that highlights how 
illnesses in the clinic are always referencing other places, this thesis demonstrates how the 
paediatric HIV clinic must consolidate outlying references in the clinic into functional 
antiretroviral medicine. 
 
Consequently, the focus of the discussion has been on the ways that adherence must be 
negotiated and re-negotiated with the end state of suppression in mind each time it is 
referred to.  The ends that those who enact adherence have in mind go towards defining 
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the boundaries of the procedure.  For example, it can be postulated that practitioners have 
the end in mind that they will bring together patients with biomedicine to manage patients 
and suppress HIV, and alternately, patients have the end in mind that they will take the pill 
everyday under the promise that their HIV will be kept invisible, this evokes different 
connotations of adherence.  The ends that patients and practitioners are striving towards in 
this postulation are translatable and so can make the medicine functional and viral 
suppression possible.  When the ends are not aligned or are incompatible the medicine 
breaks down (in the style of allies described in Latour, 1987), this would happen in the case 
of children not seeing the point in taking their medicine or the need to adhere (Anderson et 
al., 2000).  This highlights the boundaries of adherence and the emphasis, in cases like 
Jemima’s that a dialogue is maintained and all foreseeable negative connotations are 
addressed in protocol.   
 
If adherence fails it brings forwards the possibility that viral resistance could ensue and 
render future attempts to suppress the virus impossible.  Therefore, adherence is 
purposively presented in a undemanding way that circumnavigates irrelevant particularities 
such as the biochemical differences between regimes and the composition of drug 
categories (bringing to mind the idea of the black box by Latour, 1987).  Adherence is 
simplified to patients between taking medicine and ensuring suppression on the one hand, 
to not adhering and risking immunocompromisation and possibly death on the other (Gibb 
et al., 2003).  Therefore, the compromise at work in adherence between practitioners and 
patients is fragile and must be maintained with the utmost caution that ensures each party 
knows the risk of failure.  It is this real sense of danger encompassed in adherence that 
marks paediatric HIV as developing a more acute awareness of culture in the clinical 
consolidation of complexity than other studies of illness and medicine in STS (such as Mol 
2002, Mol and Law 2004). 
 
In order for adherence, and consequently the rest of the antiretroviral medicine around HIV 
to work, all parties must share a compatible idea of the consequences of non-adherence 
which justifies the maintenance of antiretroviral regimes.  It is not acceptable to maintain 
this negotiation ambiguously due to the stakes and the limited opportunities for rectifying 
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the situation if medicine is not followed.  Antiretroviral medicine must be maintained in 
ways which makes sure adherence stays functional and persuasive.  Tablets are made as 
invisible as possible by practitioners, are presented to adolescents as reliable and as a 
means to keep their virus as invisible as possible if taken precisely.  Adherence must 
successively maintain contradictions in care and render them compatible, whist 
practitioners must strive to ensure, and to continuously identify and engage with the 
reasons why children and adolescents may choose not to adhere (e.g. “facilitation” of 
adherence in Pontali, 2005; or “achieving” adherence in Cunningham et al., 2006).  
 
When carried-out efficiently, adherence makes possible a process of standardisation that 
the clinic can employ in order to compare cases against one another and maximise the 
uptake of medicine amongst the entire cohort of patients.  Through the formalisation of 
adherence as a procedure in protocol, cases can be compared and calculated against each 
other in order to make the medicine and dosing more effective (Iedema, 2007).  
Consequently, outlying cases can be brought more persuasively into antiretroviral medicine.  
Therefore, it becomes prudent to consider adherence as an entity that makes possible the 
observation of unruly bodies to scientific scrutiny via clinical management (Waldby, 1996).   
 
If (informed by Stengers, 2003) the ways in which child and adolescent patients may not 
always give a ‘reliable testimony’ are considered in terms of how well they have followed 
their regime (Kirk and the point care machine come to mind), it raises speculation that all of 
the reasons as to why children do not adhere to medicine may not be possible to explain. In 
an attempt to make the medical science around antiretroviral therapy as effective as 
possible, biomedical reasoning often attempts to circumnavigate the considerations of 
adolescent bodies that are not able to ‘testify’.  For medicine to be considered as effective 
or not, ways in which cases can be measured and made comparable alongside each other 
become essential, it  tells those designing therapies at which point medicine will become 
successful and if a patient is doing what is required or not.  However, the clinical logic of 
standardising and regulating pill taking behaviour is at odds with the attitudes of children 
who adhere through the promise of remaining healthy, as for many, taking anti-retrovirals is 
conceived as the only time their HIV becomes visible.  To counter these considerations and 
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to aid with meeting requirements, the clinic filters its behaviour through notions of ‘good 
care’ which moderates the administration of drugs between requirements and the 
considerations of patients.   
 
In relation to the STS already discussed, it can be argued here that adherence is negotiated 
between making antiretroviral medicine as effective as possible and making medicine serve 
the interests of those it is attempting to treat.  Through ‘good care’ a balance is maintained 
between requirement, quality of life and patient choice (see Mol, 2008).  However 
ideological this may seem, the negotiations that take place between practitioners and 
patients in the clinic ensures that these considerations have a bearing on the medicine.  
What is emphasised in addition to this use of STS is the cultural awareness needed in 
paediatric HIV clinical practice to consolidate patient choice with absolute drug 
requirements.  In the context of the clinic, the application of scientific method can take on 
many manifestations, as practitioners aside from biochemists must ask to what are we 
attempting to apply scientific method to?  The behaviours of individuals? the attitudes of 
individuals? the extraneous elements that take place in their lives? (and to these questions 
of child competence and the desire for confidentiality can be added and scrutinised as to 
how compatible they are to scientific method Christensen 1998).  Therefore, practitioners 
must maintain a balance as each clinical negotiation is multifarious and not exclusively 
directed from guidelines.  Guidelines must be interpreted, negotiated and reapplied in each 
respective clinical encounter.   
 
Throughout this chapter, the description of adherence in paediatric HIV has assumed a 
difference to the ways in which adherence is applied to adult populations.  Imbued within 
paediatric adherence are connotations of child incompetence and naivety.  However, the 
discussion has avoided highlighting innocence as a unidirectional imposition of power on to 
incompetent children, in order to frame ways in which childhood is a negotiation and 
associations such as innocence and naivety are emergent and accounted for in the clinic 
(see Prout, 2005; Lee, 2008 on negotiations of childhood).   Adherence applied to children 
must ensure that the task of following medicine is ‘facilitated’ or ‘achieved’ in accordance to 
the lives of children, not imposed upon them (see the pre-occupation of Pontali, 2005; 
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Cunningham et al., 2006).  These considerations have distinct implications for the question 
of how ‘scientific’ the notion of adherence can be made to be.  As adherence is formalised, 
it must adapt to the needs and comprehension of its child cohort as presented in the clinic.  
As can be seen in the chapters of disclosure and the proceeding one on transition, a great 
deal of resources and attention are spent to the task of bringing children into knowledge 
and making them responsible.  Therefore, these processes of formalising adherence must 
necessarily be integrated with notions of child incompetence and incomprehension, naivety 
and vulnerability (It forms part of a separate question to assess the merits of this process). 
 
The procedure of adherence sits integrally alongside the titles and arguments of the other 
empirical chapters of this thesis: disclosure, chronic illness and transition (forthcoming).  
The procedure forms part of a clinical logic that seeks to consolidate complexity into a 
coherent and functional antiretroviral medicine.   Adherence is at the core of processes of 
HIV care that seek to consolidate patients into care, unite groups in a shared knowledge and 
make viral suppression possible for children with HIV.  However, as part of this regime of 
care, the unique factor of adherence is that success is reliant upon it.  Indeed, the other 
procedures of disclosure, chronic illness and transition all allow themselves to be as flexible 
as possible on many factors as long as patients understand the absolute need to adhere 
100% to antiretroviral medicine.  From the point of view of the practitioner, what is 
demonstrated as under negotiation in this chapter are ways of making this absolute need 
understood and how to make it persuasive, contributing to the STS discussed in ‘object 
politics’ by suggesting the immediacy employed in the clinic to organise complexity.  This 
requirement is of central importance for each group involved, although it has the potential 
to be understood differently or understated by patients.  In comparison to all of the other 
medical procedures found in these chapters, if suppression is to take place, adherence must 
be stated, re-stated and corrected if necessary.   
 
The next chapter will look at chronic illness and demonstrate how procedures such as 
adherence are aligned into longer periods of time between the lives of patients and over the 
entire cohort.  Adherence, in the context of chronic illness becomes a factor that all groups 
must come to rely on and put their faith in with the promise of suppression and viral 
Adherence 
 
175 
 
invisibility.  Enactions of chronic illness used in the clinic and care guidelines consolidate 
disclosure, adherence and transition with wider regimes of care over the lifetime of children 
with HIV to ensure that suppression is made possible in the long term.  This line of reasoning 
will form the core discussion of the next chapter. 
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7 Paediatric HIV as Chronic Illness 
Since the discovery and implementation of antiretroviral drugs has made the suppression of 
HIV possible, services aiming to deal with Paediatric HIV have begun to plan for the long-
term care of children and the chronic management of HIV using antiretroviral therapies 
(Gibb, 2003; Foster et al., 2007).  The clinic observed at UOUH is no exception.  However, 
descriptions of HIV as chronic can be seen to be more context specific and variable than the 
simple long-term application of treatment and suppression.  Viral suppression contains 
many limitations and caveats, Dr Peters was always more cautious when describing HIV as a 
chronic condition, preferring instead to say things like: in some ways HIV can now be seen as 
a chronic condition (also see Siegel and Lekas, 2002).  Therefore, the way that paediatric HIV 
references associations of chronic illness needs some consideration.   
 
This chapter focuses on ways in which paediatric HIV can be referred to as a chronic illness.  
However, descriptions of chronic illness as a singular entity, as exclusively describing either 
large or small time-scales or as a priori to the encounters where it is referred to will be 
different.  Discussion stems from considerations of chronic illness not as innate to HIV 
management but as enacted according to a purpose and argues that chronic illness is used 
as a procedure in the clinic and protocol to consolidate patient and practitioner actions into 
HIV care.  Compared to the previous chapters on adherence and disclosure, depictions of 
chronic illness as a procedure that informs practice are perhaps more concealed, and less 
readily seen as being formalised into guidelines in the clinic.  Nevertheless, I will 
demonstrate how the usage of enactions of chronic medicine/care are heavily implicated in 
the organisation and implementation of HIV care, and are used in a similar way to 
adherence, disclosure and transition to coordinate patients and practitioners together.  
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Through the utilisation of chronic illness as a procedure, it is possible to conceptualise care 
as a continuum and gain a foresight of how to allocate care throughout a patients’ 
development through childhood, into adulthood and beyond.  Discussions of chronic illness 
are well documented over a wide range of disciplines.  In sociology, chronic illness runs from 
Parson’s classic sick role to Mol and Law’s demonstration of embodied action, enacted 
bodies.  A parallel tradition can be found in psychology literature.  two relevant examples 
would be Bradford (2002) and Eiser (1990) who have both provided theoretical and applied 
accounts of chronic illness specifically related to childhood.  Narrative analysis accounts 
have also been used between disciplines to describe patient experiences (see Williams, 
1984; Bury, 2001; Frank, 2010), but with limited attempts to consolidate patient, 
practitioner and scientific accounts.  In medical literature the numbers of references to 
chronic illness fracture further amongst disciplines, fields and traditions of medicine.  
Examples from the HIV literature, discuss concepts such as ‘adjusting to’ or ‘living with’ HIV, 
‘long term care’ and the ‘legacy of perinatal HIV’ (Foster et al., 2007, 2009; Koenig et al., 
2011).  When citing HIV, this literature refers to chronic illness as if it is innate, doesn’t need 
to be achieved and can be taken for granted. 
 
The examples cited above are indispensible in the ways that they offer conceptualisations of 
illness as continuous.  However, I will be displacing traditional ideas of chronic illness by 
avoiding considering it as something a priori that exists independently of the situation 
where it is found.  Instead, following Law (1999), the approach employed considers how 
chronic illness is presented, referred to and made useful in the clinic, and as a result will 
further the thesis argument that places the clinic as a key location of formulating medical 
procedures that consolidate complexity into a coherent antiretroviral medicine.   Drawing 
on other STS accounts that describe chronic illness as enacted such as Mol, (2002) or Mol 
and Law (2004), this account presents the clinical logic of HIV medicine to convey chronic 
illness as something that must be achieved through HIV care.  The logic of chronic illness is 
employed in the clinic to ensure that practitioners and patients conceptualise effectively the 
contingency of antiretroviral treatment.  I have identified four categorisations where 
‘chronic illness’ or ‘chronic care’ were referred to in the clinic.  Each encounter uses chronic 
illness in ways similar to a procedure to coordinate care.  The first is enacted to console 
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patients who must foresee their life with HIV.  The second is behind educating children into 
knowledge about HIV for the reason that they will have to take responsibility in the long-
term for their care.  The third is used in professional negotiations to plan the long-term care 
and field of HIV medicine.  The fourth is enacted when plotting general health care and 
other regimes of medicine.  Through adopting considerations of STS, I argue that what 
emerges are the ways in which chronic illness serves to consolidate care together.  Referring 
to HIV as a chronic illness functions to bring practitioners together with families and patients 
to create care regimes that make long term care possible.  Specifically, through the use of 
STS I wish to present the consolidating logic of chronic illness not as one of imposition by 
one actor or institution on another (as many previous explanations of ‘the social’ have 
done), but rather as a process formulated through the combination of all objects and actors 
present at the places or over the places where chronic illness is enacted (Mol, 2002).   
Compared to the last chapters on operationalising medical knowledge, the emphasis here is 
on how care is imagined by practitioners and patients and can remain stable over long 
periods of time and not just moments of pill taking or bringing patients into knowledge. 
 
It could be asserted that looking at HIV through the lens of chronic illness implies that 
‘macro’ views of the virus, or an overview of paediatric HIV over the long-term must be 
taken on board84.  Following STS however, the conventional lines of micro or macro will be 
blurred, large scale medical planning can be found in everyday practices, and vice versa, 
everyday practices can be found in medical planning.  I have left these kinds of judgements 
about scale to be defined by the actors under research (Latour, 2002, 2005).  Moreover, the 
illustration of clinical observations of chronic illness and paediatric HIV are a good example 
of the STS principle of scale not preceding its enaction by a relevant actor (see the 
discussion of Latour 2002, 2005 in chapter 3 of this thesis).  Another STS principle put to 
work in this chapter, is that rather than positing a unified definition or correspondence 
between discussions around chronic illness, drawing on Mol (2002), this chapter accepts 
that references to and usages of chronic illness have large discrepancies even amongst 
medical practices and ways of treating Paediatric HIV, resulting in many versions of chronic 
                                                        
84
 This approach to analysis is intended in the vein of debates that form ‘macrosociolgy’ or discuss the ‘macro-
micro’ divide in sociology (Latour, 2002). 
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care/illness.  This leads to an interesting contribution to STS as chronic illness is portrayed as 
a vital clinical logic that must reference a single clinical encounter as well as the lifespan of 
an individual patient.  Therefore, chronic Illness is neither confined to a specific moment nor 
suspended indefinitely over time.  Rather it is referenced and made stable through being 
referred to in the clinic.  The interactions of patients/professionals are influenced by a 
dynamic set of materialities, including the virus of HIV acting in a stable and constant way 
over time, and the body of the child developing in expected parameters (Kelle, 2001, 2010).  
This all serves to highlight the point that in the clinic, enactions of HIV as ‘chronic’ are 
integral to the way care is visualised and maintained, and acts as a force that compels 
practice, protocol and care to act together over the long-term, able to react against a range 
of unforeseeable problems that could affect care (Pickstone, 2000).  The most basic example 
being the long-term mission to keep patients upholding the responsibility to suppress the 
virus using antiretroviral drugs.  Therefore, the overall argument is served by this chapter 
when considering how the idea of HIV being chronic is utilised85 in the clinic, what chronic 
illness’ function is and how different groups of patients and practitioners combine in clinical 
practice to evoke chronic illness with a range of purposes in mind.  Therefore the clinic is 
highlighted as a key site in consolidating complexities into functional medicine. 
 
If ideas of STS that draw on process philosophy86 are used to examine ideas of HIV as 
chronic, the notion of antiretroviral medicine and HIV care as the simple restoration of 
bodily norms to maintain a chronic status can be displaced.  Instead, it can be suggested 
that the suppression of HIV is not isolated to the cause and consequence of taking a pill and 
suppressing the virus, but suppression is also linked to the act of taking the pill and the 
process it brings about to alter the patients’ immune system, body and their interactions 
with the virus.  This implies that patients must live their lives not to reach an end point or 
cure, but instead constantly maintain HIV as ‘balanced’ between compatible ways of taking 
                                                        
85 The use of the word ‘utility’ is intentionally broad, it is used to document the ways in which chronic illness is 
not only descriptive but also the way that it is used to enact practice, inspired by Law and Urry’s idea of  
‘enacting the social’ (2004). 
86
 This point refers to the conceptualisations as pioneered by Whitehead and Deleuze but modified in the work 
of Stengers and Latour amongst others. 
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medicine, living life, avoiding resistance and other unwanted effects87.  This is how it will be 
developed here, not as one concept or even one process, but a dynamic used in the clinic to 
influence the present and future of care.  Chronic illness makes that which is uncertain 
manageable for both patients and practitioners now and at a future date by consolidating 
protocol and care into conceptualisations of how care will unfold.  In relation to STS two 
limitations come to mind, one is that the concern felt by the clinic when attempting to 
maintain care as chronic is not so easily contained in enaction, and the second develops the 
previously discussed antagonism in STS around the charged child figure (echoing Casta eda, 
2002 figurations).  When consolidating care in the long-term over the span of a lifetime, 
childhood is no mere object or agency, but charged with considerations about life, lifespan 
and human experience.  The implications become poignant when considering what it must 
mean for a child to think through their entire future dealing with HIV, it is the practitioner 
that must guide them through the process.  
   
What follows are some examples of the ways in which HIV has been described as chronic 
and how enactions of chronic illness have been used between protocol and the clinic.  The 
accounts that have been selected are nuanced and extremely specific to firstly paediatric 
HIV and secondly the contexts and incidences where they occurred.  What is also 
highlighted is how enactions of HIV as chronic inform and make possible the maintenance of 
long term care over a patients’ lifespan.  Through following this line of thought, references 
to HIV being chronic can be found reverberated in dynamic and multifarious ways through 
the interactions of staff over many departments and job titles, as well as between family 
relations and medical professionals. 
 
Consolation  
The CHIVA guidelines, Talking to Children with HIV, details what to respond to a child who 
asks , ‘am I going to die?’. The text advices:  
                                                        
87 Persson (2006) talks about how taking a tablet for HIV doesn’t simply imply a restoration of bodily norms but 
instead has a complex effect.  Pearson links chronic illness to the effect pills have, here the discussion will go 
wider to encompass other ideas of chronic illness and care, (also see Rosengarten 2004) 
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HIV is still associated with dying and this does need to be addressed with the 
young person.  It can help to explain that although many children and adults do die 
from HIV in developing countries, this is usually because they do not have access to 
medicines or good health care.  Reassure the young person by saying that with 
treatment available now, most children and adults can live good quality lives and that 
we expect them to have a reasonably normal lifespan.  Explaining that HIV is a chronic 
health condition is important, that it won’t go away but can be well controlled by 
medication. It may be helpful to give examples of other chronic health conditions which 
require ongoing medications (CHIVA, 2011c). 
This question and model answer reverberates through UK institutions dealing with 
paediatric HIV and advocates using the notion of chronic illness to console patients.  
‘Learning to live with HIV’ is a common theme used to relate to parents and 
children/adolescents and help them to find ways of coping.  In a patient booklet published 
by NAM, under the heading of living with HIV it gives the advice, ‘Children with HIV can have 
a happy, normal and thanks to HIV treatment, long life’ (NAM, 2010b). 
 
Similar ideas of chronic illness and consolation can be seen to reverberate through practice 
at the clinic in UOUH.  During research, Anna was 14 and lived with both of her parents and 
her older sister.  Her mother was from Zambia and her father was white British but she had 
been born in the UK.  Anna had been attending the clinic from a young age.  She contracted 
HIV from her mother, her father and sister didn’t have the disease (at the time of this 
consultation her sister was not aware that any of the rest of her family had HIV88).  During a 
clinic with Dr Peters, Dr Wellington (the former head of the clinic) and me, Anna was asked 
to come into the consultation room alone (at adolescent age the procedure is to see 
patients alone first without their parents, see chapter 8 of this thesis), leaving her parents in 
the waiting room.  In the consultation room Anna did not say much and was looking toward 
the floor in a fixed gaze, 
                                                        
88
 I am unaware of the details of where the HIV infection originates in this case.  A lot of the dynamics of the 
partnerships discussed in this thesis are not spoken about in the clinic.  Michaud et al., (2009) discusses the 
disclosure issues between families and the complex dynamics that are exist between who is granted 
knowledge and who is not and some of the reasons for disclosing or not between family members. 
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Dr Peters: ‘Is your sister still unaware of your HIV?’  
Anna: ‘No, not sure’  
Dr Peters: ‘Are you worried about telling her?’  
Anna: ‘Not sure’ Shrugs and is looking downwards.  
At this point Dr Wellington interrupted: ‘You look serious’  
Dr Peters: ‘It’s always a bit like that with Anna, sometimes more so, do you think a lot about 
it?’  
Anna: ‘It’s ok’  
Dr Peters: ‘Did you read something about it?’  
Anna: ‘I read something’  
Dr Peters: ‘There are groups that you can join; maybe we can talk about it with mum.’ 
[silence]  
Dr Peters: ‘...You know, in the past we were very worried about how to treat HIV, but now 
we think that if you take your medicine there are enough different meds out there to last you 
for your entire life, and there’s no reason that you can't live a normal life.’ 
 
The last line of this dialogue asks Anna to consider the medicine as lasting over her lifetime.  
Dr Peters is, in effect asking Anna to consider HIV as chronic (and the advice is consistent 
with the policy highlighted of CHIVA).  The advice is meant to console and focus Anna, 
ensuring that she will uphold the belief that her potential life expectancy is in her own 
hands if she adheres to the medicine provided.  Her disposition has been interpreted as 
'serious' and perhaps a little down.  Dr Peters pre-empts the effect HIV has on her mood, 
and equates dealing with the disease with negative connotations.  As well as asking her if 
she would like to join the support group Body and Soul, he also refers Anna to the ward’s 
psychiatrist (Murphy, 2009; Melvin, 1999; Forsyth, 2003).  In this incident Dr Peters’ logic is 
to consider it helpful for Anna to regard her lifespan as long and only limited by the amount 
she will adhere to her daily medication.  What becomes noticeable in this logic is firstly, the 
emphasis placed upon the comfort gained from the possibility that she will be able to 
manage her condition for a reasonable life-span and secondly, the negation of other 
connotations differentiating her from other girls of her age who do not have to take 
medicine.   As far as presenting the disease as chronic, more emphasis is put on the fact that 
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she will be able to manage her virus with antiretrovirals for a long span into the future than 
the consideration of having to take medicine everyday for the rest of her life.  What is being 
demonstrated to Anna in this situation are ways that HIV doesn’t necessarily equate to 
death.  The version of chronic illness/care used here is meant to persuade Anna to trust the 
medicine and engage with it with fewer worries.  The example demonstrates the logic of 
clinical practice to promote HIV as chronic to allay the fears felt by practitioners towards the 
alternative connotations patients could adopt about HIV.  The clinical attentiveness to wider 
cultural versions of HIV makes paediatric HIV distinctive compared to other chronic illnesses,  
and the chronic illnesses so far discussed using STS, such as Mol’s (2002) atherosclerosis or 
Mol and Law’s (2004) hypoglycaemia.  This clinical attentiveness acts to persuade Anna to 
consolidate her attitudes of living with HIV to a medical ideal of HIV as managed by ongoing 
and stable care.  As a by-product, the idea of chronic illness presented in this circumstance 
gives the patient a line of medical advice to follow that assures that adhering will surpass 
the unwanted future effect of HIV infection, i.e. death from AIDs (also assured in articles like 
Gibb, 2003).  Therefore, the advice and execution of policy encourages patients and 
practitioners to consider the pre-eminence of virus suppression that they must attempt to 
achieve, acknowledge and accept together.  In effect adolescents are encouraged to reason 
that they have HIV, the consequence of HIV is AIDs and the only proven way to deal with it is 
through antiretroviral medicine (Wong and Ussher, 2008; Thorpe, 2009).  Therefore, one 
idea of chronic care brings patients and practitioners together in the attempt to allay fears 
of the future. 
   
In another scene, Abbey, (aged 12 whose parents were from Ghana) goes to get her blood 
test with the CNS, leaving her mother and father alone with Dr Peters to discuss Abbey’s 
case. 
  
Mother: ‘Sometimes she asks me why she comes here and what it’s for, and why she has to 
have blood tests [at the time of research Abbey had not been disclosed to], and we have to 
tell her that she comes here so that we can watch over her.  Then she comes home from 
school sometimes and she said she learnt this and that about HIV.’   
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Dr Peters: ‘HIV now is like asthma or diabetes it’s chronic, we can't cure it yet, but that’s how 
we think about it.  She can live a long normal life on the medicine.’  
Mother: ‘When she grows up I worry about where she can work, what she can do.’  
Dr Peters: ‘There’s nothing that she can’t do, possibly be a surgeon or a dentist, and when 
she’s older the tough thing for the parents to hear is that it’s almost sure that if she chooses 
to have children she will be able to prevent her children from getting it.’  
Mother: ‘She says that she doesn’t want children she must know something.’ 
Dr Peters: That’s quite normal, she probably finds sex quite disgusting at the moment, she’s 
still very young.  
Mother: ‘How will she find a man, who will understand her and take the time to make a 
relationship with her?’  
Dr Peters: ‘The CNS will go through relationships with her, not now but when she’s a bit 
older, one of the things we work on is how to maintain and make good relationships.’ 
 
After Abbey has finished her blood test and the family have left the clinic, the CNS comes 
back into the consultation room and Dr Peters says to her: 'the mum had a lot of questions 
about Abbey growing up getting a job and finding a husband.  I tried to answer them the 
best I could but I’m not sure if I did.'   
CNS:  ‘She has asked those questions before, how did the husband seem?’  
Dr Peters: ‘Supportive.’ 
 
In this conversation, Dr Peters is asked questions about the future of Abbey's life.  Again Dr 
Peters uses a certain version of HIV as being chronic, but to his own admission he feels that 
his console could not broach the gap.  The clinical logic strived towards aims to consolidate 
speculations of a patients’ future with the ongoing maintenance of care.  Abbey's mother 
asked a series of personal questions about the problems she fears that Abbey will face when 
growing up.  Dr Peters answers each one from a medical management perspective of trying 
to minimise the perceived effect of HIV in each circumstance89.  As with Anna, Dr Peters’ 
attempts to persuade patients, or in this case the parents, into putting their trust into the 
                                                        
89
 Forsyth (2003) and Murphy (2009) offer papers which advice practitioners how to approach the topic of HIV 
with children. 
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medicine.  Promising firstly, to treat Abbey in a manageable way that does not exclude her 
from any chosen career and secondly that it will support Abbey through future 
relationships.  To Dr Peters’ mind this may not have offered much reassurance, but it is one 
he can offer confidently through the logic of evidence-based medicine90. 
 
Here, as with Anna in the first example, chronic illness is implied twice: once through the 
response of antiretroviral medicine’s effect on the body and HIV, and again in the 
reassurance given to children by the doctor about being able to manage the disease into the 
future.  In both examples the use of chronic illness as consolation brings together patient 
and practitioner.  The consultant offers a promise to patients that they can put their trust 
into the medicine, it gives practitioners a clear example of what to aim for and what is at 
stake91.  In this process, the consultant comes into contact with children who must bear HIV 
over their whole lives.  Therefore, it becomes the responsibility of the consultant to explain 
the medicine and allay fears, in doing so the consultant necessarily influences how medicine 
in this context will be administered and applied to include the fears of children/adolescents 
(as well as highlighting the consideration present of the vulnerability of childhood in relation 
to taking on potentially traumatic news).  For the child patient and the family this 
consolidation serves to galvanise them to place their conviction into the medicine and alter 
their behaviour in accordance to suppressing their HIV with antiretroviral medicine.  This is 
problematical when considering that the condition remains relatively invisible to many 
patients apart from the tablets they must take, and also the amount of personal fears and 
uncertainty that must result from imagining a whole life taking medicine (Ostrow, 1999).   
Therefore, the contingency of care makes practitioners consider carefully how chronic 
illness is referenced in the clinic.  A cultural awareness in care is emphasised here that 
makes paediatric HIV practice a particular condition, this notion of clinical cultural 
awareness distinguishes paediatric HIV from existing STS descriptions of chronic illness such 
as Mol (2002), Mol and Law (2004).  The cultural attentiveness in clinical practice used to 
                                                        
90 For Mol (2008), this is what is echoed in the logic of care.  She sees a distinction between care made for the 
collective and what would constitute the best individual care.  
91 Since the 90s the promise given to patients was suppression of the virus if taken as recommended (see De 
Cock, 1997), interestingly in more recent years the ‘promise’ of antiretrovirals has broadened to include things 
like once a week therapy and HIV prevention (Mayer, 2011; see the use of the word promise in Tenorio, 2011) 
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console patients by describing HIV as a chronic illness through treatment orientates both 
patients and practitioners towards a consolidated vision of medicine.  
 
Education 
To modify the identified use of chronic illness as consolidation, if we go back to the extract 
from CHIVA, it can be seen as the role of the clinic to inform children about HIV.  I will argue 
that this role of educating serves as a way to not only console patients (as can be seen from 
the descriptions of Anna and Abbey above), but also to formulate ways of successfully living 
with HIV and maintaining the disease as chronic92.  The clinical intervention is designed to 
make patients project into the future the question of how their lifestyle is compatible with 
their care.  In effect, this ongoing action consolidates the future complexity of all possible 
patient lifestyles to the medical regimes needed to suppress the virus.  For example, the 
following extract describes the explanation of an anti-retroviral regime to an inexperienced 
patient – Rob, where a logic pertaining to chronic illness can be seen reverberating through 
the consultation. 
 
Rob (aged 12) needed to be informed about the need for him to take a drug regime to 
suppress both his HIV and hepatitis B.  Rob had recently arrived from Zimbabwe to the UK.  
He had been diagnosed and treated in Zimbabwe but his treatment had stopped when he 
arrived in the UK and consequently his CD4 count was beginning to drop, so it was 
important to re-start treatment as soon as possible.  This was the first time that a doctor 
had explained an anti-retroviral regime to Rob as although he had been diagnosed with HIV 
since very young, he had only recently had his HIV disclosed to him.  During the clinic Dr 
Peters took extra time to explain to Rob his new drug regime as he also had to talk about 
the considerations of hepatitis B:  
 
'So you’re taking Truvada which has two applications.  One is to suppress your HIV and the 
other works on your hep B.  The second drug is Atazanavir, which is what's called a protease 
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 This logic can also be  seen through literature on paediatric HIV and coping strategies (see Martin, 2004; 
Murphy, 2009) 
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inhibitor, which works in a different way to stop the virus replicating.  This drug needs to be 
boosted with Ritonavir, the third drug.  But they're all working, that's the bit that matters.' 
 
Whilst the doctor is talking to him he looks down towards the wall not interrupting or asking 
any questions when prompted.  Why then go into such detail to explain it to him?  The logic 
that is behind this description is to make Rob familiar and comfortable with the regime, to 
answer any questions he may have and make him as aware as possible of what he is taking 
and why (see Steele et al., 2001 on the role of the caregiver).  Whether or not he wants to 
know or understands fully is subordinate to the fact that if Rob is to successfully suppress 
his HIV he must take anti-retrovirals for a long time to come, and therefore he must be put 
in good habits and be knowledgeable enough to know why it is important.  It is this view of 
the chronic uptake of the regime ‘off into the future’, which makes it important for children 
to be indoctrinated in the prevailing knowledge of anti-retroviral therapy.  This practice is 
essential to the administration of medicine and is only possible through clinical practice.  It 
is not only in this isolated example that Dr Peters takes the time to explain regimes and how 
they work.  A lot of time in clinic is spent by Dr Peters explaining regimes, drugs and bodily 
mechanisms.  This demonstrates the emphasis employed in the clinic to consolidate patient 
dispositions into the requirements of care management. 
 
The following example comes from the case of Erica, aged 15.  Erica was living in the UK 
with her uncle, she had initially been living in Manchester but the family had now moved to 
London93.  In the couple of weeks prior to the incident, Erica had come into the hospital with 
what was later to be discovered as an AIDs defining illness.  An extremely rare event for the 
hospital (and complicates further the uniformity of the clinic population see introduction).  
Dr Peters deemed that it would be best if they disclosed her diagnoses to her quickly and 
begin treatment as soon as possible.  Two weeks later she attended a consultation to start 
anti-retroviral therapy: 
 
                                                        
93
 Erica was originally from the Congo but was seeking asylum the UK, leaving her mother and father behind in 
Congo after her father was placed in prison for war crimes.  The route of Erica’s HIV infection was unknown. 
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Dr Peters: ‘I’ve got your results from last week, resistance profile went missing so we’re 
going to do that again today, and I would like to start you on medicine.  It will be three 
different antiretrovirals in the form of 2 tablets a day, which I would eventually like to take 
down to 1 tablet a day.  But we will start with 2 to make sure [resistance]?  Side effects – 
we’re not expecting any side effects but you might get diarrhoea but it should pass quickly.  
The other thing is that you might feel a bit nauseous so it’s best to take them just before you 
go to bed to lessen the effects of it.  The important thing to remember is to take the 
medicine to make sure your CD4 count is high and viral load is low, if not you can become 
resistant. Have you heard of that before?  When you don’t take the medicine the virus 
replicates itself very quickly and when it does it makes a mistake each time, if it replicates 
whist you have the antiretroviral in your body it will work out how to replicate only the virus 
that is resistant to the drug.  So the point is to take them because if you become resistant 
you become resistant to all those [drugs] in the same group. The bottom line is that once you 
start you have to continue.  I don’t want to make it seem scary.  You have [the CNS’s] 
number in case you want to talk about anything.  There is a very rare side effect that could 
occur of blistering, if that happens check in to the A+E. Do you have any questions?... 
Nothing?' 
 
As well as demonstrating the desire to educate on antiretrovirals, the extract shows the 
concern that Dr Peters has that children understand how the treatment works and how 
important it is that the patient takes on responsibility for taking the medicine.  During every 
consultation I observed, Dr Peters asked the question: 'did you miss any doses?’.  If 
participants responded that they did he would then go into an explanation of the 
importance of resistance.  The logic of chronic illness used in this circumstance is an attempt 
to ensure that patients understand that their chronic status is wholly reliant upon them 
taking their medicine on time and maintaining a chronic state of care.  It again reinstates the 
point that this logic of chronic illness is essential to the administration of medicine and 
locates the clinic as a key site where complex patient lives are organised compatible with 
antiretroviral regimes.    Compared to the chronic illness discussed in STS such as 
atherosclerosis in Mol (2002) and hypoglycaemia in Mol and Law (2004) that also reference 
complexity, this consideration of educating children on the contingency of treatment in 
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paediatric HIV highlights a notion of immediacy in the approach of the clinic to consolidate 
complexity and the dangers of clinical mismanagement.  The logic of chronic illness is also 
corroborated by the extra support groups set up for children and adolescents.  Prompted by 
regimes of clinical management, one of the mantras on the home page of body and soul is 
the sentence, ‘nobody can go back and start a new beginning, but anyone can start today 
and make a new ending’ (Body and Soul, 2011c).  This sentence upholds the aim to motivate 
children and adolescents to consider ways in which they must take responsibility for their 
care. 
 
8 An image from the Body and Soul website, each of the words, ‘hope’, ‘courage’ and ‘trust’ can be clicked upon for a 
motivational message, under the caption highlighted is the word ‘life’. 
 
 
 
Hidden in the way that care is maintained is a simplification of issues and an 
accommodation for the perceived child’s frame of mind.  The education of children with 
knowledge of their condition and disease is gradually built over the years according to a 
patients’ understanding94. 
 
                                                        
94 We could raise a point here in relation to the classic Piaget (2001a, 2001b) and literature that challenges this 
linear regimented model of child development, as seen in the sociology of childhood (Walkerdine, 1993, see 
2009).  
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During a routine consultation with Gregory (one month away from being 13), Dr Peters 
explained to Gregory the results of his blood test.  After the test Dr Peters asked if there are 
any questions,  
Gregory answered directly: ‘Can you cure the virus?’   
Dr Peters responded: ‘At the moment it's not possible to cure it, the cells that HIV gets into 
are white cells and it gets into the longer term cells that can't be cured without killing the 
cells, so I think it’s a long time from a cure, but the disease has changed, we can't get rid of it 
but it has become chronic.  Do you know anyone with asthma or diabetes?  It's like that.  So 
basically were not smart enough yet.’ 
 
The logic here is that it is important for Dr Peters to convey the nuanced and conditional 
nature of maintaining HIV as a chronic condition whilst making it possible for Gregory to 
understand and make sure that his worries about the condition are allayed. 
 
Emphasis has been placed upon children understanding their diagnosis to maximise the 
possibility of adherence and therefore insuring the disease can be rendered as chronic.  Not 
only does it make it possible for medicine to maintain a continual balance, but it is an ethical 
issue that children over 12 know as much as possible about what they have and what they 
take (see the discussion around the AAP Committee on Pediatric AIDS, 1999b in chapter 6 of 
this thesis).  It is a consideration which informs the roles that each party must uphold.  For 
children like Gregory, understanding HIV is an ongoing process of realisations and 
discoveries.  Those who are in charge of administering care must ensure that each stage can 
be deemed to be worthwhile and that they act responsibly (Budd and Sharma, 1994).  
Making an ethical judgement on child ‘well-being’ requires the case-specific enaction in the 
clinic of a reliable scientific medicine that can provide knowledge on how to proceed at the 
present and in the future.  In this case, Dr Peters acts to inform Gregory of the workings of 
the medicine in order to ensure that Gregory can conceptualise the contingency of being 
able to be treated with anti-retrovirals as long into the future as possible (without causing 
distress). 
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Therefore, additional to chronic illness being used to console patients, this example of care 
management and education emphasises chronic illnesses’ use to educate patients, to make 
sure they will take responsibility for maintaining their HIV, which in turn ensures it can be 
maintained chronically by practitioners.  Practitioners and children must develop a common 
knowledge of medicine and common ways of conveying medicine and HIV to maximise the 
amount of patients that can maintain chronic care for their HIV (emphasis can be placed on 
the word “facilitating” as in Pontali, 2005).  This is done through a process of education in 
the clinic that emphasises enactions of chronic illness to describe the maintenance that will 
be necessary in the present and into the future.  In turn the virus can then be entrusted to 
respond and remain dormant.  It highlights how clinical practice incorporates patient 
complexities into medical reasoning and viral suppression is made possible. 
 
Professional Negotiations 
Contrary to these examples however, another line of enquiry regarding HIV as chronic takes 
place between professionals at the clinic in order to coordinate care, such as the 
reservations about maintaining a balance for patients who must live most of their lives on 
anti-retrovirals.  Some of these negotiations go on behind closed doors (or at least the ones 
I observed did) (Downey et al., 1998; Long et al., 2007 discuss how conversations are 
organised around the hospital). 
 
The dangers of non-adherence and resistance make HIV distinctive amongst other 
conditions mentioned in the clinic such as asthma and diabetes, or the chronic illness 
already discussed in STS such as Mol and Law’s (2004) and Mol’s (2002) discussions of 
hypoglycaemia or arthrosclerosis (for one, making adherence for HIV amongst the highest 
rates of adherence compared to other diseases DiMatteo, 2004).  Therefore, the reference 
to HIV being chronic has a particular meaning and although it pertains to the process of 
managing the disease, the balance that must be maintained, the changeability of the patient 
body and the virus itself when taking antiretrovirals can evoke ideas of repression and 
mortality rather than maintenance (Persson et al. 2003; Persson and Newman 2006; 
Rosengarten 2004).  For this reason, the way HIV is presented above as a chronic illness to 
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reassure patients, is in contrast to the ways that medical professionals must talk about and 
organise care amongst them-selves.  Practitioners must be highly aware of their activities in 
accordance with the idea of HIV projected to patients, giving an idea of the attentiveness 
required in the clinical approach of paediatric HIV (in comparison to other accounts of STS 
such as Mol 2002; Mol and Law 2004).  If these negotiations took place in front of patients 
they would have the opposite effect of consolidating patients and practitioners together 
(reminiscent of Goffman's, 1990 “backstage" or Latour's 1987 breakdown of networks).  
However, it is still necessary in the functioning of the medicine for these discussions to take 
place between clinical practice to coordinate practitioners and organise cases and medicine 
together. 
 
The following extract from the clinic is a corresponding but different perspective of chronic 
illness than the one used to reassure patients.  As part of professional development, Dr 
Peters often invites SHOs into the clinic for training.  During one of these training sessions, 
between patient consultations, Dr Peters informed an SHO about the limitations of 
maintaining paediatric HIV in a chronic state: 
 
"These children we're handing over are very complicated.  A lot of them had treatment when 
there was only one anti-retroviral drug available then they took that for a few weeks and 
they became resistant.  So they took the next one and so on.  When you become resistant to 
one [drug] you become resistant to all the drugs that are like that, so [for some of them] 
their options are now quite limited." 
 
The way that HIV care is being described here is very different to the ways used to comfort 
or educate children and parents in the previous examples.  It gives a glimpse of a different 
idea of chronic illness, of a sense of the unknown and individual nature of each case, where 
the medical team are attempting to order individual resistance profiles that may have 
become chaotic and not treatable according to general recommendations95.  Under this 
notion, chronic illness must be achieved.  Each case must be individually tailored and the 
                                                        
95
 Other ways we could site this would be from literature on psycho-social functioning of children with HIV 
(Ostrow, 1999; Mellins, 2004; Naar-King et al., 2006; Steele, 2007) 
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exact outcome of antiretroviral combinations is unknown (Cunningham et al., 2006).  The 
discussion about how to ensure the continuum of care as well as the idea of HIV they are 
describing are not as simplified as those offered to patients.  From the same virus has come 
a new possibility, a strain of HIV that may fail to respond.  This switches the once responsive 
and treatable HIV in to an unruly virus, just as it frames the possibility of antirtrovirals as 
having a limited and contrary effect.  Both the pill and the virus have become potentially 
non-compliant to the task of viral suppression.  In this eventuality, the practitioner must 
struggle to keep the virus chronic whilst the virus would no-longer respond stably.  Part of 
this struggle must be done behind closed doors, and then translated (in the sense of Callon, 
1986) and presented differently when being relayed back to patients in the process of 
educating, consoling or making them adhere in the long-term, or else it would prove 
counterproductive and result in a break down in the medicine.  It highlights the 
maintenance that must be undertaken at the clinic to ensure that the clinical logic employed 
continues to consolidate contradictory and complex patient associations such as stigma, 
vulnerability and naivety to achieve viral suppression.  In comparison to other accounts of 
chronic illness in STS or SoC (e.g. Mol 2002; Mol and Law 2004; Christensen 1998) the 
cultural awareness and attentiveness employed by practitioners when screening clinical 
conversations marks paediatric HIV as distinct.   
 
 A second set of reservations discussed between professionals is the damage done by 
antiretroviral drugs themselves.  In another discussion with an SHO between patients, Dr 
Peters was asked how long HIV can be suppressed for? Dr Peters closed the door and 
responded:  
 
“From a viral point of view it’s possible to suppress the virus indefinitely, but it seems that 
there are likely to be cardiovascular complications.  Theoretically there are enough drugs to 
last a patients’ entire life providing that they don't mess around with them.  But it seems 
that there can be complications with their cardiovascular walls from the strain of living with 
the virus for so long, which is particularly difficult in children [with HIV] because we don't 
know exactly what is going to happen.  Some of them will live for a long time on meds.  We 
measure all our kids for cholesterol here; if we see it shooting up we do something about it.” 
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The door was closed during Dr Peters’ answer to insure that any patient in the waiting room 
would not over-hear the conversation.  What is flagged up here is the unknown outcome of 
prolonged exposure to antiretroviral drugs.  For those administering care, it is prudent that 
they are aware of any potential dangers and the importance of monitoring more closely the 
possible health outcomes of these patients such as their hearts and cholesterol (Sani et al., 
2005).  This evokes another consideration of the management struggle towards chronic 
illness and the unruly antiretrovirals that begin to become counterproductive.  However, as 
can be illustrated through the act of closing the door, the doctor considers that any patient 
that would overhear the discussion may find it potentially distressing.  Therefore, the idea of 
chronic illness relayed between children in the clinic is not the same as the one discussed in 
training doctors and organising the clinic (see Kelle 2010 on age-appropriateness and 
'normal' development being used to inform clinical practice).  There are multiple versions of 
chronic illness.  The logic behind this extract, aims to ensure that practitioners organise 
adversity during practice by administering medicine consistently with an eye to the future, 
the case as a whole and an idea of the dangers in mind.  This is incompatible with the idea of 
chronic illness presented to children of a younger age as it may create unwanted negative 
connotations96.  
 
Large Scale Organisation of Complexity 
This logic of organisation is also at work over larger ‘macro’ scales of resource allocation in 
clinical medicine.  In certain discourses that take place in reference to paediatric HIV 
medicine, individual patients are hardly phased in at all.  As can be seen through the 
conclusion of a paper co-authored by many senior UK based HIV paediatricians,  
 
“The success of HAART has seen perinatally acquired HIV become a chronic disease 
of childhood. Increasing numbers of young people living with HIV will transfer to adult 
services in the United Kingdom or Ireland during the next decade. The varied and 
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 This line of reasoning is reminiscent of that of Priestley, (2000) when he demonstrates a logic at work in 
education that aims to maintain “moral” and “spiritual” growth in childhood. 
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complex needs of these young people must be met by the development of 
multidisciplinary transitional care services between pediatric and adult health care 
providers.  The legacy of their pediatric care will continue to impact in adult life and 
careful long-term follow-up of this unique cohort is required to improve outcomes for 
young people with HIV in the future.” (Foster et al., 2009) 
 
In this passage, factors affecting individual patients are not present, and so it becomes the 
responsibility of the paediatrics as a whole to ensure that HIVs chronic status is maintained.  
During a quiet morning at UOUH whilst there were no patients waiting to be seen, Dr Phelps 
(attending as part of the regular consultations from CHH) starts to discuss with Dr Peters the 
diminishing patient cohorts witnessed in both clinics.  They both reach a consensus that 
small centres like the one in UOUH would cease to be necessary in the future.  The larger 
centres would continue but there would also be increasing numbers of isolated cases 
around the UK, (a new isolated case in Stockton on Tees was highlighted).  Dr Peters then 
gave the example that in the last three years only one patient had been referred to the 
service.  [In the six months after this discussion took place both consultants went on to 
concede that what was said wasn't entirely accurate as three more patients registered to 
UOUH and two to CHH, all three from Sub Saharan Africa, but still not enough to halt the 
general decline.] 
 
In this discussion, HIV care is put into a larger scale to highlight the way that practitioners 
must think about resources into the future according to considerations of paediatric HIV 
being a chronic illness (see discussion of Latour, 2002, 2005 and “scale” in chapter 3).  The 
concern is upon numbers and the centres/services that will be needed to serve them.  The 
discussion is not so much on how they will continue to care for children with HIV, or the 
continuing lives of children who grow to be adults with HIV, instead they discuss what 
paediatric HIV will look like epidemiologically in the future97 (Judd et al., 2007; also found in 
                                                        
97 This may seem like a very specific example, but it runs alongside other ways of organising medicine and 
between patients and practitioners.  It is used when giving blood test results to parents with HIV to new-born's 
without the condition.  Quite often before they get the results of the baby's routine third test Dr Peters would 
say: 'You'll receive a letter, it will say the child doesn't have HIV.  No new babies have been diagnosed here in 
seven years'.   
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articles such as Waning et al., 2010).  This way of thinking works from an idea of HIV as 
existent between a collection of patients and not specifically in a patients’ body (see Mol 
and Law 2004 and the example of hypoglycaemia).  The chronic illness it subsequently 
evokes is one of a diminishing presence and extent.  It is a very useful conceptualisation as it 
allows practitioners to measure extent, decline, exposure and most importantly, where 
resources should be placed98.  The way this logic is presented is different to the way that HIV 
as chronic illness is relayed to children in the consultation room.  It is alternate to a way of 
presenting chronic disease that is relevant to consoling or educating children dealing with 
HIV, instead being a way to talk about chronic disease to make it relevant to organising 
paediatric HIV on a large scale.  HIV becomes a large scale entity with its own ebbs and 
flows, and the potential to be confronted beyond individual cases.  However, it still 
demonstrates the logic of the clinic as a site to organise the complex implications that arise 
in the long-term management of paediatric HIV. 
 
So far a range of enactions of HIV as chronic have been demonstrated.  Rather than there 
being one that can be used between different groups, I would like to suggest that each use 
of chronic illness in the clinic is itself a particular version aimed at different groups for 
different purposes whilst also making it possible to consolidate groups together under the 
task of viral suppression.  Two versions of chronic illness have been seen distinctly, one to 
console and educate patients, and another to ensure practitioners apply medicine with an 
eye on its long term implications.    Between these two versions it remains possible to 
translate each enaction of chronic illness into an overview that ensures that medicine is 
followed and adapted into the future99 .  This discrepancy must be accounted for in protocol 
to acknowledge acceptable versions of chronic care, to discuss regimes with patients and 
coordinate care into the future.  However, the examples already demonstrated suggest that 
rather than there being two or three distinct versions at work here, there are many different 
nuanced situated enactments of chronic illness and corresponding long term care employed 
in the clinic.  This becomes significant when describing chronic illness as discussed between 
                                                        
98 Perhaps this would be interesting to develop using literature from the Sociology of Expectations, see Borup 
et al. 2006 
99
 Lawton (2002) argues that a patients’ life-course often coincides with clinical decision making. 
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the clinic and over guidelines as it is integral to enactions of chronic illness that it can be 
applied to individual circumstances but also defined as a dynamic that stretches out over 
the future that must be sensitively navigated by practitioners.  If STS is used to analyse the 
sites where HIV is ‘enacted’, it would suggest that enactions of HIV are simultaneously 
placed in the present to consolidate and maintain care, but also over the future in the 
promise of suppression if the medicine is followed100.  However, in contrast to the 
proliferation of more and more multiplicity demonstrated in relation to Mol (2002) in the 
‘object politics’ section of chapter 2 of this thesis, the consideration stresses the need for 
the clinic to be a site that must succeed to consolidate possible future actions and 
complexities with courses of action decided in the present.  The differences between 
versions of chronic illness presented in the clinic and relayed in protocol suggest that 
paediatric HIV care is a fine balance of context specific evocations of illness that are 
simultaneously in the present and into the future.  The functioning of HIV medicine is reliant 
upon the consolidation and management of disparate versions of chronic illness into a 
coherent clinical practice and corresponding protocol. 
 
General Healthcare  
The boundaries of chronic HIV and long term care become wider and more difficult to define 
still when considering the role of the clinic to serve more conditions than those directly 
applicable to HIV.  Practitioners also assume the management of broader health and welfare 
care, blurring the lines of what is Paediatric HIV medicine and more broadly, primary health 
care (conflated by the fact that the GP and HIV patients have an ambiguous relationship due 
to confidentiality see Casserly et al., 2009).  This process consolidates yet more medicine 
together in the task of suppressing HIV.  General care is organised for paediatric HIV 
patients according to an idea of chronic illness and chronic care.  The way that this chronic 
care and chronic illness is envisaged is influenced by and influences understandings of HIV.  
                                                        
100
 This highlights an antagonism in the object of HIV that is not specifically confined to the chronic illness 
described in ANT accounts such as that of hypoglycaemia of Mol and Law (2004), where the illness is described 
as contained between its temporal and spatial enactions.  Interestingly, this line of thought seems to question 
how we conceive of the logic of temporal ordering within STS. 
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In addition to anti-retroviral medicine and medicine relating directly to HIV, the general care 
children receive must also fit into the maintenance of their chronic status. 
 
Many patients in the clinic have other requirements linked to but also aside from HIV.  One 
example is hepatitis B as in Rob’s case.  Another is Spastic Diplegia (Laverda et al., 1994). 
 
Luke (aged 15), developed Spastic Diplegia through catching meningitis when he was about 
eight years old.  Luke was born in the UK but his parents were African.  He lived with his 
mother and father and was amongst the longest attending patients at the clinic.  During the 
time of research, he had to make some decisions in relation to the ongoing care of his 
condition.  On one occasion, Luke came in alone to an afternoon surgery with only me and 
Dr Peters in attendance.  Luke had to use a frame to walk with.  As he manoeuvred the 
entrance, Dr Peters held the door open for him, gave him the time to sit down and then 
passed by him to take the place at the desk. 
Dr Peters:  “How are you doing with your walking?”   
Luke: “Yeah fine” 
Dr Peters: “I know that we spoke to your dad about surgery, he wants to wait until after the 
A levels.  You know it’s pretty serious and it’s going to take a year of physio, I can see why 
your dad wants you to get your school work done.  I’ve got the opinion of the doctor here 
and he says that it might be best to wait.  What do you think about that?” 
Luke:  “Yeah might be best” 
With that Dr Peters changed the subject and asked Luke questions about his exams.   
Towards the end of the clinic when Luke’s mother was present in the room, Dr Peters brings 
up the idea of surgery again.  Dr Peters put the letter in front of him and went over it again 
with Luke and his mother. 
Dr Peters:  “To go back to the question of surgery.  Reading between the lines, the 
Consultant implies that Luke doesn’t seem keen to have it done.  It’s a really big operation 
and I think that he [the Consultant] wants to be sure that it’s what you want.  Really at the 
end of the day it’s up to you.” 
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At the end of the clinic when I was alone with Dr Peters, I asked him again about Luke’s 
condition. 
Me: “What kind of surgery does Luke need to have?”   
Dr Peters: “Luke has Spastic Diplegia from having meningitis when he was young, it was 
through this illness that they discovered that he had HIV, and then diagnosed the mother.  
The surgery is a difficult decision for Luke and his family because the operation that he would 
have to have is extensive and would take several surgeries - about four, they would have to 
break and reset some of his bones and reattach tendons.  I can see why he has reservations 
because there is a risk that at the end of surgery he might not even be able to walk as well as 
he can now.  So it might be best to wait until his walking has become worse to go through 
with the operation.” 
 
Luke's example (and that of Rob with hepatitis B) demonstrates that it becomes the role of 
Dr Peters and the clinic to manage and coordinate other branches of medicine into the care 
that patients receive at the clinic.  HIV becomes sidelined and the task of chronic 
management becomes a task of coordination.  The focus of this task is not just about 
consolidating different groups and medicines, but rather consolidating different medical 
branches and a notion of a patients’ general healthiness alongside the chronic management 
of HIV (Vargas and Cunningham, 2006).  Viral suppression is not a lone aspiration of the 
medicine but must act alongside and become compatible with other attempts to manage 
well-being.  It consolidates ideas of life course and quality of life with HIV care.  We ask what 
is best for Luke?  Luke and his parents must also be managed to ensure that they are happy 
with decisions made about care.  Patients, parents and practitioners are consolidated 
through considerations of chronic illness that question if they are happy with their choices 
for care now and into the future.  They make a choice and take a stake in their care (or 
career for the consultant).   Chronic illness is also enacted through the process of making 
sure that it remains possible, desirable and not contradictory to follow HIV medicine, for 
both patients and practitioners.  If this was not the case patients could simply be referred to 
the GP and would not have to inform the consultant.  The conditions of hypoglycaemia or 
atherosclerosis documented in Mol (2002) and Mol and Law (2004) must also be managed 
alongside other conditions, but what is interesting in this case is the cultural awareness 
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required in the clinic to make sure that the treatment of other conditions are made 
compatible with paediatric HIV treatment and the dangers that can come about through 
mismanagement.   
 
It is not just through different ailments where this occurs however.  For instance there are 
the ongoing issue of dental care and eye care (Ramos‐Gomez, 2002).  The ward refers to a 
specialist dentist that is familiar with dealing with HIV, in the case of Erica during her second 
consultation Dr Peters gave her details of a dentist.  Dr Peters routinely examines patients’ 
eyes during their consultation every 3 months and if necessary refers them to an optician 
(detailed in the handbook of Portegies, 2007).  When Harry burnt himself by squeezing a hot 
water bottle, Dr Peters made sure that his referral was all in order.  Other examples are 
ringworm, chest x-rays for asthma, inoculations.  Patients would see the GP as well, but it 
would all be coordinated through the consultant.  In these moments, HIV orders itself 
alongside these other conditions and the practitioner must proceed in ways that will 
address, as well as comply with all possible symptoms. 
 
It is convenient for patients to ask for Dr Peters’ advice on wider health issues during 
consultations.  However, it is also the practice of those who administer medicine to 
coordinate services and collect data into medical files that aim to be as ‘complete’ as 
possible (White, 2002).  This goes beyond the jurisdiction that attempts to present medicine 
as ‘scientific’ and becomes a process in coordinating services and provisions (Pickstone, 
2000, p34).  The question for practitioners becomes what can be considered as a ‘normal’ 
lifespan and quality of life?  How to organise wider aspects of medicine into paediatric HIV 
care?  What aspects of care are necessary to maintain the chronic status of the disease?  
And what possibilities arise from the clinic taking on these responsibilities?  One such 
example is sex education, to Dr Peters own admission: ‘it’s not part of general paediatrics 
training, but very important for this clinic’ (Campbell et al., 2009; HYPNET, 2011).  Another is 
that even school can become a routine part of the consultation, each consultation would 
contain the question 'how's school’ (Melvin et al., 2007)?  And when there's a problem at 
school Dr Peters often seeks to resolve it as can be seen here: 
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Mother: Is there any reason why he would be sleepy at school? 
Dr Peters: Why would you say he is? 
Mother: At the school they ask me if he’s on medication.  
[The psychotherapist had apparently informed the school that the child was on medication 
but emphasised the need for confidentiality, prompting the mother to originally say that the 
child was on antibiotics.  The school had said that they could put somebody with the child as 
he works.  Dr Peters was concerned that once it had been said that the child is taking 
medicine that must be kept confidential, it sparks the curiosity of staff members at the 
school.] 
Dr Peters: Are literacy and numeracy going ok? 
Mother: yes he does really well, I think that he has anger problems 
Dr Peters: I think he’s doing really well, but it sounds like he just needs a little help with 
things. 
Mother: instead of putting it on his record, I could share it with someone at the school who 
could know and manage the situation 
Dr Peters: I think that if there was someone who could keep it confidential, possibly.  But 
there isn’t any way of knowing in this environment so I’d just keep on to it. 
 
General conditions of health and treatment that are dealt with in the clinic blur the lines of 
HIV care and ensure that HIV’s chronic status remains an act in process, as demonstrated in 
Mol and Law (2004).  HIV care and treatment is never uniform but must be made to fit.  
From the example above, care and the condition must fit between the requirements of 
school in order to maintain confidentiality and consistency.  Parents and patients must 
remain comfortable in their communities if care is to be upheld into the future (U.K. Select 
Committee, 2011).  Considerations around community form concerns for well-being, quality 
of life, social life and lifespan that are not so easily dismissed and must be assimilated into 
the medicine.  They contribute to sense of cultural awareness found in paediatric HIV clinical 
practice.  Another consideration found in other cases is that HIV care must be maintained 
alongside, hepatitis b, spastic diplegia, ringworm, accidents and emergencies.  When 
required, it is an essential feature of long term care that HIV care must be made compatible 
in the clinic, or if put into STS terminology, ‘translatable’ into all of these circumstances.  
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From management in the clinic to discussions between professionals over protocol, 
paediatric HIV care relies upon operationalising modes of chronic illness/care to consolidate 
the medicine and make viral suppression possible in the long-term.  
 
Rather than there being one distinct condition of paediatric HIV, there are many different 
time specific and contingent conditions.  Strategies of care, as have been discussed, are not 
uniform, the allocation of drug regimes is a negotiation between many relevant and hard to 
foresee factors over many groups, populations and time-scales (Pontali, 2005).  The 
successful administration of antiretrovirals can be dependent upon many further health 
issues or wider everyday issues.  What is required of the medicine is liable to change over 
time.  Regimes of care must alter in line with scientific enquiry and ways of persuading and 
relating to patients must be kept up to date.  The references to chronic illness in the clinic 
can be conceived as a dynamic of chronic management that ensures that care regimes 
remain relevant to practitioners and patients as a coherent whole, that is practicable into 
the future.  At the most practical level this is illustrated by the adjustments that must be 
made to antiretroviral regimes according to growth (Nachman and Pediatric AIDS Clinical 
Trials Group 377 Study Team, 2005). 
 
Many of the cohort observed at UOUH had to change their regime as they grew older.  At 
the age of eight Pierce needed to up the dosage of his tablets, as did Bianca when aged 
eight, Dr Peters charts another general change in patients at fourteen101.  The chronic 
management of HIV must follow patients as they grow.  Decisions made in the past and 
must be made compatible with present and future care. 
 
Additionally, over time medicine does not only need to be altered for children growing to 
become adults, the medicine itself alters as their effects are more fully discovered and their 
guidelines change.  These factors imply that both protocol and antiretroviral drugs are 
enacted as described in Mol and Law (2004).  When Dr Peters first started at the clinic many 
children were taking Stavudine, which was withdrawn due to Stavudine causing 
lypodystrophy (among other toxic effects).  More recently children taking Didanisine (DDI) 
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 Attested to by the need for protocols such as Cole et al. (1998) 
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have been phased off of the drug, when possible, because of the relation between the drug 
and liver problems (Giaquinto C et al., 2008).  A change currently taking place in the clinic is 
related to Atazanavir as it is known to cause jaundice (Molina et al., 2010).  During 
appointments with children on Atazanavir, Dr Peters would advice them about jaundice.  
Rob even asked to be taken off of the drug because he reported that children at school were 
bullying him because his eyes were yellow.  When faced with complex projections of drug 
requirements and drug changes in the future it highlights the need to coordinate care and 
potential issues through regular three month consultations.  It exemplifies the attentiveness 
of practitioners to consolidate complexity into clinical versions of chronic care.  In these 
examples, chronic illness is organised according to the aim of consolidating and coordinating 
clinical tasks to be compatible with the long term task of viral suppression (see the ongoing 
trial details of the WHO Technical Consultation, 2011).  Bodily elements and functions are 
ordered alongside compatibilities in medicine, growth is planned for, the attitude of the 
child is taken into account and kept positive and the diligence of the practitioner to balance 
connotations of chronic illness is used as an assurance of good care (Mol, 2008).  If these 
entities change they must do so with a coherent and compatible idea of chronic 
management in mind.  Therefore, it is important for practitioners to think in terms of what 
is compatible with the drug and care regimes they receive now, and possible consequences 
and outcomes of managing care in the future (see for example the deliberation detailed in 
Wrubel et al., 2011).  If patients grow, or want to take different drug regimes, or if a drug 
becomes incompatible with other care needs, it becomes a judgement of priorities of what 
to change and when to change it to ensure the virus is still suppressed and doesn’t become 
resistant to the antiretroviral.  All the while, the presentation of chronic illness must also be 
done in accordance with projecting a positive version of future care to child patients.  In this 
process therefore, considerations of what it means to manage a chronic illness consolidates 
medicine around HIV.  Considerations of the child body/mind, patient/parent desires, 
‘normal’ lifespan and patient quality of life are consolidated into a coherent and ongoing 
paediatric service.  What is interesting in paediatric HIV clinical practice compared to other 
STS accounts of chronic illness that emphasis enaction, such as Mol, 2002 or Mol and Law 
2004, is that paediatric HIV evokes a more sensitive range of complexities (e.g. many 
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entities in the clinic are social, cultural, political as well as medical) and the attentiveness of 
practitioners to consolidate these complexities in the clinic. 
 
Conclusion 
This chapter has looked at how enactions of chronic illness serve a function in paediatric HIV 
to consolidate care over different groups and diverse clinical scenarios.  Chronic illness has 
been distinguished in this chapter as a procedure consolidating patient complexity into 
medical requirement.  A series of instances from the clinic at UOUH are used to argue that 
chronic illness achieves consolidation through an intricate relationship between medical 
technologies, professionals, children, families and the virus.  Rather than chronic care being 
exerted by one group onto another (e.g. from the medicine onto patients), it functions as a 
dynamic whose formation relies upon a relationship where all parties compromise towards 
an accepted version of chronic illness.  Therefore, instead of there being one unified version 
of chronic illness at use and applied to paediatric HIV, chronic illness has many versions that 
are context specific to the clinic as it is presented during practice and over protocol.  
However, compared to other STS accounts that also detail how multiple versions of chronic 
illness are made to cohere, like atherosclerosis in Mol (2002), or hypoglycaemia in Mol and 
Law (2004), the account offered here demonstrates the cultural awareness needed in the 
clinic to consolidate complexity, such as the fears of patients, patient development or the 
individual circumstances of patients into the medical requirements of HIV.   Some of the 
ways in which chronic illness is referenced in the clinic have been categorised above, but the 
chapter doesn’t wish to limit it solely to the four categories offered.  Each category has its 
own specific reference to chronic illness but can also be seen to correspond together in a 
clinical logic to ensure compatibilities between versions of chronic illness. 
 
The first categorisation emphasised was the use of chronic illness when consoling patients.  
During these moments in the clinic, through protocol, the consultant asks the patient to 
imagine a future where HIV is contained through careful management of the disease with 
medication.  This idea of care encourages patients and practitioners to galvanise behind the 
promise of maintaining care into the future.  According to the practitioner this promise is to 
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ensure that they will keep up to date and practice the prevailing biomedical knowledge to 
the best of their ability now and into the future.  For the child, they must put their faith 
behind the medicine and continue to follow it throughout their lifetime (Lawton, 2002).  The 
doctrine fuses patients together by assuring them that the virus will remain invisible long 
into the future if they continue to follow medical advice.  When the process of enacting 
chronic illness takes place in practice or guidelines, it makes each party (patients and 
professionals) aware of the needs of the other and adapts the medicine accordingly.  
Similarly when children are educated about the virus, a version of chronic illness is acted out 
that emphasises to children the importance and significance of having HIV.  HIV, 
antiretrovirals and the body are presented to children as interrelated whereby the 
importance of intervention with antiretroviral medicine is stressed.  The logic of chronic 
illness acts as a cohesive that brings together representations of the virus and immune 
system into a logic that becomes persuasive for children to follow, and explains to 
practitioners what is needed to ensure viral suppression.   
 
The chronic illness enacted when consoling or educating patients (described in the first and 
second sections of this chapter) is contrasted when looking at how professionals discuss 
cases and the maintenance of viral suppression out of the view of patients.  The worry of 
maintaining HIV as a chronic condition, potential dangers/limitations of service and cases 
where suppression could be in jeopardy are all discussed covertly, before being relayed to 
patients.  The worry for practitioners is the message that children may take away if the 
implications of future HIV care are talked about openly in consultations (Kelle, 2001, 2010).  
It is necessary for practitioners to discuss concerns and dangers in order to coordinate care 
and develop action plans, guidelines and protocol.  Consequently, practitioners must be 
aware of the message about the illness that they are projecting, and to which party, to 
ensure that they maximise compliance/coordination and minimise distress.   Therefore, 
enactions of chronic illness referred to over these circumstances are not wholly compatible 
with each other, but refer to a logic of care from now into the future that is vital in the task 
of planning medical resources.  The final section of this chapter demonstrated the 
consolidation of HIV alongside wider regimes of care.  When consolidating services and 
medicine together into general healthcare, the idea of maintaining chronic HIV into the 
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future can be described as organising the provision of services and the coordination of care.  
In the process of making sure that other medicines are compatible with the HIV medicine, 
all medical tasks must be purposefully ordered from that moment with a forwards 
compatibility to possible care scenarios in the future.  It unifies all medical practitioners 
towards the same task and makes care accessible and available to patients, ensuring they 
know where to go and what to do to manage the virus (see Law and Urry, 2004 on enacting 
the social). 
 
All of the versions discussed have distinct interpretations of chronic illness, but they also 
correspond towards a unified definition of chronic illness concerted in the clinic.  Therefore, 
to use specific STS terminology chronic illness could be said to be either ‘translated’ or 
‘enacted’ between its usages to adapt to differing purposes in the clinic, and is also 
translatable back to other overarching versions of chronic illness.  In this way it is possible to 
trace the consolidation of care back to Callon’s (1986) original reference to translation and 
the four stages of problematisation, interessement, enrolment and mobilisation of allies or 
Law and Urry’s (2004) enacting the social.  However, some aspects of chronic illness as 
‘enaction’ or ‘translation’ must be modified to consider the clinical logic encountered in the 
examples of this chapter.  The demonstrations of chronic illness found in this chapter 
require a promise to be made between practitioners and patients.  A promise that the 
disease will remain invisible and antiretrovirals will be upheld.  The chronic illness that is to 
be treated is both in the present and over the future.  Therefore, the term cannot be wholly 
understood as a mobilisation of actions or a condition managed and stretched into the 
future, as it is between the two.  And so when using the procedure of translation, it must be 
clarified that precisely the allure for practitioners to use chronic illness as a procedure is its 
contingent sequencing into the future and the formulation of a resulting plan of action in 
the meantime.  Therefore, it involves a consolidation and coordination of factors that must 
be done in accordance to a desired outcome in the future, relevant to a course of action in 
the present that will ensure that the virus is suppressed and other intervening factors in the 
case remain possible to manage.  This alters the attention of Callon’s (1986) classic example 
of translation and Law and Urry’s (2004) of enaction by considering the cultural 
attentiveness required by the clinic to consolidate complex actors and associations around 
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childhood and HIV such as stigma, vulnerability and naivety into momentary interventions 
as well as avenues for future practice, whilst seemingly being indispensible to achieving viral 
suppression in both temporalities. 
 
In this section I have built upon the themes of the previous sections by presenting chronic 
illness as akin to a clinical procedure adopted to fulfil a range of purposes similar to 
disclosure and adherence.  Chronic illness has been presented as a consolidator of 
complexity mobilised in practice to bring medical requirements, patients’ lives and 
professional actions together to elucidate a course of action from a specific moment in the 
clinic, off into decisions about the future of care.  The next chapter will be the last 
procedure of paediatric HIV care that will be presented, and will give some sort of closure to 
clinical practice by dealing with transition, the process that moves patients out of paediatric 
services into adult ones. 
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8 Transition 
As children with HIV grow older through adolescence and into adulthood, questions arise 
around the transfer of care from paediatric into adult services.  The procedure of transition 
has been denoted and formalised to address this hand-over.  Depending upon its context, 
when practitioners refer to the idea of ‘transition’, at times it can seem to be so clear but at 
others such as considering when the exact moment transition occurs, it seems almost 
entirely contingent.  If it is the simple act of handing adolescents over to adult services, 
what should be included in this description? Behaviour? Circumstance? Relationships? 
Background?  Moreover, at what time does it begin and when does it end?  At the age of 
fifteen? At the first transition meeting? Once they are exclusively using adult services (RCN, 
2008)?  The preceding chapter discussed HIV as a chronic illness and how uses of chronic 
illness unite patients and practitioners in the aims of viral suppression.  If transition is 
focused upon in the same way, it can also be seen as a way of ordering patients and 
practitioners and coordinating services.  However, what is different here is that transition is 
done so under the proviso of child/adult services.   When viewed from this angle, transition 
has the role of bringing together two branches of medicine formed around a distinction of 
what it implies to be a child and an adult (see Bundock et al., 2011 on “crossing the divide”).  
Within the distinction of paediatric/adult services many corollaries can be found around the 
perceived special needs of childhood.  This chapter has not been designed to verify or falsify 
the rationale behind the foundations of a distinctive paediatric medicine, although many 
interesting questions will be raised.  Rather the aim of this chapter is to highlight the ways in 
which transition is used to make and to consolidate these differences across the medicine.  
Through the maintenance of transition as a procedure, the functioning of the medicine, the 
distinction of two branches of medicine and the chronic status of HIV are made possible.  
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However, it also becomes important, as will be seen, for practitioners to shape transition 
into a progressive logic that smoothes the way for children to become responsible adults 
able to manage their own HIV effectively (Taylor and Bury, 2007). 
 
As the positive results of antiretroviral treatment in suppressing HIV and preventing mother 
to child transition have become apparent, a successively growing problem over the last 
decade for those perinatally infected with HIV (as well as those caring for them) has been 
the transition from paediatrics to adult services (Bernard, 2008).  Paediatric services are 
encountering unprecedented numbers of adolescents reaching the age where they need to 
leave paediatric care.  Due to the fact that HIV suppression with antiretroviral therapy relies 
on almost 100% adherence to insure against resistance, practitioners make a large effort to 
ensure that patients continue to get the support transitioning adolescents require 
(Campbell et al., 2010; Wiener et al., 2011).  The cultural sensitivity of the complex 
associations found in paediatric HIV such as naivety, stigma and vulnerability requires 
clinical practice to be flexible and meticulous in the way it manages this complexity.  This 
cultural awareness differentiates paediatric HIV from other descriptions of complexity in 
medicine in STS such as Mol (2002) and Mol and Law (2004).   During research at UOUH the 
term transition seemed to loom in and around every case that had reached a certain age.  
Usually at around fifteen, questions started to be raised about transition in managerial 
discussions by consultants or the CNS, then the question would usually begin to come up in 
patent consultations.  Further on in this section I will share some of these encounters, 
alongside discussions around the ways in which transition is operationalised and made 
effective.  I will argue that transition is used and maintained in practice in order to bring 
together and address distinctions between adult and child services in HIV medicine and 
make whatever differences presented between the two possible to manage.  This process 
takes place in many ways in the clinic and there are many tasks associated with transition.  
For example, negotiations with patients ask them to take on responsibility for their 
condition as they reach adulthood, another would be the tasks done by practitioners in 
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meetings, emails and file swapping when coordinating cases and services together102.  It is 
for this reason I am cautious in fully placing or positioning definitively what transition is. 
       
In the literature, transition has an extensive selection of definitions, in terms of both HIV 
and other chronic conditions103.  The general guidelines set by CHIVA offer their own 
definition: 
 
[Transition is defined as] “a purposeful, planned process that addresses the 
medical, psychosocial and educational/vocational needs of adolescents and young 
adults with chronic physical and medical conditions as they move from child-centred to 
adult-orientated health care systems.” The UK National Service Framework (NSF) sets 
clear recommendations for transitional care supported by a wealth of Department of 
Health (DOH) guidance and resources. In contrast, transfer is the physical event of the 
young person moving from paediatric to adult services and if unsupported by the 
process of transition has been associated with increased morbidity and mortality in 
other chronic diseases of childhood” (CHIVA 2011, p.5). 
 
Even from this broad starting point the boundaries of transition can already be imagined as 
broad and transient, this explanation offers no definitive statement pertaining to transitions 
beginning or end.  The passage makes reference to an act, frameworks, guidance and the 
need for support.  What is more, it introduces us to the notion of transition as a process.  
 
                                                        
102
 Amongst the literature broader notions of trasition are also emphasised as in Viner, (1999) who emphasises 
that transition is more than just an administrative hand-over 
103 A common distinction frequently posed is that HIV transition is distinct from transitions in other childhood 
illnesses.  One distinction encountered in the literature is that the level of stigma and confidentiality involved 
with HIV transition make it markedly different from other illnesses (NCB, 2011).  This must without doubt 
make HIV distinct, and for the purposes of the report, fulfils a certain requisite in coordination.  However, 
transition will also be considered as distinct from the point of view of multiple ontologies (well demonstrated 
in Mol, 2002), this will mean that forms of transition are not only distinct from each other but also the contexts 
and places where it is demonstrated and referenced are also distinct, whilst also coming together to form 
coherent wholes.  And so I will avoid making that initial distinction too heavily as from this perspective it would 
be seen as one enaction amongst many.  Care will be made however, to attempt to focus as specifically as 
possible, places which can be inferred to refer to the explicit act of transition of patients in HIV services. 
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To those familiar with STS the last statement will seem noteworthy, as central tenets of STS 
are imbued with ‘process philosophy’ (as originating from Whitehead 1972).  In the quoted 
definition of transition, CHIVA acknowledge the difficulty to offer even a provisional set of 
boundaries and the quote implies that practitioners and parents should imagine transition 
as a process.  This suggestion is highly significant to discussions of STS (or this kind of 
process philosophy), where all entities are seen as in the process of becoming.  Transition, 
according to this notion would be a series of hybridised references around the medicine, the 
child’s care needs, differences between services, countless other possibilities around the 
case and other outside influences104.  The importance of this process and the reasons why it 
is deemed as necessary by practitioners to formalise guidelines of transition, lies in what 
defining transition as an open process makes possible.  In this case, comprising factors of 
adolescence into transition makes it possible to consolidate care regimes together, between 
paediatrics built around the perceived needs of childhood and general HIV medicine.  My 
ruminations of transition may not be exactly from the stand point that CHIVA policy is 
coming from.  For the purposes of creating guidelines for CHIVA, transition is referred to as 
a process with the belief that to best mange the situation practitioners, patients and 
families should not think of an end point or ideal situation but rather highlight and ensure 
that patients are prepared for and will be supported through what could be a long process 
(Fair et al., 2010).  Therefore, practitioners may not hold a distinct notion along the lines of 
enquiry found in Deleuze (2004) on becoming, but there is a relation, as transition’s aim is 
to organise the act of switching care whilst emphasising the need for flexibility and the 
patient themselves assuming responsibility for their care, in the process practitioners are 
made aware of the many broad implications possible between the different services of 
paediatric and general medicines without offering a fixed end point for how this should look 
like other than changing the hospital ward.  My argument is that knowingly or unknowingly 
there is a convergence.  The reference above of transition being a ‘purposeful, planned, 
process’ implies that organising care will have to be sensitive to individual contexts and 
situations and not able to hold one definition that fits all circumstances without 
interpretation.  Again in this chapter, the clinic is highlighted as a key site where pressing 
                                                        
104
 This point is reminiscent of Place (2000) who offers a monograph which demonstrates how a child body in 
intensive care is hybridised between the technologies keeping the child alive. 
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and seemingly contradictory complexities in patients’ lives, in this case issues around 
adolescents growing older, are organised in accordance with medical requirement to ensure 
the continuation of care. 
 
In the CHIVA protocol, models of transition are added, diversifying the attempt to organise 
the possibilities of how handing over care services can be carried-out.  Transition according 
to these perspectives is extensive and on-going well into the hand-over to the new service.  
It ensures that practitioners must always be aware of transition when practicing the 
medicine and ensures that actions that take place in the consultation are made compatible 
with the notion of transition and work towards a successful transition as their goal105.  
However, caution must be displayed when isolating these practices as each reference to 
transition necessarily invokes an irresponsible child and the ideal state of a fully grown 
responsible adult patient.  In this sense, the transitioning patient is dealt with as if in the 
state of becoming a responsible and independent adult until being transferred.  After 
transition irrespective of if patients are responsible or not, references to transition slowly 
disappear as patients are no longer regarded as children (Persson and Newman, 2012). 
 
Discussions from the Sociology of Childhood (SoC) therefore, also bring transition into 
question by pointing out that it feeds into a misconception of childhood as a process of 
becoming that obscures recognition of childhood in the present (Christensen, 2004; Prout, 
2005).  This chapter will follow this question alongside the general enquiry of the thesis 
around maintenance and consolidation, to highlight how transition maintains distinctions in 
the clinic between the adult, adolescent and child in order to ensure that ongoing viral 
suppression remains possible.  The procedure of transition is needed as a way to think 
through end-points, outcomes and the different patient requirements between adult and 
paediatric services.  In this sense, transition is already a method to address and rectify 
situations where over fixation on ideas around childhood is a problem and to facilitate 
childhood into HIV medicine.  Linked to questions around childhood lies a question about 
the foundations of paediatrics as a specialism aside from general medicine.  When 
considering what exactly is implied in a specialised medicine for childhood, there becomes a 
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 Fair et al., (2011) provides an overview indicators of transition success 
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need to define what is specific about the child to warrant a specific branch of medicine 
(Armstrong, 1979).  There are many propositions that could be discussed in relation to why 
paediatrics is upheld, like for example, the rise of child centric moralities and ethics in 
relation to child mortality rates (Armstrong, 1986), development (Kelle, 1993, 2009, 2010), 
the vulnerability and competence of children in medicine (Christensen, 1998, 2000), or the 
specialist configuration of child rights and clinical decision making (Bluebond-Langner, 2005; 
Alderson et al., 2006).  As with other chapters, these questions will be modified through 
focusing upon transition as a clinical procedure designed to adjudicate childhood and 
adolescence within paediatrics, and make children compatible with adult services.  The 
discussion will set a tone that attempts to describe the existing dynamics of medicine that 
require the formalisation of transition into clinical care rather than questioning the 
necessity of the paediatric/general medicine distinction (as with Oswell, 2012 the point is 
not to police the line between adolescence and adulthood but to describe its 
manifestations).  To this end it becomes an active question of this chapter to ask the extent 
to which the facilitation of adolescence is taken up into medical practice?  At times in the 
clinic, transitioning patients are not in the position of either adults or children.  This 
consideration is important to bear in mind as the accounts below are read further.   
 
A poignant if basic question to ask at this stage will be why it is deemed as vital to transition 
patients?  Transition makes certain modes of care and medical regimes possible.  
Accordingly, making patients transition when they reach a certain age sustains the 
opportunity for paediatric HIV medicine to specialise its care to children. This is an 
important idea in relation to the medicine and allows the reasoning as found in previous 
chapters; that patients and care must inevitably change and adapt to different clinical 
eventualities.  Splitting the services into different categories allows practitioners to focus 
more specifically and prepare protocols that deal minutely with all possible barriers to 
care106.  In the process, these categories also become prescriptive, patients are ordered into 
categories of specialities and over time must conform to care regimes.  Consequently, this 
process of adapting services must necessarily be mutually constituted around patients and 
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 Both White et al. (2012) and Bowker and Star (2000) describe clinical classification as a process that is 
continually maintained. 
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practitioners to ensure that it is relevant and persuasive to patients, making it an elaborate 
assemblage over many time-scales and contexts that are difficult to reduce to binaries such 
as becoming and actuality, usefulness and uselessness.  In what follows I will discuss clinical 
examples of transition at work and discuss some of the key concerns voiced in the clinic, 
firstly, around passing on problems to new services, secondly, that practitioners must let 
relationships with patients go and thirdly, that the population of children with HIV in the UK 
is ageing, which has a number of considerations.  These considerations will serve to display 
how transition is used to ‘bridge the gap’ between services and coordinate medical practices 
through harbouring a reflexive and dynamic relationship between patients and practitioners 
(Viner, 1999).  During transition, the clinic seeks to replicate its effectiveness as a key site in 
managing complexity by moving adolescent patients out into a more suitably attuned clinic, 
ensuring that the paediatric HIV clinic remains specialised and relevant to the complex 
issues and associations presented by child patients such as stigma, sex and alcohol.     
 
Transition in Action  
Each case of transition is necessarily caught between the requirement to move patients out 
to adult services, whilst minimising disruption and maintaining the same level of care.  The 
first step taken in this process is to begin to see children without their parents.  In general, 
with the parents out of the room, the doctor takes the opportunity to ask if adolescents 
have had any problems with their care and make children think independently about issues 
affecting their care (Fair et al., 2012).  This practice was upheld with all adolescents at 
UOUH, most usually after the age of about 14.  Dr Peters would see children on their own 
for a few minutes before asking parents to come and join them.  During this time Dr Peters 
would ask questions about medicine, school work, and then as they got older towards 
fifteen, about sex, alcohol and cigarettes.  At the time of research most of the patients at 
the clinic would see the Dr alone for a percentage of their consultation.  The discussions, 
especially about sex and alcohol are seen as part of Dr Peter's job, and should be discussed 
long in advance to transition.  
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‘Sexual health promotion including hepatitis B and HPV vaccination and sexual 
health education for adolescents needs to start in paediatric services prior to coitarche, 
continue through transition and into adult service.’ (CHIVA, 2011h) 
 
Interestingly, it is seen as part of the role of the clinic to educate children with HIV about 
sex, alcohol and cigarettes.  Dr Peters admitted an apprehension in taking up this role and 
on occasion questioned whether he was qualified and if paediatrics gives the adequate 
training to provide sex education.  To trainee doctors sitting in on the clinic he would advice 
them that ‘paediatrics doesn’t normally involve sex education so you need to be prepared’.  
Sex in this instance is something that is excluded from paediatrics and must be introduced in 
the interests of transition and bridging the gap between the two services.  Members of 
CHIVA are referred to HYPNET for guidelines on what it is important for adolescents with 
HIV to know about sex107.  This set of guidelines is in turn compliant with guidelines set 
more generally about transition from the Department of Health (Department of Health, 
2006, 2008).  The resulting guidelines by CHIVA contain a list of issues that practitioners 
must negotiate with adolescents.  This includes epidemiology and public health implications, 
HIV transmission and the risk of transmitting, the importance of consent, confidentiality and 
child protection with potential partners, the law around transmission and disclosure of HIV 
status to others and partners (HYPNET 2011).  This concern with a potentially broad and 
highly significant list of issues demonstrates that transition is not the neatly contained act of 
passing over cases to adult services.  A sense of immediacy is placed upon consolidating the 
complex associations around adolescence and sex with public health concerns to halt 
further transmission (one unique to paediatric HIV in comparison to STS and SoC 
descriptions of medicine).  Practitioners are well aware of and geared towards resolving the 
potential issues that can become problematic to managing the health care of patients into 
                                                        
107 It is an issue which has a broader set of discussions in the literature.  Ferrand et al. (2007) in a study of 
London youths with HIV identified the potential and increasing problem of children with HIV becoming 
‘sexually active’, a point shared by Bernard (2008) who states that most of the issues now being faced by an 
ageing population were unforeseen.  Brown et al (1994), put forwards that adolescents with HIV are more 
likely to partake in risky behaviour, although the idea of a heightened risk beyond average is unlikely given the 
fact that children with HIV must talk about sex more extensively than their peers.  Recurrently in the literature, 
as well as observational data, there is a big concern about ‘sexual activity’.  There are numerous reasons for 
this but it is interesting as a side note to think of ways that the sexuality of these children is conceptualised 
during these policy interventions, in literature or when advising adolescents (Fernet et al., 2011; Elkington et 
al., 2012). 
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the future.  The process of transition is entrusted with ensuring that patients meet the 
requirements of adult medicine that are absent from paediatric care.  Issues around sex 
have been identified as important for adolescents to understand in order to ensure a 
smooth hand-over, make children aware of the significance of HIV, and protect public health 
(Hekster and Melvin, 2006).  In regards to transition, practitioners and governing bodies 
identify incompatibilities between paediatric regimes of medicine and the responsibilities 
counted upon for adults using HIV services and use the period of transition to formally 
address what is missing.  The inherent morals within paediatrics of child vulnerability and 
diminished competence are often contrary or irrelevant to the notion of child patients being 
sexually aware, whereas adult HIV services rely upon and aspire to the notion of a sexually 
responsible and aware patient.  One of the roles of transition therefore, is to prompt a 
clinical negotiation with patients in an attempt to order their attitudes in accordance with 
what is expected of them once in adult services.  In doing so, transition can be seen as 
cohering together paediatrics with more general HIV medicine and public health, making 
these branches compatible and sustained viral suppression possible.  
 
The set up in the clinic is that Dr Peters would talk to the boys about sex and the CNS would 
talk to the girls.  The general message of these talks was that teenagers should not begin to 
smoke, be careful not to binge drink and become aware of how to have safe sex and when it 
is necessary to tell potential partners about their HIV.  During these talks, questions ranged 
from boys like Marty asking for condoms to try on, to Virgil asking whether it will be possible 
for him to have children.  Like Luke, most adolescents had dismissive undertones and found 
the conversation awkward:    
Dr Peters: Do you drink?  
Luke: Everyone drinks.  
Dr Peters: I drink, good, I should say bad if it were my son I’d say bad – [Dr Peters continues 
to talk about binge drinking and then starts to talk about sex and how he needs to take care 
that he has safe sex, advising him that if anything goes wrong that it is Luke’s responsibility 
to get PEP108 from the hospital for his partner.] 
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 Post-exposure prophylaxis is a method of HIV prevention to give those exposed to HIV a HIV-attacking 
medication to stop the virus replicating and avoid them contracting HIV (Christenson et al. 2008).   
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Luke: I know all that.  
Dr Peters: Good I'd rather that you heard it a 100 times than say to me that you didn’t know. 
 
Pedagogic overtones can be seen in the above passage operating through policy that 
highlights the importance of discussing with adolescents specific issues around sex.  A 
connotation prevails that adolescents need to be prepared for the time when they will be 
considered an adult from the point of view of the medicine109.  Although the types of issues 
to be discussed have been alluded to in policy, the way that these discussions are framed 
around the responses, concerns and outcomes of each case are acknowledged to be broad 
and unpredictable.  In order for practitioners to be able to address the complexity presented 
they must adopt flexibility with patients.  What is made expressly clear in guidelines, is that 
practitioners go through the process of negotiating with adolescents, ‘adult’ topics around 
health, HIV and responsibility to assert them into configurations of transition and beyond 
(Campbell et al. 2009; Campbell et al. 2010 have conducted research on the anticipation of 
transitioning). 
 
In the consultations I observed, none of the parents had a problem with the idea that the 
doctor wanted to see their child alone.  Dr Peters would often send parents up to get 
medicine before rejoining their child in the consultation room.  In the context of the clinic, 
there were no challenges from parents on Dr Peters’ judgment of when to start seeing the 
adolescent independently.  In this sense the parent’s role would also have to be made 
compatible with protocol.  Within paediatrics parents are required to attend each 
consultation whereas after transition, adolescents must get used to taking over the role 
their parents would have once played (Battles and Wiener, 2002).  When these independent 
sessions begin to take place, they do not specifically reference transition.  It is later on, 
                                                        
109 We could consider Foucault’s (1998) notion of confession here as presented in reference to science 
sexualis, i.e. that adolescents are being formulated to be disciplined sexual individuals. Christianson et al 
(2008) for example argues that teaching adolescents the law around HIV transmission (and we can extend this 
to all public health warnings) made adolescents feel as if they must ‘switch off lust’ or ‘balance lust’.  We could 
ask how much interventions are designed for individuals to learn how to discipline themselves.  However, 
there are some omissions to this, because to stray from Foucault I would like to disband with the idea of 
power conceived as travelling in one direction, i.e. from medical discourse on to the subject/patient. 
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when patients were nearing the age of sixteen that Dr Peters would start to approach the 
subject of transition. 
 
In theory, adolescents have a choice of where they would like to go.  CHIVA guidelines 
emphasise choice when approaching the subject:  
 
“Different models of transition exist and the model chosen is determined by the 
patient group, available resources and geographical setting. It is thought that there is 
no superior transition mode and that the key to a successful transition is a flexible 
approach paced to the individual needs of the adolescent.” (CHIVA, 2011h) 
 
Again the emphasis of this guidance is on process and flexibility, individual need and 
circumstance.  Guidelines argue that this approach is the ‘key to a successful transition’110.  
Therefore, complexity is addressed in clinical practice through flexibility.  However, in all 
observed cases patients chose to stay at UOUH and go upstairs to T1 (the name given to the 
adult HIV clinic at UOUH).  At the time of research a new clinic which specialised in 
adolescents and young adults had opened up in central London, but none of the adolescents 
in UOUH wanted to go there.   
 
Dr Peters: “There’s a really nice clinic that’s just opened in the centre of town, but none of 
our children want to go there which makes it easier for us because Dr Chambers comes down 
from T1.  The children from CHH have all signed up but we haven’t managed to sell a single 
one yet.  It was set up because the cohorts from CHH and here are both aging so they set up 
this service, really nice service just for 16 – 24 year olds and we haven’t managed to sell it to 
a single one.” 
 
Dr Peters would present the different models to adolescents but they would invariably elect 
to stay at the clinic.  What can’t be under-estimated is that choice and flexibility in the 
framework of the clinic have been proven to result in improved adherence and compliance 
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 What makes up a ‘successful’ transition is highly contingent and will be dealt with here as such (Fair et al., 
2011) 
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with the advice of practitioners and subsequently aid the causes of individual and public 
health (Fair et al., 2011).  Choice and flexibility in transitioning is an acknowledgement of 
adolescence as a time for experimentation and development.  Accordingly, transition is built 
to address a specific resonance around facilitating adolescence into HIV care (Persson and 
Newman, 2012).  The attentiveness required to deal with adolescence and HIV in the clinic 
emphasises the need for flexibility in guidelines.  This contributes to STS accounts of medical 
multiplicity such as Mol (2002) and Mol and Law (2004) by highlighting the clinical 
awareness of diversity and the effort put in to consolidating multiplicity into care regimes.  If 
the question is raised: what is being included in this category of adolescence and where it 
sits between childhood and adulthood?  Consequently, transition can be considered as a 
regime of medicine in itself not quite paediatrics and not yet adult services? 
 
When a patient would confirm that they wanted to stay on at T1, Dr Peters would consult 
them as to which doctor their parents saw and make sure that they saw a different 
consultant through fears about confidentiality.  In most cases this wasn't an issue, with the 
exception of Luke, who after a chat with Dr Peters, was undecided where to go to, but was 
sure that he didn't want to go to the same Doctor as his mother and confronted her with it 
when she later came into the consultation room.  
 
Dr Peters: ‘we were having a little chat before you came in about transition [of care]. I 
wonder if it’s good to refer him to the same doctor as you.  We were thinking of Dr Schunk, I 
also have a good relationship with him.’  
Mother: ‘mmm but...’  
Luke: ‘...I might want a different doctor’  
Dr Peters: ‘Dr Chambers may have to keep confidential which he’s very good at, but it might 
not be good as a young man growing up to have to confide in the same person as your 
mother.’ 
 
This process is designed to make adolescents take a stake in their care.  In the example, a 
potential compromise had been identified and avoided by Dr Peters.  It serves the aim of 
encouraging Luke to develop questions about his independence and promotes Luke’s trust 
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and confidence in the medicine.  This concern with Luke as a patient aside from his mother 
also demonstrates the desire that each branch of HIV medicine is allowed to specialise itself 
with the specific populations and issues that are important to them (Bowker and Star, 2000; 
White et al., 2012).  Services like the adolescent clinic in central London attempt to 
specialise in order to address issues relative to this age group.  Within transition there is a 
consolidatory logic in operation.  The relevant logic here would be that a smaller group 
means that the ranges of possible issues can be addressed more specifically, and that 
adolescents and their specific needs can be accommodated and compiled together into a 
specialist group that can become dedicated to define and address adolescence and its 
facilitation into HIV medicine.  This again highlights transition as a regime between 
paediatrics and adult services designed to ‘bridge the gap’, but also introduces the notion 
that transition not only works out incompatibilities between two regimes of medicine but 
actually has its own specificities. 
 
Once these issues are worked out, the process of transition continues by inviting the 
transitioning consultant from T1 to the clinic to have a consultation together with Dr Peters 
and the adolescent patient.  For patients staying at UOUH this would usually be Dr 
Chambers.  These sessions are designed so that the new consultant can get to know the 
case and specific issues regarding the patients’ treatment.  It further demonstrates the 
attention put into ensuring a ‘smooth’ hand over. 
 
In one of these planned sessions in the consultation room, Dr Peters and Virgil were talking 
whilst waiting for Dr Chambers to come down.  Virgil was 17 and at the age to transition.    
He was born in Angola and had spent time in other European countries but had been 
attending the clinic for several years.  At the time of research Virgil was living with his 
mother.  When Dr Chambers arrived he came in and shook hands with Virgil. 
Dr Peters: When they’re taller than me I transition them, do you want to say a bit about 
yourself...  Well you were born in Portugal but you’ve lived in many other places like 
Switzerland, Portugal, Germany and you were diagnosed in Germany weren’t you?  I don’t 
know about that.  We knew there was a problem with resistance from a phenotype test they 
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sent to us, but his CD4 was high so we didn’t restart him on treatment, viral load is not high 
either... 
Dr Chambers: Though there are plenty of possibilities. 
Dr Peters: Yes but at the moment it’s all fine... and he has a retinochoroiditis. 
Dr Chambers: Do you have any brothers sisters? 
Virgil: Yes both younger. 
Dr Peters: They’ve not been tested, the mother has said that they were tested [not at the 
hospital] and are negative. 
Dr Chambers: You live locally? 
Virgil: Yes. 
Dr Chambers: Does your mum come here? 
Virgil: Yes. 
Dr Chambers: Do your siblings know? 
Virgil: No not sure. 
Dr Chambers: What are you doing at the moment? 
Virgil: I’m at college. 
Dr Chambers: So what would be the best time to come in? 
Virgil: Morning 
Dr Chambers: Well it’s up to you when you come in there’s no absolute time to transition 
Dr Peters: When they’re taller than me... 
Dr Chambers: We have three sessions a week; we need to speak to your mum to make sure 
that you’re ok with everything.  I don’t know if [Dr Peters] keeps you waiting? 
Dr Peters: Yes like today. 
Dr Chambers: We try not to keep people waiting but sometimes like most hospital wards we 
can get delayed.  It’s the same set up as down here with a specialist nurse. 
 
After the consultant from T1 has sat in on a session or two, the patient then transfers to 
adult services. 
 
The passage demonstrates the lengths taken to ensure that the continuation of care is as 
smooth as possible, as well as the attempt to consolidate complex patient cases from one 
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clinic to another.  From the point of view of practitioners that must organise HIV care, many 
voice concerns that the cases that are being handed over are highly complicated with much 
diversity, age considerations, resistance to medicine, and movement of patients between 
national territories (Fair et al., 2010, 2011).  It is engrained in the policy of the clinic that this 
complexity is addressed during transition and deemed as necessary for policy to remain 
relevant.  Dr Chambers then continues to make compatible the paediatric branch of 
medicine into adult services, the task of adhering to antiretrovirals remains principal, but 
the way that patients are expected to relate to this medicine and the ways in which the 
medicine is administered are not identical.  The process of transition that is referred to in 
CHIVA guidelines purposefully allows for an open interpretation by practitioners to insure 
that models of care and adherence to antiretrovirals are compatible with adolescent’s lives 
(CHIVA, 2011h).  Guidelines have at their base the necessity to hand over cases and re-
manage them into recurrent clinical encounters with the idea that flexible services will be 
more able to cater for patients’ continuing needs.  Therefore, according to this process, 
transition is a multi-faceted/dimensional technology used to organise large and small scale 
patient care.  Transition is charged with the consolidation of paediatric regimes of medicine 
and the consequent morals of vulnerability, naivety and incompetence to adult ideals of 
patients being responsible for their own care and sexual awareness.  Complementary to 
existing accounts of complexity in medicine like Mol (2002) and Mol and Law (2004), a sense 
of cultural awareness is implied through-out clinical practice and guidelines to consolidate 
this complexity to ensure a smooth hand over.   What becomes unclear in this process 
however is the extent to which this period of transition constitutes its own medical regime, 
geared around the specificities of adolescence. 
 
Passing on Problems or Straight Forwardness  
In the example of Virgil, staff at the clinic in UOUH considered this case to be straight 
forwards.  The case itself fitted nicely with the outcomes that CHIVA and clinical guidelines 
are trying to attain.  Dr Peters would mention in departmental staff meetings or to 
interested trainees that Virgil was his most straight-forwards case of transition.  But what 
about the application of policy to more troublesome cases, where adolescents are in 
violation of the broad aims of the guidelines to maintain adherence? 
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Practitioners aim to hand over cases as neatly, with as few problems as possible.  In the case 
of Virgil, the team were enthusiastic to pass him over, however there were cases at UOUH 
that were more problematic.  The process of having to transition children to adult services 
creates questions about benchmarks for practitioners to maintain.  One is that when passing 
over adolescents, Dr Peters professes that he tries to hand them over in the ‘best shape 
possible’, which involves the adolescent being knowledgeable of their condition, the 
associated dangers and adhering to medicine (Bundock et al., 2011). 
 
In the case of Wendy, it was mentioned on a few occasions that it may not be a good idea to 
transition Wendy without the case being in ‘good order’.  This was discussed mainly during 
staff meetings with Dr Phelps (attending as part of the regular consultations from CHH) and 
Dr Chambers from T1.  At the age of 16 Wendy was not adhering to her medicine and not 
coming to appointments.  During this time, Dr Peters became divided between the idea that 
Wendy may wish to associate herself with the adult ward and be more likely to attend the 
adult clinic, and on the other hand that Wendy may give up completely if she loses the 
familiarity and guidance of the paediatric HIV clinic that she visited throughout her 
childhood. 
 
The following example was noted down in a meeting of clinical staff, initially Dr Peters was 
asking advice from Dr Phelps with the nursing team and pharmacologist listening on, 
awaiting the arrival of Dr Chambers. 
Dr Peters: One option is that I could refer her [Wendy]. 
Dr Phelps: How old is she? 
Dr Peters: 16, T1 [the adult clinic] is more flexible, but I feel as if I can do better, it may be 
arrogant but you feel like you messed up if you refer them and they’re not sorted out. 
[At this point, Dr Chambers from T1 walks in.] 
Dr Peters: Come in we were just talking about how to make your life more difficult.  We’re 
talking about what to do with a 16 year old of mine who’s not attending the clinic.  Half of 
me wants to sort it out before I hand her over, half of me wonders if she’s sick of the 
paediatric services. 
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Dr Chambers: well it’s good to have things tied up before you hand her over. 
Dr Peters: the difficulty is that I might not see her again, she hasn’t been attending. 
Dr Chambers: Well I’m happy to do whatever. 
 
As can be seen, there is an absolute and pressing need running through this passage to 
ensure that the case, or the complexity of the case as could be referred to by STS, is in 
‘order’, emphasising again the desire to consolidate complexity.  The task of transition 
involves sharing stories and experiences of dealing with the particular patient in question.  
This is done in an attempt to organise complex patient negotiations into neat case files.  
Towards the end of fieldwork a new technique of building narratives was being introduced 
at the UK’s largest paediatric HIV clinic and consequently being practiced by Dr Peters.  It 
involved the consultant handing over, to provide a case history of the adolescent being 
transitioned.  This case history would entail the doctor going over case notes and, 
documenting the key moments in the case history, starting with ‘presenting’.  Dr Peters was 
beginning to implement this at UOUH at the end of fieldwork, whilst I was still observing 
cases at the clinic, he had done one such case history which was five pages long111.  Dr 
Peters said to me that the purpose of producing the document is to make children conscious 
of some things that they may have not been aware of, to provide a resource to practitioners 
and to consolidate care.  When these documents are produced, cases are formulated into 
one narrative or one logical structure, and consolidated into one document.  The case notes 
are essential to the creation of this document as well as the memories and experiences of 
the consultant handing over.  An official story is finalised and cases are translated (Callon, 
1986) and made comprehendible to other services.  In these case histories, narratives 
flatten complexity and attempt to turn the unruly into that which is straight-forward.  
Therefore, this stands as an obvious example of transition as a force to compel services to 
unify and render visible aspects that may have been difficult to deal with previously during 
care. 
 
                                                        
111 This is reminiscent of several papers which highlight that practitioner deliberations on how to classify cases 
are crucial to organising clinical medicine.  For example White, (2002); or Atkinson (1995) on case 
management; or White et al. (2012) and; Bowker and Star(2000).  
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Case histories are designed to further coordinate as many aspects of case management as 
possible.  However, for Dr Peters the problem is further expounded by the fact that the 
process of transition involves balancing very extensive and sometimes limited drug histories:  
 
These children are very complicated who we’re handing over.  A lot of them had treatment 
when there was only one antiretroviral drug available, then they took that for a few weeks 
and they became resistant.  So they took the next one and when you become resistant to one 
you become resistant to all of the drugs like that, so some of their options are now quite 
limited112. 
 
This is why the guidelines are designed to ensure, as much as possible, that practitioners can 
interpret transition as an open-ended process with many possibilities.  It is not practical for 
practitioners to employ one technique or a range of techniques in the hope they will work in 
each circumstance, the freedom to attempt a range of creative solutions must be available 
to practitioners.  As alluded to in the passage above, compared to other conditions (such as 
those already described in STS of Mol 2002 and Mol and Law 2004) there is a cultural 
sensitivity to the complexity presented to the clinic by adolescence and HIV (such as sex, 
alcohol, ‘social life’).  Amongst CHIVA recommendations and patient case histories, there 
are impositions from the antiretroviral medicine that must be engaged with effectively to 
ensure viral suppression.  The refusal of Wendy to negotiate with viral suppression renders 
her incompatible with the process of transition, whist reaching the age she will be 
considered an adult and so need to transition to adult services.  The guideline 
considerations exampled here are concerned with the continuity of medicine and the 
management of a case from its history into the future.  It is important that transition is done 
efficiently to make it possible to maintain the case.  Adolescents are required to become 
more compliant with maintaining their condition and practitioners must continue to 
specialise in their field of medicine (Bowker and Star, 2000; White et al., 2012).  
Practitioners are encouraged to acknowledge the peculiarities of each case whilst 
administering care over the whole demographic of the patient cohort.  Wendy’s refusal to 
                                                        
112 Taken from informal interview with Dr Peter’s Oct/2010 
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attend causes incompatibilities with care and it becomes uncertain how the protocol of 
transition should be applied to the situation.  The formalised transition guidelines therefore, 
must be designed and interpreted by Dr Peters in ways that attempt to engage with 
adolescent specific factors, such as the facilitation of Wendy’s refusal.  
 
This offers a contrast to cases like Virgil’s where he attends, adheres and follows with little 
protest.  His case is seen as the most 'straight forward' as the application of transition takes 
place with less need for intervention.  However, it is the desire of those who design 
transition to make guidelines as applicable as possible.  The procedure of transition is 
designed to address care regimes in paediatrics and make notions of child vulnerability, 
naivety and incompetence compatible with adult services and ‘patient responsibility’.  In the 
process it creates a third transitional regime that attempts to understand adolescence and 
cater for its needs, and consequently aligns case histories into one coherent discourse of 
viral suppression.  The enaction of transition in the clinic makes it possible to manage 
medical regimes and adolescence into one lifelong task of viral suppression (Department of 
Health, 2006; Fair et al., 2010).  However, some cases prove to fit neatly whist others need 
more work to become compliant.  
 
Letting Go of Relationships – Versus Formalised Structures? 
The passing on of problems is not the only consideration made when children reach the 
recommended age of transition.  Another consideration made by both practitioners and 
some children is that there is often some anxiety and sorrow at the prospect of ending of a 
long relationship (see for example Fair et al., 2012 “It’s like losing part of my family”).   It is 
also something that is expressed in the medical literature.  In a report aimed at improving 
transition for adolescents with HIV commissioned by the NCB there is a discussion about the 
result on adolescents of the change in relationships and the adjustment to greater 
autonomy occurring during transition (NCB 2011).  This leads us to consider the possible 
alternatives to transition and why it is deemed necessary to transfer patients.  Children with 
HIV have to fit the pre-existing restrictions of paediatric medicine, which means that after a 
certain age patients are required to leave the service. 
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In consultations with Dorothy, Jemima and Luke, Dr Peters repeated a similar quip to each 
patient.  That when they reach the age of sixteen and a half, people begin to shout at him to 
transition them over to adult services, then adding that if they’re not transferred by the age 
of 18 people start to scream at him and so on. 
 
Although it is not made explicit who are the people that will ‘scream’ at Dr Peters in the 
event of non referral, the idea being conveyed to adolescents is the inevitability of their 
transition and that it is part of an unchangeable scheme.  The reference to transition being 
made here is that it is a necessary process that is beyond the individual.  The traditions of 
medicine that distinguish paediatrics as necessary are not so easy for individuals to 
challenge, even if notions of vulnerability, naivety and incompetence can be identified 
within them.  Some practitioners get a sense of adolescents becoming lost in the process 
transition.  The Royal College of Nurses released a guideline more generally on transition, 
titled Lost in Transition, demonstrating the sense of loss imagined through a pun on the film 
title Lost in Translation (RCN 2008).  Those who deal with HIV (including Dr Peters) would 
say that HIV causes more issues in transition than other chronic diseases due to 
confidentiality and stigma, and so adding to the feeling of being lost.  This can be linked to 
the argument running through this thesis that paediatric HIV needs an extra cultural 
awareness in contrast to other conditions discussed in STS accounts of medicine, such as 
atherosclerosis in Mol (2002) or hypoglaecaema in Mol and Law (2004).  
 
The majority of the children at the clinic have grown up in the care of Dr Peters.  He would 
often talk to me or to staff and trainees about how he does not like to pass patients over 
and how he is becoming less and less aware of the passage of time.  For example, in an 
instance between appointments Dr Peters said to me and an SHO: 'I've been here for 6 years 
and Dorothy is one of those that I still see as a kid’ 
 
At the time of research Dr Peters had been head of the clinic for 6 years and so for many of 
the adolescents who were fifteen or sixteen, appointments to the clinic are amongst their 
early memories.  In the clinic some children even expressed how unhappy they were to 
leave, like this example from Jemima: 
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Dr Peters: Have we talked about transition? 
Jemima: I don’t want to go. 
Dr Peters: You want to see me until you're twenty nine? 
Jemima: No I’m used to it here. 
Dr Peters: Well I would go to Dr Chamber’s clinic.  
Jemima: Don’t want to go. 
Dr Peters: Let me explain.  I would come up and we would do it gradually, [the CNS] 
would still be here to make sure that it went through smoothly. 
Jemima: Can she come up too? 
Dr Peters: One day you’ll be sick of all the kids around here,  
Jemima: No I won’t I’ve been coming here for 17 years.  
Dr Peters: Yes I know you're very used to it. 
 
This poignant example highlights that transition is not inevitable in the minds of every 
adolescent.  The clinic is attentive to what adolescent patients expect and attempts 
negotiate their attitudes to comply with transition.  Dr Peters highlights the reasons why it is 
important for her to leave and evokes an idea of maturity that he expects Jemima to feel in 
retrospect sometime in the future.  To ensure a smooth transition of care it is important for 
practitioners to attune patients to the reasons why transition is necessary.  This clinical 
action once again highlights the attentiveness employed by the clinic to consolidate complex 
patient attitudes to necessary medical regimes.  What are consolidated here are the 
attitudes of adolescents with the clinical reasoning that the adult clinic will be able to meet 
their needs more readily.   Most other children didn't express the same sentiments, but for 
the clinic this is a time when they would observe patients carefully for signs of psychological 
strain.  The following practitioner conference paper demonstrates that there are some 
difficult discrepancies to assimilate when transitioning adolescents: 
 
“The issues were raised in a series of studies from St. Mary’s Hospital, the London 
hospital which for many years has had the largest paediatric HIV clinic in the country 
and has more recently developed the 900 Clinic, a transitional services to help young 
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people manage the shift from child-friendly services into an adult clinic. In addition, a 
national survey shed light on adherence issues for young people with HIV.  
Tania Wan presented data on the health outcomes of 58 perinatally infected young 
people who were seen between 2006 and 2011 at the 900 Clinic. The young people 
transferred from the paediatric clinic between the ages of 16 and 18 and their current 
median age is 20, with the youngest 16 and the oldest 26. Three quarters are black 
African; there are more women than men.  
At their last follow-up, two-thirds of the young people were taking antiretroviral 
treatment, and 95% of this sub-group had an undetectable viral load. 
However there were a considerable number of complications. A fifth of patients had a 
CD4 cell count below 200 cells/mm. A few of those with undetectable viral load had 
failed to fully restore their immune function. 
At the time of last follow-up, a quarter had chosen to discontinue antiretroviral 
treatment, despite considerable support and intervention from clinic staff. Just under 
half of this group had a CD4 cell count below 200 cells/mm” (Pebody 2011; also see 
Wan 2011).   
 
The causes as to why transitioned children may choose to stop taking their treatment is 
under contest (Miles et al., 2004; Wiener, Battles, et al., 2007; see Vijayan et al., 2009).  
However, an attempt to formally organise transition can be seen in the ways that those 
practising the medicine are attempting to address it rationally.  Interestingly here, and 
echoed in the decision to emphasise the central London adolescent clinic at UOUH and CHH, 
is the idea that children need a certain amount of specific and focused support.  A body of 
literature is geared towards identifying reasons why transition may be undesirable to 
adolescents (for example Vijayan et al., 2009 takes on this task). Whilst not all practitioners 
uphold a simplistic line of causation that reasons that adolescents who are unsupported will 
stray (Miles et al., 2004 offers some long-term adjustments as to why adolescents may 
prefer to transition).  What seems more certain is the need that some sort of specialised 
clinic evolves (in the UK at least) to assess some of the problems in the age group (as is the 
aim of setting up the adolescent specific 400 club at St Marys).  In this instance, transition is 
being formalised to offer methods designed to negotiate adolescence and case histories and 
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make them compatible with adult services.  What is also thrown into doubt is the idea of 
exclusivity in HIV medicine between paediatrics, general medicine and a regime of 
adolescence set up around transition.  HIV and adolescence blurs the lines between 
childhood and adulthood, development and child/adult rights.  Each case is unique and 
requires patients to follow antiretroviral regimes closely.  Therefore, cases need specific, 
sometimes intensive and individual support, the support required is difficult to define solely 
by age.  CHIVA transition guidelines escape questions of age by setting a broad and flexible 
method that attempts to consolidate gaps in care with a set of procedures that are open to 
the many possible circumstances presented by adolescents at the clinic.  Therefore, a 
contrasting consideration would be to question if transition also causes some patients to 
adapt abruptly to being managed? As with Jemima.  Following Latour (1987), if transition is 
described as a ‘battle between allies’ to define scientific fact in antiretroviral medicine, the 
sorrow felt over the loss of the paediatrician/patient relationship has little credence in the 
rationalisation and organisation of care in relation to medical science.  Although, it is open 
to speculation that issues around the benefits of a close paediatrician/patient relationship 
can be found in the rationale behind the set up of the 400 clinic or the central London 
adolescent clinic. 
 
Considered from this angle, the question can be raised as to the amount the medicine asks 
patients and practitioners to comply, adapt, cohere and take responsibility.  As with other 
chapters I would like to assert that the channels in which actions and decisions are made are 
diverse, and that transition is not the result of one rationale or even a set of rationales, but 
is enacted and made operational through a range of nuanced assemblages (that are not 
directly comparable or translatable see Callon, 1986).  However, what is emphasised 
complimentarily to this nuanced STS view of medicine and the condition as an assemblage is 
the immediacy expressed in practice to consolidate the complexities of adolescence 
between services.  From these processes, transition acts in the clinic to consolidate the non-
responsible child patients of paediatrics to approaches of care characteristic of ‘responsible’ 
adult patients.  This consolidation means that both practitioners and patients are attuned to 
the rationale that the clinic’s effectiveness relies upon its ability to specialise to a specific 
cohort.  
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Aging Population 
UOUH and other Paediatric HIV clinics in the UK are responsible for formulating and sending 
off data about their service for use in the Collaborative HIV Paediatric Survey113 (CHIPS).  It 
was the responsibility of the CNS to compile and send off the necessary data for CHIPS.  The 
survey collates data from virtually all UK clinics dealing with paediatric HIV.  One of the 
outcomes of the data has been that the population of children with HIV has been revealed 
to be ageing:   
 
“Similarly the age distribution of the cohort has changed considerably over the 
years.  In 1996 the median age was 5.1 years (inter-quartile range, IQR 2.9-7.6) and this 
increased year on year to 12.4 years (IQR 9.1-15.2) in 2010.  Furthermore, the 
proportion of the cohort aged ≥10 years increased from 11% in 1996 to 70% in 2010.” 
(CHIPS 2010, p.1) 
 
If the number of patients registered at these clinics continues to decline it shows a decline in 
perinatally infected children.  Tellingly, it is not discussed in the report whether the number 
of adolescents infected in other ways has grown.  However, it can be asserted that 
transition from child to adult services is likely to become more emphasised as the numbers 
peak.  The CHIPS 2010 annual report states as one of its aims that it will concentrate on 
looking at transition related issues: 
 
‘[our future plans are to] begin an analysis of the whole of the CHIPS cohort, 
concentrating on adolescence, secondline, mortality, and transition to adult care’ 
(CHIPS 2010, p.2). 
 
For practitioners therefore, the significance of transition for children infected with HIV at 
birth is rising as the population is aging.  At UOUH as prenatal screening of HIV has become 
more successful the general trend is that children are getting older not to be replaced by 
                                                        
113
 http://www.chipscohort.ac.uk/summary_data.asp 
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younger patients.  The birth of a child in UOUH with HIV had become highly improbable at 
the time of research.  In a telling discussion in the clinic, Dr Peters was talking to Dr Phelps 
about what an aging population means.  Dr Peters expressed that he thinks that as 
populations continue to age that it will become necessary to close clinics like the one at 
UOUH and Dr Phelps concurred with this.  Although this was to be contradicted by the fact 
that numbers at UOUH remained stable – in the low 20s – due to an influx of African 
immigration into the area, the general trend still holds and therefore has a bearing on the 
way that adolescence and transition are conceptualised in HIV medicine.  
 
Another aim of CHIPS is to: 
 
‘gain ethics approval to enable young people leaving paediatric care to be followed-up 
in adult care through the UK Register of HIV Seroconverters’ (CHIPS 2010, p.2). 
 
Following through this report gives us an interesting impression as to how the boundaries of 
the paediatric HIV population become visible.  The concern of the report demonstrates a 
perceived lack of overview of the future of this population.  It highlights that medicine needs 
to interpret and reinterpret data to make sure that it is possible to coordinate services 
around populations (Fair et al. 2011 highlights the difficulty even in how to measure a 
successful transition).  If transition is to retain the purpose of coordinating medicine, the 
task at hand for those organising paediatric HIV care has been to create clinical services that 
specialise and respond specifically to the needs of children with HIV in the UK.  As is 
exemplified in paediatric HIV, in comparison to STS descriptions of atherosclerosis by Mol 
(2002) or hypoglycaemia by Mol and Law (2004), there is a significant sense of cultural 
sensitivity in the logic of paediatric HIV clinical practice that attempts to consolidate the 
complex and contradictory associations of patients, such as stigma and vulnerability with 
drug requirements.  In Mol (2002) or Mol and Law (2004) issues akin to vulnerability and 
stigma are diverted in favour of tracing the multiplicity of found over different sites and 
different objects of the hospital or on the body of the patient, what the study of paediatric 
HIV makes salient is the attentiveness needed in the clinic to manage complexity, or in this 
case to organise adolescence specific services.    The impetus of vulnerability in the clinic 
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makes it important to follow patients and see what becomes of them.  However, as the 
group of transitional patients grows and the extent of paediatric HIV increases and 
decreases accordingly, there becomes an issue of traceability and follow-up of long-term 
patients who have grown from one service to another.  These channels of visibility and 
traceability of patients who have transferred must be organised and maintained in order to 
achieve a visible follow up (Allen and Pilnick, 2005; Currie et al., 2012).  And so the 
boundaries of paediatrics and transition is not neat and finalised, once adolescents are 
transitioned to adult services, there is a line of enquiry that is present between the two, and 
deemed as important to maintain by practitioners for improving adult services.  
 
Those administering care must ensure that problems of all scales and sizes fit with regimes 
of individual care, the broad allocation of resources and demography.  It is not possible for 
the agency of one individual person or institution to oversee the whole coordination of 
resources, but if care (or the suppression of HIV with antiretroviral drugs) is to be replicated 
in the long term over as much of the population as possible, practitioners must act in ways 
that are compatible with the rest of HIV medicine.  In the process of care, children and 
parents must also be asked to take on board these conceptualisations.  As with Virgil and 
Wendy, Virgil would follow and fit protocol whilst Wendy was more unruly and so transition 
was delayed.  Far from being fully laid out in protocol, much is asked of families and 
practitioners.  In the clinic, during transition practitioners must consider what is available, 
what is for the best and what is possible, and adolescents must be prepared to form new 
relationships and take on new roles.  As the organisation and demography of HIV is shifting 
with policy and politics practitioners, patients and practice must adapt.  Teenagers and 
practitioners alike must specialise, adapt and take on responsibility for care.  They must 
forge ways of negotiating with broad structures of biomedicine, whilst finding solutions for 
the unique problems that arise in maintaining HIV.  Therefore, the clinic is a key site of 
formulation for how HIV medicine will be consolidated into the dispositions of transitioning 
adolescents.  As argued, the scope of the complexity of adolescence and HIV engaged with 
by the clinic, marks paediatric HIV clinical practice as distinct for the way that a sense of 
cultural attentiveness must be employed in comparison to other STS studies, such as Mol 
(2002) or Mol and Law (2004).  In this context, transition as practiced in the clinic, is part of 
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the process of organising complex (often contradictory) adolescent associations such as 
stigma, vulnerability, sex and social-life with the task of attuning medicine to patient 
requirements.    Transition assumes its place alongside established and formalised channels 
of medicine, but is also never fully formulated so as to become counterproductive.  
Transition works fluidly, as demonstrated in Mol and Law (2004), between adult and child 
services to promote responsibility, dispel vulnerability, naivety and incompetence whilst 
adapting adolescent specific issues to adult care. 
 
Conclusion 
This chapter has attempted to highlight transition as a vital procedure of paediatric HIV 
medicine.  Although it is not clear where transition begins and ends, it has been argued that 
transition plays the fundamental role of bridging two regimes of care, from paediatrics to 
adult HIV services.  Transition is enacted in the clinic to consolidate complex case histories 
between two services to ensure a ‘smooth’ handover and ensure services remain attuned to 
paediatric cohorts.  Paediatric medicine is influenced by associations that emphasis 
childhood as a time when patients are deemed vulnerable and naive and therefore 
incapable of taking on the requirements of medicine, such as regularly taking antiretrovirals, 
arriving for appointments at the anointed time or comprehending and enacting effectively 
the advice of doctors.  In contrast, HIV patients in adult services are required to be 
responsible for their care and must be sexually aware.  Once patients become ‘sexually 
active’ they are at risk of causing an offence if their actions can be seen as ‘reckless 
endangerment’ in the eyes of the law (Christianson et al., 2008).  This complexity is felt 
acutely by clinical services.  In comparison to other STS accounts that emphasise complexity 
in medicine, for example Mol (2002), or Mol and Law (2004), the account offered here 
demonstrates the attentiveness of practitioners to consolidate adolescent complexity to 
medical services.  In these STS accounts, emotive, moral or vulnerable objects are not 
specifically represented.  Within paediatric HIV it is imposible to overlook the ways in which 
practitioners must purposefully be attentive to moralistic adolescent complexities of 
vulnerability, and stigma, actively consolidating them into medicine.  Transition is enacted 
to offer a bridge between the two temporal stages of adolescence and adulthood in the 
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medicine.  In doing so however, the transitionary period forms a part of the medicine that 
takes on board adolescent-specific considerations.  It opens itself to questions that 
adolescents may have about relationships, sex, drugs, alcohol, friendships and socialising.  
Whether it does so convincingly is open to debate, but the medicine formally invites 
consultants to become aware and ask questions about adolescents’ attitudes relating to 
their condition.  Rather than being wholly defined by these questions however, transition 
remains tailored towards ensuring the continuation of viral suppression with regimes of 
antiretroviral medicine.  If transition was set up as dedicated to predefined adolescent 
problems it would not be as effective.  It is precisely the adaptability and openness of the 
procedure of transition in clinical practice and the negotiation of protocol to balance 
adolescent attitudes with drug requirements that ensures the medicine’s effectiveness.  This 
point of view lends itself to an STS discussion around becoming.  Transition functions 
through its ability to assemble medicine between paediatrics and ideas of responsibility that 
come from adult medicine, as well as making it possible to address age related specificities.  
This renders transition not as a clinical procedure built solely around a stage of 
development, but a period of absolving the healthcare of the past in preparation for the 
responsibility of future care.  Imagining transition in this way highlights how the upkeep of a 
specialised paediatric HIV service and the consolidation of children into adult HIV medicine 
is made possible.  However, to this sense of managing the future (in contrast to STS 
accounts of complexity in medicine such as Mol 2002; Mol and Law 2004) paediatric HIV 
also brings with it an immediate set of dangers that could occur in the case of clinical 
mismanagement. 
 
This example of the need to make multiplicity compatible can be seen through the examples 
given of passing on problems, letting go of relationships and aging populations.  ‘Passing on 
problems’ demonstrated that transition must be formulated to remain flexible enough to be 
applicable to both straight-forwards and more complex cases.  It was shown to be important 
that transition should be designed to facilitate the possibility of collating cases even if this 
collation often breaks down.  The section on letting go of relationships highlighted that 
there exists formal traditions within the medicine that inform the negotiation practitioners 
and patients must have when changing care.  Therefore, it clarifies that the procedure of 
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transition is not solely set up in relation to age and adolescence, but is better seen as a force 
that colludes together several already highly developed regimes of care in order to allay the 
real danger of adolescents failing to uphold adherence.  Finally, the consideration that the 
paediatric HIV population is aging emphasises that transition needs to be systematically 
formalised around the needs of the patient cohort.  Throughout this chapter therefore, I 
have argued that transition is being systematically designed and executed to address the 
needs of patients and ensure that patients continue to stick to requirements, but it is done 
so by promoting flexibility in care.  In this sense it remains balanced between paediatrics, 
adult responsibilities and adolescent specificities.    Therefore, transition can’t be placed in 
either paediatric or adult services but is made necessary between the need to specialise 
care to each service to ensure that both paediatric and adult services can continue to attune 
their services to complex needs of their cohorts.  As a result, this account of transition 
contributes to STS views of multiplicity, such as Mol (2002) and Mol and Law (2004), by 
demonstrating the importance employed by services to consolidate complexity. 
 
Compared to the previous chapters, transition fits alongside the thesis by elaborating on 
aspects of practice and protocol that consolidate care and ensure that practice is attuned to 
the paediatric cohort.  As a procedure, transition can be seen to manage different services 
within medicine and inform practitioners and patients on their roles and responsibilities. 
The clinic is highlighted as a key site where complexity (often contradictory and presenting a 
real danger in the case of mismanagement) is consolidated into functional medicine.  
Transition forms the final empirical examination detailed in this project and aptly, is the 
impetus that sees individuals leaving paediatrics.  The final chapter will conclude and 
summarise together the combination of procedures described throughout these chapters. 
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9 Conclusion: medical procedures in practice, the consolidation 
of medicine, science and ‘society’ into the clinical practice of 
paediatric HIV. 
 
The research chapters of this thesis have attempted to highlight that within the clinical 
management of paediatric HIV medicine there lies a clinical logic114 produced and followed 
by patients, practitioners and protocol, configured around the procedures of disclosure, 
adherence, chronic illness and transition115.  Or to be more precise, each of these 
procedures is one procedure amongst many designed and performed to work within many 
possible care scenarios, (albeit that from situation to situation they will differ in importance, 
maintenance and conceptual weight).  The administration of medicine and the consequent 
suppression of HIV through antiretroviral medicine have been shown as enacted and made 
possible through the negotiations of patients, practitioners and protocol in the clinic (Callon 
and Rabeharisoa, 2004, 2003).  Therefore, what is significant in the model of practice 
demonstrated is that firstly, the equation that protocol dictates practice is displaced, and 
secondly that the clinic is a key site in consolidating complexity through the enaction of 
                                                        
114 The use of the word ‘logic’ wishes to imply that there is a recurrent deliberation in the clinic about how 
these procedures are designed, exercised and can be employed to work together towards a common goal of 
managing HIV care and virus suppression with antiretroviral drugs (these issues are relevant to STS as applied 
to organizational studies Czarniawska and Hernes, 2005; Jones and Munro, 2005; Whittle and Spicer, 2008; 
Woolgar et al., 2009). 
115 If I refer to a ‘procedure’ or ‘these procedures’ further into this text, it is in reference to the chapter 
headings of disclosure, adherence, chronic illness and transition.  It is not to say that these are the only 
medical procedures at work in paediatric HIV, or that we can so easily define the boundaries of these concepts 
as procedures, but I am using the word procedure here to imply that these concepts are stabilised and 
formalised to achieve a certain purpose in the medicine.  
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these procedures to make functional antiretroviral medicine possible.  The contribution of 
this account is that alongside STS and SoC such as Mol (2002) or Mol and Law (2004), the 
requirement to consolidate cultural complexity is highly pressing and managed with a high 
level of clinical attentiveness in comparison to other conditions, such as atherosclerosis or 
hypoglycaemia.  This management takes place through the procedures described. 
 
As paediatric HIV requires an acute culture awareness, throughout the thesis I have 
presented the notion of consolidation as a supplement to the ideas of multiplicity and 
enaction in Mol (2002) or Mol and Law (2004).  Consolidation describes the aim of 
practitioners to take on the complex or diverse situations presented by patients in the clinic 
and incorporate them into a general medical framework.  In the case of clinical enactions 
around paediatric HIV, the clinic must work to make possible the suppression of HIV using 
anti-retroviral therapy.  This means that practitioners must consolidate outlying cultural or 
incompatible medical elements into the overall task of viral suppression.  I have used the 
concept of consolidation to describe the purposeful actions of practitioners to bring 
together incompatible medical and cultural objects.  The existing literature on enaction 
overlooks notions of vulnerability and stigma, consolidation attempts to account for how 
practitioners incorporate much larger, much more hidden associations of stigma and 
vulnerability into a functioning clinic or strict antiretroviral regime.  Consolidation therefore, 
is used as a way to conceptualise the cultural and ethical implications encountered in the 
clinic that an idea of enaction cannot attain with a strict focus on objects and actors.   
 
I am not suggesting that the procedures or the vulnerabilities described pre-emanate the 
situations they are found in, or are essentially unchanged from one clinical scenario to 
another. Rather, that through the formalisation of these procedures into guidelines and 
protocols, and the fastidious application and reapplication of each procedure, in the clinic, 
they can be found to guide, consolidate and unify care.  Therefore, if each procedure of 
disclosure, adherence, chronic illness and transition could be described separately as 
technologies applied at relevant moments in the clinic, they also form a logic together that 
works toward a common goal in the management of care (Berg, 1997a; Latimer et al., 2006).  
Together these formalised procedures coalesce as an assemblage to serve a number of 
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functions to enable that many ‘outside’ cultural/everyday-life associations (such as stigma, 
vulnerability and naivety) remain compatible with the task of virus suppression with 
antiretroviral medicine.  For example, these procedures bring patients into knowledge, 
sustain a shared knowledge between patients and professionals, give guidance to each party 
on how to proceed, consolidate care regimes, unify medical science with practice, make 
compatible/integrate care requirements alongside many other outside associations, and 
most importantly make viral suppression possible and ensure suppressions compatibility 
with wider medical and patient networks.  To simplify and stress the sociological aspect, all 
of the discussed procedures do the task in the clinic of consolidating complexity into 
medicine by offering each relevant party involved in HIV care with a way to proceed, and 
sets out a list of responsibilities that each group is tasked with upholding towards the goal 
of viral suppression.  I do not wish to suggest that this list of functions is exhaustive, or to 
even say it is necessarily coherent and non-contradictory.  The use of each of the 
procedures separately or in combination opens up a range of possibilities for managing care 
regimes and populations, whilst ensuring that viral suppression is to be dynamically worked 
towards.  What is emphasised in contrast to object politics is not the simultaneous enaction 
of actors across multiple sites, but the sustained consolidation of possible complexities 
(often contradictory and dangerous if mismanaged) through procedures performed in the 
clinic (see the section of the literature review on object politics de Laet and Mol, 2000; Law 
and Singleton, 2000; Mol, 2002; Mol and Law, 2004).  Each group involved must interpret, 
perform and maintain these procedures in order to make them functional, and so are 
dependent upon the scenario they are enacted within.   The integrity and therefore purpose 
of the procedure changes in accordance to the clinical encounter and interpretation of 
protocol. 
 
Accordingly, each procedure can be seen to combine and overlap in various ways.  
Disclosure brings child patients into knowledge of their HIV.  The clinic begins to deal with 
patients from the assumption that they are in a state of innocence and need to be brought 
into knowledge of their HIV, and encouraged to take on responsibility for its management.  
The formalisation of this goal is done in the clinic and across protocol in the procedure of 
disclosure.  Disclosure brings patients and professionals together with the aim of creating a 
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shared knowledge that lays out each party’s responsibilities.  Professionals must facilitate 
and build a common knowledge with patients, and patients must endeavour to internalise 
and comprehend what is required of them from the medicine (Committee on Pediatric AIDS, 
1999b).  According to this feature therefore, disclosure can be seen to unify and consolidate 
the medicine between the different groups necessary, from the knowledge that is discussed 
within the medical science around antiretroviral drugs, through the guidelines surrounding 
medical practice and to the knowledge prominent amongst children.  Disclosure makes an 
attempt to unify all three branches with a common knowledge.  At disclosure’s boundaries, 
it comes into contact and links with the other procedures outlined in the logic introduced at 
the start of this conclusion.  Within the attempt to disclose and introduce children into 
knowledge about their HIV, adherence is heavily stressed (Santamaria et al., 2011).  Within 
the first sessions of disclosure, children are educated using age specific explanations about 
how antiretroviral medicine interacts with HIV and the immune-system.  This installs 
comprehension amongst children from a young and impressionable age that it is of the 
utmost importance to adhere to their medicine.  Furthermore, professionals anticipate that 
this knowledge that disclosure installs will be built upon and result in children becoming 
responsible and diligent adults.  Therefore, disclosure is relevant to both how HIV is 
perceived as a chronic illness and the later aims of transition, doing the utmost to 
commence a smooth and integrated style of care management.   
 
Adherence does the job of communicating the absolute importance of following drug 
requirements as close to 100% as possible.  Child patients, professionals and guidelines are 
coordinated through negotiations of adherence in the clinic which formulate the specific 
tasks and responsibilities each individual must uphold.  Adherence persuades children and 
parents to take medicine with the promise of the virus remaining dormant and otherwise 
‘invisible’ (Gibb et al., 2003).  To practitioners, formalised adherence allows them to make 
very clear demonstrations on what must be done to explain to patients the consequences of 
not adhering, to make assessments as to whether requirements have been met and, if 
necessary, offer possible solutions and recommendations to ensure the smooth 
continuation of care (this could be associated with the notion of shared knowledge in 
disclosure from chapter 4).  To biomedicine, adherence offers an absolute measure of 
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requirements and allows the biochemist the opportunity of stating what dose of which 
isolated chemical will suppress the virus or not.  Over all of these versions and purposes of 
adherence the overall justification presented to each party becomes the continued 
possibility of virus suppression and the avoidance of resistance (Merzel et al., 2008).  
Therefore, the accounts of adherence demonstrated in this thesis are not entirely coherent 
amongst different branches of medicine and patients, but it is possible to see the clear link 
between how these versions of adherence are coordinated between each other.  Adherence 
unifies children, HIV, practice, guidelines and antiretroviral medicine in the task of viral 
suppression.  Adherence is also one and the same time at the heart of all the other 
procedures described here.  In the performance of disclosure, adherence is often the 
underlying or embedded message that allows practitioners to make claims about the 
promise of care, and for patients to have faith that their HIV will be managed in a chronic 
state into the future.  It is also the pressing concern during transition to make the passing 
over of services, medical records, antiretroviral history and management of adolescence to 
have as little consequence as possible on a patient’s continued adherence to antiretroviral 
medicine.  Therefore, compared to the other procedures in this logic adherence is non-
negotiable.  In relation to disclosure and transition the application of adherence and 
stipulation for patients to adhere is usually the primary requirement. 
 
Placing chronic illness alongside these other well-documented procedures may make it 
seem like the odd one out compared to the other three described, as it is not clearly defined 
as a procedure or distinct in protocol.  However, from the evidence presented in chapter 7, 
chronic illness clearly lines up in the clinical management of paediatric HIV and has clear 
applications in the clinic in similar ways to disclosure, adherence and transition.  In the 
practice of HIV care and in the literature, one bold statement often comes up over and 
again, that ‘HIV can now be thought of as a chronic illness’ (CHIVA, 2011a).  Therefore, in the 
clinical management of paediatric HIV, chronic illness has a definition, a set of connotations 
and as I have argued, a usage and purpose that becomes apparent through the process of 
describing HIV as chronic to children routinely over similar contexts – as would a procedure.  
Following through these uses of chronic illness highlights it as being relayed to patients by 
inviting them to place their faith in the medicine to keep HIV invisible over their entire life 
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course, unlimited by HIV.  For practitioners, the use of chronic illness as a procedure serves 
a further purpose to enable them to take on large scale views of the medicine and allow 
practitioners to organise care and resources into projected futures.  It is in this way that the 
role that chronic illness plays in consolidating and organising medicine together now and 
into the future can be seen (also see Williams, 1984).  Chronic illness allows practitioners 
and patients to imagine a future where ‘normal’ life is possible and only slightly affected by 
medicine, and allows practitioners to imagine potential pitfalls and solutions before they 
arise.  From this point of view chronic illness can be aligned within the demonstrated clinical 
logic of HIV care.  Chronic illness puts into perspective the task of adherence and reinstates 
why it is of the utmost importance to ensure that antiretrovirals are followed 100% (also 
without this perspective adherence would possibly seem unassailably grim to patients).  In 
addition, the task of disclosure is altered through considerations of chronic illness towards 
the deliberation that knowledge must be installed correctly to children and built upon over 
their entire life time.  Moreover, within transition, chronic illness is present when imagining 
the past, present and future of a case and how it must be subsequently managed effectively 
in order to make patients responsible adults capable of managing their own care 
requirements.  Therefore, from this view the unifying and consolidating obligation that the 
implementation of chronic illness has on paediatric HIV cannot be understated.   
 
Finally in terms of the procedures outlined in this thesis, transition aims to bring together 
paediatric HIV services with general adult HIV services and so complete the patients’ time as 
a ‘child’ and hand over a responsible, knowledgeable and diligent self-adhering adult (Fair et 
al., 2011).  This is not always as straightforward as it seems however, as concepts of 
childhood and development concealed in the medicine do not always meet with the actual 
case at hand in the clinic.  Transition is formalised in protocol and practice to resolve 
incompatibilities between services, and does so by treading the line between childhood, 
adulthood and adolescence.  Transition in this context has two purposes: firstly to make 
adolescent patients take on a more individual and responsible approach to their own 
healthcare, and secondly to make sure that practitioners over the two services are aligned 
and coordinated to tailor care to individuals and ensure that care is continued seamlessly 
(Viner, 1999).  Between these two bodies of medicine however, the adolescent patient has 
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their own specific requirements that are important to acknowledge and manage within 
transition.   Therefore, as with the other procedures, transition plays a vital part in 
consolidating medicine and allowing paediatrics to maintain its specialism towards children 
whilst keeping antiretroviral regimes operational and adhered to (White et al., 2012).  
Transition combines with the procedure of disclosure by converting the knowledge 
imparted to children at a young age to that required by a responsible, antiretroviral-
adhering adult.  Transition also ensures that adherence is still the inalienable goal that will 
be followed and upheld during the change of services.  It allows a smooth continuous 
management of care that will be made available to chronic illness to provide an overview 
between practitioner and patient as to how care will unfold once they are in, and continue 
to receive adult care throughout their life time.  
 
When assembled together, the procedures described in each chapter combine and overlap 
together in the practice and protocol of HIV medicine.  The importance of this clinical logic 
to make medical requirements compatible with patient complexity is exemplified by the 
cultural sensitivity required in paediatric HIV.  Through the presentation of research data it 
can be reasoned that there is a clinical logic guiding the formalised procedures at work in 
paediatric HIV medicine that shapes the administration of care.  The descriptions above of 
procedures of consolidation and unification are not fixed however, but dynamic and also 
have the potential to breakdown.  If each of the procedures of care are to be maintained, 
they must be reinstated over and again in the clinic, in protocol, over the 
hospital/laboratory and in the patients’ homes (Latour, 1987).  This gives these entities the 
possibility to be superseded, ignored or forgotten.  It is precisely the task of those engaging 
in medicine to reinstate the dynamics of care over and again and formalise them into a 
regulated and stable protocol and practice.  I argue that this is done in part through the 
procedures in the clinic that I have detailed above.  I do not wish to argue that there is a set 
way in which these procedures must work or that the way in which these procedures are 
practiced must always follow a set pattern.  The attentiveness required in the clinic for 
paediatric HIV highlights that it is precisely the strength of these procedures that they are 
adaptable, interpreted and applicable in multiple ways that ensure their effectiveness, 
usefulness and relevance.  Entities can be combined together in ways unforeseen, and even 
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contradictory to the encounters described above in the ultimate pursuit of caring for those 
with HIV and viral suppression.  The account given here is one that aims to demonstrate the 
dynamics that were observed and were deemed to be repetitively practiced and necessary 
to maintain and consolidate medicine and patients into paediatric HIV care practices 
(Dodier, 1998; Latimer et al., 2006; Timmermans S and Buchbinder M, 2010, 2012). 
 
If, as stated earlier, these procedures work as part of a logic that must be constantly re-
applied in a constructive and effective way to a range of adverse situations, paediatric HIV 
highlights the strength of the approach adopted at the clinic in practice and over the 
negotiations of protocol.  It also reveals the ‘clinic’ and ‘consultation’ as prime technologies 
(especially in reference to the object politics/turn to enaction detailed in the literature 
review).  What has often remained implicit throughout these chapters is that it is in the 
consultation room that the procedures of disclosure, adherence, chronic illness and 
transition intersect.  The clinic becomes the crucible where all activities are mutually forged 
and centralised: through the organisation of patients attending at regular intervals, the 
routine taking of blood tests, administration of antiretrovirals/blood tests, routine 
measurements of development, discussions with patients, discussions amongst 
professionals, negotiations of protocol, even as the base for the CNS to carry out her 
community work.  The list could go on as the clinic has no fully defined inventory of what its 
responsibilities are, it is open to the possibilities of what will be required for ongoing care 
(also see Dodier, 1998).  I began this thesis with an analogy of how the space of the clinic 
necessarily moulds itself around circumstance.  In the case of paediatric HIV, this process of 
‘moulding’ seems especially exemplified.  Symbolically, the research took place at a time 
when the old ward at UOUH was being demolished and the clinic was being relocated in a 
new building.  The space of the clinic in the context of paediatric HIV is difficult to define, it 
is an ongoing process of consolidation and unification between disparate corporealities116.  
Within the clinic, the encounters and categorisations of paediatric HIV necessitates the 
formalisation of procedures such as disclosure, adherence, chronic illness and transition into 
                                                        
116
 Mol (2002) would use the word ontologies (in the plural), the term corporealities is useful here however as 
it offers an interesting contrast between spirituality, essence or immateriality.  We could argue that the clinic 
is in the process of making that which is spiritual, essential or immaterial into something tangible to which 
scientific medicine can be applied to. 
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protocol.  These formal procedures become developed and enacted through the 
presentation of patients over regular periods and the desire of professionals to standardise 
care to ensure maximum effectiveness.  It is within the clinic and through regular 
consultations that the need for these procedures becomes salient.  The formalisation of 
procedure can be rooted in practice and the continued relevance, applicability and 
unification of procedures that go towards maintaining ‘useful’ and ‘functional’ medicine 
(Berg, 1997a, 1997b; Timmermans and Berg, 1997, 2003). 
 
By continuing to look retrospectively at research data, the medical forums such as CHIVA 
and PENTA can also hold their own versions of the procedures described here that are 
negotiated in the clinic.  Through these forums an agency is formed and mutually 
constituted between what goes on at the clinic, and the impact that the recommendations, 
guidelines and protocol that these forums present to practice.  Over these forums the clinic 
is brought into dialogue with other clinics and with the laboratory.  Therefore, guidelines do 
not dictate practice.  The clinic and the forum also overlap and must be maintained side by 
side in the formalisation and consolidation of care practices.   Patients are not isolated from 
these discussions or practices, they actively participate in clinical practice and inform the 
formalisation of procedure into protocol.  As stated above the negotiation between the 
clinic, the forum and formalised procedure is directly linked to the effectiveness of the 
ensuing procedures described in this thesis.  The interaction between patients, the clinical 
management of paediatric HIV and what goes on within these paediatric HIV forums 
ensures that care regimes and formalised procedures can be maintained as functional 
networks (to use the terminology of ANT, Latour, 1987). 
 
The use of STS combined with the clinical context presented, has perpetuated a central 
question throughout the thesis around how medical science is made compatible with the 
complex populations of children presented in practice.  Stengers (2003, also see 2010, 2000) 
argues that the formation of medical science in the clinic must operate around the suffering 
body of the patient which is not able to give a reliable testimony in comparison to the 
objects under investigation in the natural sciences.  Stengers (2003) contends that this 
results in the recurrent question of whether or not medical practitioners are treading the 
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line of the scientist or the charlatan.  Stengers’ analogy is useful to highlight the question of 
how clinical practices are ordered to negotiate the requirements of antiretroviral medicine 
with patient complexities as chaotic as those in paediatric HIV (or as poison or remedy as 
she terms it in relation to Plato’s pharmakon Stengers, 2010).  To Stengers’ (2003) account, 
the question could be posed of how does one make the body of a child provide objective 
medical testimony.  Especially in the context as has been described here of vulnerability, 
innocence, naivety, ethnicity, stigma and inner city life.  This has been of high concern to the 
research chapters.  Analysis can begin to contemplate the procedures and ‘logic’ described 
above for their ability to render objects compatible with scientific method.  Disclosure 
makes bodies aware of knowledge and behaviour that will allow patients to partake in care.  
Adherence makes bodies conform to medical regimes.  Chronic illness makes bodies 
contextualise and install faith in medical science.  Transition makes bodies responsible for 
their own care.   These attempts to render children as scientifically observable should not be 
read as a forceful imposition of power and knowledge on to child bodies but a relationship 
that is fostered and developed together with the aid of patients, practitioners, protocol and 
the laboratory.  I would like to add a note of caution however with the interpretation of the 
rendering of children as scientific testifiers. From the consultations I observed, in many 
situations in the clinic, practitioners in one way or another, were only too are aware of the 
contingency of procedures, and I hope this is obvious when reading my presentation of 
disclosure, adherence or transition.  It is of the utmost importance to clinical staff and the 
writers of protocols to make these formalised procedures as flexible and applicable to 
patients (in this case the lives of inner city children and adolescents) as possible.  Even if 
adherence, for example, is ultimately non-negotiable, if it is to be successful in a condition 
as complex as paediatric HIV, practitioners must go beyond questions of scientific method in 
the clinical practice of medicine.  Scientific method must be made applicable to patients’ 
lives.  The clinic is the key site where complexity must be consolidated and regimes made 
compatible.  Therefore, as has been demonstrated in research chapters, disclosure, 
adherence and transition must be set up to make the science of antiretroviral medicine 
flexible and malleable to patients’ lives.  Through concepts such as ‘good care’, the overall 
case outcome, the wishes of patients and ‘quality of life’ become clinical aims that 
supersede the priorities of pure scientific method.  Therefore, these questions and 
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considerations of rendering bodies as scientifically observable are never isolated from 
clinical practice and good care (Mol, 2008). 
 
In accordance with the sensitive matter of research, this thesis has chosen to allay a 
representation of power as imposed from an imagined scientific hierarchy, to the clinic, 
then onto patients, in favour of focusing upon the ways in which the agency of all clinical 
actors have the ability to enact an influence multi-directionally, mutually and 
contradictorily.    In STS this argument is implied in the conception of enactment.  According 
to enactment power does not exist ulterior to a clinical negotiation, but must be enacted 
and re-enacted each time authority is implied.  This means that clinical authority must be 
successively re-negotiated in the clinic between patients, practitioners and all other 
intervening agents.  Even if this thesis has argued that enaction doesn’t capture fully the 
vulnerability and stigma associated with the condition, it exposes the vulnerability and 
stigma of patients as having an influence on the ways in which paediatric HIV medicine must 
be practiced.  For example, when a child patient is being practiced upon in the clinic, the 
agency of the child has an implication for the ways in which medicine must be practiced 
upon the child and the responsibilities that the practitioner must uphold in the consultation 
room.  This diversifies the ways in which power is viewed and prohibits a simplified model of 
power as exercised from medical authority down to patients.   
 
Throughout this thesis, analysis has used STS to present antagonisms between scientific 
method, clinical practice/protocol of paediatric HIV and the child patient.  In the process, 
the incompatibilities of STS with paediatric HIV and the differing significances that the 
change of focus to paediatric HIV brings about have also been highlighted (see the literature 
review, especially 'object politics' Mol and Law, 2004).  For example, the idea of ‘translation’ 
or ‘enaction’ is complicated by the breadth and immediacy of associations that the child 
cohort presents in the clinic at UOUH.  Associations presented included childhood, 
adolescence, immigration, stigma, sex, public health, confidentiality, mortality, innocence, 
vulnerability, naivety and lack of competence (Christensen, 1998; Cohen et al., 1999).  These 
associations emphasise the clinic as a key site to consolidate medical and cultural 
complexity over other STS accounts of disease and the clinic such as hypoglycaemia and 
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atherosclerosis.  This is in contrast to STS accounts such as Mol (2002) and Mol and Law 
(2004) which focus on dispersal of disease across multiple enactions and localities.  The 
clinical encounters of paediatric HIV highlight the need for practice to develop specialised 
and attuned attention that remains flexible and adaptable to diverse individual cases.  
Paediatric HIV also highlights the immediate need for the employment of a logic at the clinic 
that manages patient complexity with medical requirement in order to ensure that 
suppression is successful.  Therefore, compared to Mol’s (2002) account of clinic practice 
where the focus is on how multiple versions of the disease and medicine are momentarily 
‘tamed’ this thesis emphasises the sustained consolidation of a much wider notion of 
cultural, patient and medical complexity into clinical practice.  Although the enactions taking 
place during practice can be seen to refer to wider associations beyond the clinic, what is 
emphasised is the cultural awareness required by the clinic to consolidate complexity into 
functional medicine.  In a similar way, the notion of time or sequential ordering confuses 
translation/enaction in considerations of chronic illness.  Translation over the life-span of an 
individual requires a consolidation and coordination of factors that must be done in 
accordance to a desired outcome in the future, relevant to a course of action in the present 
that will ensure that the virus is suppressed and other intervening factors in the case remain 
possible to manage.  Life-course brings into question humanity, essentiality and the 
meaning of life.  When engaging in practice, practitioners must act with the proviso that 
what is decided will make ongoing clinical management possible in the future.  It points 
again to the attentiveness employed by the clinic to consolidate future and present 
complexities to the task of virus suppression.  Neither of these considerations about the 
child or life-span fully negates the concept of translation but offer points with which to think 
more specifically about how it relates to the underlying context of paediatric HIV and 
sensitive care management. 
 
Within STS or ANT there is a concerted attempt to systematically evade providing a 
normative statement.  Any normative statement dealt with in STS is usually explained in 
terms of the statement’s association to the assemblage it is enacted into (Law, 2004b).  
However, associations collated under paediatric HIV are so ethically charged and seen as 
stigmatised or vulnerable that it is difficult to imagining them only through the associations 
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found in the paediatric clinic.  The subject of paediatric HIV used in this thesis contributes to 
ANT and STS through its focus on these sensitive and potentially sensationalistic 
associations.   The stigma and vulnerability associated with paediatric HIV serves as an 
impetus in the clinic for action but their value cannot be fully explained in terms of an 
‘enacted object’ and cannot be followed as other objects are followed.    Clinical enactions 
of paediatric HIV seem to point to further forces that out lie any imprint of that which is 
enacted.  With paediatric HIV there exists an ethical and normative value that is beyond 
rationalisation with ANT/STS.  This thesis has made its contribution to these highly present 
ethical/moral issues, not by attempting to resolve them, but through pointing to their 
existence and the ways in which they must be confronted and consolidated by HIV services. 
 
The resulting argument of this thesis is significant to social theory and for those who make 
policy or maintain practice.  The contribution it provides demonstrates how paediatric HIV 
relates to the populations that develop, perpetuate and maintain care.  In the face of the 
seeming overwhelming complexity of paediatric HIV, this thesis highlights the importance of 
a flexible approach in practice and the need for a high regard of clinical practice in the policy 
making processes.  It is hoped that the discussions found here emphasise to potential 
readers (possibly practitioners and patients) the importance of finding common ground, 
negotiation, flexibility and compatibility in the way those involved with the condition 
interact and partake in the medicine.  In comparison to the prevailing sociological literature 
on medicine, there is a rejection in this thesis of the idea that medicine takes a solitary role 
in defining ‘normality’ and imposing it onto patients with a requisite power structure.  These 
power structures seem to be a central assertion of Foucault through to social 
constructionism.  Although analyses of this kind have played a central role in developing 
thinking around clinical practice and biomedicine in balancing out and questioning the 
morality of practice, I believe that the time has possibly come to readdress that balance.  
Therefore, the focus of this thesis has been on clinical negotiation and the multi-
directionality of power when interpreting of medical doctrine.   Through the use of ANT it 
has been possible to offer a basis to readdress clinical practice and protocol.  However, 
paediatric HIV, practice and protocol are too complex and sensitive to be simply described 
as ‘enacted’.  It also becomes important to ask what formalised enactions of practice such 
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as disclosure and adherence are encompassing moralistically in terms of vulnerability and 
stigma.  The central strand of this thesis therefore, is not to primarily approach paediatric 
HIV care from the view that it must be managed, but rather that it must be made possible 
through consolidation, highlighting the importance of participation and the ways that 
practice and protocol is negotiated between clinical, medical and patient encounters.   
 
Therefore, this thesis and the notion of consolidation will be useful to readers looking to 
develop an account of vulnerability, stigma and ethically sensitive topics using STS and ANT.  
In foresight, this project has hopefully contributed to the objective of promoting a more 
nuanced approach, the key role of the clinic and the indispensability of what happens there 
to those who must think regularly about the relationship between medicine, society and 
complex entities such as childhood and HIV. 
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Information sheet for adolescent 
participants (ages 11 – 18) 
Title of Project: Children living with HIV  
Contact: Richard Boulton, PhD student at Goldsmiths University of London 
Email: Removed Tel: Removed 
Opening statement: I want to tell you about a research study I am doing.  A 
research study is a special way to find out about something.  I am trying to find 
out more about how young people with HIV live their lives when taking 
medication going to the doctor a lot.  I would like you to tell me how you live 
your life and what is important to you.  If you talk to me, I can understand 
better how you live your life with the medicines you take and the care you 
receive.  
Why am I being asked to take part?  I am asking you to take part because 
you are a young person living with HIV.  There isn’t much information about 
children who have HIV, so the information you choose to give to me will be very 
useful. Your doctor passed you on to me but I haven’t read anything about you 
that your doctor or the nurses have previously written about you. 
What will I be required to do?  This is what will happen if you are in this 
study: I will sit in on some sessions that you have with the doctor, recording and 
taking notes on what happens but not saying anything.  Later on, I will also 
interview you and ask you some questions about yourself.  It may sound a bit 
scary but it isn’t really, it will be more like a chat than anything else.  The 
questions I will ask you will be very simple and easy to answer.  It won’t be like a 
test more like a conversation, and you can choose not to answer any questions 
that you don’t want to.  Our conversation may last about 40 minutes, but you can 
stop at any time you want to.  I will also send a letter out to your GP to tell 
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them that you will be involved in this study, it will not affect the treatment you 
get in anyway, and your doctor won’t be able to see anything you say to me. 
Where will this take place?  All of this study will take place in the clinic at 
North Middlesex University Hospital.  
How often will I have to take part, and for how long?  I would like to sit in 
on around three of the meetings you have with your doctor, and have one 
interview with you of about 40 minutes.  All this will take place over the next 
year or so. 
When will I have the opportunity to discuss my participation?  Your parents 
or guardians have to say it’s OK for you to be in the study. After they decide, 
you get to choose if you want to do it too.  If you don’t want to be in the study, 
no one will be mad at you.  If you want to be in the study now and change your 
mind later, that’s OK. You can stop at any time.  My contact details are on this 
form in case you want to discuss anything about the study.  Once I have finished 
interviewing and sitting in on consultations and I have looked over all of the 
notes and recordings I have taken, a newsletter will be sent out to everyone who 
has participated in the study with the results of my work.  If you have any 
comments you would like to add or discuss, you will have the opportunity to do 
so.   
Who will be responsible for all of the information when this study is over?   
No one else will look at my notes or listen to the recordings of you.  I will store 
it on a secure  at university where nobody else will be able to look at them.  I 
will put things I learn about you together with things I learn about other teens, 
so no one can tell what things came from you.  When I tell other people about 
my research, I will not use your name, so no one can tell who I am talking about. 
What will happen to the information when this study is over?  Once the 
study is over, I will destroy all of the information that could identify you.  Any 
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information that I will keep will not have your name your address or anything 
else that will make it possible to see who you are. 
How will you use what you find out? The information that you give to me will 
be used to make a report, or a book, about young people living with HIV. 
How long is the whole study likely to last?   The study will last for about 3 
years  
What if I do not wish to take part? Participation is totally voluntary  
What if I change my mind during the study? You are free to withdraw from 
the study at anytime  
Do you have any other questions? The details of who to contact if you have 
any questions or concerns are on this sheet. 
Summary 
 I would like you to take part in some social research to understand better how 
you live your life. 
 You are being asked if I can sit in on 3 of your consultations, not saying 
anything. 
 I would like to interview you, which will be more like a chat with no right or 
wrong answers for about 40 minutes. 
 I will record what you say and take notes but the information you give to me will 
have your name taken off it so nobody can tell that it’s you. 
 Nobody else will hear the recording of what you say to me or the notes that I 
take. 
 I will write some articles with the things that you say to me, but no one will be 
able to tell if it’s you from anything I put down in an article. 
 You don’t have to say yes or answer any questions if you don’t want to.
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Information sheet for Parents of Children with HIV 
Title of Project: Children living with HIV  
Contact: Richard Boulton , PhD student at 
Goldsmiths University of London 
Email: Removed  Tel: Removed 
Opening statement: I am a Sociologist from Goldsmiths University, and I am conducting a study that 
aims to find out how young people with HIV carry out their lives whilst having to take medication or 
organise their time around going to appointments.  I would like your child to tell me how they live 
their life and what is important to them.  If either you or your child choose to talk to me, I will be 
able to understand more fully how your child lives their life alongside the medicine and care they 
receive.  The things that you and other families taking part will say to me will be used to make a 
book or an article.  This will help sociologists and the doctors who care for your child and other 
young people living with HIV to be more familiar with the issues they face.  
Why am I being asked to take part?  I am asking you and your child to take part because they are a 
young person living with HIV.  There isn’t much information that exists on illness and childhood or 
children and HIV, so by talking to me your child will help people to understand these subjects better.  
Your child’s doctor at North Middlesex has passed you on to me but I have not seen the medical 
records of either you or your child. 
What will I be required to do?  If you decide to take part in the study I will sit in on some sessions 
that you and your child have with the doctor, recording and taking notes on what happens but won’t 
say anything.   
If your child is older than 12 then I will ask if they would like to be interviewed in private, on 
questions about themselves, their HIV and their day-to-day life. Our conversation may last about 40 
minutes, but they can stop at any time that they want to. 
You, as a parent, will also be asked if you would like to be interviewed separately from your child, 
where you will be asked question about your child’s day-to-day life and problems they have.  This 
interview may last up to 30 mins.  You can choose not to answer any questions that you don’t want 
to.  This interview will be voluntary and you may choose not to take part even if your child does take 
part.   
Where will this take place?  All of this study will take place in the clinic at North Middlesex 
University Hospital.  
How often will I have to take part, and for how long?  I would like to sit in on the meetings you and 
your child have with your doctor, and if applicable, have one interview with your child of about 40 
minutes, and one with you lasting up to 30 mins.  All this will take place over the next year or so. 
When will I have the opportunity to discuss my participation?  If at any time during the study, you 
wish to pull out or choose not to take part in something you can do so, my contact details are on this 
form in case you want to discuss anything about the study.  Once I have finished interviewing and 
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sitting in on consultations and I have looked over all of the notes and recordings I have taken, a 
newsletter will be sent out to everyone who has participated in the study with the results of my 
work.  If you have any comments you would like to add or discuss, you will have the opportunity to 
do so.   
Who will be responsible for all of the information when this study is over?   No one else will look at 
my notes or listen to the recordings taken, your identities will remain confidential.  I will put data on 
a secure university hard drive where nobody else will be able to look at them.  If I use any of the 
notes or recordings in anything I write, I will make what you said anonymous.  This means that I will 
make sure that nobody will be able to know what you or your child said. 
What will happen to the information when this study is over?  Once the study is over, I will destroy 
all of the information that could identify you.  Any information that I will keep will not have your 
name your address or anything else that will make it possible to see who you are. 
How will you use what you find out? The information that is gathered will be used to compile a 
report on what is found, a group of articles and possibly a book.  
How long is the whole study likely to last?   The study will last for about 3 years  
What if I do not wish to take part? Participation is voluntary  
What if I change my mind during the study? You are free to withdraw from the study at anytime  
Do you have any other questions? The details of who to contact if you have any questions concerns 
are on this sheet. 
Summary 
 I would like your child to take part in some social research to understand the issues they 
face. 
 You are being asked if I can sit in on your consultations not saying anything. 
 I would like to interview you but more importantly, if applicable, your child, for about 40 
minutes. 
 I will record what you and your child says and take notes but the information you give to me 
will have your name taken off it so nobody can tell that it’s you. 
 Nobody else will hear the recording of what you say to me or the notes that I take. 
 I will write some articles with the things that you say to me, but no one will be able to tell if 
it’s you from anything I put down in an article. 
 You don’t have to say yes or answer any questions if you don’t want to. 
Appendix 1.3 
 
276 
 
ADOLECENT ASSENT FORM 
 
Full title of Project: Children Living with HIV: negotiating the everyday 
Principal Investigator: Richard Boulton, PhD student at Goldsmiths University of 
London 
Email: Removed Tel: Removed 
 
Agreement 
 
I have read and understood the information sheet.   
I have decided to be in the study even though I know that I don’t have to do it.   
Richard Boulton has answered all my questions.   
  
  
  
______________________________   ________________ 
Signature of Study Participant    Date 
 
______________________________   ________________ 
Signature of Researcher     Date 
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PARENT CONSENT FORM  
 
 
Full title of Project: Children Living with HIV: negotiating the everyday 
 
Principal Investigator: Richard Boulton, PhD student at Goldsmiths University of 
London 
 
Email: Removed Tel: Removed 
 
 
 Please initial box 
 
1. I confirm that I have read and understand the information 
sheet for the above study and have had the opportunity to 
ask questions. 
 
  
 
2. I understand that our participation is voluntary and that we  
 are free to withdraw at any time, without giving reason. 
 
 
3. I agree to take part in the above study, 
and allow my child to participate. 
 
 
  
 
 Please tick box 
 
   Yes            No 
   
 
4. I agree to the interview / consultation being audio 
recorded and to the use of anonymised quotes in 
publications  
 
   
6. I agree that my data gathered in this study may be stored 
(after it has been anonymised) on a universiy computer 
and may be used for future research. 
 
  
   
 
 
Name of Participant    Date    Signature 
 
 
 
Name of Researcher    Date    Signature 
 
 
 
 
 
 
 
 
